Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (72846)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2018 (publication date) through Mar 28, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol 2018; 24(43): 4846-4861 [PMID: 30487695 DOI: 10.3748/wjg.v24.i43.4846] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i43/4846.htm |
| Number | Citing Articles |
| 1 |
De Luo, Fei Kuang, Juan Du, Mengjia Zhou, Fangyi Peng, Yu Gan, Cheng Fang, Xiaoli Yang, Bo Li, Song Su. Characterization of the Immune Cell Infiltration Profile in Pancreatic Carcinoma to Aid in Immunotherapy. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.677609
|
| 2 |
Jong Ho Park, Mahsa Mortaja, Heehwa G. Son, Xutu Zhao, Lauren M. Sloat, Marjan Azin, Jun Wang, Michael R. Collier, Krishna S. Tummala, Anna Mandinova, Nabeel Bardeesy, Yevgeniy R. Semenov, Mari Mino-Kenudson, Shadmehr Demehri. Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-48441-8
|
| 3 |
Qian Zhang, Liping Lv, Ping Ma, Yangyang Zhang, Jiang Deng, Yanyu Zhang. Identification of an Autophagy-Related Pair Signature for Predicting Prognoses and Immune Activity in Pancreatic Adenocarcinoma. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.743938
|
| 4 |
Lina Elsalem, Ahmad A Jum'ah, Mahmoud A Alfaqih, Osama Aloudat. <p>The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives</p>. Clinical and Experimental Gastroenterology 2020; : 151 doi: 10.2147/CEG.S243337
|
| 5 |
Xi Ma, Yu-Rui Wang, Li-Yong Zhuo, Xiao-Ping Yin, Jia-Liang Ren, Cai-Ying Li, Li-Hong Xing, Tong-Tong Zheng. Retrospective Analysis of the Value of Enhanced CT Radiomics Analysis in the Differential Diagnosis Between Pancreatic Cancer and Chronic Pancreatitis. International Journal of General Medicine 2022; : 233 doi: 10.2147/IJGM.S337455
|
| 6 |
Hiroki Sato, Andrew Scott Liss, Yusuke Mizukami. Large-duct pattern invasive adenocarcinoma of the pancreas–a variant mimicking pancreatic cystic neoplasms: A minireview. World Journal of Gastroenterology 2021; 27(23): 3262-3278 doi: 10.3748/wjg.v27.i23.3262
|
| 7 |
Supriyo Chakraborty, Sunanda Paul, Durbba Nath, Yashmin Choudhury, Yeongseon Ahn, Yoon Shin Cho, Arif Uddin. Synonymous codon usage and context analysis of genes associated with pancreatic cancer. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2020; 821: 111719 doi: 10.1016/j.mrfmmm.2020.111719
|
| 8 |
|
| 9 |
María-Pilar Martínez-Moral, María Teresa Tena, Alfonso Martín-Carnicero, Alfredo Martínez. Highly sensitive serum volatolomic biomarkers for pancreatic cancer diagnosis. Clinica Chimica Acta 2024; 557: 117895 doi: 10.1016/j.cca.2024.117895
|
| 10 |
Risa Akahira, Koji Fukuda, Kazuhiro Shimazu, Taichi Yoshida, Daiki Taguchi, Hanae Shinozaki, Hiroshi Nanjyo, Hiroyuki Shibata. Clinical response of pancreatic cancer bearing a germline BRCA2 p.I3169M fs*48 variant for platinum-based drug and PARP inhibitor. Japanese Journal of Clinical Oncology 2024; 54(2): 201 doi: 10.1093/jjco/hyad157
|
| 11 |
Paola Cura Daball, Hanno Tröger, Severin Daum. Langzeitremission bei einem Patienten mit metastasiertem Adenokarzinom des Pankreas: Aktuelle Therapiemöglichkeiten und neue Therapiealgorithmen mit Hilfe des Molekularen Tumorboards
. Zeitschrift für Gastroenterologie 2022; 60(10): 1510 doi: 10.1055/a-1695-3528
|
| 12 |
Laudy Chehade, Charbel Elias, Deborah Mukherji, Sally Temraz, Ziad Salem, Maya Charafeddine, Monita Al Darazi, Ali Shamseddine. Maintenance chemotherapy in advanced and metastatic pancreatic cancer, a narrative review and case series. Asia-Pacific Journal of Clinical Oncology 2023; 19(4): 419 doi: 10.1111/ajco.13912
|
| 13 |
Moumita Mukherjee, Srikanta Goswami. Identification of Key Deregulated RNA-Binding Proteins in Pancreatic Cancer by Meta-Analysis and Prediction of Their Role as Modulators of Oncogenesis. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.713852
|
| 14 |
Madelaine Magalì Audero, Tiago Miguel Amaral Carvalho, Federico Alessandro Ruffinatti, Thorsten Loeck, Maya Yassine, Giorgia Chinigò, Antoine Folcher, Valerio Farfariello, Samuele Amadori, Chiara Vaghi, Albrecht Schwab, Stephan J. Reshkin, Rosa Angela Cardone, Natalia Prevarskaya, Alessandra Fiorio Pla. Acidic Growth Conditions Promote Epithelial-to-Mesenchymal Transition to Select More Aggressive PDAC Cell Phenotypes In Vitro. Cancers 2023; 15(9): 2572 doi: 10.3390/cancers15092572
|
| 15 |
Alessandro Paro, Djhenne Dalmacy, J. Madison Hyer, Aslam Ejaz, Jordan Cloyd, Mary Dillhoff, Allan Tsung, Diamantis I. Tsilimigras, Timothy M. Pawlik. Patterns of health care utilization among Medicare beneficiaries diagnosed with pancreatic adenocarcinoma. The American Journal of Surgery 2022; 223(3): 560 doi: 10.1016/j.amjsurg.2021.10.027
|
| 16 |
R. Sguinzi, F. Pugin, C. Bader, A. Meyer, L. Buhler, L. Widmer, D. Staudenmann, B. Egger, Neil Donald Merrett. Massive Haematochezia due to Splenic Artery Bleeding into the Colon: Unusual Manifestation of Advanced Pancreatic Cancer. Case Reports in Surgery 2023; 2023: 1 doi: 10.1155/2023/7443508
|
| 17 |
Eli P. Darnell, Thomas J. Wang, Melissa A. Lumish, Yasmin G. Hernandez-Barco, Maximilian Weniger, Brenna W. Casey, Motaz Qadan, Keith D. Lillemoe, Cristina R. Ferrone, C. Fernandez-Del Castillo, Kumar Krishnan. Preoperative cholangitis is an independent risk factor for mortality in patients after pancreatoduodenectomy for pancreatic cancer. The American Journal of Surgery 2021; 221(1): 134 doi: 10.1016/j.amjsurg.2020.07.025
|
| 18 |
Hyun-Jin Jang, Jae Ho Yang, Eunmi Hong, Eunbi Jo, Soon Lee, Sanghun Lee, Jong Soon Choi, Hwa Seung Yoo, Hyuno Kang. Chelidonine Induces Apoptosis via GADD45a-p53 Regulation in Human Pancreatic Cancer Cells. Integrative Cancer Therapies 2021; 20 doi: 10.1177/15347354211006191
|
| 19 |
Jorge A. Roacho-Pérez, Elsa N. Garza-Treviño, Paulina Delgado-Gonzalez, Zuca G-Buentello, Juan Luis Delgado-Gallegos, Christian Chapa-Gonzalez, Margarita Sánchez-Domínguez, Celia N. Sánchez-Domínguez, Jose Francisco Islas. Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in Therapy. Life 2021; 11(11): 1187 doi: 10.3390/life11111187
|
| 20 |
Jae Hee Lee, Chae Gyu Lee, Min Seo Kim, Seungyeob Kim, Myoung Song, Haohui Zhang, Eunbyeol Yang, Yoon Hee Kwon, Young Hoon Jung, Dong Yeol Hyeon, Yoon Ji Choi, Seyong Oh, Daniel J. Joe, Taek‐Soo Kim, Sanghun Jeon, Yonggang Huang, Tae‐Hyuk Kwon, Keon Jae Lee. Deeply Implantable, Shape‐Morphing, 3D MicroLEDs for Pancreatic Cancer Therapy. Advanced Materials 2024; doi: 10.1002/adma.202411494
|
| 21 |
Steffen M. Heckl, Franziska Mau, Anke Senftleben, Tina Daunke, Silje Beckinger, Samir Abdullazade, Stefan Schreiber, Christoph Röcken, Susanne Sebens, Heiner Schäfer. Programmed Death-Ligand 1 (PD-L1) Expression Is Induced by Insulin in Pancreatic Ductal Adenocarcinoma Cells Pointing to Its Role in Immune Checkpoint Control. Medical Sciences 2021; 9(3): 48 doi: 10.3390/medsci9030048
|
| 22 |
Genki Fukushima, Kodai Abe, Minoru Kitago, Eisuke Iwasaki, Aya Hirata, Ryo Takemura, Ryota Ishii, Hiroshi Yagi, Yuta Abe, Yasushi Hasegawa, Seiichiro Fukuhara, Shutaro Hori, Masayuki Tanaka, Yutaka Nakano, Takahiro Yokose, Gaku Shimane, Yuko Kitagawa. Association Between Clinical Backgrounds and Malignant Progression of Suspected Intraductal Papillary Mucinous Neoplasm. Pancreas 2022; 51(6): 617 doi: 10.1097/MPA.0000000000002064
|
| 23 |
Lu-Hong Wang, Yi Jiang, Chen-Hang Sun, Peng-Tao Chen, Yi-Nan Ding. Advancements in the application of ablative therapy and its combination with immunotherapy in anti-cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2025; 1880(2): 189285 doi: 10.1016/j.bbcan.2025.189285
|
| 24 |
Nawal Amhis, Julie Carignan, Lee-Hwa Tai. Transforming pancreaticobiliary cancer treatment: Exploring the frontiers of adoptive cell therapy and cancer vaccines. Molecular Therapy: Oncology 2024; 32(3): 200825 doi: 10.1016/j.omton.2024.200825
|
| 25 |
Salwa O. Mekki, Azza A. Zulfu, Abderrhaim Dabora, Waleed Elhaj, Salah Osman, Musaab Ahmed, Mohamed H. Ahmed. Histopathological Features of Whipple Pancreaticoduodenectomy in Sudan: A Single-center Experience. Sudan Journal of Medical Sciences 2022; 17(1): 39 doi: 10.18502/sjms.v17i1.10684
|
| 26 |
L. Tharrun Daniel Paul, Ganesh Munuswamy-Ramanujam, Rajappan Chandra Satish Kumar, Vasukidevi Ramachandran, Dhanavathy Gnanasampanthapandian, Kanagaraj Palaniyandi. Biomarkers in Cancer Detection and Monitoring of Therapeutics. 2024; : 121 doi: 10.1016/B978-0-323-95114-2.00025-X
|
| 27 |
Tia R. Tidwell, Gro Røsland, Karl Johan Tronstad, Kjetil Søreide, Hanne R. Hagland. Comparing in vitro cytotoxic drug sensitivity in colon and pancreatic cancer using 2D and 3D cell models: Contrasting viability and growth inhibition in clinically relevant dose and repeated drug cycles. Cancer Medicine 2024; 13(11) doi: 10.1002/cam4.7318
|
| 28 |
Ruben D. Houvast, Maurice van Duijvenvoorde, JiaXin Chua, Mireille Vankemmelbeke, Lindy G. Durrant, Akin Inderson, Jeanin E. van Hooft, J. Sven D. Mieog, Bert A. Bonsing, Cornelis F. M. Sier, A. Stijn L. P. Crobach, Alexander L. Vahrmeijer, Peter J. K. Kuppen. Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach. Molecular Diagnosis & Therapy 2023; 27(2): 261 doi: 10.1007/s40291-022-00635-w
|
| 29 |
Rohit Sarkar, Zhihong Xu, Chamini J. Perera, Minoti V. Apte. Emerging role of pancreatic stellate cell-derived extracellular vesicles in pancreatic cancer. Seminars in Cancer Biology 2023; 93: 114 doi: 10.1016/j.semcancer.2023.05.007
|
| 30 |
Tianchen Sheng, Bronson Dokmanovich, Yunpeng Yu, Chunliang Liu, Hao Fan, Anna E. Prizment, Kristin E. Anderson, Jianjun Zhang. Associations Between Intakes of Carotenoids and Tocopherols with Risk of Pancreatic Cancer in a Population-Based Case-Control Study. Journal of the American Nutrition Association 2025; 44(2): 128 doi: 10.1080/27697061.2024.2404578
|
| 31 |
Haibo Huo, Weiqi Jiang, Feifei Sun, Jian Li, Baojun Shi. Synthesis and biological evaluation of novel steroidal pyrazole amides as highly potent anticancer agents. Steroids 2021; 176: 108931 doi: 10.1016/j.steroids.2021.108931
|
| 32 |
Xing Wang, Yu-Qiang Shan, Qing-Quan Tan, Chun-Lu Tan, Hao Zhang, Jin-Heng Liu, Neng-Wen Ke, Yong-Hua Chen, Xu-Bao Liu. MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-1146-x
|
| 33 |
Dandan Luo, Xiaochun Xu, M. Zubair Iqbal, Qingwei Zhao, Ruibo Zhao, Jabeen Farheen, Quan Zhang, Peiliang Zhang, Xiangdong Kong. siRNA-Loaded Hydroxyapatite Nanoparticles for KRAS Gene Silencing in Anti-Pancreatic Cancer Therapy. Pharmaceutics 2021; 13(9): 1428 doi: 10.3390/pharmaceutics13091428
|
| 34 |
Shunxin Hao, Zhi Yao, Yifeng Liu. Hsa_circ_0000106 Acts as a Tumor Promoter in Pancreatic Cancer by
Targeting the MiR-455–3p/HDAC4. Hormone and Metabolic Research 2023; 55(10): 722 doi: 10.1055/a-2125-7018
|
| 35 |
Wenbo Zou, Dingguo Wu, Yunyang Wu, Kuiping Zhou, Yuanshu Lian, Gengyun Chang, Yuze Feng, Jifeng Liang, Gao Huang. Nomogram predicts risk of perineural invasion based on serum biomarkers for pancreatic cancer. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02819-y
|
| 36 |
Devashish Desai, Pushti Khandwala, Meghana Parsi, Rashmika Potdar. PARP inhibitors: shifting the paradigm in the treatment of pancreatic cancer. Medical Oncology 2021; 38(6) doi: 10.1007/s12032-021-01507-9
|
| 37 |
Janina Werner, Patrick Bernhard, Miguel Cosenza-Contreras, Niko Pinter, Matthias Fahrner, Prama Pallavi, Johannes Eberhard, Peter Bronsert, Felix Rückert, Oliver Schilling. Targeted and explorative profiling of kallikrein proteases and global proteome biology of pancreatic ductal adenocarcinoma, chronic pancreatitis, and normal pancreas highlights disease-specific proteome remodelling. Neoplasia 2023; 36: 100871 doi: 10.1016/j.neo.2022.100871
|
| 38 |
Jiujie Cui, Qihan Fu, Xiaobing Chen, Yanling Wang, Qi Li, Feng Wang, Zhihua Li, Guanghai Dai, Yusheng Wang, Hongmei Zhang, Houjie Liang, Jun Zhou, Liu Yang, Fenghua Wang, Leizhen Zheng, Xiaofeng Chen, Ping Gong, Jiang Liu, Ying Yuan, Lin Wang, Yuejuan Cheng, Jun Zhang, Yuhong Zhou, Weijian Guo, Xianbao Zhan, Zhengyun Zou, Da Li, Shan Zeng, Enxiao Li, Zhiwei Li, Zan Teng, Dan Cao, Jie Kan, Jianping Xiong, Ming Quan, Jiayu Yao, Haiyan Yang, Liwei Wang. The real-world study of the clinical characteristics, diagnosis, and treatment of advanced pancreatic cancer in China. Journal of Pancreatology 2024; 7(1): 1 doi: 10.1097/JP9.0000000000000155
|
| 39 |
Marios Efthymiou, Sujievvan Chandran, Leonardo Zorron Cheng Tao Pu, Allison Collins, Anton Rajadurai, Mehrdad Nikfarjam, Rhys Vaughan. Outcomes of endoscopic ultrasound as a one‐off pancreatic cancer screening tool for 122 high‐ and moderate‐risk patients. JGH Open 2020; 4(6): 1217 doi: 10.1002/jgh3.12432
|
| 40 |
Luca Digiacomo, Erica Quagliarini, Daniela Pozzi, Roberto Coppola, Giulio Caracciolo, Damiano Caputo. Stratifying Risk for Pancreatic Cancer by Multiplexed Blood Test. Cancers 2023; 15(11): 2983 doi: 10.3390/cancers15112983
|
| 41 |
Cai Lu, Lu Fan, Peng-Fei Zhang, Wei-Wei Tao, Cheng-Bin Yang, Er-Xin Shang, Fei-Yan Chen, Chun-Tao Che, Hai-Bo Cheng, Jin-Ao Duan, Ming Zhao. A novel P38α MAPK activator Bruceine A exhibits potent anti-pancreatic cancer activity. Computational and Structural Biotechnology Journal 2021; 19: 3437 doi: 10.1016/j.csbj.2021.06.011
|
| 42 |
Hariharan Jayaraman, Ashwin Anandhapadman, Nalinkanth Veerabadran Ghone. In Vitro and In Vivo Comparative Analysis of Differentially Expressed Genes and Signaling Pathways in Breast Cancer Cells on Interaction with Mesenchymal Stem Cells. Applied Biochemistry and Biotechnology 2023; 195(1): 401 doi: 10.1007/s12010-022-04119-9
|
| 43 |
Pengfei Lyu, Zhengwen Hao, Haoruo Zhang, Jun Li. Identifying pancreatic cancer‑associated miRNAs using weighted gene co‑expression network analysis. Oncology Letters 2022; 24(3) doi: 10.3892/ol.2022.13417
|
| 44 |
Bailey Nelson, Michelle Barrord, Kyle Wang, Nolan A. Wages, Mickaela Sudhoff, Jordan Kharofa. Relationship of dose to vascular target volumes and local failure in pancreatic cancer patients undergoing neoadjuvant chemoradiation. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.906484
|
| 45 |
Giammaria Fiorentini, Donatella Sarti, Virginia Casadei, Carlo Milandri, Patrizia Dentico, Andrea Mambrini, Roberto Nani, Caterina Fiorentini, Stefano Guadagni. Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients. Integrative Cancer Therapies 2019; 18 doi: 10.1177/1534735419878505
|
| 46 |
Sultan Abdullah Alomari, Ahmed Sami Alfaqihi, Khalid Abdullah Alzahrani, Khalid Hassan Alzahrani, Khalid Mohammed Alzahrani, Khalid Abdulrahman Alzahrani, Abdulrahman Ahmed Asiri, Amjad Ali Durayb, Abdulaziz Marzouq Aloatibi, Mohammed Bassam Ghandourah. An Overview on the Role of Surgery in Resectable Pancreatic Tumors, Literature Review. Pharmacophore 2021; 12(4): 86 doi: 10.51847/RxWepx87LV
|
| 47 |
Takahiro Kasai, Shoma Tamori, Yuta Takasaki, Izumi Matsuoka, Ayaka Ozaki, Chika Matsuda, Yohsuke Harada, Kazunori Sasaki, Shigeo Ohno, Kazunori Akimoto. High expression of PKCλ and ALDH1A3 indicates a poor prognosis, and PKCλ is required for the asymmetric cell division of ALDH1A3-positive cancer stem cells in PDAC. Biochemical and Biophysical Research Communications 2023; 669: 85 doi: 10.1016/j.bbrc.2023.05.086
|
| 48 |
Tao Wang, Lin Ye, Yingjie Zhou, Xionghan Zhang, Renjian Li, Yi Zhou, Jun Weng, Qingrong Mo, Yaqun Yu. Pancreatic cancer-derived exosomal miR-510 promotes macrophage M2 polarization and facilitates cancer cell aggressive phenotypes. Human Cell 2024; 38(1) doi: 10.1007/s13577-024-01144-0
|
| 49 |
Teresa Starzyńska, Jakub Karczmarski, Agnieszka Paziewska, Maria Kulecka, Katarzyna Kuśnierz, Natalia Żeber-Lubecka, Filip Ambrożkiewicz, Michał Mikula, Beata Kos-Kudła, Jerzy Ostrowski. Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling. International Journal of Molecular Sciences 2020; 21(12): 4470 doi: 10.3390/ijms21124470
|
| 50 |
Juan Tan, Waner Liu, Jie Li, Xi Zhang, Yang Liu, Yuan Yuan, Zewen Song. Over-expressed RHEB promotes the progression of pancreatic adenocarcinoma. Life Sciences 2021; 277: 119462 doi: 10.1016/j.lfs.2021.119462
|
| 51 |
Cristina Mesas, Francisco Quiñonero, Kevin Doello, José L. Revueltas, Gloria Perazzoli, Laura Cabeza, Jose Prados, Consolación Melguizo. Active Biomolecules from Vegetable Extracts with Antitumoral Activity against Pancreas Cancer: A Systematic Review (2011–2021). Life 2022; 12(11): 1765 doi: 10.3390/life12111765
|
| 52 |
Fanny Castanet, Jeanne Dembinski, Bastien Cabarrou, Jonathan Garnier, Christophe Laurent, Nicolas Regenet, Antonio Sa Cunha, Charlotte Maulat, Laurence Chiche, Gabriella Pittau, Nicolas Carrère, Jean-Marc Regimbeau, Olivier Turrini, Alain Sauvanet, Fabrice Muscari. Influence of pancreatic fistula on survival after upfront pancreatoduodenectomy for pancreatic ductal adenocarcinoma: multicentre retrospective study. BJS Open 2024; 8(5) doi: 10.1093/bjsopen/zrae125
|
| 53 |
Yufei Zhu, Dijie Zheng, Linhan Lei, Kun Cai, Huahua Xie, Jian Zheng, Chao Yu. High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10128-y
|
| 54 |
Илья Наумович Лейдерман, А. Ю. Медведев, О. Г. Еремеева, Р. А. Зуков. Проблемы ранней диагностики и коррекции белково-энергетической недостаточности у пациентов высокого операционно-анестезиологического риска в абдоминальной онкохирургии: обзор литературы. Annals of Critical Care 2024; (3): 96 doi: 10.21320/1818-474X-2024-3-96-113
|
| 55 |
Faustino Mollinedo, Consuelo Gajate. Direct Endoplasmic Reticulum Targeting by the Selective Alkylphospholipid Analog and Antitumor Ether Lipid Edelfosine as a Therapeutic Approach in Pancreatic Cancer. Cancers 2021; 13(16): 4173 doi: 10.3390/cancers13164173
|
| 56 |
Zun Fan, Ming Li, Yinjie Xu, Chenxing Ge, Jianfeng Gu. EPS8L3 promotes pancreatic cancer proliferation and metastasis by activating GSK3B. Journal of Medical Biochemistry 2023; 42(1): 105 doi: 10.5937/jomb0-38840
|
| 57 |
Chen Yang, Yanchun Li, Wanye Hu, Xu Wang, Jiayu Hu, Chen Yuan, Chaoting Zhou, Hairui Wang, Jing Du, Ying Wang, Xiangmin Tong. TEOA Promotes Autophagic Cell Death via ROS-Mediated Inhibition of mTOR/p70S6k Signaling Pathway in Pancreatic Cancer Cells. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.734818
|
| 58 |
Ye Ding, Yong Yu. Therapeutic potential of flavonoids in gastrointestinal cancer: Focus on signaling pathways and improvement strategies (Review). Molecular Medicine Reports 2025; 31(4): 1 doi: 10.3892/mmr.2025.13474
|
| 59 |
Paul Wong, Thuy B. Tran, Tommaso Pollini, Sophia Hernandez, Marco Zampese, Letizia Todeschini, Luis Laurean Aguilar, Vijay K. Maker, Ajay V. Maker. Impact of Coronary Artery Stenting on Perioperative Mortality and Complications in Patients Undergoing Pancreaticoduodenectomy. Journal of Gastrointestinal Surgery 2025; : 102020 doi: 10.1016/j.gassur.2025.102020
|
| 60 |
Maria Cristina Sini, Maria Grazia Doro, Laura Frogheri, Angelo Zinellu, Panagiotis Paliogiannis, Alberto Porcu, Fabrizio Scognamillo, Daniele Delogu, Davide Adriano Santeufemia, Ivana Persico, Grazia Palomba, Giovanni Battista Maestrale, Antonio Cossu, Giuseppe Palmieri. Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-04923-3
|
| 61 |
Ahmed M Badheeb, Mohammad A Awad, Ali G Al Masad, Mohammed S Alyami, Mohammed A Fagihi, Mugahed Al Walani, Samer Alkarak, Hamad M Al Bahili, Abdallah Alatawi, Nadeem M Nagi, Ahmed R Madbouly, Abdullah Abu Bakar, Faisal Ahmed, Mohamed Badheeb. Pancreatic Cancer: A Retrospective Study From the Najran Region of Saudi Arabia. Cureus 2024; doi: 10.7759/cureus.65685
|
| 62 |
Jian Xu, Wei Zhang. EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02222-1
|
| 63 |
Xiaoqing Xu, Xiaomin Lu, Liping Chen, Ke Peng, Fuhai Ji. Downregulation of MMP1 functions in preventing perineural invasion of pancreatic cancer through blocking the NT‐3/TrkC signaling pathway. Journal of Clinical Laboratory Analysis 2022; 36(11) doi: 10.1002/jcla.24719
|
| 64 |
Dexter L. Puckett, Mohammed Alquraishi, Dina Alani, Samah Chahed, Dallas Donohoe, Brynn Voy, Jay Whelan, Ahmed Bettaieb. Zyflamend induces apoptosis in pancreatic cancer cells via modulation of the JNK pathway. Cell Communication and Signaling 2020; 18(1) doi: 10.1186/s12964-020-00609-7
|
| 65 |
Longlan Zhou, Lin Zhang. Effect of postsurgical adjuvant chemotherapy timing on outcomes in patients with pancreatic cancer – a systematic review and meta-analysis. Journal of Chemotherapy 2024; : 1 doi: 10.1080/1120009X.2024.2402175
|
| 66 |
Rong Wu, Zhichao Xi, Mengfan Liu, Hangui Ren, Rongchen Dai, Xue Jiang, Wan Najbah Nik Nabil, Yalin Wang, Jiling Feng, Qiong Chai, Qihan Dong, Hongxi Xu. Pulsatilla Decoction and its bioactive component β-peltatin induce G2/M cell cycle arrest and apoptosis in pancreatic cancer. Chinese Medicine 2023; 18(1) doi: 10.1186/s13020-023-00774-0
|
| 67 |
Caiyan Wang, Wen Yin, Hui Liu. MicroRNA‐10a promotes epithelial‐to‐mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition. Journal of Cellular Biochemistry 2020; 121(11): 4505 doi: 10.1002/jcb.29716
|
| 68 |
Molly C. Holbrook, Dakota W. Goad, Valery Z. Grdzelishvili. Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions. Cancers 2021; 13(5): 1171 doi: 10.3390/cancers13051171
|
| 69 |
Shalini Preethi P., Sindhu V., Karthik Sambath, Arun Reddy Ravula, Geetha Palani, Sivakumar Vijayaraghavalu, Shanmuga Sundari I., Venkatesan Perumal. Recent Advances in Nanocarriers for Pancreatic Cancer Therapy. 2024; : 169 doi: 10.1016/B978-0-443-19142-8.00004-8
|
| 70 |
Seyedeh Mahdieh Khoshnazar, Nazanin Zeinali, Mohammad Mohagheghi, Sara Shafieipour. Safety and Efficacy of Geraniol in Gastrointestinal System. Revista Brasileira de Farmacognosia 2024; 34(6): 1218 doi: 10.1007/s43450-024-00568-x
|
| 71 |
Chiara Bazzichetto, Fabiana Conciatori, Claudio Luchini, Francesca Simionato, Raffaela Santoro, Vanja Vaccaro, Vincenzo Corbo, Italia Falcone, Gianluigi Ferretti, Francesco Cognetti, Davide Melisi, Aldo Scarpa, Ludovica Ciuffreda, Michele Milella. From Genetic Alterations to Tumor Microenvironment: The Ariadne’s String in Pancreatic Cancer. Cells 2020; 9(2): 309 doi: 10.3390/cells9020309
|
| 72 |
Yutaka Takigawa, Junichi Matsui, Takao Igarashi, Masateru Uchiyama, Aya Sasaki. Investigating the early diagnosis of pancreatic cancer by surveillance of patients with “K‐sign” of the pancreas by computed tomography: A prospective study. Journal of Hepato-Biliary-Pancreatic Sciences 2024; 31(3): 193 doi: 10.1002/jhbp.1411
|
| 73 |
Andrew S Knight, Freedom L Ha, Werner T de Riese. Diagnostic and therapeutic challenges of synchronous renal mass and pancreatic mass: a review. Journal of Clinical Urology 2022; 15(5): 404 doi: 10.1177/2051415820979099
|
| 74 |
Mallika C. Asar, April Franco, Mette Soendergaard. Phage Display Selection, Identification, and Characterization of Novel Pancreatic Cancer Targeting Peptides. Biomolecules 2020; 10(5): 714 doi: 10.3390/biom10050714
|
| 75 |
Jie Zhu, Ke Zhang, Yuan Chen, Xinyu Ge, Junqing Wu, Peng Xu, Jie Yao. Progress of single-cell RNA sequencing combined with spatial transcriptomics in tumour microenvironment and treatment of pancreatic cancer. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05307-3
|
| 76 |
Qingmei Sun, Jiarong Li, Xiaoping Fang, Jie Jin, Lei Cui. Current status and influencing factors of care burden of pancreatic cancer caregivers under COVID-19. Frontiers in Psychology 2023; 13 doi: 10.3389/fpsyg.2022.1066278
|
| 77 |
Hye Soo Chung, Ji Sung Lee, Eyun Song, Jung A Kim, Eun Roh, Ji Hee Yu, Nam Hoon Kim, Hye Jin Yoo, Ji A Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Kyung Mook Choi. Effect of Metabolic Health and Obesity Phenotype on the Risk of Pancreatic Cancer: A Nationwide Population-Based Cohort Study. Cancer Epidemiology, Biomarkers & Prevention 2021; 30(3): 521 doi: 10.1158/1055-9965.EPI-20-1262
|
| 78 |
Maximilian Hauschulz, Sophia Villwock, Jennifer Kosinski, Florian Steib, Lara Rosaline Heij, Jan Bednarsch, Ruth Knüchel-Clarke, Edgar Dahl. Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene SFRP1 in Pancreatic Cancer. Cancers 2023; 15(3): 683 doi: 10.3390/cancers15030683
|
| 79 |
Takuro Kobori, Yui Ito, Yuka Sawada, Yoko Urashima, Takuya Ito, Tokio Obata. Cellular Membrane Localization of Innate Immune Checkpoint Molecule CD47 Is Regulated by Radixin in Human Pancreatic Ductal Adenocarcinoma Cells. Biomedicines 2023; 11(4): 1117 doi: 10.3390/biomedicines11041117
|
| 80 |
Fatemeh Aminaltojjari, Ali Neamati, Ehsan Karimi. Synthesis of anticancer drug polymeric carrier based on safranal encapsulated PLGA nanoparticles. Polymer Bulletin 2024; 81(14): 12543 doi: 10.1007/s00289-024-05298-7
|
| 81 |
Alfred Akinlalu, Zachariah Flaten, Komila Rasuleva, Md Saimon Mia, Aaron Bauer, Santhalingam Elamurugan, Nega Ejjigu, Sudipa Maity, Amara Arshad, Min Wu, Wenjie Xia, Jia Fan, Ang Guo, Sijo Mathew, Dali Sun. Integrated proteomic profiling identifies amino acids selectively cytotoxic to pancreatic cancer cells. The Innovation 2024; 5(3): 100626 doi: 10.1016/j.xinn.2024.100626
|
| 82 |
Yu-Chuan Shen, Hui-Ching Hsu, Tzu-Min Lin, Yu-Sheng Chang, Li-Fang Hu, Lung-Fang Chen, Sheng-Hong Lin, Pei-I. Kuo, Wei-Sheng Chen, Yi-Chun Lin, Jin-Hua Chen, Yu-Chih Liang, Chi-Ching Chang. H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection. Journal of Clinical Oncology 2022; 40(11): 1206 doi: 10.1200/JCO.21.01802
|
| 83 |
Claudia Geismann, Alexander Arlt. Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer. Cells 2020; 9(11): 2353 doi: 10.3390/cells9112353
|
| 84 |
Lei Dai, Joseph Mugaanyi, Xingchen Cai, Caide Lu, Changjiang Lu. Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in hepatocellular carcinoma. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-16155-w
|
| 85 |
İ Güler, RP Kavak. Pancreatic Morphology/Contour Variations should be Recognized and Remembered. Nigerian Journal of Clinical Practice 2023; 26(6): 749 doi: 10.4103/njcp.njcp_619_22
|
| 86 |
Jie Hou, Zhan Wang, Hong Li, Hongzhi Zhang, Lan Luo. Gene Signature and Identification of Clinical Trait-Related m6 A Regulators in Pancreatic Cancer. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00522
|
| 87 |
Animesh Acharjee, Daniella Okyere, Dipanwita Nath, Shruti Nagar, Georgios V. Gkoutos. Network dynamics and therapeutic aspects of mRNA and protein markers with the recurrence sites of pancreatic cancer. Heliyon 2024; 10(10): e31437 doi: 10.1016/j.heliyon.2024.e31437
|
| 88 |
Alessandro Cavazzani, Claudia Angelini, Dario Gregori, Luca Cardone. Cancer incidence (2000–2020) among individuals under 35: an emerging sex disparity in oncology. BMC Medicine 2024; 22(1) doi: 10.1186/s12916-024-03574-x
|
| 89 |
Chinmay S. Potnis, Rajat Chauhan, Theodore S. Kalbfleisch, Evan Alexander, Lindsay Eichhold, Meenakshi Bansal, Craig A. Grapperhaus, Robert S. Keynton, Mark W. Linder, Gautam Gupta. Enhancing the compatibility of BioCaRGOS silica sol-gel technology with ctDNA extraction and droplet digital PCR (ddPCR) analysis. RSC Advances 2022; 12(45): 29399 doi: 10.1039/D2RA05862F
|
| 90 |
Samuel J. Martínez-Domínguez, Viviana Laredo, Guillermo García-Rayado. The role of vitamin C in the prevention of pancreatic cancer: a systematic-review. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1398147
|
| 91 |
Dongyuan Wu, Xinyuan Li, Xiaohan Zhang, Fang Han, Xin Lu, Lei Liu, Junsheng Zhang, Mei Dong, Huanjie Yang, Hui Li. Pharmacometabolomics Identifies 3-Hydroxyadipic Acid, d-Galactose, Lysophosphatidylcholine (P-16:0), and Tetradecenoyl-l-Carnitine as Potential Predictive Indicators of Gemcitabine Efficacy in Pancreatic Cancer Patients. Frontiers in Oncology 2020; 9 doi: 10.3389/fonc.2019.01524
|
| 92 |
Lisa M. Nilsson, Caroline Vilhav, Joakim W. Karlsson, Johan Bourghardt Fagman, Daniel Giglio, Cecilia E. Engström, Peter Naredi, Jonas A. Nilsson. Genetics and Therapeutic Responses to Tumor-Infiltrating Lymphocyte Therapy of Pancreatic Cancer Patient-Derived Xenograft Models. Gastro Hep Advances 2022; 1(6): 1037 doi: 10.1016/j.gastha.2022.07.006
|
| 93 |
Samar Mahmood, Hafiz Muhammad Sameer, Arooba Ejaz, Syed Muhammad Ahsan, Urooj Mazhar, Komal Zulfiqar. Rising Mortality among Non-Hispanics due to Pancreatic Cancer in the United States. A CDC Database analysis. Journal of Gastrointestinal Cancer 2024; 55(3): 1229 doi: 10.1007/s12029-024-01084-w
|
| 94 |
Sarah Peisl, Claudia Mellenthin, Lucie Vignot, Carmen Gonelle-Gispert, Leo Bühler, Bernhard Egger, Gautam Sethi. Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature. PLOS ONE 2021; 16(6): e0252397 doi: 10.1371/journal.pone.0252397
|
| 95 |
Anderson Matheus Pereira da Silva, Kaline Oliveira de Sousa, Maria Eduarda Phaelante Brito Fagundes, Alice Veras Santos, Antônio Frederico Areias Regis, Luiz Alves de Oliveira Netto, Nicolle Lima de Cerqueira, Kahlil Napy Charara Hamad Pereira, José William Oliveira dos Santos Justa, Luiza Leal Mendes, Matheus Rodrigues da Silva de Oliveira, Guilherme Henrique Ramos Bezerra Sales, Aline Moraes de Abreu. Eficácia e toxicidade dos regimes quimioterápicos no tratamento do Câncer Pancreático metastático . Caderno Pedagógico 2024; 21(8): e6995 doi: 10.54033/cadpedv21n8-196
|
| 96 |
Ming He, Marcy Martin, Traci Marin, Zhen Chen, Brendan Gongol. Endothelial mechanobiology. APL Bioengineering 2020; 4(1) doi: 10.1063/1.5129563
|
| 97 |
Muhammad Nurmahir Mohamad Sehmi, Mohammad Faizal Ahmad Fauzi, Wan Siti Halimatul Munirah Wan Ahmad, Elaine Wan Ling Chan. Pancreatic cancer grading in pathological images using deep learning convolutional neural networks. F1000Research 2022; 10: 1057 doi: 10.12688/f1000research.73161.2
|
| 98 |
Qing Li, Yu Liu, Renhou Zhi, Yinquan Wang. The prognostic significance of twist in pancreatic cancer and its role in cancer promotion through the regulation of the immune microenvironment and EMT mechanisms. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01478-z
|
| 99 |
Aaditya Narendra, Peter D. Baade, Joanne F. Aitken, Jonathan Fawcett, Bernard Mark Smithers. Pancreaticoduodenectomy in a low-resection volume region: a population-level study examining the impact of hospital-volume on surgical quality and longer-term survival. HPB 2020; 22(9): 1288 doi: 10.1016/j.hpb.2019.11.015
|
| 100 |
Andrés Moreno Roca, Luciana Armijos Acurio, Ruth Jimbo Sotomayor, Carlos Céspedes Rivadeneira, Carlos Rosero Reyes, Carlos López Ayala. Cohort study of the overall survival of patients with pancreatic cancer in a hospital of specialties of Quito-Ecuador in the period 2007–2017. Innovative Surgical Sciences 2021; 6(2): 75 doi: 10.1515/iss-2020-0030
|
| 101 |
Davide Di Fusco, Maria Teresa Segreto, Giulia Di Maggio, Andrea Iannucci, Claudia Maresca, Antonio Di Grazia, Marco Colella, Carmine Stolfi, Giovanni Monteleone, Ivan Monteleone. Insulin-like Growth Factor II mRNA-Binding Protein 1 Regulates Pancreatic Cancer Cell Growth through the Surveillance of CDC25A mRNA. Cancers 2023; 15(20): 4983 doi: 10.3390/cancers15204983
|
| 102 |
Dushyant Singh Dahiya, Mohammad Al-Haddad, Saurabh Chandan, Manesh Kumar Gangwani, Muhammad Aziz, Babu P. Mohan, Daryl Ramai, Andrew Canakis, Jay Bapaye, Neil Sharma. Artificial Intelligence in Endoscopic Ultrasound for Pancreatic Cancer: Where Are We Now and What Does the Future Entail?. Journal of Clinical Medicine 2022; 11(24): 7476 doi: 10.3390/jcm11247476
|
| 103 |
Ashleigh Hull, Yanrui Li, Dylan Bartholomeusz, William Hsieh, Barry Allen, Eva Bezak. Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma: A Review of the Current Status of Literature. Cancers 2020; 12(2): 481 doi: 10.3390/cancers12020481
|
| 104 |
Xiaomin Jiang, Wenbo Han, Jianqiao Liu, Jianming Mao, Morten J. Lee, Megan Rodriguez, Youyou Li, Taokun Luo, Ziwan Xu, Kaiting Yang, Marc Bissonnette, Ralph R. Weichselbaum, Wenbin Lin. Tumor‐Activatable Nanoparticles Target Low‐Density Lipoprotein Receptor to Enhance Drug Delivery and Antitumor Efficacy. Advanced Science 2022; 9(24) doi: 10.1002/advs.202201614
|
| 105 |
Yanhua Du, Yizhou Zhao, Judong Li, Jiaxin Wang, Shenglan You, Yao Zhang, Li Zhang, Jihong Yang, Hamid Alinejad‐Rokny, Shujie Cheng, Chenghao Shao, Duowu Zou, Youqiong Ye. PLXDC1+ Tumor‐Associated Pancreatic Stellate Cells Promote Desmoplastic and Immunosuppressive Niche in Pancreatic Ductal Adenocarcinoma. Advanced Science 2025; doi: 10.1002/advs.202415756
|
| 106 |
Nana Kimura, Suguru Yamada, Hideki Takami, Kenta Murotani, Isaku Yoshioka, Kazuto Shibuya, Fuminori Sonohara, Yui Hoshino, Katsuhisa Hirano, Toru Watanabe, Hayato Baba, Kosuke Mori, Takeshi Miwa, Mitsuro Kanda, Masamichi Hayashi, Koshi Matsui, Tomoyuki Okumura, Yasuhiro Kodera, Tsutomu Fujii. Optimal Preoperative Multidisciplinary Treatment in Borderline Resectable Pancreatic Cancer. Cancers 2020; 13(1): 36 doi: 10.3390/cancers13010036
|
| 107 |
Seonghee Lim, Van Gia Truong, Jongman Choi, Hye Jung Jeong, Sun-Ju Oh, Jin-Seok Park, Hyun Wook Kang. Endoscopic Ultrasound-Guided Laser Ablation Using a Diffusing Applicator for Locally Advanced Pancreatic Cancer Treatment. Cancers 2022; 14(9): 2274 doi: 10.3390/cancers14092274
|
| 108 |
K.R. Manu, Gurleen Kaur, Ananya Kar, Lopamudra Giri, Waleed H. Almalki, Neelima Gupta, Amirhossein Sahebkar, Prashant Kesharwani, Rambabu Dandela. Recent Advances in Nanocarriers for Pancreatic Cancer Therapy. 2024; : 419 doi: 10.1016/B978-0-443-19142-8.00007-3
|
| 109 |
Dongnan Ping, Xiaofan Pu, Guoping Ding, Chaolei Zhang, Junbin Jin, Chengjie Xu, Jiazheng Liu, Shengnan Jia, Liping Cao. Sirtuin4 impacts mitochondrial homeostasis in pancreatic cancer cells by reducing the stability of AlkB homolog 1 via deacetylation of the HRD1-SEL1L complex. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2023; 1866(2): 194941 doi: 10.1016/j.bbagrm.2023.194941
|
| 110 |
Günay Kibarer, Cemal Kavalcıoğlu. 10th International Conference on Theory and Application of Soft Computing, Computing with Words and Perceptions - ICSCCW-2019. Advances in Intelligent Systems and Computing 2020; 1095: 175 doi: 10.1007/978-3-030-35249-3_22
|
| 111 |
Ivy M. Dambuza, Gordon D. Brown. Fungi accelerate pancreatic cancer. Nature 2019; 574(7777): 184 doi: 10.1038/d41586-019-02892-y
|
| 112 |
Jian Zhang, Jiangwei Li, Yongqiang Xiong, Ren Li. Circ_0000284 upregulates RHPN2 to facilitate pancreatic cancer proliferation, metastasis, and angiogenesis through sponging miR‐1179. Journal of Biochemical and Molecular Toxicology 2023; 37(3) doi: 10.1002/jbt.23274
|
| 113 |
V. E. Moiseenko, A. V. Pavlovsky, D. A. Granov, L. V. Kochorova, N. I. Vishnjakov, V. V. Hizha, A. V. Yazenok, N. Ju. Shirshova, L. A. Solovyova. Analysis of types of medical interventions for patients with pancreatic adenocarcinoma in hospitals of Saint Petersburg for the period from 2014 to 2020. The Scientific Notes of the Pavlov University 2023; 30(1): 19 doi: 10.24884/1607-4181-2023-30-1-19-26
|
| 114 |
Zhiqiang Zhang, Jiangning Gu, Menghong Yin, Di Wang, Chi Ma, Jian Du, Zhikun Lin, Siling Hu, Xuelong Wang, Ying Li, Guang Tan, Haifeng Luo, Gang Wei, Taiyoun Rhim. Establishment and Investigation of a Multiple Gene Expression Signature to Predict Long‐Term Survival in Pancreatic Cancer. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/1570862
|
| 115 |
Kohei Yamakawa, Michiyo Koyanagi-Aoi, Keiichiro Uehara, Atsuhiro Masuda, Hiroaki Yanagimoto, Hirochika Toyama, Takumi Fukumoto, Yuzo Kodama, Takashi Aoi, Khushboo Irshad. Increased expression of SPRR1A is associated with a poor prognosis in pancreatic ductal adenocarcinoma. PLOS ONE 2022; 17(5): e0266620 doi: 10.1371/journal.pone.0266620
|
| 116 |
Zhen Yang, Honglin Li, Jie Hao, Hanwei Mei, Minghan Qiu, Huaqing Wang, Ming Gao. EPYC functions as a novel prognostic biomarker for pancreatic cancer. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-51478-w
|
| 117 |
登基 王. Research Progress in Pancreatic Cancer. Advances in Clinical Medicine 2022; 12(06): 5181 doi: 10.12677/ACM.2022.126751
|
| 118 |
Leiming Zhang, Rong Jin, Xuanang Yang, Dongjian Ying. A population-based study of synchronous distant metastases and prognosis in patients with PDAC at initial diagnosis. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1087700
|
| 119 |
Monica M. Rostom, Alaa A. Rashwan, Christina D. Sotiropoulou, Sama Z. Hozayen, Abdelhamid M. Abdelhamid, Miriam Mokhtar Abdelhalim, Omar Eltahtawy, Hadir M. Emara, Noha M. Elemam, Christos K. Kontos, Rana A. Youness. MIAT: A pivotal oncogenic long noncoding RNA tunning the hallmarks of solid malignancies. Translational Oncology 2025; 54: 102329 doi: 10.1016/j.tranon.2025.102329
|
| 120 |
Lingming Kong, Peng Liu, Mingjun Zheng, Zhongpeng Wang, Yang Gao, Keke Liang, Huaitao Wang, Xiaodong Tan. <p>The miR-1224-5p/ELF3 Axis Regulates Malignant Behaviors of Pancreatic Cancer via PI3K/AKT/Notch Signaling Pathways</p>. OncoTargets and Therapy 2020; : 3449 doi: 10.2147/OTT.S248507
|
| 121 |
Aryl hydrocarbon receptor interacting protein (AIP) significantly influences prognosis of pancreatic carcinoma. Annals of Diagnostic Pathology 2021; 53: 151742 doi: 10.1016/j.anndiagpath.2021.151742
|
| 122 |
Simone Furini, Chiara Falciani. Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.695858
|
| 123 |
Susana G Barrientos-Robledo, Jorge A Cebada-Ruiz, Juan C Rodríguez-Alba, Shantal L Baltierra-Uribe, Maria A Díaz y Orea, Héctor Romero-Ramírez. Cd38 A Biomarker and Therapeutic Target in Non-Hematopoietic Tumors. Biomarkers in Medicine 2022; 16(5): 387 doi: 10.2217/bmm-2021-0575
|
| 124 |
Yuan Feng, Junjun Yang, Wentao Duan, Yu Cai, Xiaohong Liu, Yong Peng. LASSO-derived prognostic model predicts cancer-specific survival in advanced pancreatic ductal adenocarcinoma over 50 years of age: a retrospective study of SEER database research. Frontiers in Oncology 2024; 13 doi: 10.3389/fonc.2023.1336251
|
| 125 |
Sajid Khan, Vivekananda Budamagunta, Daohong Zhou. Pancreatic Cancer: Basic Mechanisms and Therapies. Advances in Cancer Research 2023; 159: 145 doi: 10.1016/bs.acr.2023.02.004
|
| 126 |
Kennedy Yao Yi Ng, Edwin Wei Xiang Chow, Bochao Jiang, Cindy Lim, Brian Kim Poh Goh, Ser Yee Lee, Jin Yao Teo, Damien Meng Yew Tan, Peng Chung Cheow, London Lucien Peng Jin Ooi, Pierce Kah Hoe Chow, Joycelyn Jie Xin Lee, Juinn Huar Kam, Ye Xin Koh, Prema Raj Jeyaraj, Ek Khoon Tan, Su Pin Choo, Chung Yip Chan, Alexander Yaw Fui Chung, David Tai. Resected pancreatic adenocarcinoma: An Asian institution's experience. Cancer Reports 2021; 4(5) doi: 10.1002/cnr2.1393
|
| 127 |
Ruben Verloy, Angela Privat-Maldonado, Evelien Smits, Annemie Bogaerts. Cold Atmospheric Plasma Treatment for Pancreatic Cancer–The Importance of Pancreatic Stellate Cells. Cancers 2020; 12(10): 2782 doi: 10.3390/cancers12102782
|
| 128 |
Manish Manrai, T V S V G K Tilak, Saurabh Dawra, Sharad Srivastava, Anupam Singh. Current and emerging therapeutic strategies in pancreatic cancer: Challenges and opportunities. World Journal of Gastroenterology 2021; 27(39): 6572-6589 doi: 10.3748/wjg.v27.i39.6572
|
| 129 |
Céline Tiffon. Defining Parallels between the Salivary Glands and Pancreas to Better Understand Pancreatic Carcinogenesis. Biomedicines 2020; 8(6): 178 doi: 10.3390/biomedicines8060178
|
| 130 |
Wenli Fu, Huijun Hu, Xinyue Li, Rui Guo, Tao Chen, Xiaohua Qian. A Generalizable Causal-Invariance-Driven Segmentation Model for Peripancreatic Vessels. IEEE Transactions on Medical Imaging 2024; 43(11): 3794 doi: 10.1109/TMI.2024.3400528
|
| 131 |
Huaibin Mabel Ko, Runjan Chetty. Pancreatic pathology for the surgeon. Surgery (Oxford) 2025; 43(1): 16 doi: 10.1016/j.mpsur.2024.10.008
|
| 132 |
Xiang Gu, Qunshan Zhu, Guangyu Tian, Wenbo Song, Tao Wang, Ali Wang, Xiaojun Chen, Songbing Qin. KIF11 manipulates SREBP2‐dependent mevalonate cross talk to promote tumor progression in pancreatic ductal adenocarcinoma. Cancer Medicine 2022; 11(17): 3282 doi: 10.1002/cam4.4683
|
| 133 |
Deepak Raj, Maria Nikolaidi, Irene Garces, Daniela Lorizio, Natalia M. Castro, Sabrina G. Caiafa, Kate Moore, Nicholas F. Brown, Hemant M. Kocher, Xiaobo Duan, Brad H. Nelson, Nicholas R. Lemoine, John F. Marshall. CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research 2021; 27(5): 1538 doi: 10.1158/1078-0432.CCR-19-2163
|
| 134 |
Carly Jade Carter, Ahmed H Mekkawy, David L Morris. Role of human nucleoside transporters in pancreatic cancer and chemoresistance. World Journal of Gastroenterology 2021; 27(40): 6844-6860 doi: 10.3748/wjg.v27.i40.6844
|
| 135 |
Alexandra Martins, Brigida C. Ferreira, Maria Manuela Gaspar, Sandra Vieira, Joana Lopes, Ana S. Viana, António Paulo, Filipa Mendes, Maria Paula Cabral Campello, Rui Martins, Catarina Pinto Reis. Enhanced Cytotoxicity against a Pancreatic Cancer Cell Line Combining Radiation and Gold Nanoparticles. Pharmaceutics 2024; 16(7): 900 doi: 10.3390/pharmaceutics16070900
|
| 136 |
Sorina-Mădălina Boariu, Ana‑Maria Scutariu, Valentina Anton, Delia Reurean‑Pintilei. The impact of nutrition on post-duodenopancreatectomy recovery in a patient with cephalic and body-tail pancreatic neoplasm – case report. The Romanian Journal of Nutrition 2024; 3(3): 4 doi: 10.26416/Diet.3.3.2024.10166
|
| 137 |
Changjie Shao, Juntao Zhang, Jing Guo, Liang Zhang, Yuhan Zhang, Leiyuan Ma, Chuanxin Gong, Yaqi Tian, Jingjing Chen, Ning Yu. A radiomics nomogram model for predicting prognosis of pancreatic ductal adenocarcinoma after high-intensity focused ultrasound surgery. International Journal of Hyperthermia 2023; 40(1) doi: 10.1080/02656736.2023.2184397
|
| 138 |
Tanja Belčič Mikič, Gregor Mlinšek, Manca Oblak, Aljoša Kandus, Jadranka Buturović-Ponikvar, Simon Hawlina, Tomaž Milanez, Nika Kojc, Maja Frelih, Miha Arnol. Transmission of pancreatic adenocarcinoma by a single multiorgan donor to two kidney transplant recipients: A case report. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1142611
|
| 139 |
Wei Kang Ye, Jin Wang, Jie Zheng, Ming Jiang, Yi Nong Zhou, Zhi Xiang Wu. Predictive value of the nutritional risk index for postoperative complications in individuals with pancreatic cancer undergoing pancreaticoduodenectomy. Geriatric Nursing 2025; 61: 605 doi: 10.1016/j.gerinurse.2024.12.006
|
| 140 |
Kirby P. Gardner, Mohammed Aldakkak, Cha-Mei Tang, Susan Tsai, Daniel L. Adams. Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes. npj Precision Oncology 2021; 5(1) doi: 10.1038/s41698-021-00161-8
|
| 141 |
Khan Mohammad Imran, Benjamin Tintera, Holly A. Morrison, Juselyn D. Tupik, Margaret A. Nagai-Singer, Hannah Ivester, McAlister Council-Troche, Michael Edwards, Sheryl Coutermarsh-Ott, Christopher Byron, Sherrie Clark-Deener, Kyungjun Uh, Kiho Lee, Paul Boulos, Cliff Rowe, Christian Coviello, Irving C. Allen. Improved Therapeutic Delivery Targeting Clinically Relevant Orthotopic Human Pancreatic Tumors Engrafted in Immunocompromised Pigs Using Ultrasound-Induced Cavitation: A Pilot Study. Pharmaceutics 2023; 15(6): 1585 doi: 10.3390/pharmaceutics15061585
|
| 142 |
Liwen Fan, Xinyu Wang, Qing Chang, Yue Wang, Wenjie Yang, Linlin Liu. IL2RA is a prognostic indicator and correlated with immune characteristics of pancreatic ductal adenocarcinoma. Medicine 2022; 101(42): e30966 doi: 10.1097/MD.0000000000030966
|
| 143 |
Justin Thomas, Molly A. Torok, Kriti Agrawal, Timothy Pfau, Trang T. Vu, Justin Lyberger, Hsiaochi Chang, Alyssa Marie M. Castillo, Min Chen, Bryan Remaily, Kyeongmin Kim, Zhiliang Xie, Mary E. Dillhoff, Samuel K. Kulp, Gregory K. Behbehani, Zobeida Cruz-Monserrate, Latha P. Ganesan, Dwight H. Owen, Mitch A. Phelps, Christopher C. Coss, Thomas A. Mace. The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic Cancer. International Journal of Molecular Sciences 2022; 23(13): 7066 doi: 10.3390/ijms23137066
|
| 144 |
Ching-Feng Chiu, Hsin-Yi Chang, Chun-Yine Huang, Chen-Zou Mau, Tzu-Ting Kuo, Hsiu-Chuan Lee, Shih-Yi Huang. Betulinic Acid Affects the Energy-Related Proteomic Profiling in Pancreatic Ductal Adenocarcinoma Cells. Molecules 2021; 26(9): 2482 doi: 10.3390/molecules26092482
|
| 145 |
Matias Estaras, Remigio Martinez, Alfredo Garcia, Candido Ortiz-Placin, Juan L. Iovanna, Patricia Santofimia-Castaño, Antonio Gonzalez. Melatonin modulates metabolic adaptation of pancreatic stellate cells subjected to hypoxia. Biochemical Pharmacology 2022; 202: 115118 doi: 10.1016/j.bcp.2022.115118
|
| 146 |
Fiona K. Bangs, Paul Miller, Eric O'Neill. Ciliogenesis and Hedgehog signalling are suppressed downstream of KRAS during acinar-ductal metaplasia in mouse. Disease Models & Mechanisms 2020; 13(7) doi: 10.1242/dmm.044289
|
| 147 |
Wei Wang, Ying He, Lun Wu, Lin Ye, Lichao Yao, Zhigang Tang. Efficacy of extended versus standard lymphadenectomy in pancreatoduodenectomy for pancreatic head adenocarcinoma. An update meta-analysis. Pancreatology 2019; 19(8): 1074 doi: 10.1016/j.pan.2019.10.003
|
| 148 |
Yangyang Lei, Tianzhu Yu, Changyu Li, Jianke Li, Yicheng Liang, Xinyuan Wang, Yi Chen, Xiaolin Wang. Expression of CAMK1 and its association with clinicopathologic characteristics in pancreatic cancer. Journal of Cellular and Molecular Medicine 2021; 25(2): 1198 doi: 10.1111/jcmm.16188
|
| 149 |
Aixin Ou, Xiangxuan Zhao, Zaiming Lu. The potential roles of p53 signaling reactivation in pancreatic cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(1): 188662 doi: 10.1016/j.bbcan.2021.188662
|
| 150 |
Kaidi Yang, Tongxin Yang, Jian Yu, Fang Li, Xiang Zhao. Integrated transcriptional analysis reveals macrophage heterogeneity and macrophage-tumor cell interactions in the progression of pancreatic ductal adenocarcinoma. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10675-y
|
| 151 |
Seung Soo Hong, Ho Kyung Hwang, Woo Jung Lee, Chang Moo Kang. Feasibility and Safety of Laparoscopic Radical Distal Pancreatosplenectomy with Adrenalectomy in Advanced Pancreatic Cancer. Annals of Surgical Oncology 2020; 27(13): 5235 doi: 10.1245/s10434-020-08670-9
|
| 152 |
Lei Zhao, Yaming Cao. PD-L1 Expression Level Displays a Positive Correlation with Immune Response in Pancreatic Cancer. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/8843146
|
| 153 |
Sayra Dilmac, Bulent Ozpolat. MicroRNA in Human Malignancies. 2022; : 281 doi: 10.1016/B978-0-12-822287-4.00003-7
|
| 154 |
Megan J. Fitzpatrick, Yasmin Genevieve Hernandez-Barco, Kumar Krishnan, Brenna Casey, Martha B. Pitman. Evaluating triage protocols for endoscopic ultrasound-guided fine needle biopsies of the pancreas. Journal of the American Society of Cytopathology 2020; 9(5): 396 doi: 10.1016/j.jasc.2020.05.008
|
| 155 |
Khem Raj Limbu, Rashmi Bhandari Chhetri, Yoon Sin Oh, Dong Jae Baek, Eun-Young Park. Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules 2022; 27(23): 8127 doi: 10.3390/molecules27238127
|
| 156 |
Ashna A. Kumar, Benjamin J. Buckley, Marie Ranson. The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets. Biomolecules 2022; 12(2): 152 doi: 10.3390/biom12020152
|
| 157 |
Yuan-Mei Dong, Hong-Nian Sun, De-Cong Sun, Mu-Hong Deng, Yong-Gang Peng, Yan-Yun Zhu. Pancreatic cancer with synchronous liver and colon metastases: A case report. World Journal of Clinical Cases 2021; 9(33): 10265-10272 doi: 10.12998/wjcc.v9.i33.10265
|
| 158 |
Haisu Dai, Yan Jiang, Zhipeng Liu, Xingxing Su, Yishi Yang, Zhiyu Chen, Ravindran Caspa Gokulan. Pumilio RNA-Binding Family Member 1 Plays a Promoting Role on Pancreatic Cancer Angiogenesis. Canadian Journal of Gastroenterology and Hepatology 2022; 2022: 1 doi: 10.1155/2022/9202531
|
| 159 |
Juxiang Zhang, Fei Teng, Beiyuan Hu, Wanshan Liu, Yida Huang, Jiao Wu, Yuning Wang, Haiyang Su, Shouzhi Yang, Lumin Zhang, Lingchuan Guo, Zhe Lei, Meng Yan, Xiaoyu Xu, Ruimin Wang, Qingui Bao, Qiongzhu Dong, Jiang Long, Kun Qian. Early Diagnosis and Prognosis Prediction of Pancreatic Cancer Using Engineered Hybrid Core‐Shells in Laser Desorption/Ionization Mass Spectrometry. Advanced Materials 2024; 36(18) doi: 10.1002/adma.202311431
|
| 160 |
Kyohei Abe, Kenei Furukawa, Tomoyoshi Okamoto, Michinori Matsumoto, Yasuro Futagawa, Koichiro Haruki, Yoshihiro Shirai, Toru Ikegami. Impact of osteopenia on surgical and oncological outcomes in patients with pancreatic cancer. International Journal of Clinical Oncology 2021; 26(10): 1929 doi: 10.1007/s10147-021-01986-w
|
| 161 |
Bach Ardalan, Jose Ignacio Azqueta, Jonathan England, Tiffany Alyssa Eatz. Potential benefit of treatment with MEK inhibitors and chemotherapy in BRAF-mutated KRAS wild-type pancreatic ductal adenocarcinoma patients: a case report. Molecular Case Studies 2021; 7(5): a006108 doi: 10.1101/mcs.a006108
|
| 162 |
Shunsuke Watanabe, Jun Miyoshi, Masao Toki, Komei Kambayashi, Shuichi Kitada, Takeshi Nosaka, Tomoyuki Goto, Hirotaka Ota, Kazushige Ochiai, Koichi Gondo, Nobuhito Ikeuchi, Shujiro Tsuji, Kenji Nakamura, Junji Shibahara, Tadakazu Hisamatsu. Effectiveness of introducing a 20-gauge core biopsy needle with a core trap in EUS-FNA/B for diagnosing pancreatic cancer. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-020-01583-7
|
| 163 |
Milan Beljkas, Dusan Ruzic, Ana Djuric, Ana Vuletic, Guilaine Nchugoua Tchiehe, Corinne Jallet, Véronique Cadet-Daniel, Paola B. Arimondo, Juan F. Santibanez, Tatjana Srdic-Rajic, Katarina Nikolic, Slavica Oljacic, Milos Petkovic. Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents. Future Medicinal Chemistry 2025; 17(4): 393 doi: 10.1080/17568919.2025.2459589
|
| 164 |
Tomas Koltai, Stephan Joel Reshkin, Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Khalid Omer Alfarouk, Rosa Angela Cardone. Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. Cancers 2022; 14(10): 2486 doi: 10.3390/cancers14102486
|
| 165 |
Hongtao Xu, Yan Li, James W. Paxton, Zimei Wu. Co-Delivery Using pH-Sensitive Liposomes to Pancreatic Cancer Cells: the Effects of Curcumin on Cellular Concentration and Pharmacokinetics of Gemcitabine. Pharmaceutical Research 2021; 38(7): 1209 doi: 10.1007/s11095-021-03072-2
|
| 166 |
Esther N. Pijnappel, Nienke P. M. Wassenaar, Oliver J. Gurney-Champion, Remy Klaassen, Koen van der Lee, Marjolein C. H. Pleunis-van Empel, Dick J. Richel, Marie C. Legdeur, Aart J. Nederveen, Hanneke W. M. van Laarhoven, Johanna W. Wilmink. Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer. Cancers 2021; 13(19): 4869 doi: 10.3390/cancers13194869
|
| 167 |
Tasnimul Alam Taz, Md Kawsar, Sinthia Siddique, Kawsar Ahmed, Mohammad Ali Moni, Bikash Kumar Paul. Drug compound prediction-based analysis of cigarette smoking to Pancreatic Cancer patients: A Bioinformatics study. 2020 IEEE International Women in Engineering (WIE) Conference on Electrical and Computer Engineering (WIECON-ECE) 2020; : 320 doi: 10.1109/WIECON-ECE52138.2020.9397979
|
| 168 |
Lijuan Gui, Weiqing Li, Yanping Pan, Junyuan Zhao, Xiangkai Kong, Ji Liu, Kaixuan Zuo, Jun Yan, Yong Ling, Changchun Ling, Ruixi Li, Zhenwei Yuan. γ-Glutamyl transpeptidase activatable probe for fluorescence-assisted guiding surgery and imaging of human tumors via spraying. Sensors and Actuators B: Chemical 2024; 398: 134718 doi: 10.1016/j.snb.2023.134718
|
| 169 |
Nitish Chauhan, Mrunesh Koli, Rajib Ghosh, Ananda Guha Majumdar, Ayan Ghosh, Tapan K. Ghanty, Soumyaditya Mula, Birija Sankar Patro. A BODIPY-Naphtholimine-BF2 Dyad for Precision Photodynamic Therapy, Targeting, and Dual Imaging of Endoplasmic Reticulum and Lipid Droplets in Cancer. JACS Au 2024; 4(8): 2838 doi: 10.1021/jacsau.3c00539
|
| 170 |
Felipe Pacheco, Emmanuel Luciano, Danielle Hebert, Omar Marar. Metastatic pancreatic adenocarcinoma presenting as large bowel obstruction: A case report. International Journal of Surgery Case Reports 2023; 102: 107801 doi: 10.1016/j.ijscr.2022.107801
|
| 171 |
Keisuke Taniuchi, Makoto Ueno, Tomoyuki Yokose, Masahiko Sakaguchi, Reiko Yoshioka, Mitsunari Ogasawara, Takuhiro Kosaki, Seiji Naganuma, Mutsuo Furihata, Surinder K. Batra. Upregulation of PODXL and ITGB1 in pancreatic cancer tissues preoperatively obtained by EUS-FNAB correlates with unfavorable prognosis of postoperative pancreatic cancer patients. PLOS ONE 2022; 17(3): e0265172 doi: 10.1371/journal.pone.0265172
|
| 172 |
Dominika Mękal, Jacek Sobocki, Anna Badowska-Kozakiewicz, Katarzyna Sygit, Elżbieta Cipora, Ewa Bandurska, Aleksandra Czerw, Andrzej Deptała. Evaluation of Nutritional Status and the Impact of Nutritional Treatment in Patients with Pancreatic Cancer. Cancers 2023; 15(15): 3816 doi: 10.3390/cancers15153816
|
| 173 |
Ahyeon Kim, Jiwon Ha, Jeongeun Kim, Yongmin Cho, Jimyung Ahn, Chunhoo Cheon, Sung-Hoon Kim, Seong-Gyu Ko, Bonglee Kim. Natural Products for Pancreatic Cancer Treatment: From Traditional Medicine to Modern Drug Discovery. Nutrients 2021; 13(11): 3801 doi: 10.3390/nu13113801
|
| 174 |
Pavan Kumar Chintamaneni, Sai Kiran S.S. Pindiprolu, Swati Swagatika Swain, Veera Venkata Satyanarayana Reddy Karri, Jerry Nesamony, Selvam Chelliah, Mahendran Bhaskaran. Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia. Cancer Letters 2024; 588: 216782 doi: 10.1016/j.canlet.2024.216782
|
| 175 |
Eric Jinyi Wu, Tousif Kabir, Joseph J. Zhao, Brian K. P. Goh. Minimally Invasive Versus Open Radical Antegrade Modular Pancreatosplenectomy: A Meta‐Analysis. World Journal of Surgery 2022; 46(1): 235 doi: 10.1007/s00268-021-06328-5
|
| 176 |
Nathaniel E. Wiest, Varun P. Moktan, Sven P. Oman, Răzvan M. Chirilă. Screening for pancreatic cancer: a review for general clinicians. Romanian Journal of Internal Medicine 2020; 58(3): 119 doi: 10.2478/rjim-2020-0009
|
| 177 |
Samar Naamo, Katherine Chung, Sahil Rawal, Mutshipay Mpoy, Pablo R. Ros. Marbles and Bubbles of the Pancreas: Imaging and Management of Pancreatic Solid and Cystic Lesions. Contemporary Diagnostic Radiology 2023; 46(22): 1 doi: 10.1097/01.CDR.0000990064.84915.68
|
| 178 |
Adrián Palencia-Campos, Laura Ruiz-Cañas, Marcelina Abal-Sanisidro, Juan Carlos López-Gil, Sandra Batres-Ramos, Sofia Mendes Saraiva, Balbino Yagüe, Diego Navarro, Sonia Alcalá, Juan A. Rubiolo, Nadège Bidan, Laura Sánchez, Simona Mura, Patrick C. Hermann, María de la Fuente, Bruno Sainz. Reprogramming tumor-associated macrophages with lipid nanosystems reduces PDAC tumor burden and liver metastasis. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-03010-5
|
| 179 |
Iasmin Moreira Costa Bispo, Henry Paul Granger, Palloma Porto Almeida, Patricia Belini Nishiyama, Leandro Martins de Freitas. Systems biology and OMIC data integration to understand gastrointestinal cancers. World Journal of Clinical Oncology 2022; 13(10): 762-778 doi: 10.5306/wjco.v13.i10.762
|
| 180 |
Oliver Beetz, Akin Sarisin, Alexander Kaltenborn, Jürgen Klempnauer, Michael Winkler, Gerrit Grannas. Multivisceral resection for adenocarcinoma of the pancreatic body and tail—a retrospective single-center analysis. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01973-x
|
| 181 |
Liya Huang, Ting Ye, Jingjing Wang, Xiaojing Gu, Ruiting Ma, Lulu Sheng, Binwu Ma. Identification of Survival-Associated Hub Genes in Pancreatic Adenocarcinoma Based on WGCNA. Frontiers in Genetics 2022; 12 doi: 10.3389/fgene.2021.814798
|
| 182 |
Xi-Feng Fu, Hai-Chao Zhao, Chuan-Li Yang, Chang-Zhou Chen, Kang Wang, Fei Gao, Yang-Zhang Tian, Hao-Liang Zhao. MicroRNA‑203‑3p inhibits the proliferation, invasion and migration of pancreatic cancer cells by downregulating fibroblast growth factor 2. Oncology Letters 2021; 22(2) doi: 10.3892/ol.2021.12887
|
| 183 |
Jun Yao, Ce Zhang, Yanfei Chen, Shegan Gao. Downregulation of circular RNA circ-LDLRAD3 suppresses pancreatic cancer progression through miR-137-3p/PTN axis. Life Sciences 2019; 239: 116871 doi: 10.1016/j.lfs.2019.116871
|
| 184 |
Felista L. Tansi, Andrea Schrepper, Michael Schwarzer, Ulf Teichgräber, Ingrid Hilger. Identifying the Morphological and Molecular Features of a Cell-Based Orthotopic Pancreatic Cancer Mouse Model during Growth over Time. International Journal of Molecular Sciences 2024; 25(11): 5619 doi: 10.3390/ijms25115619
|
| 185 |
Guang-Rui Wang, Han-Qi Wang, Nian-Nian Zhong, Lei-Ming Cao, Zi-Zhan Li, Xuan-Hao Liu, Yao Xiao, Bing Liu, Lin-Lin Bu. Suicide among patients with oral cancer: A population-based study. Cancer Epidemiology 2024; 92: 102625 doi: 10.1016/j.canep.2024.102625
|
| 186 |
Paola Gualtieri, Rossella Cianci, Giulia Frank, Erica Pizzocaro, Gemma Lou De Santis, Silvia Giannattasio, Giuseppe Merra, Giovanni Butturini, Antonino De Lorenzo, Laura Di Renzo. Pancreatic Ductal Adenocarcinoma and Nutrition: Exploring the Role of Diet and Gut Health. Nutrients 2023; 15(20): 4465 doi: 10.3390/nu15204465
|
| 187 |
Nobuhiko Fukuba, Hitomi Ishitobi, Yoshiko Takahashi, Makoto Nagaoka, Hiroyuki Fukuhara, Mika Yuki, Yoshinori Komazawa, Hiroyuki Kuroda, Shuichi Sato, Toshihiro Shizuku. Real-world Evidence of Diffusion-weighted Imaging Combined With Magnetic Resonance Cholangiopancreatography for Pancreatic Tumor Screening. Pancreas 2020; 49(9): 1182 doi: 10.1097/MPA.0000000000001653
|
| 188 |
Muttanagouda Giriyappagoudar, Basavaraj Vastrad, Rajeshwari Horakeri, Chanabasayya Vastrad. Identification and Interaction Analysis of Molecular Markers in Pancreatic Ductal Adenocarcinoma by Bioinformatics and Next-Generation Sequencing Data Analysis. Bioinformatics and Biology Insights 2023; 17 doi: 10.1177/11779322231186719
|
| 189 |
Iga Gromny, Katarzyna Neubauer. Pancreatic Cancer in Celiac Disease Patients—A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health 2023; 20(2): 1565 doi: 10.3390/ijerph20021565
|
| 190 |
Waqas Farooqui, Karina Adler Riemenschneider, Luit Penninga, Christian Dacesin Vyrdal, Carsten Palnaes Hansen, Jan Henrik Storkholm. The diagnostic value of C-reactive protein for predicting pancreatic fistula following pancreatoduodenectomy. Scandinavian Journal of Gastroenterology 2021; 56(3): 329 doi: 10.1080/00365521.2020.1867895
|
| 191 |
Yang Guo, Ferenc Czeyda-Pommersheim, Joseph A. Miccio, Sowmya Mahalingam, Michael Cecchini, Jay Pahade. Can a simplified CT response criteria for vascular involvement in pancreatic adenocarcinoma after neoadjuvant therapy predict survival in patients who achieved subsequent R0 resection?. Abdominal Radiology 2021; 46(12): 5609 doi: 10.1007/s00261-021-03284-5
|
| 192 |
Grigory Karmazanovsky, Ivan Gruzdev, Valeriya Tikhonova, Evgeny Kondratyev, Amiran Revishvili. Computed tomography-based radiomics approach in pancreatic tumors characterization. La radiologia medica 2021; 126(11): 1388 doi: 10.1007/s11547-021-01405-0
|
| 193 |
Yang Zhang, Anqing Lu, Zixuan Zhuang, Su Zhang, Sicheng Liu, Haining Chen, Xuyang Yang, Ziqiang Wang. Can Organoid Model Reveal a Key Role of Extracellular Vesicles in Tumors? A Comprehensive Review of the Literature. International Journal of Nanomedicine 2023; : 5511 doi: 10.2147/IJN.S424737
|
| 194 |
Shang-Long Liu, Shuo Li, Yu-Ting Guo, Yun-Peng Zhou, Zheng-Dong Zhang, Shuai Li, Yun Lu. Establishment and application of an artificial intelligence diagnosis system for pancreatic cancer with a faster region-based convolutional neural network. Chinese Medical Journal 2019; 132(23): 2795 doi: 10.1097/CM9.0000000000000544
|
| 195 |
Pawan Kedar, Apeksha Saraf, Rahul Maheshwari, Mayank Sharma. Advances in Dendritic Systems and Dendronized Nanoparticles: Paradigm Shifts in Cancer Targeted Therapy and Diagnostics. Molecular Pharmaceutics 2025; 22(1): 28 doi: 10.1021/acs.molpharmaceut.4c00856
|
| 196 |
Hariss G Paremes Sivam, Beek Yoke Chin, Sook Yee Gan, Jia Hao Ng, Agnes Gwenhure, Elaine Wan Ling Chan. Lipopolysaccharide (LPS) stimulation of Pancreatic Ductal Adenocarcinoma (PDAC) and macrophages activates the NLRP3 inflammasome that influences the levels of pro-inflammatory cytokines in a co-culture model. Cancer Biology & Therapy 2023; 24(1) doi: 10.1080/15384047.2023.2284857
|
| 197 |
Panpan Wu, Xiao Wang, Yuran Ma, Xuetao Xu, Wenfeng Liu, Zhaojun Sheng, Min Chen, Renping Zhou, Kun Zhang, Susan Goodin, Xi Zheng, Dongli Li. (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancreatic cancer cells. Bioorganic Chemistry 2020; 101: 104022 doi: 10.1016/j.bioorg.2020.104022
|
| 198 |
Xueyong Zheng, Xiaolong Liu, Haishui Zheng, Huina Wang, Defei Hong. Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma. International Immunopharmacology 2021; 90: 106982 doi: 10.1016/j.intimp.2020.106982
|
| 199 |
Maria Urbanova, Marina Cihova, Verona Buocikova, Jan Slopovsky, Peter Dubovan, Daniel Pindak, Miroslav Tomas, Laura García-Bermejo, Mercedes Rodríguez-Garrote, Julie Earl, Yvonne Kohl, Agapi Kataki, Maria Dusinska, Bruno Sainz, Bozena Smolkova, Alena Gabelova. Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival. Biomedicine & Pharmacotherapy 2023; 165: 115179 doi: 10.1016/j.biopha.2023.115179
|
| 200 |
SANDRA STICKLER, BARBARA RATH, GERHARD HAMILTON. Targeting KRAS in pancreatic cancer. Oncology Research 2024; 32(5): 799 doi: 10.32604/or.2024.045356
|
| 201 |
S. B. Akopov, E. V. Snezhkov, M. V. Konovalova, M. A. Kostromina, R. S. Esipov, E. V. Svirshchevskaya. Pan02 pancreatic tumor models carrying the GFP marker in mice. Medical Immunology (Russia) 2024; 26(5): 1099 doi: 10.15789/1563-0625-PPT-16858
|
| 202 |
Daisuke Nose, Masahiro Sugimoto, Tsuneo Muta, Shin-Ichiro Miura. Salivary Polyamines Help Detect High-Risk Patients with Pancreatic Cancer: A Prospective Validation Study. International Journal of Molecular Sciences 2023; 24(3): 2998 doi: 10.3390/ijms24032998
|
| 203 |
Madeline T. Olson, Nicholas E. Wojtynek, Thomas C. Caffrey, Prakash Radhakrishnan, Quan P. Ly, Geoffrey A. Talmon, Michael A. Hollingsworth, Aaron M. Mohs, Summer L. Gibbs, Brian W. Pogue, Sylvain Gioux. MUC16 as a potential target for the surgical detection of pancreatic cancer. Molecular-Guided Surgery: Molecules, Devices, and Applications VI 2020; : 21 doi: 10.1117/12.2550648
|
| 204 |
Naoomi Tominaga. Anti-Cancer Role and Therapeutic Potential of Extracellular Vesicles. Cancers 2021; 13(24): 6303 doi: 10.3390/cancers13246303
|
| 205 |
B. Salas, L. Ferrera-Alayón, A. Espinosa-López, A. Vera-Rosas, E. Salcedo, A. Kannemann, A. Alayon, R. Chicas-Sett, M. LLoret, P.C. Lara. Dose-escalated SBRT for borderline and locally advanced pancreatic cancer. Feasibility, safety and preliminary clinical results of a multicenter study. Clinical and Translational Radiation Oncology 2024; 45: 100753 doi: 10.1016/j.ctro.2024.100753
|
| 206 |
Ting Shi, Ge Gao. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma. Bioscience Reports 2022; 42(2) doi: 10.1042/BSR20212523
|
| 207 |
Ai-Lin Wei, Mao Li, Guo-Qing Li, Xuan Wang, Wei-Ming Hu, Zhen-Lu Li, Jue Yuan, Hong-Ying Liu, Li-Li Zhou, Ka Li, Ang Li, Mei Rosemary Fu. Oral microbiome and pancreatic cancer. World Journal of Gastroenterology 2020; 26(48): 7679-7692 doi: 10.3748/wjg.v26.i48.7679
|
| 208 |
Breanna C. Perlmutter, Mir Shanaz Hossain, Robert Naples, Chao Tu, Valery Vilchez, John McMichael, Katherine Tullio, Robert Simon, R. Matthew Walsh, Toms Augustin. Survival impact based on hepatic artery lymph node status in pancreatic adenocarcinoma: A study of patients receiving modern chemotherapy. Journal of Surgical Oncology 2021; 123(2): 399 doi: 10.1002/jso.26281
|
| 209 |
Leonardo Mercanti, Maria Sindaco, Mariangela Mazzone, Maria Carmela Di Marcantonio, Mariagrazia Piscione, Raffaella Muraro, Gabriella Mincione. PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies. Cancers 2023; 15(11): 2923 doi: 10.3390/cancers15112923
|
| 210 |
Craig M. Goodwin, Andrew M. Waters, Jennifer E. Klomp, Sehrish Javaid, Kirsten L. Bryant, Clint A. Stalnecker, Kristina Drizyte-Miller, Bjoern Papke, Runying Yang, Amber M. Amparo, Irem Ozkan-Dagliyan, Elisa Baldelli, Valerie Calvert, Mariaelena Pierobon, Jessica A. Sorrentino, Andrew P. Beelen, Natalie Bublitz, Mareen Lüthen, Kris C. Wood, Emanuel F. Petricoin, Christine Sers, Autumn J. McRee, Adrienne D. Cox, Channing J. Der. Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer. Cancer Research 2023; 83(1): 141 doi: 10.1158/0008-5472.CAN-22-0391
|
| 211 |
Chaojun Wang, Shengqian Xu, Yong Qin. Tumor-derived exosome PPP3CB induce gemcitabine resistance by regulating miR-298/STAT3 in pancreatic cancer. Heliyon 2024; 10(16): e36434 doi: 10.1016/j.heliyon.2024.e36434
|
| 212 |
Danna Xie, Baolin Qian, Jing Yang, Xinya Peng, Yinghua Li, Teng Hu, Simin Lu, Xiaojing Chen, Yunwei Han. Can Elderly Patients With Pancreatic Cancer Gain Survival Advantages Through More Radical Surgeries? A SEER-Based Analysis. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.598048
|
| 213 |
Alessandro Di Federico, Valentina Tateo, Claudia Parisi, Francesca Formica, Riccardo Carloni, Giorgio Frega, Alessandro Rizzo, Dalia Ricci, Mariacristina Di Marco, Andrea Palloni, Giovanni Brandi. Hacking Pancreatic Cancer: Present and Future of Personalized Medicine. Pharmaceuticals 2021; 14(7): 677 doi: 10.3390/ph14070677
|
| 214 |
Samuel Amintas, Benjamin Fernandez, Alexandre Chauvet, Laurence Chiche, Christophe Laurent, Geneviève Belleannée, Marion Marty, Etienne Buscail, Sandrine Dabernat. KRAS gene mutation quantification in the resection or venous margins of pancreatic ductal adenocarcinoma is not predictive of disease recurrence. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-07004-x
|
| 215 |
Carlo Caputo, Michela Falco, Anna Grimaldi, Angela Lombardi, Chiara Carmen Miceli, Mariateresa Cocule, Marco Montella, Luca Pompella, Giuseppe Tirino, Severo Campione, Chiara Tammaro, Antonio Cossu, Grazia Fenu Pintori, Margherita Maioli, Donatella Coradduzza, Giovanni Savarese, Antonio Fico, Alessandro Ottaiano, Giovanni Conzo, Madhura S. Tathode, Fortunato Ciardiello, Michele Caraglia, Ferdinando De Vita, Gabriella Misso. Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma. Cancers 2024; 16(4): 824 doi: 10.3390/cancers16040824
|
| 216 |
Patrik Larsson, Kari Feldt, Marcus Holmberg, Oskar Swartling, Ernesto Sparrelid, Fredrik Klevebro, Poya Ghorbani. Preoperative heart disease and risk for postoperative complications after pancreatoduodenectomy. HPB 2022; 24(11): 1854 doi: 10.1016/j.hpb.2022.07.002
|
| 217 |
Bo Zhu, Ruwei Huo, Qi Zhi, Mingjie Zhan, Xiao Chen, Zi-Chun Hua. Increased expression of zinc transporter ZIP4, ZIP11, ZnT1, and ZnT6 predicts poor prognosis in pancreatic cancer. Journal of Trace Elements in Medicine and Biology 2021; 65: 126734 doi: 10.1016/j.jtemb.2021.126734
|
| 218 |
Somayeh Jafari, Hossein Motedayyen, Parisa Javadi, Kazem Jamali, Amin Moradi Hasan-Abad, Amir Atapour, Gholamreza Anani Sarab. The roles of lncRNAs and miRNAs in pancreatic cancer: a focus on cancer development and progression and their roles as potential biomarkers. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1355064
|
| 219 |
Ali Tavakoli Pirzaman, Pouyan Ebrahimi, Shokat Niknezhad, Turan vahidi, Dariush Hosseinzadeh, Sousan Akrami, Arash M Ashrafi, Mohammad Moeen Velayatimehr, Rezvan Hosseinzadeh, Sohrab Kazemi. Toxic mechanisms of cadmium and exposure as a risk factor for oral and gastrointestinal carcinomas. Human & Experimental Toxicology 2023; 42 doi: 10.1177/09603271231210262
|
| 220 |
Madeline Kubiseski, Min Hu, Mohammad Hajizadeh. Trends in socioeconomic inequalities in pancreatic cancer mortality in Canada: Evidence from the Canadian Vital Statistics Death Database. Surgical Oncology Insight 2024; 1(2): 100051 doi: 10.1016/j.soi.2024.100051
|
| 221 |
Byung Soo Kwan, Ok Jae Lee, Hyun Jin Kim, Kwang Min Kim, Sang Goon Shim, Dae Hyeon Cho, Sung Min Kong, Jun Young Kim, Jun Ho Ji. Efficacy and Safety of Chemotherapy in Elderly Patients with Unresectable Pancreatic Cancer. Journal of Clinical Medicine 2023; 12(9): 3334 doi: 10.3390/jcm12093334
|
| 222 |
Adriana Bueno, Aloisio Felipe‐Silva, Mauro Saieg. Small biopsies for pancreatic lesions: Is there still room for fine needle aspiration?. Cytopathology 2024; 35(1): 70 doi: 10.1111/cyt.13323
|
| 223 |
Kazuki Kobayashi, Yoji Kishi, Takazumi Tsunenari, Naoto Yonamine, Yasuhiro Takihata, Akiko Nakazawa, Mikiya Takao, Takahiro Einama, Hironori Tsujimoto, Hideki Ueno. Risk of hepatic steatosis with the preoperative treatment of pancreatic cancer and the short-term postoperative outcomes. Surgery Today 2025; 55(2): 211 doi: 10.1007/s00595-024-02895-x
|
| 224 |
Tingting Zhang, Hongyang Yu, Yuxian Bai, Jiaming Song, Jiexin Chen, Yingjie Li, Yue Cui. Extracellular vesicle-derived LINC00511 promotes glycolysis and mitochondrial oxidative phosphorylation of pancreatic cancer through macrophage polarization by microRNA-193a-3p-dependent regulation of plasminogen activator urokinase. Immunopharmacology and Immunotoxicology 2023; 45(3): 355 doi: 10.1080/08923973.2022.2145968
|
| 225 |
Ying Zhu, Jianbo Tian, Xiating Peng, Xiaoyang Wang, Nan Yang, Pingting Ying, Haoxue Wang, Bin Li, Yue Li, Ming Zhang, Yimin Cai, Zequn Lu, Siyuan Niu, Yao Li, Rong Zhong, Jiang Chang, Xiaoping Miao. A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosis. European Journal of Cancer 2021; 151: 94 doi: 10.1016/j.ejca.2021.04.008
|
| 226 |
Ahamed Basha Abdul Bari, Prince Johnson Samuel. Therapeutic Proteins Against Human Diseases. 2022; : 125 doi: 10.1007/978-981-16-7897-4_8
|
| 227 |
Peter De Rosa, Anna Jewell. The potential use for patient reported outcome measures in people with pancreatic cancer, with a specific focus on older patients. European Journal of Surgical Oncology 2021; 47(3): 495 doi: 10.1016/j.ejso.2020.05.010
|
| 228 |
Hindole Ghosh, Sangita Bhattacharyya, Rainer Schobert, Prasad Dandawate, Bernhard Biersack. Fluorinated and N-Acryloyl-Modified 3,5-Di[(E)-benzylidene]piperidin-4-one Curcuminoids for the Treatment of Pancreatic Carcinoma. Pharmaceutics 2023; 15(7): 1921 doi: 10.3390/pharmaceutics15071921
|
| 229 |
Mohammad A. Anwar, Ammar H. Keshteli, Haiyan Yang, Windy Wang, Xukun Li, Helen M. Messier, Pieter R. Cullis, Christoph H. Borchers, Robert Fraser, David S. Wishart. Blood-Based Multiomics-Guided Detection of a Precancerous Pancreatic Tumor. OMICS: A Journal of Integrative Biology 2024; 28(4): 182 doi: 10.1089/omi.2023.0278
|
| 230 |
Samuel H. Cass, Loretta A. Williams, Ravi Rajaram, Yuki Hirata, David Rice, Ching‐Wei D. Tzeng, Matthew H. G. Katz, Brian D. Badgwell, Xin Shelley Wang, Naruhiko Ikoma. Patient‐reported outcome measures in surgical patients with upper gastrointestinal cancers: A qualitative interview study. Journal of Surgical Oncology 2024; 130(1): 117 doi: 10.1002/jso.27687
|
| 231 |
U. A. Wittel, D. Lubgan, M. Ghadimi, O. Belyaev, W. Uhl, W. O. Bechstein, R. Grützmann, W. M. Hohenberger, A. Schmid, L. Jacobasch, R. S. Croner, A. Reinacher-Schick, U. T. Hopt, A. Pirkl, H. Oettle, R. Fietkau, H. Golcher. Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma – results of the Conko-007 multicenter trial. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6148-5
|
| 232 |
Semim Akhtar Ahmed, Dey Parama, Enush Daimari, Sosmitha Girisa, Kishore Banik, Choudhary Harsha, Uma Dutta, Ajaikumar B. Kunnumakkara. Rationalizing the therapeutic potential of apigenin against cancer. Life Sciences 2021; 267: 118814 doi: 10.1016/j.lfs.2020.118814
|
| 233 |
Ashok Kumar Balaraman, Ehssan Moglad, Muhammad Afzal, M Arockia Babu, Kavita Goyal, R. Roopashree, Irwanjot Kaur, Sachin Kumar, MRavi Kumar, Ashish Singh Chauhan, S. Hemalatha, Gaurav Gupta, Haider Ali. Liquid biopsies and exosomal ncRNA: Transforming pancreatic cancer diagnostics and therapeutics. Clinica Chimica Acta 2025; 567: 120105 doi: 10.1016/j.cca.2024.120105
|
| 234 |
Olamide T. Olaoba, Temitope I. Adelusi, Ming Yang, Tessa Maidens, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Guangfu Li. Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy. Cancers 2024; 16(10): 1808 doi: 10.3390/cancers16101808
|
| 235 |
Prateek Suresh Harne, Vaishali Harne, Curtis Wray, Nirav Thosani. Endoscopic innovations in diagnosis and management of pancreatic cancer: a narrative review and future directions. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241297434
|
| 236 |
Diana Pinkert-Leetsch, Jasper Frohn, Philipp Ströbel, Frauke Alves, Tim Salditt, Jeannine Missbach-Guentner. Three-dimensional analysis of human pancreatic cancer specimens by phase-contrast based X-ray tomography – the next dimension of diagnosis. Cancer Imaging 2023; 23(1) doi: 10.1186/s40644-023-00559-6
|
| 237 |
Pengyu Li, Hanyu Zhang, Lixin Chen, Xingyu Gao, Ya Hu, Qiang Xu, Wenjing Liu, Weijie Chen, Haomin Chen, Shuai Yuan, Mingfei Wang, Shili Liu, Menghua Dai. Oral and fecal microbiota as accurate non-invasive tools for detection of pancreatic cancer in the Chinese population. Cancer Letters 2025; 612: 217456 doi: 10.1016/j.canlet.2025.217456
|
| 238 |
Sonia Perales, Carolina Torres, Cristina Jimenez-Luna, Jose Prados, Joaquina Martinez-Galan, Jose Manuel Sanchez-Manas, Octavio Caba. Liquid biopsy approach to pancreatic cancer. World Journal of Gastrointestinal Oncology 2021; 13(10): 1263-1287 doi: 10.4251/wjgo.v13.i10.1263
|
| 239 |
Tatsuya Onishi, Kisyo Mihara, Sachiko Matsuda, Satoshi Sakamoto, Akihiro Kuwahata, Masaki Sekino, Moriaki Kusakabe, Hiroshi Handa, Yuko Kitagawa. Application of Magnetic Nanoparticles for Rapid Detection and In Situ Diagnosis in Clinical Oncology. Cancers 2022; 14(2): 364 doi: 10.3390/cancers14020364
|
| 240 |
Man Kyu Shim, Jinhee Na, In Kyung Cho, Eun Hyang Jang, Jooho Park, Sangmin Lee, Jong-Ho Kim. Targeting of claudin-4 by Clostridium perfringens enterotoxin-conjugated polysialic acid nanoparticles for pancreatic cancer therapy. Journal of Controlled Release 2021; 331: 434 doi: 10.1016/j.jconrel.2021.01.031
|
| 241 |
Pratibha Malhotra, Ranjith Palanisamy, Jose A. Caparros-Martin, Marco Falasca. Bile Acids and Microbiota Interplay in Pancreatic Cancer. Cancers 2023; 15(14): 3573 doi: 10.3390/cancers15143573
|
| 242 |
Narmeen Al-Awwad, Sabika Allehdan, Tareq Al-Jaberi, Ahmad Hushki, Yazan Albtoush, Kamal Bani-Hani, Reema Fayez Tayyem. Dietary and Lifestyle Factors Associated with Gastric and Pancreatic Cancers: A Case-Control Study. Preventive Nutrition and Food Science 2021; 26(1): 30 doi: 10.3746/pnf.2021.26.1.30
|
| 243 |
Cheng Wei, Yi-Chen Li, Hong-Tao Jin, De-Feng Li, Li-Sheng Wang, Jun Yao. Early detection of pancreatic cancer in patients with recurrent pancreatitis: A case report. World Journal of Clinical Cases 2024; 12(19): 3936-3941 doi: 10.12998/wjcc.v12.i19.3936
|
| 244 |
Oğuz Kağan Bakkaloğlu, Tuğçe Eşkazan, İlkay Gültürk, Süleyman Yıldırım, Kadri Atay, Nuray Kepil, Yusuf Erzin, Ahmet Merih Dobrucalı. Partial Atrophy of The Pancreas in Endoscopic Ultrasonography may be a Sign of Pancreatic Cancer. Istanbul Medical Journal 2023; 24(2): 210 doi: 10.4274/imj.galenos.2023.52386
|
| 245 |
Stina Margrethe Stålberg, Laxmi Silwal-Pandit, Nasser Ezzatkhah Bastani, Daniel Johan Hammer Nebdal, Ole Christian Lingjærde, Bjørn Steen Skålhegg, Elin Hegland Kure. Preoperative profiles of plasma amino acids and derivatives distinguish periampullary cancer and benign disease. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12320-8
|
| 246 |
Jian Cheng, Yanghui Lou, Kai Jiang. Downregulation of long non-coding RNA LINC00460 inhibits the proliferation, migration and invasion, and promotes apoptosis of pancreatic cancer cells via modulation of the miR-320b/ARF1 axis. Bioengineered 2021; 12(1): 96 doi: 10.1080/21655979.2020.1863035
|
| 247 |
Giulia Girolimetti, Barbara Balena, Paola Cordella, Tiziano Verri, Leonardo Henry Eusebi, Maria Pia Bozzetti, Cecilia Bucci, Flora Guerra. Characterization of Chemoresistance in Pancreatic Cancer: A Look at MDR-1 Polymorphisms and Expression in Cancer Cells and Patients. International Journal of Molecular Sciences 2024; 25(15): 8515 doi: 10.3390/ijms25158515
|
| 248 |
Sami Shoucair, Jianan Chen, James R. Martinson, Joseph R. Habib, Benedict Kinny-Köster, Ning Pu, A. Floortje van Oosten, Ammar A. Javed, Eun Ji Shin, Syed Z. Ali, Kelly J. Lafaro, Christopher L. Wolfgang, Jin He, Jun Yu. Association of Matrix Metalloproteinase 7 Expression With Pathologic Response After Neoadjuvant Treatment in Patients With Resected Pancreatic Ductal Adenocarcinoma. JAMA Surgery 2022; 157(7): e221362 doi: 10.1001/jamasurg.2022.1362
|
| 249 |
Kai Siang Chan, Sameer Padmakumar Junnarkar, Bei Wang, Yen Pin Tan, Jee Keem Low, Cheong Wei Terence Huey, Vishalkumar Girishchandra Shelat. Outcomes of an outpatient home-based prehabilitation program before pancreaticoduodenectomy: A retrospective cohort study. Annals of Hepato-Biliary-Pancreatic Surgery 2022; 26(4): 375 doi: 10.14701/ahbps.22-028
|
| 250 |
Galab M. Hassan, Louise Laporte, Sarto C. Paquin, Charles Menard, Anand V. Sahai, Benoît Mâsse, Helen Trottier. Endoscopic Ultrasound Guided Fine Needle Aspiration versus Endoscopic Ultrasound Guided Fine Needle Biopsy for Pancreatic Cancer Diagnosis: A Systematic Review and Meta-Analysis. Diagnostics 2022; 12(12): 2951 doi: 10.3390/diagnostics12122951
|
| 251 |
Masashi Utsumi, Masaru Inagaki, Koji Kitada, Naoyuki Tokunaga, Kosuke Yunoki, Hiroki Okabayashi, Ryosuke Hamano, Hideaki Miyasou, Yousuke Tsunemitsu, Shinya Otsuka, Takehiko Hanaki. Combination of sarcopenia and systemic inflammation-based markers for predicting the prognosis of patients undergoing pancreaticoduodenectomy for pancreatic cancer. PLOS ONE 2024; 19(6): e0305844 doi: 10.1371/journal.pone.0305844
|
| 252 |
Filipe Marques, Francisco Baldaque‐Silva, Wouter van der Wijngaart, Urban Arnelo, Niclas Roxhed. A loop‐shaped minimally invasive brush for improved cytology sampling of pancreatic cysts during EUS‐FNA. MEDICAL DEVICES & SENSORS 2021; 4(1) doi: 10.1002/mds3.10165
|
| 253 |
Zekiye Altan, Yunus Sahin. miR-203 suppresses pancreatic cancer cell proliferation and migration by modulating DUSP5 expression. Molecular and Cellular Probes 2022; 66: 101866 doi: 10.1016/j.mcp.2022.101866
|
| 254 |
Patrick L. Quinn, Donald Ohioma, Anja M.K. Jones, Sushil K. Ahlawat, Ravi J. Chokshi. Treatment of Rare and Aggressive Pancreatic Carcinosarcoma. ACG Case Reports Journal 2020; 7(5): e00379 doi: 10.14309/crj.0000000000000379
|
| 255 |
Zahra Tolou-Ghamari. Pancreatic cancer: Demographics and prevalence. Clinical Cancer Investigation Journal 2020; 9(4): 155 doi: 10.4103/ccij.ccij_13_20
|
| 256 |
Ji Eun Lee, Yeo Wool Kang, Kyung Hee Jung, Mi Kwon Son, Seung-Min Shin, Ji-Sun Kim, Soo Jung Kim, Zhenghuan Fang, Hong Hua Yan, Jung Hee Park, Young-Chan Yoon, Boreum Han, Min Ji Cheon, Min Gyu Woo, Myung Sung Seo, Joo Han Lim, Yong-Sung Kim, Soon-Sun Hong. Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escape. Cancer Letters 2021; 507: 97 doi: 10.1016/j.canlet.2021.03.015
|
| 257 |
Goutam Chowdhury, Dharanidharan Ramamurthy. Human Microbiome. 2022; : 73 doi: 10.1007/978-981-16-7672-7_4
|
| 258 |
Stefano Partelli, Francesco Sclafani, Sorin Traian Barbu, Marc Beishon, Pierluigi Bonomo, Graça Braz, Filippo de Braud, Thomas Brunner, Giulia Martina Cavestro, Mirjam Crul, Maria Die Trill, Piero Ferollà, Ken Herrmann, Eva Karamitopoulou, Cindy Neuzillet, Franco Orsi, Hanna Seppänen, Martina Torchio, Danila Valenti, Giulia Zamboni, Marc Zins, Alberto Costa, Philip Poortmans. European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer. Cancer Treatment Reviews 2021; 99: 102208 doi: 10.1016/j.ctrv.2021.102208
|
| 259 |
Varintra E. Lander, Jad I. Belle, Natalie L. Kingston, John M. Herndon, Graham D. Hogg, Xiuting Liu, Liang-I Kang, Brett L. Knolhoff, Savannah J. Bogner, John M. Baer, Chong Zuo, Nicholas C. Borcherding, Daniel P. Lander, Cedric Mpoy, Jalen Scott, Michael Zahner, Buck E. Rogers, Julie K. Schwarz, Hyun Kim, David G. DeNardo. Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade. Cancer Discovery 2022; 12(12): 2774 doi: 10.1158/2159-8290.CD-22-0192
|
| 260 |
A. Carrato, L. Cerezo, J. Feliu, T. Macarulla, E. Martín-Pérez, R. Vera, J. Álvarez, J. I. Botella-Carretero. Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus. Clinical and Translational Oncology 2022; 24(1): 112 doi: 10.1007/s12094-021-02674-x
|
| 261 |
Alberto Nicoletti, Marcantonio Negri, Mattia Paratore, Federica Vitale, Maria Elena Ainora, Enrico Celestino Nista, Antonio Gasbarrini, Maria Assunta Zocco, Lorenzo Zileri Dal Verme. Diagnostic and Prognostic Role of Extracellular Vesicles in Pancreatic Cancer: Current Evidence and Future Perspectives. International Journal of Molecular Sciences 2023; 24(1): 885 doi: 10.3390/ijms24010885
|
| 262 |
Małgorzata Guz, Witold Jeleniewicz, Marek Cybulski. An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential. International Journal of Molecular Sciences 2022; 23(3): 1234 doi: 10.3390/ijms23031234
|
| 263 |
Elisabetta Pilotti, Tiziana Cassetti, Vincenzo G. Mirante, Giuliana Sereni, Paolo Giorgi Rossi, Romano Sassatelli. Exhaled breath condensate proteomic signatures potentially distinguish adenocarcinoma from benign cystic lesions of the pancreas. Current Research in Translational Medicine 2022; 70(4): 103361 doi: 10.1016/j.retram.2022.103361
|
| 264 |
Chen-Xu Ni, Yu Zhao, Hong Qian, Hui Fu, Yu-Ying Yan, Yu-Shuang Qiu, Can-Can Zhou, Fang Huang, Fu-Ming Shen, Dong-Jie Li, Qing Xu. Long survival in a pancreatic carcinoma patient with multi-organ toxicities after sintilimab treatment: A case report. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1121122
|
| 265 |
Anne Sofie Bruun‐Sørensen, Sarannya Edamana, Frédéric H. Login, Signe Borgquist, Lene N. Nejsum. Aquaporins in pancreatic ductal adenocarcinoma. APMIS 2021; 129(12): 700 doi: 10.1111/apm.13184
|
| 266 |
Eetu Heervä, Vesa Väliaho, Heidi Nurmi, Elina Lietzen, Annika Ålgars, Saila Kauhanen. Outcomes After Multimodality Treatment of Pancreatic Cancer in an Unselected Single-Center Cohort. Cancer Management and Research 2024; : 1065 doi: 10.2147/CMAR.S465512
|
| 267 |
Katarzyna Ratajczak, Natalia Glatzel-Plucińska, Katarzyna Ratajczak-Wielgomas, Katarzyna Nowińska, Sylwia Borska. Effect of Resveratrol Treatment on Human Pancreatic Cancer Cells through Alterations of Bcl-2 Family Members. Molecules 2021; 26(21): 6560 doi: 10.3390/molecules26216560
|
| 268 |
Danlei Ni, Jiayi Wu, Jingjing Pan, Yajing Liang, Zihui Xu, Zhiying Yan, Kequn Xu, Feifei Wei. The value of a metabolic and immune-related gene signature and adjuvant therapeutic response in pancreatic cancer. Frontiers in Genetics 2025; 15 doi: 10.3389/fgene.2024.1475378
|
| 269 |
Xueli Fu, Jiaqi Ma, Fangyuan Ma, Shiman Guo, Xue Wang, Ye Li, Yanxin Tang, Jingwei Qi, Weiying Zhang, Lihong Ye. MISP-mediated enhancement of pancreatic cancer growth through the Wnt/β-catenin signaling pathway is suppressed by Fisetin. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2025; 1871(1): 167515 doi: 10.1016/j.bbadis.2024.167515
|
| 270 |
Yixing Yao, Rui Zhan, Chanchan Gong, Jiaying Lv, Xialiang Lu. Clinicopathological and prognostic values of MET expression in pancreatic adenocarcinoma based on bioinformatics analysis. Medicine 2023; 102(41): e34656 doi: 10.1097/MD.0000000000034656
|
| 271 |
Kang Hee Lee, Seung Soo Hong, Seung-seob Kim, Ho Kyoung Hwang, Woo Jung Lee, Chang Moo Kang. Laparoscopic distal pancreatosplenectomy for left-sided pancreatic cancer in patients with radical subtotal gastrectomy for gastric cancer. Annals of Hepato-Biliary-Pancreatic Surgery 2022; 26(4): 395 doi: 10.14701/ahbps.22-016
|
| 272 |
Oluseyi Abidoye, Young Min Cho, Sheena Bhushan, Comfort Adewunmi, Hasan Choudhury. Trends in pancreatic cancer incidence and mortality in the United States from 2000 to 2019; a SEER based study. F1000Research 2023; 12: 15 doi: 10.12688/f1000research.122872.1
|
| 273 |
Xueyuan Bi, Jihan Wang, Cuicui Liu. Intratumoral Microbiota: Metabolic Influences and Biomarker Potential in Gastrointestinal Cancer. Biomolecules 2024; 14(8): 917 doi: 10.3390/biom14080917
|
| 274 |
Boma E Jacks, Chinwendum U Ekpemiro, Adeyemi A Adeosun, Uchechukwu O Ogbonna, Faithful T Ogundiran, Funmilola Babalola, Nkemputaife P Onyechi, Olamide O Ajayi, Maureen G Boms, Adaugo N Nwanguma, Uduak A Udo, Okelue E Okobi, Evidence E Ohikhuai, Endurance O Evbayekha. Molecular Markers of Pancreatic Cancer: A 10-Year Retrospective Review of Molecular Advances. Cureus 2022; doi: 10.7759/cureus.29485
|
| 275 |
Chandra Kumar Elechalawar, Md Nazir Hossen, Priya Shankarappa, Cody J Peer, William D Figg, J David Robertson, Resham Bhattacharya, Priyabrata Mukherjee. <p>Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro</p>. International Journal of Nanomedicine 2020; : 991 doi: 10.2147/IJN.S234112
|
| 276 |
Sarah Clelland, Christina L. Nuttall, Helen E. Stott, Joseph Cope, Natalie L. Barratt, Kelly Farrell, Manyi V. Eyong, Jack P. Gleeson, Angela Lamarca, Richard A. Hubner, Juan W. Valle, Mairéad G. McNamara. Prognosis Discussion and Referral to Community Palliative Care Services in Patients with Advanced Pancreatic Cancer Treated in a Tertiary Cancer Centre. Healthcare 2023; 11(20): 2802 doi: 10.3390/healthcare11202802
|
| 277 |
Shuai Xu, Hui-lan Wang, Chao Xia, Jun Lv, Gang Zhang. Associations Between Poor Oral Hygiene and Risk of Pancreatic Cancer. Pancreas 2022; 51(8): 985 doi: 10.1097/MPA.0000000000002143
|
| 278 |
Laura A Rechner, Mette Felter, Susanne Bekke, Susan Biancardo, Marianne F Rønjom, Mette Pedersen, David Sjöström, Inna M Chen, Patrik Sibolt. Transition of Online Adaptive Stereotactic Radiotherapy for Pancreatic Cancer From Magnetic Resonance-Guided Linear Accelerator (MR-Linac) to State-of-the-Art Cone-Beam Computed Tomography (CBCT). Cureus 2024; doi: 10.7759/cureus.68386
|
| 279 |
Eiman Abdo, Mohammad A. Ismail, Sabal Al Hadidi, Mairvat Al-Mrahleh, Tareq Saleh, Malik Zihlif, Nidaa A. Ababneh, Khushboo Irshad. Effect of cytotoxic CD8+ T-cells secretory proteins on hypoxic pancreatic cancer cells. PLOS ONE 2025; 20(1): e0311615 doi: 10.1371/journal.pone.0311615
|
| 280 |
Randa G. Hanna-Sawires, Jorinde H. Schiphuis, Manfred Wuhrer, Hans F. A. Vasen, Monique E. van Leerdam, Bert A. Bonsing, Wilma E. Mesker, Yuri E. M. van der Burgt, Rob A. E. M. Tollenaar. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. International Journal of Molecular Sciences 2021; 22(5): 2655 doi: 10.3390/ijms22052655
|
| 281 |
Katarzyna Nadolska, Agnieszka Białecka, Elżbieta Zawada, Wojciech Kazimierczak, Zbigniew Serafin. Analysis of IVIM Perfusion Fraction Improves Detection of Pancreatic Ductal Adenocarcinoma. Diagnostics 2024; 14(6): 571 doi: 10.3390/diagnostics14060571
|
| 282 |
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Hisayuki Amano, Masahiko Honda, Masahito Kawazu, Hitoshi Okada. MYC/Glutamine Dependency Is a Therapeutic Vulnerability in Pancreatic Cancer with Deoxycytidine Kinase Inactivation-Induced Gemcitabine Resistance. Molecular Cancer Research 2023; 21(5): 444 doi: 10.1158/1541-7786.MCR-22-0554
|
| 283 |
Teizo Asano, Tomohiro Tanaka, Hiroyuki Suzuki, Guanjie Li, Tomokazu Ohishi, Manabu Kawada, Takeo Yoshikawa, Mika K. Kaneko, Yukinari Kato. A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG2a-f) Exerts Antitumor Activity in Xenograft Model. Antibodies 2022; 11(4): 74 doi: 10.3390/antib11040074
|
| 284 |
Ryodai YAMAMURA, Masahiro SONOSHITA. Fecal microbiota transplantation as a novel therapeutic strategy for pancreatic cancer. Translational and Regulatory Sciences 2025; doi: 10.33611/trs.2025-003
|
| 285 |
Noor Mohamad, Amirah Rahman, Siti Hamimah Sheikh Abdul Kadir. Hydroxychavicol as a potential anticancer agent (Review). Oncology Letters 2022; 25(1) doi: 10.3892/ol.2022.13620
|
| 286 |
Michael A. McHugh, Nealie T. Ngo, Anthony C. Mitchell, Susan M. Morand, Sean T. Mack, Punit Kaur, Alexzander Asea. Signaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targets. International Journal of Molecular and Immuno Oncology 2023; 8: 93 doi: 10.25259/IJMIO_29_2022
|
| 287 |
Jiacheng Huang, Zhitao Chen, Chenchen Ding, Shengzhang Lin, Dalong Wan, Kuiwu Ren. Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.711402
|
| 288 |
Bohan Yang, Kai Chen, Weikang Liu, Di Long, Yingjin Wang, Xinxin Liu, Yongsu Ma, Xiaodong Tian, Yinmo Yang. The benefits of neoadjuvant therapy for patients with resectable pancreatic cancer: an updated systematic review and meta-analysis. Clinical and Experimental Medicine 2023; 23(7): 3159 doi: 10.1007/s10238-023-01112-2
|
| 289 |
Florentine E. F. Timmer, Bart Geboers, Sanne Nieuwenhuizen, Madelon Dijkstra, Evelien A. C. Schouten, Robbert S. Puijk, Jan J. J. de Vries, M. Petrousjka van den Tol, Anna M. E. Bruynzeel, Mirte M. Streppel, Johanna W. Wilmink, Hans J. van der Vliet, Martijn R. Meijerink, Hester J. Scheffer, Tanja D. de Gruijl. Pancreatic Cancer and Immunotherapy: A Clinical Overview. Cancers 2021; 13(16): 4138 doi: 10.3390/cancers13164138
|
| 290 |
Sneha Satish Deshpande, Anagha Rajeev Joshi, Diksha Mankar. Pancreatic Neoplasms: CT Evaluation of the Uncommon Presentations of Common Lesions and Common Presentations of the Uncommon Lesions!. Indian Journal of Radiology and Imaging 2022; 32(04): 531 doi: 10.1055/s-0042-1754359
|
| 291 |
Alissa Hendricks-Wenger, Kenneth N. Aycock, Margaret A. Nagai-Singer, Sheryl Coutermarsh-Ott, Melvin F. Lorenzo, Jessica Gannon, Kyungjun Uh, Kayla Farrell, Natalie Beitel-White, Rebecca M. Brock, Alexander Simon, Holly A. Morrison, Joanne Tuohy, Sherrie Clark-Deener, Eli Vlaisavljevich, Rafael V. Davalos, Kiho Lee, Irving C. Allen. Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarcinoma and irreversible electroporation. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-87228-5
|
| 292 |
Yang Chen, Fang-jing Qian, Zhi-qiang Ye, Wen-xia Xie, You-di He, Jing-ren Huang, Ling Tian, Dian-na Gu. Anticancer Benefit of Metformin in Patients With Early-Stage Pancreatic Cancer: A Retrospective Cohort Study. Technology in Cancer Research & Treatment 2022; 21 doi: 10.1177/15330338221138208
|
| 293 |
Wenwen Wang, Guo Chen, Wenli Zhang, Xihua Zhang, Manli Huang, Chen Li, Ling Wang, Zifan Lu, Jielai Xia. The crucial prognostic signaling pathways of pancreatic ductal adenocarcinoma were identified by single-cell and bulk RNA sequencing data. Human Genetics 2024; 143(9-10): 1109 doi: 10.1007/s00439-024-02663-4
|
| 294 |
Hongkai Zhuang, Shujie Wang, Bo Chen, Zedan Zhang, Zuyi Ma, Zhenchong Li, Chunsheng Liu, Zixuan Zhou, Yuanfeng Gong, Shanzhou Huang, Baohua Hou, Yajin Chen, Chuanzhao Zhang. Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.790661
|
| 295 |
Zsófia Szász, Kata Nóra Enyedi, Angéla Takács, Nóra Fekete, Gábor Mező, László Kőhidai, Eszter Lajkó. Characterisation of the cell and molecular biological effect of peptide-based daunorubicin conjugates developed for targeting pancreatic adenocarcinoma (PANC-1) cell line. Biomedicine & Pharmacotherapy 2024; 173: 116293 doi: 10.1016/j.biopha.2024.116293
|
| 296 |
|
| 297 |
Gabriela Reyes-Castellanos, Nadine Abdel Hadi, Alice Carrier. Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors. Cells 2022; 11(3): 426 doi: 10.3390/cells11030426
|
| 298 |
Mohamed J. Saadh, Mohammed Ahmed Mustafa, H. Malathi, Gunveen Ahluwalia, Sumeet Kaur, Ahmed Naser Faisal, Mahmood Hasen Shuhata Alubiady, Salah Hassan Zain Al-Abdeen, Hussein Ghafel Shakier, Zainab H. Ali, Irfan Ahmad, Ahmed Hussein Zwamel. Nanoparticle-based targeting of pancreatic tumor stroma and extracellular matrix: A promising approach for improved treatment. Journal of Drug Delivery Science and Technology 2024; 99: 105938 doi: 10.1016/j.jddst.2024.105938
|
| 299 |
Kadir Çorbacı, Meryem Gunay Gurleyik, Aylin Gonultas, Fugen Aker, Mehmet Onur Gul, Metin Tilki. Evaluation of prognostic significance of histopathological characteristics and tumor-infiltrating lymphocytes for pancreatic cancer survival. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-79342-x
|
| 300 |
Hussein Hassan Okasha, Mohammed Tag-Adeen, Hossam Eldin Shaaban. Role of pancreatic juice cytology in diagnosis of high-grade pancreatic intraepithelial neoplasia. World Journal of Clinical Cases 2025; 13(10): 94437 doi: 10.12998/wjcc.v13.i10.94437
|
| 301 |
Xun Gong, Yuchen Liu, Chenglong Zheng, Peikai Tian, Minjie Peng, Yihang Pan, Xiaowu Li. Establishment of a 4-miRNA Prognostic Model for Risk Stratification of Patients With Pancreatic Adenocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.827259
|
| 302 |
Ashraf Bahi el-din Abd, Usama Ahmed Fahmy. Alendronate Sodium Combined Glatiramer Acetate Nanocomplex Suppresses Pancreatic Cancer Cell Growth. International Journal of Pharmacology 2024; 20(7): 1281 doi: 10.3923/ijp.2024.1281.1291
|
| 303 |
Fangqi Ma, Hong Wang, Kefen Liu, Zhongqiang Wang, Shijun Chen. CSN6 inhibition suppresses pancreatic adenocarcinoma metastasis via destabilizing the c-Fos protein. Experimental Cell Research 2020; 391(1): 112004 doi: 10.1016/j.yexcr.2020.112004
|
| 304 |
Hanzhang Zhu, Weijiang Zhou, Yafeng Wan, Jun Lu, Ke Ge, Changku Jia. CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression. International Journal of Molecular Sciences 2022; 23(20): 12061 doi: 10.3390/ijms232012061
|
| 305 |
Yugal Limbu, Sujan Regmee, Roshan Ghimire, Dhiresh Kumar Maharjan, Prabin Bikram Thapa. Arterial Divestment and Resection in Post-neoadjuvant Pancreatic Adenocarcinoma. Cureus 2021; doi: 10.7759/cureus.20275
|
| 306 |
Xiao F. He, Yue Y. Xiao, Xiao Zhang, Xiao B. Zhang, Xin Zhang, Ying T. Wei, Zhong L. Zhang, Philipp Wiggermann. Preliminary clinical application of the robot‐assisted CT‐guided irreversible electroporation ablation for the treatment of pancreatic head carcinoma. The International Journal of Medical Robotics and Computer Assisted Surgery 2020; 16(4) doi: 10.1002/rcs.2099
|
| 307 |
Esther Frimpong. Sociodemographic characteristics associated with pancreatic cancer incidence and mortality among Blacks in the United States: a SEER-based study. American Journal of Cancer Research 2025; 15(2): 705 doi: 10.62347/GJCX1238
|
| 308 |
Huilin Zheng, Bisha Ding, Ke Xue, Jinxiao Yu, Weiyang Lou. Construction of a lncRNA/pseudogene-hsa-miR-30d-5p-GJA1 regulatory network related to metastasis of pancreatic cancer. Genomics 2021; 113(4): 1742 doi: 10.1016/j.ygeno.2021.04.013
|
| 309 |
Izumi Matsuoka, Takahiro Kasai, Chotaro Onaga, Ayaka Ozaki, Hitomi Motomura, Yuki Maemura, Yuna Tada, Haruka Mori, Yasushi Hara, Yuyun Xiong, Keiko Sato, Shoma Tamori, Kazunori Sasaki, Shigeo Ohno, Kazunori Akimoto. Co‑expression of SLC20A1 and ALDH1A3 is associated with poor prognosis, and SLC20A1 is required for the survival of ALDH1‑positive pancreatic cancer stem cells. Oncology Letters 2024; 28(3) doi: 10.3892/ol.2024.14558
|
| 310 |
Shreya Singh, Anupama Sawal. Comprehensive Review on Pancreatic Head Cancer: Pathogenesis, Diagnosis, and Treatment Challenges in the Quest for Improved Survival. Cureus 2024; doi: 10.7759/cureus.54290
|
| 311 |
Ying Yu Liang, Smaranda Bacanu, Lekshmy Sreekumar, Anderson Daniel Ramos, Lingyun Dai, Martin Michaelis, Jindrich Cinatl, Takahiro Seki, Yihai Cao, Cynthia R. Coffill, David P. Lane, Nayana Prabhu, Pär Nordlund. CETSA interaction proteomics define specific RNA-modification pathways as key components of fluorouracil-based cancer drug cytotoxicity. Cell Chemical Biology 2022; 29(4): 572 doi: 10.1016/j.chembiol.2021.06.007
|
| 312 |
Povilas Kavaliauskas, Audrius Dulskas, Inga Kildusiene, Rokas Arlauskas, Rimantas Stukas, Giedre Smailyte. Trends in Pancreatic Cancer Incidence and Mortality in Lithuania, 1998–2015. International Journal of Environmental Research and Public Health 2022; 19(2): 949 doi: 10.3390/ijerph19020949
|
| 313 |
Ewa M. Wysokinska, Damon E. Houghton, Danielle T. Vlazny, Aneel A. Ashrani, David A. Froehling, Ryan Meverden, David O. Hodge, Lisa G. Peterson, Robert D. McBane, Waldemar E. Wysokinski, Ana I. Casanegra. Incidental pulmonary embolism in cancer and noncancer patients: Prospective cohort study. European Journal of Haematology 2023; 110(1): 88 doi: 10.1111/ejh.13877
|
| 314 |
Kun Liu, Shuxuan Song, Ting Fu, Yiwen Liu, Hui Zhang, Min Yan, Zhen He, Weilu Zhang, Haixia Su, Zhao Li, Zhaohua Ji, Zhongjun Shao. Spatiotemporal Trends in the Incidence of Gastrointestinal Neoplasms in Wuwei City of Northwestern China From 1995 to 2016: A Hospital-Based Retrospective Observational Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.712857
|
| 315 |
Wenbin Kuang, Xiao Wang, Jiayu Ding, Jiaxing Li, Minghui Ji, Weijiao Chen, Liping Wang, Peng Yang. PTPN2, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and Metastasis. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.805311
|
| 316 |
Christina Stengl, Kathrin Panow, Eric Arbes, Iván D Muñoz, Jeppe B Christensen, Christian Neelsen, Fabian Dinkel, Artur Weidner, Armin Runz, Wibke Johnen, Jakob Liermann, Gernot Echner, José Vedelago, Oliver Jäkel. A phantom to simulate organ motion and its effect on dose distribution in carbon ion therapy for pancreatic cancer. Physics in Medicine & Biology 2023; 68(24): 245013 doi: 10.1088/1361-6560/ad0902
|
| 317 |
Mirza S. Baig, Anjali Roy, Sajjan Rajpoot, Dongfang Liu, Rajkumar Savai, Sreeparna Banerjee, Manabu Kawada, Syed M. Faisal, Rohit Saluja, Uzma Saqib, Tomokazu Ohishi, Kishore K. Wary. Tumor-derived exosomes in the regulation of macrophage polarization. Inflammation Research 2020; 69(5): 435 doi: 10.1007/s00011-020-01318-0
|
| 318 |
Qinying Zhao, Yingquan Ye, Quan Zhang, Yue Wu, Gaoxiang Wang, Zhongxuan Gui, Mei Zhang. PANoptosis-related long non-coding RNA signature to predict the prognosis and immune landscapes of pancreatic adenocarcinoma. Biochemistry and Biophysics Reports 2024; 37: 101600 doi: 10.1016/j.bbrep.2023.101600
|
| 319 |
Samar M. Etman, Ossama Y. Abdallah, Radwa A. Mehanna, Yosra S.R. Elnaggar. Lactoferrin/Hyaluronic acid double-coated lignosulfonate nanoparticles of quinacrine as a controlled release biodegradable nanomedicine targeting pancreatic cancer. International Journal of Pharmaceutics 2020; 578: 119097 doi: 10.1016/j.ijpharm.2020.119097
|
| 320 |
César Beugniez, Alain Sauvanet, Laurent Sulpice, Sébastien Gaujoux, Olivier Turrini, Stéphanie Truant, Lilian Schwarz, Guillaume Piessen, Jean Marc Regimbeau, Fabrice Muscari, Mustapha Adham, François Pattou, Lucil Schneider, Guillaume Clement, Jean-Robert Delpero, François-René Pruvot, Mehdi El Amrani. Root-cause Analysis of Mortality After Pancreatic Resection (CARE Study). Annals of Surgery 2021; 274(5): 789 doi: 10.1097/SLA.0000000000005118
|
| 321 |
Nadya Rykina-Tameeva, Jaswinder S Samra, Sumit Sahni, Anubhav Mittal. Drain fluid biomarkers for prediction and diagnosis of clinically relevant postoperative pancreatic fistula: A narrative review. World Journal of Gastrointestinal Surgery 2022; 14(10): 1089-1106 doi: 10.4240/wjgs.v14.i10.1089
|
| 322 |
Chiara Cencioni, Silvia Malatesta, Virginia Vigiano Benedetti, Valerio Licursi, Livia Perfetto, Federica Conte, Danilo Ranieri, Armando Bartolazzi, Martina Kunkl, Loretta Tuosto, Alberto Larghi, Geny Piro, Antonio Agostini, Giampaolo Tortora, Vincenzo Corbo, Carmine Carbone, Francesco Spallotta. The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylation and favoring T lymphocyte infiltration. Journal of Experimental & Clinical Cancer Research 2025; 44(1) doi: 10.1186/s13046-024-03263-w
|
| 323 |
Madeline T. Olson, Nicholas E. Wojtynek, Geoffrey A. Talmon, Thomas C. Caffrey, Prakash Radhakrishnan, Quan P. Ly, Michael A. Hollingsworth, Aaron M. Mohs. Development of a MUC16-Targeted Near-Infrared Fluorescent Antibody Conjugate for Intraoperative Imaging of Pancreatic Cancer. Molecular Cancer Therapeutics 2020; 19(8): 1670 doi: 10.1158/1535-7163.MCT-20-0033
|
| 324 |
Deepika Tanwar, Tashmeen Kaur, Athul Sudheendranath, Umesh Kumar, Deepika Sharma. Pd(ii) complexes bearing NNS pincer ligands: unveiling potent cytotoxicity against breast and pancreatic cancer. Dalton Transactions 2024; 53(23): 9798 doi: 10.1039/D4DT00282B
|
| 325 |
Ashwin Mukund, Muhammad Ali Afridi, Aleksandra Karolak, Margaret A. Park, Jennifer B. Permuth, Ghulam Rasool. Pancreatic Ductal Adenocarcinoma (PDAC): A Review of Recent Advancements Enabled by Artificial Intelligence. Cancers 2024; 16(12): 2240 doi: 10.3390/cancers16122240
|
| 326 |
Siddhant Baldota, Sukkrit Sharma, C Malathy. Deep Transfer Learning for Pancreatic Cancer Detection. 2021 12th International Conference on Computing Communication and Networking Technologies (ICCCNT) 2021; : 1 doi: 10.1109/ICCCNT51525.2021.9580000
|
| 327 |
Yi Yu, Yunxing Wang, Yufeng Zou, Yuan Yu, Xuan Huang. CYP26A1 Is a Novel Cancer Biomarker of Pancreatic Carcinoma: Evidence from Integration Analysis and In Vitro Experiments. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/5286820
|
| 328 |
I.A. Kryvoruchko, I. A. Lurin, M.V. Krasnoselskyi, N.M. Honcharova, A.A.M. Habib Tamer, M.M. Nessonova, A.S. Honcharov, O.V. Kuzmenko, V.P. Kolesnyk . Significance of preoperative levels biomarkers TGF-β1 and CA 19-9 in distinguishing benign and malignant pancreatic neoplasms. Український радіологічний та онкологічний журнал 2024; 32(4): 428 doi: 10.46879/ukroj.4.2024.428-447
|
| 329 |
Jerry B. Harvey, Luan H. Phan, Oscar E. Villarreal, Jessica L. Bowser. CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00508
|
| 330 |
Pınar KOÇATAKAN, Hilmi ATASEVEN. PANKREAS KANSERİ. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi 2021; 54(1): 59 doi: 10.20492/aeahtd.806164
|
| 331 |
Kenneth H. Yu, Paul Cockrum, Andy Surinach, Neil Lamarre, Shu Wang, Eileen M. O'Reilly. Prior irinotecan exposure does not preclude benefit to liposomal irinotecan in patients with metastatic pancreatic ductal adenocarcinoma. Cancer Medicine 2023; 12(8): 9496 doi: 10.1002/cam4.5714
|
| 332 |
Dooyeon Lee, Mun Sem Liew, Spiros Fourlanos, Julian Choi. Metformin use and pancreatic ductal adenocarcinoma outcomes: a narrative review. ANZ Journal of Surgery 2025; doi: 10.1111/ans.19405
|
| 333 |
Qian Xiao, Rena R. Jones, Peter James, Rachael Z. Stolzenberg-Solomon. Light at Night and Risk of Pancreatic Cancer in the NIH-AARP Diet and Health Study. Cancer Research 2021; 81(6): 1616 doi: 10.1158/0008-5472.CAN-20-2256
|
| 334 |
Huaping Gong, Long Chen, Ruipeng Dong. Effects and Mechanisms of Tripartite Motif Containing 14 Downregulation on Proliferation, Migration, and Invasion of Cancerous Pancreatic PANC-1 Cells. Journal of Biomaterials and Tissue Engineering 2021; 11(3): 402 doi: 10.1166/jbt.2021.2407
|
| 335 |
Yongji Sun, Sien Hu, Xiawei Li, Yulian Wu. Development and Application of a Novel Machine Learning Model Predicting Pancreatic Cancer-Specific Mortality. Cureus 2024; doi: 10.7759/cureus.57161
|
| 336 |
Alexander Kuzmin, Hasan Chasib Al-Darraji, Artem Sukhomlinov, Sergei Filist. Creativity in Intelligent Technologies and Data Science. Communications in Computer and Information Science 2023; 1909: 467 doi: 10.1007/978-3-031-44615-3_32
|
| 337 |
Guorong Li, Dongdong Liu, Pascale Flandrin, Yang Zhang, Claude Lambert, Nora Mallouk, Michèle Cottier. Tumor-Derived Exosomal RNA From Fine-Needle Aspiration Supernatant as a Novel Liquid Biopsy for Molecular Diagnosis of Cancer. Pathology and Oncology Research 2022; 28 doi: 10.3389/pore.2022.1610344
|
| 338 |
Mohini Singh, Bani Kumar Jana, Paulami Pal, Ishita Singha, Ananya Rajkumari, Pinky Chowrasia, Venessa Nath, Bhaskar Mazumder. Nanoparticles in pancreatic cancer therapy: a detailed and elaborated review on patent literature. Expert Opinion on Therapeutic Patents 2023; 33(10): 681 doi: 10.1080/13543776.2023.2287520
|
| 339 |
|
| 340 |
Sahar F. Bannoura, Md. Hafiz Uddin, Misako Nagasaka, Farzeen Fazili, Mohammed Najeeb Al-Hallak, Philip A. Philip, Bassel El-Rayes, Asfar S. Azmi. Targeting KRAS in pancreatic cancer: new drugs on the horizon. Cancer and Metastasis Reviews 2021; 40(3): 819 doi: 10.1007/s10555-021-09990-2
|
| 341 |
Takuro Kobori, Rina Doukuni, Honami Ishikawa, Yui Ito, Rie Okada, Chihiro Tanaka, Mayuka Tameishi, Yoko Urashima, Takuya Ito, Tokio Obata. Ezrin and Radixin Differentially Modulate Cell Surface Expression of Programmed Death Ligand-1 in Human Pancreatic Ductal Adenocarcinoma KP-2 Cells. Immuno 2022; 2(1): 68 doi: 10.3390/immuno2010006
|
| 342 |
Doğukan DURAK, Ertugrul Gazi ALKURT, Ramazan TOPCU, Murat KENDİRCİ, İbrahim Tayfun ŞAHİNER. The significance of haematological parameters and CA 19-9 in assessing vascular invasion and inoperability in pancreatic cancer. Journal of Medicine and Palliative Care 2022; 3(2): 81 doi: 10.47582/jompac.1101766
|
| 343 |
Pierpaolo Vendittelli, Esther M. M. Smeets, Geert Litjens, Richard M. Levenson, John E. Tomaszewski, Aaron D. Ward. Automatic tumour segmentation in H&E-stained whole-slide images of the pancreas.. Medical Imaging 2022: Digital and Computational Pathology 2022; : 47 doi: 10.1117/12.2611542
|
| 344 |
Naomi Fei, Sijin Wen, Rajesh Ramanathan, Melissa E. Hogg, Amer H. Zureikat, Michael T. Lotze, Nathan Bahary, Aatur D. Singhi, Herbert J. Zeh, Brian A. Boone. SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma. Clinical and Translational Science 2021; 14(5): 1822 doi: 10.1111/cts.13029
|
| 345 |
Maria Giulia Demarzo, Chiara Facchini, Giuliana Rosa Bisso, Ciro Marrone, Maria Caterina Parodi. Traditional Biomarkers in Patients with Pancreatic Cancer Staged by Computed Tomography and Endoscopic Ultrasound: Is There Still a Role in the Molecular Era?. Gastrointestinal Disorders 2024; 6(3): 733 doi: 10.3390/gidisord6030049
|
| 346 |
Luoyingzi Xie, Jie Gong, Zhiqiang He, Weinan Zhang, Haoyu Wang, Shitao Wu, Xianxing Wang, Pijiang Sun, Lei Cai, Zhongjun Wu, Huaizhi Wang. A Copper‐Manganese Based Nanocomposite Induces Cuproptosis and Potentiates Anti‐Tumor Immune Responses. Small 2025; doi: 10.1002/smll.202412174
|
| 347 |
Ajaykumar C. Morani, Abdelrahman K. Hanafy, Nisha S. Ramani, Venkata S. Katabathina, Sireesha Yedururi, Anil K. Dasyam, Srinivasa R. Prasad. Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging. Radiology: Imaging Cancer 2020; 2(2): e190020 doi: 10.1148/rycan.2020190020
|
| 348 |
Katarina Popovic, Brigita Smolović, Milica Martinović, Ljiljana Vučković. The Relationship between Diabetes Mellitus and Pancreatic Cancer—Diabetes Mellitus as a Red Flag for Pancreatic Cancer. Cancer Epidemiology, Biomarkers & Prevention 2023; 32(3): 298 doi: 10.1158/1055-9965.EPI-22-0951
|
| 349 |
Lakmini Senavirathna, Cheng Ma, Ru Chen, Sheng Pan. Proteomic Investigation of Glyceraldehyde-Derived Intracellular AGEs and Their Potential Influence on Pancreatic Ductal Cells. Cells 2021; 10(5): 1005 doi: 10.3390/cells10051005
|
| 350 |
Shunmugam Iniyaval, Vadivel Saravanan, Chun-Wai Mai, Chennan Ramalingan. Tetrazolopyrimidine-tethered phenothiazine molecular hybrids: synthesis, biological and molecular docking studies. New Journal of Chemistry 2024; 48(30): 13384 doi: 10.1039/D3NJ05817D
|
| 351 |
Lakshay Malhotra, Harsh K.V. Goyal, Sunita Jhuria, Kapil Dev, Saroj Kumar, Manoj Kumar, Punit Kaur, Abdul S. Ethayathulla. Curcumin rescue p53Y220C in BxPC-3 pancreatic adenocarcinomas cell line: Evidence-based on computational, biophysical, and in vivo studies. Biochimica et Biophysica Acta (BBA) - General Subjects 2021; 1865(2): 129807 doi: 10.1016/j.bbagen.2020.129807
|
| 352 |
Marion Lassalle, Thien Le Tri, Pauline Afchain, Marine Camus, Julien Kirchgesner, Mahmoud Zureik, Rosemary Dray-Spira. Use of Proton Pump Inhibitors and Risk of Pancreatic Cancer: A Nationwide Case–Control Study Based on the French National Health Data System (SNDS). Cancer Epidemiology, Biomarkers & Prevention 2022; 31(3): 662 doi: 10.1158/1055-9965.EPI-21-0786
|
| 353 |
Guo-Hua Liu, Xiao-Yu Tan, Zhen-Yue Xu, Jia-Xing Li, Guo-Hui Zhong, Jing-Wei Zhai, Ming-Yi Li. REEP3 is a potential diagnostic and prognostic biomarker correlated with immune infiltration in pancreatic cancer. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-64720-2
|
| 354 |
Ethan Alexander Burns, Saro Kasparian, Usman Khan, Maen Abdelrahim. Pancreatic adenocarcinoma with early esophageal metastasis: A case report and review of literature. World Journal of Clinical Oncology 2020; 11(2): 83-90 doi: 10.5306/wjco.v11.i2.83
|
| 355 |
Haokai Xu, Jiayan Mao, Xiaodan Yang, Fei Chen, Zhengwei Song, Jianguo Fei, Wei Chen, Zhengxiang Zhong, Xiaoguang Wang. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas . Molecular Medicine Reports 2020; doi: 10.3892/mmr.2020.11504
|
| 356 |
Sara De Dosso, Alexander R. Siebenhüner, Thomas Winder, Alexander Meisel, Ralph Fritsch, Christoforos Astaras, Petr Szturz, Markus Borner. Treatment landscape of metastatic pancreatic cancer. Cancer Treatment Reviews 2021; 96: 102180 doi: 10.1016/j.ctrv.2021.102180
|
| 357 |
Yasmine ElEsawy, Eman Khaled, Badawea Biomy, Samar Elsheikh, Dina El-Yasergy. The Role of Maspin Expression as Diagnostic Tissue Marker in Pancreaticoduodenal Malignant Tumors and Benign Lesions. Open Access Macedonian Journal of Medical Sciences 2022; 10(A): 1042 doi: 10.3889/oamjms.2022.9765
|
| 358 |
Do Yeon Kim, Hyeseon Yun, Ji-Eun You, Dong-In Koh, Yea Seong Ryu, Dong-Il Yoon, Chul Hee Kim, Ji-U Lee, Dong- Hee Kang, Dong-Hoon Jin. NME1 functions as a metastasis suppressor in pancreatic cancer. Molecular & Cellular Toxicology 2023; 19(4): 767 doi: 10.1007/s13273-022-00305-2
|
| 359 |
Seyed Aria Nejadghaderi, Ali‐Asghar Kolahi, Maryam Noori, Mark J M Sullman, Saeid Safiri. The burden of pancreatic cancer and its attributable risk factors in the Middle East and North Africa region, 1990–2019. Journal of Gastroenterology and Hepatology 2023; 38(9): 1535 doi: 10.1111/jgh.16217
|
| 360 |
Ildikó Fritz, Philippe Wagner, Håkan Olsson. Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine. Translational Oncology 2021; 14(4): 101029 doi: 10.1016/j.tranon.2021.101029
|
| 361 |
Meihui Song, Ying Tang, Kaimei Cao, Ling Qi, Keping Xie. Unveiling the role of interleukin-6 in pancreatic cancer occurrence and progression. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1408312
|
| 362 |
Hironobu Suto, Hiroyuki Matsukawa, Takuro Fuke, Mina Nagao, Yasuhisa Ando, Minoru Oshima, Hiroki Yamana, Hideki Kamada, Hideki Kobara, Hiroyuki Okuyama, Kensuke Kumamoto, Keiichi Okano. Tumor location, clinicopathological features, and perioperative and prognostic outcomes in patients who underwent pancreatic resection following neoadjuvant chemoradiotherapy for resectable pancreatic cancer: A retrospective study. Pancreatology 2024; 24(3): 431 doi: 10.1016/j.pan.2024.02.007
|
| 363 |
Fan Yang, Na Jiang, Xiao-Yu Li, Xing-Si Qi, Zi-Bin Tian, Ying-Jie Guo. Construction and validation of a pancreatic cancer prognostic model based on genes related to the hypoxic tumor microenvironment. World Journal of Gastroenterology 2024; 30(36): 4057-4070 doi: 10.3748/wjg.v30.i36.4057
Abstract(289) |
Core Tip(228) |
Full Article(HTML)(1204)
|
Full Article with Cover (PDF)-15566K(58)
|
Audio-202K(7)
|
Peer-Review Report-228K(37)
|
Answering Reviewers-145K(36)
|
Supplementary Material-103K(37)
|
Full Article (PDF)-15150K(69)
|
Full Article (XML)-126K(41)
|
Times Cited (2)
|
Total Visits (3441)
|
Open
|
| 364 |
Mahip Grewal, Victor J. Kroon, Sarah R. Kaslow, Anthony M. Sorrentino, Megan D. Winner, John D. Allendorf, Paresh C. Shah, Diane M. Simeone, Theodore H. Welling, Russell S. Berman, Steven M. Cohen, Christopher L. Wolfgang, Greg D. Sacks, Ammar A. Javed. Longitudinal assessment of disparities in pancreatic cancer care: A retrospective analysis of the National Cancer Database. World Journal of Surgery 2025; 49(1): 262 doi: 10.1002/wjs.12431
|
| 365 |
Małgorzata Lasota, Daniel Jankowski, Anna Wiśniewska, Łukasz Szeleszczuk, Anna Misterka-Kozaka, Marta Kaczor-Kamińska, Marta Zarzycka, Maksym Patena, Tomasz Brzozowski. Interaction of Avapritinib with Congo Red in Pancreatic Cancer Cells: Molecular Modeling and Biophysical Studies. International Journal of Molecular Sciences 2025; 26(5): 1980 doi: 10.3390/ijms26051980
|
| 366 |
Ahmed Arafa, Ehab S. Eshak, Tarek A. Abdel Rahman, Manal M. Anwar. Hepatitis C virus infection and risk of pancreatic cancer: A meta-analysis. Cancer Epidemiology 2020; 65: 101691 doi: 10.1016/j.canep.2020.101691
|
| 367 |
Juan Manuel Castillo Tuñón, María Elisa Valle Rodas, Francisco Botello Martínez, Adela Rojas Holguín, Diego López Guerra, Jesús Santos Naharro, Isabel Jaén Torrejímeno, Gerardo Blanco Fernández. Implementación de un centro de referencia regional en cirugía pancreática. Experiencia tras 631 procedimientos. Cirugía Española 2021; 99(10): 745 doi: 10.1016/j.ciresp.2020.09.013
|
| 368 |
Junaid Anwar, Hafiz Muhammad Arslan, Zouina Sarfraz, Juwairiya Shuroog, Ahmed Abdelhakeem, Ali Saeed, Anwaar Saeed. Immunotherapy Responses in Viral Hepatitis-Induced HCC: A Systematic Review and Meta-Analysis. Current Oncology 2024; 31(11): 7204 doi: 10.3390/curroncol31110532
|
| 369 |
Iliya I. Dzidzava, Ivan V. Gayvoronsky, Andrei B. Kotiv, Sergey A. Alentyev. The topographo-anatomical conditions of reconstruction of the trunk and roots of the portal vein during gastropancreatoduodenal resection. Bulletin of the Russian Military Medical Academy 2021; 23(1): 33 doi: 10.17816/brmma60216
|
| 370 |
Marco Mascitti, Lucrezia Togni, Giuseppe Troiano, Vito Carlo Alberto Caponio, Davide Bartolomeo Gissi, Lucio Montebugnoli, Maurizio Procaccini, Lorenzo Lo Muzio, Andrea Santarelli. Beyond Head and Neck Cancer: The Relationship Between Oral Microbiota and Tumour Development in Distant Organs. Frontiers in Cellular and Infection Microbiology 2019; 9 doi: 10.3389/fcimb.2019.00232
|
| 371 |
Clara S. Mundry, Kirsten C. Eberle, Pankaj K. Singh, Michael A. Hollingsworth, Kamiya Mehla. Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor’s arsenal. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(1): 188387 doi: 10.1016/j.bbcan.2020.188387
|
| 372 |
Maria Saveria Gilardini Montani, Nives Cecere, Marisa Granato, Maria Anele Romeo, Luca Falcinelli, Umberto Ciciarelli, Gabriella D’Orazi, Alberto Faggioni, Mara Cirone. Mutant p53, Stabilized by Its Interplay with HSP90, Activates a Positive Feed-Back Loop Between NRF2 and p62 that Induces Chemo-Resistance to Apigenin in Pancreatic Cancer Cells. Cancers 2019; 11(5): 703 doi: 10.3390/cancers11050703
|
| 373 |
J Gowthami, N Gururaj, V Mahalakshmi, R Sathya, TR Sabarinath, DaffneyMano Doss. Genetic predisposition and prediction protocol for epithelial neoplasms in disease-free individuals: A systematic review. Journal of Oral and Maxillofacial Pathology 2020; 24(2): 293 doi: 10.4103/jomfp.JOMFP_348_19
|
| 374 |
Sally Kfoury, Patrick Michl, Laura Roth. Modeling Obesity-Driven Pancreatic Carcinogenesis—A Review of Current In Vivo and In Vitro Models of Obesity and Pancreatic Carcinogenesis. Cells 2022; 11(19): 3170 doi: 10.3390/cells11193170
|
| 375 |
Christopher W. Mangieri, Cristian D. Valenzuela, Ian B. Solsky, Richard A. Erali, Timothy Pardee, Caio Max S. Rocha Lima, Russell Howerton, Clancy J. Clark, Perry Shen. Comparison of survival for metastatic pancreatic cancer patients treated with CPI‐613 versus resected borderline‐resectable pancreatic cancer patients. Journal of Surgical Oncology 2023; 128(5): 844 doi: 10.1002/jso.27365
|
| 376 |
Martijn A. van Dam, Floris A. Vuijk, Judith A. Stibbe, Ruben D. Houvast, Saskia A. C. Luelmo, Stijn Crobach, Shirin Shahbazi Feshtali, Lioe-Fee de Geus-Oei, Bert A. Bonsing, Cornelis F. M. Sier, Peter J. K. Kuppen, Rutger-Jan Swijnenburg, Albert D. Windhorst, Jacobus Burggraaf, Alexander L. Vahrmeijer, J. Sven D. Mieog. Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy. Cancers 2021; 13(23): 6088 doi: 10.3390/cancers13236088
|
| 377 |
Sitwat Ali, Renhua Na, Karen Tuesley, Katrina Spilsbury, Louise M. Stewart, Michael Coory, Penelope M. Webb, Peter Donovan, Sallie-Anne Pearson, Susan J. Jordan, Rachel E. Neale. The association between diabetes mellitus of different durations and risk of pancreatic cancer: an Australian national data-linkage study in women. Cancer Epidemiology 2022; 81: 102266 doi: 10.1016/j.canep.2022.102266
|
| 378 |
Mrinmay Kumar Mallik, Kusum Kapila, Asit Kumar Mohanty, Shafi Ahmed Inamdar, Ali AlAli, Abdullah Al Naseer. Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology of Pancreatic Adenocarcinomas Revisited. A Detailed Cytological Analysis. Journal of Cytology 2021; 38(1): 31 doi: 10.4103/JOC.JOC_177_20
|
| 379 |
Maria Miquel, Shuman Zhang, Christian Pilarsky. Pre-clinical Models of Metastasis in Pancreatic Cancer. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.748631
|
| 380 |
Xinlei Zou, Ziyue Huang, Canghai Guan, Wujiang Shi, Jianjun Gao, Jiangang Wang, Yunfu Cui, Mei Wang, Yi Xu, Xiangyu Zhong. Exosomal miRNAs in the microenvironment of pancreatic cancer. Clinica Chimica Acta 2023; 544: 117360 doi: 10.1016/j.cca.2023.117360
|
| 381 |
Abdulaziz Alhussan, Nolan Jackson, Norman Chow, Ermias Gete, Nicole Wretham, Nancy Dos Santos, Wayne Beckham, Cheryl Duzenli, Devika B. Chithrani. In Vitro and In Vivo Synergetic Radiotherapy with Gold Nanoparticles and Docetaxel for Pancreatic Cancer. Pharmaceutics 2024; 16(6): 713 doi: 10.3390/pharmaceutics16060713
|
| 382 |
Mulkyawan BAHRUN, Ibrahim LABEDA, Mappincara MAPPINCARA, Joko HENDARTO, Ronald E. LUSIKOOY, Warsinggih WARSINGGIH, Samuel SAMPETODING, Muhammad I. KUSUMA, Julianus A. UWURATUW, Erwin SYARIFUDDIN, Muhammad FARUK. Plasma D-dimer and urine D-dimer are associated with resectability of pancreatic cancer. Chirurgia 2023; 36(6) doi: 10.23736/S0394-9508.23.05538-9
|
| 383 |
Bo-Wen Zheng, Xin-Yu Yang, Jun Zheng, Ru-Cheng Yao. Dynamic evaluation of postoperative survival in pancreatic ductal adenocarcinoma. Medicine 2025; 104(12): e41942 doi: 10.1097/MD.0000000000041942
|
| 384 |
Jian Yang, Yongzheng Li, Zhaowei Sun, Zhiyao Fan, Ming Shi, Shujie Liu, Yufan Meng, Bin Zhou, Yuanyuan Jiang, Hanxiang Zhan. COL17A1 facilitates tumor growth and predicts poor prognosis in pancreatic cancer. Biochemical and Biophysical Research Communications 2022; 632: 1 doi: 10.1016/j.bbrc.2022.09.049
|
| 385 |
Tomoaki Toyoda, Nami Miura, Shingo Kato, Takeshi Masuda, Ryuji Ohashi, Akira Matsushita, Fumio Matsuda, Sumio Ohtsuki, Akira Katakura, Kazufumi Honda. Identification of TPI1 As a potential therapeutic target in pancreatic cancer with dependency of TP53 mutation using multi‐omics analysis. Cancer Science 2024; 115(11): 3622 doi: 10.1111/cas.16302
|
| 386 |
Daniel R. Principe, Matthew Narbutis, Sandeep Kumar, Alex Park, Navin Viswakarma, Matthew J. Dorman, Suneel D. Kamath, Paul J. Grippo, Melissa L. Fishel, Rosa F. Hwang, Dinesh Thummuri, Patrick W. Underwood, Hidayatullah G. Munshi, Jose G. Trevino, Ajay Rana. Long-Term Gemcitabine Treatment Reshapes the Pancreatic Tumor Microenvironment and Sensitizes Murine Carcinoma to Combination Immunotherapy. Cancer Research 2020; 80(15): 3101 doi: 10.1158/0008-5472.CAN-19-2959
|
| 387 |
Juling Jiang, Rui Liu, Zhenhua Zhang, Xiwen Zhang, Runzhi Qi, Shuntai Chen, Xing Zhang, Yupeng Xi, Qiujun Guo, Honggang Zheng, Baojin Hua. Study on the treatment of pancreatic cancer with integrated traditional Chinese and Western medicine. Medicine 2019; 98(47): e17975 doi: 10.1097/MD.0000000000017975
|
| 388 |
Tina Daunke, Silje Beckinger, Sascha Rahn, Sandra Krüger, Steffen Heckl, Heiner Schäfer, Daniela Wesch, Christian Pilarsky, Markus Eckstein, Arndt Hartmann, Christoph Röcken, Anna Maxi Wandmacher, Susanne Sebens. Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1157397
|
| 389 |
Andrej Petrovich Koshel', Evgenij Sergeevich Drozdov, Evgenij Bogdanovich Topolnitskiy, Sergej S Klokov, Nikolay Anatolievich Shefer. The Role of Prehabilitation in Patients Undergoing Pancreatoduodenal Resection. Journal of Experimental and Clinical Surgery 2021; 14(2): 128 doi: 10.18499/2070-478X-2021-14-2-128-135
|
| 390 |
Kaisong Bai, Tong Zhao, Yilong Li, Xinjian Li, Zhantian Zhang, Zuchao Du, Zimin Wang, Yan Xu, Bei Sun, Xuewei Bai. Integrating Genetic and Transcriptomic Data to Reveal Pathogenesis and Prognostic Markers of Pancreatic Adenocarcinoma. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.747270
|
| 391 |
James A. McCubrey, Akshaya K. Meher, Shaw M. Akula, Stephen L. Abrams, Linda S. Steelman, Michelle M. LaHair, Richard A. Franklin, Alberto M. Martelli, Stefano Ratti, Lucio Cocco, Fulvio Barbaro, Przemysław Duda, Agnieszka Gizak. Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties. Aging 2022; 14(8): 3365 doi: 10.18632/aging.204038
|
| 392 |
Li Zhu, Shuai Ren, Marcus J. Daniels, Wenli Qiu, Lian Song, Tao You, Dongqing Wang, Zhongqiu Wang. Exogenous HMGB1 Promotes the Proliferation and Metastasis of Pancreatic Cancer Cells. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.756988
|
| 393 |
Arzu Hazal Aydın, Nesrin Turhan. Comparison of mismatch repair and immune checkpoint protein profile with histopathological parameters in pancreatic, periampullary/ampullary, and choledochal adenocarcinomas. World Journal of Gastrointestinal Oncology 2024; 16(3): 875-882 doi: 10.4251/wjgo.v16.i3.875
Abstract(433) |
Core Tip(488) |
Full Article(HTML)(1325)
|
Full Article with Cover (PDF)-7649K(63)
|
Full Article (Word)-2427K(3)
|
Audio-1604K(2)
|
Peer-Review Report-250K(37)
|
Answering Reviewers-50K(46)
|
Full Article (PDF)-7379K(85)
|
Full Article (XML)-86K(51)
|
Times Cited (0)
|
Total Visits (4423)
|
Open
|
| 394 |
Erika Stefàno, Luca Giulio Cossa, Federica De Castro, Erik De Luca, Viviana Vergaro, Giulia My, Gianluca Rovito, Danilo Migoni, Antonella Muscella, Santo Marsigliante, Michele Benedetti, Francesco Paolo Fanizzi, Giovanni Natile. Evaluation of the Antitumor Effects of Platinum-Based [Pt(η1-C2H4-OR)(DMSO)(phen)]+ (R = Me, Et) Cationic Organometallic Complexes on Chemoresistant Pancreatic Cancer Cell Lines. Bioinorganic Chemistry and Applications 2023; 2023: 1 doi: 10.1155/2023/5564624
|
| 395 |
Hadass Rom, Shlomit Tamir, Jeroen L. A. Van Vugt, Yael Berger, Gali Perl, Sara Morgenstern, Ana Tovar, Baruch Brenner, Daniel Benchimol, Hanoch Kashtan, Eran Sadot. Sarcopenia as a Predictor of Survival in Patients with Pancreatic Adenocarcinoma After Pancreatectomy. Annals of Surgical Oncology 2022; 29(3): 1553 doi: 10.1245/s10434-021-10995-y
|
| 396 |
Scott D. Haller, Michael L. Monaco, Karim Essani. The Present Status of Immuno-Oncolytic Viruses in the Treatment of Pancreatic Cancer. Viruses 2020; 12(11): 1318 doi: 10.3390/v12111318
|
| 397 |
Tingting Zhao, Xufan Cai, Hui Chen, Zhaohong Wang, Heqi Bu, Shengzhang Lin. Rg3 inhibits hypoxia-induced tumor exosomes from boosting pancreatic cancer vasculogenic mimicry through the HIF-1α/LARS1/mTOR axis. Phytomedicine 2025; 139: 156437 doi: 10.1016/j.phymed.2025.156437
|
| 398 |
Bolni Marius Nagalo, Camilo Ayala Breton, Yumei Zhou, Mansi Arora, James M. Bogenberger, Oumar Barro, Michael B. Steele, Nathan J. Jenks, Alexander T. Baker, Dan G. Duda, Lewis Rowland Roberts, Stephen J. Russell, Kah Whye Peng, Mitesh J. Borad. Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers. Molecular Therapy - Oncolytics 2020; 18: 546 doi: 10.1016/j.omto.2020.08.007
|
| 399 |
Gustavo A. Arias-Pinilla, Helmout Modjtahedi. Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities. Cancers 2021; 13(8): 1781 doi: 10.3390/cancers13081781
|
| 400 |
Toshihide Sasaki, Satoshi Nishiwada, Kenji Nakagawa, Minako Nagai, Taichi Terai, Daisuke Hokuto, Satoshi Yasuda, Yasuko Matsuo, Shunsuke Doi, Masayuki Sho. Integrative analysis identifies activated anti-tumor immune microenvironment in lung metastasis of pancreatic cancer. International Journal of Clinical Oncology 2022; 27(5): 948 doi: 10.1007/s10147-022-02131-x
|
| 401 |
Alexandra Sala, James M. Cameron, Cerys A. Jenkins, Hugh Barr, Loren Christie, Justin J. A. Conn, Thomas R. Jeffry Evans, Dean A. Harris, David S. Palmer, Christopher Rinaldi, Ashton G. Theakstone, Matthew J. Baker. Liquid Biopsy for Pancreatic Cancer Detection Using Infrared Spectroscopy. Cancers 2022; 14(13): 3048 doi: 10.3390/cancers14133048
|
| 402 |
Asuman Argon, Özden Öz, Tulu Ayata Kebat. Evaluation and prognostic significance of tumor budding in pancreatic ductal adenocarcinomas. Indian Journal of Pathology and Microbiology 2023; 66(1): 38 doi: 10.4103/ijpm.ijpm_905_21
|
| 403 |
Paulo Michel Pinheiro Ferreira, Rayran Walter Ramos de Sousa, José Roberto de Oliveira Ferreira, Gardenia Carmen Gadelha Militão, Daniel Pereira Bezerra. Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms. Pharmacological Research 2021; 168: 105582 doi: 10.1016/j.phrs.2021.105582
|
| 404 |
Yuan Li, Caiming Xu, Haiyong Han, Silvia Pascual-Sabater, Cristina Fillat, Ajay Goel. Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer. Pharmaceuticals 2024; 17(7): 911 doi: 10.3390/ph17070911
|
| 405 |
Anna O. Giarratana, Conor M. Prendergast, Mary M. Salvatore, Kathleen M. Capaccione. TGF-β signaling: critical nexus of fibrogenesis and cancer. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05411-4
|
| 406 |
Kelly E. Henry, Travis M. Shaffer, Kyeara N. Mack, Janine Ring, Anuja Ogirala, Susanne Klein-Scory, Christina Eilert-Micus, Wolff Schmiegel, Thilo Bracht, Barbara Sitek, Marguerite Clyne, Colm J. Reid, Bence Sipos, Jason S. Lewis, Holger Kalthoff, Jan Grimm. Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer. Journal of Nuclear Medicine 2021; 62(10): 1384 doi: 10.2967/jnumed.120.256776
|
| 407 |
Qi Zhou, Xufeng Tao, Shilin Xia, Fangyue Guo, Chen Pan, Hong Xiang, Dong Shang. T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00382
|
| 408 |
Jinping Hou, Mingsong Guo, Yongqiong Li, Yijin Liao. Lactylated histone H3K18 as a potential biomarker for the diagnosis and prediction of the severity of pancreatic cancer. Clinics 2025; 80: 100544 doi: 10.1016/j.clinsp.2024.100544
|
| 409 |
Jian-Xiong Hu, Cheng-Fei Zhao, Wen-Biao Chen, Qi-Cai Liu, Qu-Wen Li, Yan-Ya Lin, Feng Gao. Pancreatic cancer: A review of epidemiology, trend, and risk factors. World Journal of Gastroenterology 2021; 27(27): 4298-4321 doi: 10.3748/wjg.v27.i27.4298
|
| 410 |
Feng Yin, Qian Zhang, Zhihui Dong, Jie Hu, Zhiqiang Ma. <p>LncRNA HOTTIP Participates in Cisplatin Resistance of Tumor Cells by Regulating miR-137 Expression in Pancreatic Cancer</p>. OncoTargets and Therapy 2020; : 2689 doi: 10.2147/OTT.S234924
|
| 411 |
Ting Li, Tianyi Ren, Chumei Huang, Yufang Li, Pengfei Yang, Gang Che, Lisi Luo, Yutong Chen, Siqi Peng, Yujing Lin, Linjuan Zeng. S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine. Biochemical Pharmacology 2021; 189: 114396 doi: 10.1016/j.bcp.2020.114396
|
| 412 |
Margaret A. Park, Kristyn Gumpper-Fedus, Somashekar G. Krishna, Maria C. Genilo-Delgado, Stephen Brantley, Phil A. Hart, Mary E. Dillhoff, Maria F. Gomez, Toni L. Basinski, Shaffer R. Mok, Anjuli K. Luthra, Jason B. Fleming, Amir Mohammadi, Barbara A. Centeno, Kun Jiang, Aleksandra Karolak, Daniel Jeong, Dung-Tsa Chen, Paul A. Stewart, Jamie K. Teer, Zobeida Cruz-Monserrate, Jennifer B. Permuth. Molecular Pathway and Immune Profile Analysis of IPMN-Derived Versus PanIN-Derived Pancreatic Ductal Adenocarcinomas. International Journal of Molecular Sciences 2024; 25(23): 13164 doi: 10.3390/ijms252313164
|
| 413 |
Marzia Conte, Valentina Cauda. Multimodal Therapies against Pancreatic Ductal Adenocarcinoma: A Review on Synergistic Approaches toward Ultimate Nanomedicine Treatments. Advanced Therapeutics 2022; 5(11) doi: 10.1002/adtp.202200079
|
| 414 |
Dastan Salim Hassan, Hemin Jumaa Hasary, Zhwan Salim Hassan. Role of Probiotics in the Prevention and Treatment of GIT Cancers: Updated Review. Al-Rafidain Journal of Medical Sciences ( ISSN: 2789-3219 ) 2023; 4: 52 doi: 10.54133/ajms.v4i.103
|
| 415 |
Wei Wang, Ying He, Lu-Lu Zhai, Long-Jiang Chen, Li-Chao Yao, Lun Wu, Zhi-Gang Tang, Jin-Zhuo Ning. m6A RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2. Epigenetics 2022; 17(12): 1738 doi: 10.1080/15592294.2022.2061117
|
| 416 |
Elmira Zolali, Sina Rashedi, Elaheh Dalir Abdolahinia, Nasim Rashedi, Saeideh Allahyari, Nastaran Hashemzadeh. Principles of Biomaterials Encapsulation : Volume Two. 2023; : 589 doi: 10.1016/B978-0-12-824345-9.00019-2
|
| 417 |
M. B. Potievskii, P. V. Shegai, A. D. Kaprin. Prospects for the Application of Methods of Evolutionary Biology in Oncology. Journal of Evolutionary Biochemistry and Physiology 2022; 58(2): 318 doi: 10.1134/S0022093022020028
|
| 418 |
Mina Wang, Feiyu Xie, Jiaran Lin, Yihan Zhao, Qian Zhang, Zehuan Liao, Peng Wei. Diagnostic and Prognostic Value of Circulating CircRNAs in Cancer. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.649383
|
| 419 |
Dr Paula Murphy, Mr Aditya Kanwar, Mr David Stell, Mr Christopher Briggs, Mr Matthew Bowles, Mr Somaiah Aroori. The prevalence of micronutrient deficiency in patients with suspected pancreatico-biliary malignancy: Results from a specialist Hepato-Biliary and Pancreatic unit. European Journal of Surgical Oncology 2021; 47(7): 1750 doi: 10.1016/j.ejso.2021.03.227
|
| 420 |
Ryan N. Fuller, Ann Morcos, Joab Galvan Bustillos, David Caba Molina, Nathan R. Wall. Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and therapeutic potential. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(5): 189153 doi: 10.1016/j.bbcan.2024.189153
|
| 421 |
Xin Gao, Haoran Xu, Zhuoyi Ye, Xin Chen, Xin Wang, Qi Chang, Yueqing Gu. PDGFRβ targeted innovative imaging probe for pancreatic adenocarcinoma detection. Talanta 2023; 255: 124225 doi: 10.1016/j.talanta.2022.124225
|
| 422 |
Francis Kobia, Jesse Gitaka, Francis Makokha, Moses Kamita, Joshua Kibera, Cynthia Mwenda, Gladys Mucee, Bactrin Kilingo. The state of cancer in Meru, Kenya: a retrospective study. AAS Open Research 2019; 2: 167 doi: 10.12688/aasopenres.13027.1
|
| 423 |
S. Lautenschlaeger, C. Dumke, L. Exeli, H. Hauswald, R. Engenhart-Cabillic, F. Eberle. Treatment of primary or recurrent non-resectable pancreatic cancer with proton beam irradiation combined with gemcitabine-based chemotherapy. Strahlentherapie und Onkologie 2023; 199(11): 982 doi: 10.1007/s00066-023-02106-5
|
| 424 |
Alberto Nicoletti, Federica Vitale, Giuseppe Quero, Mattia Paratore, Claudio Fiorillo, Marcantonio Negri, Angela Carlino, Frediano Inzani, Antonio Gasbarrini, Sergio Alfieri, Lorenzo Zileri Dal Verme. Immunohistochemical Evaluation of the Expression of Specific Membrane Antigens in Patients with Pancreatic Ductal Adenocarcinoma. Cancers 2023; 15(18): 4586 doi: 10.3390/cancers15184586
|
| 425 |
Wael T. Mohamed, Vinay Jahagirdar, Fouad Jaber, Mohamed K. Ahmed, Ifrah Fatima, Thomas Bierman, Zhuxuan Fu, Philip G. Jones, Amira F. Hassan, Erin Faber, Wendell K. Clarkston, Hassan Ghoz, Ossama W. Tawfik, Sreeni Jonnalagadda. Endoscopic Ultrasound-Guided Fine-Needle Biopsy Versus Aspiration for Tissue Sampling Adequacy for Molecular Testing in Pancreatic Ductal Adenocarcinoma. Cancers 2024; 16(4): 761 doi: 10.3390/cancers16040761
|
| 426 |
Serkan Özdemir, Hüseyin Ayhan. Anticancer Potential of Lyophilised Medicinal Leech (Hirudo verbana) of Saliva Extract Against Pancreatic Cancer (MIA PaCa-2) Cell Lines. Journal of Anatolian Environmental and Animal Sciences 2025; 10(2): 167 doi: 10.35229/jaes.1619391
|
| 427 |
Dema Maher Shobaki, Manoop S. Bhutani. Pancreatic Cancer: A Multidisciplinary Approach. 2022; : 1 doi: 10.1007/978-3-031-05724-3_1
|
| 428 |
Adam B. Schweber, Emil Agarunov, Christian Brooks, Chin Hur, Tamas A. Gonda. Prevalence, Incidence, and Risk of Progression of Asymptomatic Pancreatic Cysts in Large Sample Real-world Data. Pancreas 2021; 50(9): 1287 doi: 10.1097/MPA.0000000000001918
|
| 429 |
Ying-Cheng Chen, Ying-Wei Lan, Shiaw-Min Huang, Chih-Ching Yen, Wei Chen, Wan-Ju Wu, Theresa Staniczek, Kowit-Yu Chong, Chuan-Mu Chen. Human amniotic fluid mesenchymal stem cells attenuate pancreatic cancer cell proliferation and tumor growth in an orthotopic xenograft mouse model. Stem Cell Research & Therapy 2022; 13(1) doi: 10.1186/s13287-022-02910-3
|
| 430 |
Katarzyna Ratajczak, Sylwia Borska. Cytotoxic and Proapoptotic Effects of Resveratrol in In Vitro Studies on Selected Types of Gastrointestinal Cancers. Molecules 2021; 26(14): 4350 doi: 10.3390/molecules26144350
|
| 431 |
Maira du Plessis, Marios Loukas. A comprehensive study of the abdominal ganglia part 3: An overview of the most commonly observed ganglion patterns. Clinical Anatomy 2022; 35(7): 1014 doi: 10.1002/ca.23940
|
| 432 |
Kian Heshmat-Ghahdarijani, Vida Sarmadi, Afshin Heidari, Alireza Falahati Marvasti, Sina Neshat, Sina Raeisi. The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1228076
|
| 433 |
John B. Kisiel, Jon O. Ebbert, William R. Taylor, Catherine R. Marinac, Omair A. Choudhry, Seema P. Rego, Tomasz M. Beer, Michelle A. Beidelschies. Shifting the Cancer Screening Paradigm: Developing a Multi-Biomarker Class Approach to Multi-Cancer Early Detection Testing. Life 2024; 14(8): 925 doi: 10.3390/life14080925
|
| 434 |
Dushyant Singh Dahiya, Saurabh Chandan, Hassam Ali, Bhanu Siva Mohan Pinnam, Manesh Kumar Gangwani, Hashem Al Al Bunni, Andrew Canakis, Harishankar Gopakumar, Ishaan Vohra, Jay Bapaye, Mohammad Al-Haddad, Neil R. Sharma. Role of Therapeutic Endoscopic Ultrasound in Management of Pancreatic Cancer: An Endoscopic Oncologist Perspective. Cancers 2023; 15(12): 3235 doi: 10.3390/cancers15123235
|
| 435 |
Parvin Yavari, Amir Roointan, Mohammadjavad Naghdibadi, Yosef Masoudi-Sobhanzadeh. In-silico identification of therapeutic targets in pancreatic ductal adenocarcinoma using WGCNA and Trader. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-74252-4
|
| 436 |
Peng Li, Yaoyue Hu, Ghislaine Scelo, Mikko Myrskylä, Pekka Martikainen. Pre-Existing Psychological Disorders, Diabetes, and Pancreatic Cancer: A Population-Based Study of 38,952 Finns. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4128736
|
| 437 |
Zhaozhi Xia, Shuchao Zhao, Xin Gao, Hongrui Sun, Faji Yang, Huaqiang Zhu, Hengjun Gao, Jun Lu, Xu Zhou. LHPP Inhibits the Viability, Migration, and Proliferation of PDAC Cells and Significantly Affects the Expression of SDC1 and S100p. Technology in Cancer Research & Treatment 2023; 22 doi: 10.1177/15330338231177807
|
| 438 |
A. V. Shabunin, M. M. Tavobilov, S. S. Lebedev, I. Yu. Korzheva, A. A. Karpov, A. V. Lantsynova. THE CHOICE OF THE METHOD OF ENDOSCOPIC STENTING IN PATIENTS WITH UNRESECTABLE ADENOCARCINOMA OF THE PANCREATIC HEAD. Siberian journal of oncology 2020; 19(3): 116 doi: 10.21294/1814-4861-2020-19-3-116-121
|
| 439 |
Sujani M. K. Gamage, Chamath D. Ranaweera, Tracie T. Cheng, Sharmin Aktar, Vinod Gopalan, Farhadul Islam. Current Cancer Biomarkers. 2023; : 11 doi: 10.2174/9789815079364123010005
|
| 440 |
Riley J. Arseneau, Emma Kempster, Carley Bekkers, Thomas Samson, Boris L. Gala-Lopez, Ravi Ramjeesingh, Jeanette E. Boudreau, Thomas Arnason. Claudin 18 (43–14A clone) expression in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker for zolbetuximab therapy. Translational Oncology 2025; 55: 102362 doi: 10.1016/j.tranon.2025.102362
|
| 441 |
Kevin Dzobo, Chelene Ganz, Nicholas Ekow Thomford, Dimakatso Alice Senthebane. Cancer Stem Cell Markers in Relation to Patient Survival Outcomes: Lessons for Integrative Diagnostics and Next-Generation Anticancer Drug Development. OMICS: A Journal of Integrative Biology 2021; 25(2): 81 doi: 10.1089/omi.2020.0185
|
| 442 |
HuaGen Li, RongXuan Zhu, XiaoLong Liu, Kai Zhao, DeFei Hong, Tian Li. Siglec-15 Regulates the Inflammatory Response and Polarization of Tumor-Associated Macrophages in Pancreatic Cancer by Inhibiting the cGAS-STING Signaling Pathway. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/3341038
|
| 443 |
Han-Xiao Nie, Ling Zhang, Tao He, Li Wang, Bai-Shun Wan, Xiao-Qian Wang, Feng Han. RETRACTED: lncRNA-XLOC_012370 Promotes the Development of Pancreatic Cancer and Inactivates the NF-κB Pathway Through miR-140-5p. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.620550
|
| 444 |
Rafał Pęksa, Michał Kunc, Piotr Czapiewski, Michał Piątek, Stanisław Hać, Barbara Radecka, Wojciech Biernat. Tumor Budding Is an Independent Prognostic Factor in Pancreatic Adenocarcinoma and It Positively Correlates with PD-L1 Expression on Tumor Cells. Biomedicines 2022; 10(7): 1761 doi: 10.3390/biomedicines10071761
|
| 445 |
Minsol Kim, Joshua P. Schiff, Alex Price, Eric Laugeman, Pamela P. Samson, Hyun Kim, Shahed N. Badiyan, Lauren E. Henke. The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR). Radiation Oncology 2022; 17(1) doi: 10.1186/s13014-022-02125-z
|
| 446 |
Sai Sandeep Annamaraju, Sai Charitha Mullaguri, Sharat Putta, Ravikanth Vishnubhotla, Rama Krishna Kancha. Biomedical Aspects of Solid Cancers. 2024; : 73 doi: 10.1007/978-981-97-1802-3_7
|
| 447 |
萍 范. Study on the Application of Home Nutrition Management for Patients with Pancreatic Cancer after Operation. Advances in Clinical Medicine 2023; 13(05): 7349 doi: 10.12677/ACM.2023.1351027
|
| 448 |
Aryan Salahi‐Niri, Paniz Zarand, Negar Mansouri, Parvaneh Rastgou, Omid Yazdani, Romina Esbati, Fatemeh Shojaeian, Behnaz Jahanbin, Zhaleh Mohsenifar, Hamid Asadzadeh Aghdaei, Farid Azmoudeh Ardalan, Seyed Amir Ahmad Safavi‐Naini. Potential of Proliferative Markers in Pancreatic Cancer Management: A Systematic Review. Health Science Reports 2025; 8(3) doi: 10.1002/hsr2.70412
|
| 449 |
Chi-Cheng Huang, Chih-Yi Liu, Chi-Jung Huang, Yao-Chun Hsu, Heng-Hui Lien, Jia-Uei Wong, Feng-Chuan Tai, Wen-Hui Ku, Chi-Feng Hung, Jaw-Town Lin, Ching-Shui Huang, Han-Sun Chiang. Deciphering Genetic Alterations of Taiwanese Patients with Pancreatic Adenocarcinoma through Targeted Sequencing. International Journal of Molecular Sciences 2022; 23(3): 1579 doi: 10.3390/ijms23031579
|
| 450 |
Nicolas A. Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, Odile Gayet, Julie Roques, Remy Nicolle, Gwen Lomberk, Raul Urrutia, Nelson Dusetti, Juan Iovanna. Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction. npj Precision Oncology 2022; 6(1) doi: 10.1038/s41698-022-00299-z
|
| 451 |
Vignesh Vudatha, Kelly M. Herremans, Devon C. Freudenberger, Christopher Liu, Jose G. Trevino. Pancreatic Cancer: Basic Mechanisms and Therapies. Advances in Cancer Research 2023; 159: 75 doi: 10.1016/bs.acr.2023.02.002
|
| 452 |
Martha B. Pitman. The World Health Organization Reporting System for Pancreaticobiliary Cytopathology: Review and Comparison to the Papanicolaou Society of Cytopathology System. Archives of Pathology & Laboratory Medicine 2025; 149(3): e39 doi: 10.5858/arpa.2023-0411-RA
|
| 453 |
Sila Appak Baskoy, Amardeep Khunkhuna, Bianca Scuric, Zlatina Tarmakova, Imogen R Coe. Characterization of equilibrative nucleoside transport of the pancreatic cancer cell line: Panc-1. Turkish Journal of Pharmaceutical Sciences 2023; 0(0): 0 doi: 10.4274/tjps.galenos.2023.86727
|
| 454 |
Wenbo Zou, Zizheng Wang, Fei Wang, Gong Zhang, Rong Liu. A nomogram predicting overall survival in patients with non-metastatic pancreatic head adenocarcinoma after surgery: a population-based study. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08250-4
|
| 455 |
Anna La Salvia, Irene Persano, Elena Parlagreco, Alessandro Audisio, Massimiliano Cani, Maria Pia Brizzi. Pancreatic adenocarcinoma and pancreatic high-grade neuroendocrine carcinoma: two sides of the moon. Medical Oncology 2022; 39(11) doi: 10.1007/s12032-022-01764-2
|
| 456 |
Nitika Patwa, Ritu Chauhan, Abhishek Chauhan, Manoj Kumar, Seema Ramniwas, Darin Mansor Mathkor, Adesh Kumar Saini, Hardeep Singh Tuli, Shafiul Haque, Petr Slama. Garcinol in gastrointestinal cancer prevention: recent advances and future prospects. Journal of Cancer Research and Clinical Oncology 2024; 150(7) doi: 10.1007/s00432-024-05880-6
|
| 457 |
Naoyoshi Nagata, Suguru Nishijima, Yasushi Kojima, Yuya Hisada, Koh Imbe, Tohru Miyoshi-Akiyama, Wataru Suda, Moto Kimura, Ryo Aoki, Katsunori Sekine, Mitsuru Ohsugi, Kuniko Miki, Tsuyoshi Osawa, Kohjiro Ueki, Shinichi Oka, Masashi Mizokami, Ece Kartal, Thomas S.B. Schmidt, Esther Molina-Montes, Lidia Estudillo, Nuria Malats, Jonel Trebicka, Stephan Kersting, Melanie Langheinrich, Peer Bork, Naomi Uemura, Takao Itoi, Takashi Kawai. Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study. Gastroenterology 2022; 163(1): 222 doi: 10.1053/j.gastro.2022.03.054
|
| 458 |
Silviu Stanciu, Florentina Ionita-Radu, Constantin Stefani, Daniela Miricescu, Iulia-Ioana Stanescu-Spinu, Maria Greabu, Alexandra Ripszky Totan, Mariana Jinga. Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects. International Journal of Molecular Sciences 2022; 23(17): 10132 doi: 10.3390/ijms231710132
|
| 459 |
Jessica L. Nickerson, Chloe Cyr, Riley J. Arseneau, Stacey N. Lee, Stefanie Condon-Oldreive, George Zogopoulos, Keith Roberts, Christina A. Kim, Sylvia S. W. Ng, Masoom Haider, Eva Villalba, Leah Stephenson, Erica Tsang, Brent Johnston, Boris Gala-Lopez, Valerie Cooper, Breffni Hannon, Anne Gangloff, Sharlene Gill, Filomena Servidio-Italiano, Ravi Ramjeesingh. Canadian National Pancreas Conference 2023: A Review of Multidisciplinary Engagement in Pancreatic Cancer Care. Current Oncology 2024; 31(10): 6191 doi: 10.3390/curroncol31100461
|
| 460 |
Daniel J. Campbell, Emily L. Isch, Geoffrey M. Kozak, Charles J. Yeo. Primary Pancreatic Signet Ring Cell Carcinoma: A Case Report and Review of the Literature. Journal of Pancreatic Cancer 2021; 7(1): 1 doi: 10.1089/pancan.2020.0013
|
| 461 |
Poppy Anjelisa Zaitun Hasibuan, Jane Melita Keliat, Muhammad Fauzan Lubis, Annisa Nasution. The ethyl acetate extract of Vernonia amygdalina leaf ameliorates gemcitabine effect against migration and invasion of PANC-1 cells via down-regulation the VEGF, COX2, and RAS/MEK pathways. Saudi Pharmaceutical Journal 2024; 32(1): 101872 doi: 10.1016/j.jsps.2023.101872
|
| 462 |
Sung Jun Ma, Lucas M. Serra, Austin J. Bartl, Hye Ri Han, Fatemeh Fekrmandi, Austin J. Iovoli, Kavitha M. Prezzano, Gregory M. Hermann, Han Yu, Anurag K. Singh. Association of survival with stereotactic body radiation therapy following induction chemotherapy for unresected locally advanced pancreatic cancer. Journal of Radiotherapy in Practice 2022; 21(3): 403 doi: 10.1017/S1460396921000212
|
| 463 |
Xiaoyuan Sun, Huijun Chu, Ke Lei, Yandong Ci, Haijun Lu, Jia Wang, Meng Zhou, He Ren, Tongsen Zheng. GPR120 promotes metastasis but inhibits tumor growth in pancreatic ductal adenocarcinoma. Pancreatology 2022; 22(6): 749 doi: 10.1016/j.pan.2022.06.006
|
| 464 |
Jeremy Chang, Yanan Liu, Stephanie A. Saey, Kevin C. Chang, Hannah R. Shrader, Kelsey L. Steckly, Maheen Rajput, Milan Sonka, Carlos H. F. Chan. Machine-learning based investigation of prognostic indicators for oncological outcome of pancreatic ductal adenocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.895515
|
| 465 |
Malek Zihlif, Tareq Hameduh, Nailya Bulatova, Hana Hammad. Alteration in the expression of the chemotherapy resistance‑related genes in response to chronic and acute hypoxia in pancreatic cancer. Biomedical Reports 2023; 19(6) doi: 10.3892/br.2023.1670
|
| 466 |
Chao Chen, Ying Wang, Qing Zhao, Guo-dong Li, Yao-hui Wang, Li-chao Xu, Hao-zhe Huang, Ge Song, Wen-tao Li, Xin-hong He. E3 Ubiquitin Ligase MARCH8 Promotes Pancreatic Cancer Growth and Metastasis by Activating STAT3 via Degradation of PTPN4. Pancreas 2023; 52(4): e224 doi: 10.1097/MPA.0000000000002244
|
| 467 |
Clémentine Aubrun Fulbert, Frédéric Chaput, Sarah Stelse‐Masson, Maxime Henry, Benoit Chovelon, Sylvain Bohic, Dennis Brueckner, Jan Garrevoet, Christine Moriscot, Benoit Gallet, Julien Vollaire, Olivier Nicoud, Frédéric Lerouge, Sandrine Denis‐Quanquin, Xavier Jaurand, Thibault Jacquet, Anthony Nomezine, Véronique Josserand, Jean‐Luc Coll, Jean‐Luc Ravanat, Hélène Elleaume, Anne‐Laure Bulin. Nanoscintillator Coating: A Key Parameter That Strongly Impacts Internalization, Biocompatibility, and Therapeutic Efficacy in Pancreatic Cancer Models. Small Science 2024; 4(5) doi: 10.1002/smsc.202400041
|
| 468 |
Tao Cheng, Zhiheng Zhang, Hua Shen, Ziying Jian, Junsheng Li, Yujun Chen, Yi Shen, Xinyi Dai. Topically applicated curcumin/gelatin-blended nanofibrous mat inhibits pancreatic adenocarcinoma by increasing ROS production and endoplasmic reticulum stress mediated apoptosis. Journal of Nanobiotechnology 2020; 18(1) doi: 10.1186/s12951-020-00687-2
|
| 469 |
E.A. Drobyazgin, Yu.V. Chikinev, K.I. Scherbina. Thoracoscopic sympathetic-splanchnicectomy for unresectable abdomen tumors and chronic pancreatitis. Endoskopicheskaya khirurgiya 2021; 27(4): 11 doi: 10.17116/endoskop20212704111
|
| 470 |
Mrinmay Kumar Mallik, Laila Rafiq Qadan, Asit Kumar Mohanty, Ali Alali, Kusum Kapila. Grading pancreatic adenocarcinomas on fine needle aspiration cytology. The outstanding issues. Cytopathology 2024; 35(2): 256 doi: 10.1111/cyt.13343
|
| 471 |
Zhiyin Tang, Wanfeng Xu, Mingming Zhang. Association between type 2 diabetes and 5-year overall survival in early-stage pancreatic cancer: a retrospective cohort study. PeerJ 2022; 10: e14538 doi: 10.7717/peerj.14538
|
| 472 |
Qinfen Xie, Lidong Wang, Shusen Zheng. Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis. Dose-Response 2020; 18(2): 155932582093129 doi: 10.1177/1559325820931290
|
| 473 |
Sini Vehviläinen, Hanna Seppänen, Anna Nurmi, Caj Haglund, Harri Mustonen, Marianne Udd, Leena Kylänpää. Use of self-expandable metallic stents for endoscopic biliary decompression decreases stent complications in pancreatic cancer patients receiving chemotherapy. Surgical Endoscopy 2022; 36(1): 614 doi: 10.1007/s00464-021-08327-y
|
| 474 |
Kodai Abe, Minoru Kitago, Yuko Kitagawa, Akira Hirasawa. Hereditary pancreatic cancer. International Journal of Clinical Oncology 2021; 26(10): 1784 doi: 10.1007/s10147-021-02015-6
|
| 475 |
P Laoveeravat, S Thavaraputta, W Vutthikraivit, S Suchartlikitwong, T Mingbunjerdsuk, A Motes, K Nugent, A Rakvit, E Islam, S Islam. Proton pump inhibitors and histamine-2 receptor antagonists on the risk of pancreatic cancer: a systematic review and meta-analysis. QJM: An International Journal of Medicine 2019; doi: 10.1093/qjmed/hcz234
|
| 476 |
Ningyi Wan, Jing Shi, Jianguo Xu, Juan Huang, Delu Gan, Min Tang, Xiaohan Li, Ying Huang, Pu Li. Gasdermin D: A Potential New Auxiliary Pan-Biomarker for the Detection and Diagnosis of Diseases. Biomolecules 2023; 13(11): 1664 doi: 10.3390/biom13111664
|
| 477 |
Navni Sharma, Vimal Arora. Strategies for drug targeting in pancreatic cancer. Pancreatology 2022; 22(7): 937 doi: 10.1016/j.pan.2022.08.001
|
| 478 |
Morgan Connaughton, Mahsa Dabagh. Impact of stroma remodeling on forces experienced by cancer cells and stromal cells within a pancreatic tumor tissue. BioMedical Engineering OnLine 2024; 23(1) doi: 10.1186/s12938-024-01278-0
|
| 479 |
Mehrdad Zarei, Rupesh Shrestha, Sneha Johnson, Zuhua Yu, Keshav Karki, Ali Vaziri-Gohar, Jessica Epps, Heng Du, Larry Suva, Mahsa Zarei, Stephen Safe. Nuclear Receptor 4A2 (NR4A2/NURR1) Regulates Autophagy and Chemoresistance in Pancreatic Ductal Adenocarcinoma. Cancer Research Communications 2021; 1(2): 65 doi: 10.1158/2767-9764.CRC-21-0073
|
| 480 |
Can Yu, Yuli Ruan, Lan Yu, Xinxin Wang, Zhaoshen Hu, Guanyu Zhu, Tao Huang. Predicting postoperative prognosis of pancreatic cancer using a computed tomography-based radio-clinical model: exploring biologic functions. Journal of Gastrointestinal Surgery 2024; 28(4): 458 doi: 10.1016/j.gassur.2024.02.005
|
| 481 |
Jiaxin Huang, Qiqi Mao, Xu Sun. Identification of a DNA repair 9-gene signature for the overall survival prediction of pancreatic cancer. Annals of Diagnostic Pathology 2022; 57: 151883 doi: 10.1016/j.anndiagpath.2021.151883
|
| 482 |
Mukulika Bose, Priyanka Grover, Alexa J. Sanders, Ru Zhou, Mohammad Ahmad, Sophia Shwartz, Priyanka Lala, Sritama Nath, Mahboubeh Yazdanifar, Cory Brouwer, Pinku Mukherjee. Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.821875
|
| 483 |
Peng Li, Yaoyue Hu, Ghislaine Scelo, Mikko Myrskylä, Pekka Martikainen. Pre-existing psychological disorders, diabetes, and pancreatic cancer: A population-based study of 38,952 Finns. Cancer Epidemiology 2023; 82: 102307 doi: 10.1016/j.canep.2022.102307
|
| 484 |
Yuexian Li, Zhou Su, Biwei Wei, Zhihai Liang. KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma. International Journal of General Medicine 2021; : 2677 doi: 10.2147/IJGM.S313584
|
| 485 |
Constança Oliveira, João Calmeiro, Mylène A. Carrascal, Amílcar Falcão, Célia Gomes, Bruno Miguel Neves, Maria Teresa Cruz. Exosomes as new therapeutic vectors for pancreatic cancer treatment. European Journal of Pharmaceutics and Biopharmaceutics 2021; 161: 4 doi: 10.1016/j.ejpb.2021.02.002
|
| 486 |
Weizhen Huang, Jun Li, Siwei Zhou, Yi Li, Xia Yuan. Discovering a Four-Gene Prognostic Model Based on Single-Cell Data and Gene Expression Data of Pancreatic Adenocarcinoma. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.883548
|
| 487 |
Marc Hilmi, Cindy Neuzillet. Nouvelle AMM : olaparib — cancer du pancréas avec mutation germinale de BRCA. Bulletin du Cancer 2020; 107(10): 961 doi: 10.1016/j.bulcan.2020.06.009
|
| 488 |
Yuan-yuan Liang, Zhou Lu, Hong-wei Liu, Qi Huang, Xue-ting Zheng, Xiao-an Li, Yan Zhou. Anti-tumor effects of nanosecond pulsed electric fields in a murine model of pancreatic cancer. Bioelectrochemistry 2025; 161: 108803 doi: 10.1016/j.bioelechem.2024.108803
|
| 489 |
Valentina Giansante, Gianmarco Stati, Silvia Sancilio, Emanuela Guerra, Saverio Alberti, Roberta Di Pietro. The Dual Role of Necroptosis in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2023; 24(16): 12633 doi: 10.3390/ijms241612633
|
| 490 |
Yoo Na Lee, Min Kyu Sung, Dae Wook Hwang, Yejong Park, Bong Jun Kwak, Woohyung Lee, Ki Byung Song, Jae Hoon Lee, Changhoon Yoo, Kyu-Pyo Kim, Heung-Moon Chang, Baek-Yeol Ryoo, Song Cheol Kim. Clinical Outcomes of Surgery after Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Ductal Adenocarcinoma. Cancer Research and Treatment 2024; 56(4): 1240 doi: 10.4143/crt.2023.977
|
| 491 |
Ben George, Matthew Kent, Andy Surinach, Neil Lamarre, Paul Cockrum. The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.754687
|
| 492 |
Maximos Frountzas, Efstathia Liatsou, Dimitrios Schizas, Vasilios Pergialiotis, Michail Vailas, Neoklis Kritikos, Konstantinos G. Toutouzas. The impact of surgery delay on survival of resectable pancreatic cancer: A systematic review of observational studies. Surgical Oncology 2022; 45: 101855 doi: 10.1016/j.suronc.2022.101855
|
| 493 |
Pinaki Mondal, Neesha S. Patel, Katie Bailey, Shruthishree Aravind, Sara B. Cartwright, Michael A. Hollingsworth, Audrey J. Lazenby, Mark A. Carlson. Induction of pancreatic neoplasia in the KRAS/TP53 Oncopig. Disease Models & Mechanisms 2023; 16(1) doi: 10.1242/dmm.049699
|
| 494 |
Yanhua Zhang, Hui Xu, Yue Li, Yang Sun, Xiaochun Peng. Advances in the treatment of pancreatic cancer with traditional Chinese medicine. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1089245
|
| 495 |
Grace G. Bushnell, Sophia M. Orbach, Jeffrey A. Ma, Howard C. Crawford, Max S. Wicha, Jacqueline S. Jeruss, Lonnie D. Shea. Disease-induced immunomodulation at biomaterial scaffolds detects early pancreatic cancer in a spontaneous model. Biomaterials 2021; 269: 120632 doi: 10.1016/j.biomaterials.2020.120632
|
| 496 |
Dey Parama, Monikongkona Boruah, Kumari Yachna, Varsha Rana, Kishore Banik, Choudhary Harsha, Krishan Kumar Thakur, Uma Dutta, Aditya Arya, Xinliang Mao, Kwang Seok Ahn, Ajaikumar B. Kunnumakkara. Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases. Life Sciences 2020; 260: 118182 doi: 10.1016/j.lfs.2020.118182
|
| 497 |
Xiao-Fan Tian, Ling-Yun Yu, Dao-Hui Yang, Dan Zuo, Jia-Ying Cao, Ying Wang, Zi-Yi Yang, Wen-Hui Lou, Wen-Ping Wang, Wei Gong, Yi Dong. Contrast-enhanced ultrasound (CEUS) and shear wave elastography (SWE) features for characterizing serous microcystic adenomas (SMAs): In comparison to pancreatic neuroendocrine tumors (pNETs). Heliyon 2024; 10(3): e25185 doi: 10.1016/j.heliyon.2024.e25185
|
| 498 |
Dan Jiang, Xiaona Fan, Pengfei Li, Yang Zhou, Kaige Chen, Hengzhen Li, Jinshuang Liu, Wenjing Zhang, Yisheng Dai, Ning Sun, Zhiwei Li. Prediction scores of postoperative liver metastasis and long‐term survival of pancreatic head cancer based on the distance between the mesenteric vessels and tumor, preoperative serum carbohydrate antigen 19‐9 level, and lymph node metastasis rate. Cancer Medicine 2023; 12(2): 1064 doi: 10.1002/cam4.4957
|
| 499 |
Wenqian Huang, Yile Dai, Liming Xu, Yefan Mao, Zhengwei Huang, Xiaoke Ji. Dihydrotanshinone I Inhibits Pancreatic Cancer Progression via Hedgehog/
Gli Signal Pathway. Current Cancer Drug Targets 2023; 23(9): 731 doi: 10.2174/1568009623666230328123915
|
| 500 |
Wismaji Sadewo, Zuherman Rustam, Hamidah Hamidah, Alifah Roudhoh Chusmarsyah. Pancreatic Cancer Early Detection Using Twin Support Vector Machine Based on Kernel. Symmetry 2020; 12(4): 667 doi: 10.3390/sym12040667
|
| 501 |
S Zwyea, L Naji, S Almansouri. Kaplan-Meier plotter data analysis model in early prognosis of pancreatic cancer. Journal of Physics: Conference Series 2021; 1853(1): 012033 doi: 10.1088/1742-6596/1853/1/012033
|
| 502 |
Maryam Alavi, Ana Mejia-Bautista, Meiyi Tang, Jela Bandovic, Avi Z. Rosenberg, Agnieszka B. Bialkowska. Krüppel-like Factor 5 Plays an Important Role in the Pathogenesis of Chronic Pancreatitis. Cancers 2023; 15(22): 5427 doi: 10.3390/cancers15225427
|
| 503 |
Deniz Sadighbayan, Khosrow Sadighbayan, Ahmad Yari Khosroushahi, Mohammad Hasanzadeh. Recent advances on the DNA-based electrochemical biosensing of cancer biomarkers: Analytical approach. TrAC Trends in Analytical Chemistry 2019; 119: 115609 doi: 10.1016/j.trac.2019.07.020
|
| 504 |
Hua Amanda Fang, Ahmer Irfan, Selwyn M. Vickers, Olumide Gbolahan, Grant R. Williams, Darryl Outlaw, Thomas Nien-Tsu. Wang, Vikas Dudeja, J. Bart Rose, Sushanth Reddy. Are Lymph Node Metastases Associated With Survival in Black Patients With Pancreatic Cancer?. Journal of Surgical Research 2023; 284: 143 doi: 10.1016/j.jss.2022.11.031
|
| 505 |
Jane E. Rogers, Jonathan D. Mizrahi, Lianchun Xiao, Chirayu Mohindroo, Rachna T. Shroff, Robert Wolff, Gauri R. Varadhachary, Milind M. Javle, Michael Overman, David R. Fogelman, Kanwal P. S. Raghav, Shubham Pant, Florencia McAllister. Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma. Cancer Medicine 2020; 9(15): 5406 doi: 10.1002/cam4.3229
|
| 506 |
M. Cisneros-Villanueva, L. Hidalgo-Pérez, M. Rios-Romero, A. Cedro-Tanda, C. A. Ruiz-Villavicencio, K. Page, R. Hastings, D. Fernandez-Garcia, R. Allsopp, M. A. Fonseca-Montaño, S. Jimenez-Morales, V. Padilla-Palma, J. A. Shaw, A. Hidalgo-Miranda. Cell-free DNA analysis in current cancer clinical trials: a review. British Journal of Cancer 2022; 126(3): 391 doi: 10.1038/s41416-021-01696-0
|
| 507 |
E. Panagiotou, G. Gomatou, I. P. Trontzas, N. Syrigos, E. Kotteas. Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials. Clinical and Translational Oncology 2022; 24(2): 161 doi: 10.1007/s12094-021-02688-5
|
| 508 |
Graziantonio Lauria, Rosita Curcio, Paola Lunetti, Stefano Tiziani, Vincenzo Coppola, Vincenza Dolce, Giuseppe Fiermonte, Amer Ahmed. Role of Mitochondrial Transporters on Metabolic Rewiring of Pancreatic Adenocarcinoma: A Comprehensive Review. Cancers 2023; 15(2): 411 doi: 10.3390/cancers15020411
|
| 509 |
Kei Takahashi, Shogo Ehata, Kensuke Miyauchi, Yasuyuki Morishita, Keiji Miyazawa, Kohei Miyazono. Neurotensin receptor 1 signaling promotes pancreatic cancer progression. Molecular Oncology 2021; 15(1): 151 doi: 10.1002/1878-0261.12815
|
| 510 |
Oluwatoba Emmanuel Oyeneyin, Babatunde Samuel Obadawo, Adesoji Alani Olanrewaju, Taoreed Olakunle Owolabi, Fahidat Adedamola Gbadamosi, Nureni Ipinloju, Helen Omonipo Modamori. Predicting the bioactivity of 2-alkoxycarbonylallyl esters as potential antiproliferative agents against pancreatic cancer (MiaPaCa-2) cell lines: GFA-based QSAR and ELM-based models with molecular docking. Journal of Genetic Engineering and Biotechnology 2021; 19(1): 38 doi: 10.1186/s43141-021-00133-2
|
| 511 |
Benjamin Rail, Erica Ogwumike, Emmanuel Adeyemo, Olatunde Badejo, Umaru Barrie, Yves J. Kenfack, Tarek Y. El Ahmadieh, Benjamin Kafka, Kristen Hall, Carlos A. Bagley, Salah G. Aoun. Pancreatic Cancer Metastasis to the Spine: A Systematic Review of Management Strategies and Outcomes with Case Illustration. World Neurosurgery 2022; 160: 94 doi: 10.1016/j.wneu.2022.01.016
|
| 512 |
Vanessa F. Bonazzi, Lauren G. Aoude, Sandra Brosda, Julia J. Bradford, James M. Lonie, Kelly A. Loffler, Michael G. Gartside, Kalpana Patel, Pamela Mukhopadhyay, Colm Keane, Val Gebski, James G. Kench, David Goldstein, Nicola Waddell, Andrew P. Barbour. C‐reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients. Asia-Pacific Journal of Clinical Oncology 2025; 21(1): 77 doi: 10.1111/ajco.13993
|
| 513 |
Amal AlZahmi, Irena Cenzer, Ulrich Mansmann, Helmut Ostermann, Sebastian Theurich, Tobias Schleinkofer, Karin Berger, Isabelle Durand-Zaleski. Usability of German hospital administrative claims data for healthcare research: General assessment and use case of multiple myeloma in Munich university hospital in 2015–2017. PLOS ONE 2022; 17(7): e0271754 doi: 10.1371/journal.pone.0271754
|
| 514 |
Etienne Buscail, Laurence Chiche, Christophe Laurent, Véronique Vendrely, Quentin Denost, Jérôme Denis, Matthieu Thumerel, Jean‐Marc Lacorte, Aurélie Bedel, François Moreau‐Gaudry, Sandrine Dabernat, Catherine Alix‐Panabières. Tumor‐proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells. Molecular Oncology 2019; 13(9): 1811 doi: 10.1002/1878-0261.12534
|
| 515 |
Yi Yu, Yu‐Feng Zou, Run‐Qi Hong, Wen‐Jie Chen, Liang Chen, Wen‐Qi Chen, Hui‐Peng Wang, Yuan Yu. Long non‐coding RNA SNHG16 decreased SMAD4 to induce gemcitabine resistance in pancreatic cancer via EZH2‐mediated epigenetic modification. The Kaohsiung Journal of Medical Sciences 2022; 38(10): 981 doi: 10.1002/kjm2.12574
|
| 516 |
Helon Guimarães Cordeiro, Jordana Maria Azevedo-Martins, Alessandra Valéria de Sousa Faria, Karin Juliane Pelizzaro Rocha-Brito, Renato Milani, Maikel Peppelenbosch, Gwenny Fuhler, Ângelo de Fátima, Carmen Veríssima Ferreira-Halder. Calix[6]arene dismantles extracellular vesicle biogenesis and metalloproteinases that support pancreatic cancer hallmarks. Cellular Signalling 2024; 119: 111174 doi: 10.1016/j.cellsig.2024.111174
|
| 517 |
Hillary G. Pratt, Kayla J. Steinberger, Nicole E. Mihalik, Sascha Ott, Thomas Whalley, Barbara Szomolay, Brian A. Boone, Timothy D. Eubank. Macrophage and Neutrophil Interactions in the Pancreatic Tumor Microenvironment Drive the Pathogenesis of Pancreatic Cancer. Cancers 2021; 14(1): 194 doi: 10.3390/cancers14010194
|
| 518 |
Chung-Tsui Huang, Yao-Jen Liang. Anti-tumor effect of statin on pancreatic adenocarcinoma: From concept to precision medicine. World Journal of Clinical Cases 2021; 9(18): 4500-4505 doi: 10.12998/wjcc.v9.i18.4500
|
| 519 |
Guiming Wang, Lifeng Pan, Rende Guo. Restoration of miR-200 expression suppresses proliferation and mobility of pancreatic cancer cell. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; doi: 10.1007/s00210-024-03717-0
|
| 520 |
Rituraj Chakraborty, Anupam Dutta, Bhargab Jyoti Baruah, Rajni Kumari, Priyanku Sarma, Ankita Sharma, Krishangi Goswami, Haritha Myakala, Akalesh Kumar Verma. Pancreatic Cancer: A Review on Pathophysiology, Naturopathy, Clinical Treatment and Outcomes. Current Cancer Therapy Reviews 2024; 20(3): 263 doi: 10.2174/1573394719666230830125213
|
| 521 |
K Saaketh Raja Ram, Annamalai R. Ensembling Model Approach for Prediction of Pancreatic Cancer Using a Biomarker Panel and Multi-Model Classifiers. 2023 International Conference on Next Generation Electronics (NEleX) 2023; : 1 doi: 10.1109/NEleX59773.2023.10421733
|
| 522 |
Kosuke Fukuda, Naohiko Seki, Ryutaro Yasudome, Reiko Mitsueda, Shunichi Asai, Mayuko Kato, Tetsuya Idichi, Hiroshi Kurahara, Takao Ohtsuka. Coronin 1C, Regulated by Multiple microRNAs, Facilitates Cancer Cell Aggressiveness in Pancreatic Ductal Adenocarcinoma. Genes 2023; 14(5): 995 doi: 10.3390/genes14050995
|
| 523 |
Xiaofang Wang, Wanfeng Xu, Xiaoru Hu, Xianghong Yang, Mingming Zhang. The Prognostic Role of Glycemia in Patients With Pancreatic Carcinoma: A Systematic Review and Meta-Analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.780909
|
| 524 |
Marwa Elsayed, Maen Abdelrahim. The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies. Biomedicines 2021; 9(4): 389 doi: 10.3390/biomedicines9040389
|
| 525 |
Bai-Shun Wan, Ming Cheng, Ling Zhang. Insulin-like growth factor 2 mRNA-binding protein 1 promotes cell proliferation <i>via</i> activation of AKT and is directly targeted by microRNA-494 in pancreatic cancer. World Journal of Gastroenterology 2019; 25(40): 6063-6076 doi: 10.3748/wjg.v25.i40.6063
|
| 526 |
Lisa M. Wintner, Monika Sztankay, Bernhard Holzner. Textbook of Pancreatic Cancer. 2021; : 1169 doi: 10.1007/978-3-030-53786-9_75
|
| 527 |
Büşra Küçükekmekci, Fatma Azize Budak Yıldıran. Investigation of the efficacy of siRNA-mediated KRAS gene silencing in pancreatic cancer therapy. PeerJ 2024; 12: e18214 doi: 10.7717/peerj.18214
|
| 528 |
Rong-jia Shi, Bo-wen Ke, Ya-ling Tang, Xin-hua Liang. Perineural invasion: A potential driver of cancer-induced pain. Biochemical Pharmacology 2023; 215: 115692 doi: 10.1016/j.bcp.2023.115692
|
| 529 |
Rossana Berardi, Silvia Rinaldi, Giulio Belfiori, Stefano Partelli, Stefano Crippa, Mariangela Torniai, Massimo Falconi. The Role of Hyponatraemia Before Surgery in Patients With Radical Resected Pancreatic Cancer. Clinical Medicine Insights: Oncology 2020; 14 doi: 10.1177/1179554920936605
|
| 530 |
Xin Wen, Zhiying Shao, Shuyi Chen, Wei Wang, Yan Wang, Jinghua Jiang, Qinggong Ma, Longzhen Zhang. Construction of an RNA-Binding Protein-Related Prognostic Model for Pancreatic Adenocarcinoma Based on TCGA and GTEx Databases. Frontiers in Genetics 2021; 11 doi: 10.3389/fgene.2020.610350
|
| 531 |
Wei Guo, Peng Cao, Xuanbin Wang, Min Hu, Yibin Feng. Medicinal Plants for the Treatment of Gastrointestinal Cancers From the Metabolomics Perspective. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.909755
|
| 532 |
Hao Chen, Wenhao Luo, Xiaoyue Lu, Taiping Zhang. Regulatory role of RNA modifications in the treatment of pancreatic ductal adenocarcinoma (PDAC). Heliyon 2023; 9(11): e20969 doi: 10.1016/j.heliyon.2023.e20969
|
| 533 |
David H. Ballard, Gerard K. Nguyen, Norman Atagu, Garrett Camps, Amber Salter, Shama Jaswal, Muhammad Naeem, Daniel R. Ludwig, Vincent M. Mellnick, Linda R. Peterson, William G. Hawkins, Ryan C. Fields, Jingqin Luo, Joseph E. Ippolito. Female-specific pancreatic cancer survival from CT imaging of visceral fat implicates glutathione metabolism in solid tumors. Academic Radiology 2024; 31(6): 2312 doi: 10.1016/j.acra.2023.11.012
|
| 534 |
Junhong Liu, Lin Ye, Kangqiang Lin, Tieshan Zhong, Jiguang Luo, Tao Wang, Liya Suo, Qingrong Mo, Shuqun Li, Qian Chen, Yaqun Yu. miR-4299 inhibits tumor progression in pancreatic cancer through targeting ADAM17. Molecular and Cellular Biochemistry 2023; 478(8): 1727 doi: 10.1007/s11010-022-04617-8
|
| 535 |
Miaomiao Lin, Yanyi Xiao, Yile Dai, Yefan Mao, Liming Xu, Qiyu Zhang, Zhe Chen. Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway. Clinical and Translational Oncology 2023; 26(4): 951 doi: 10.1007/s12094-023-03328-w
|
| 536 |
Hiroyuki Inoue, Akiko Eguchi, Yoshinao Kobayashi, Eri Usugi, Reiko Yamada, Junya Tsuboi, Teruo Akuta, Noriyuki Horiki, Motoh Iwasa, Yoshiyuki Takei. Extracellular vesicles from pancreatic ductal adenocarcinoma endoscopic ultrasound‐fine needle aspiration samples contain a protein barcode. Journal of Hepato-Biliary-Pancreatic Sciences 2022; 29(3): 394 doi: 10.1002/jhbp.1048
|
| 537 |
Jongkwang Kim, Sumok Bae, Seong-Mi Yoon, Sungmoon Jeong. Roadmap for providing and leveraging annotated data by cytologists in the PDAC domain as open data: support for AI-based pathology image analysis development and data utilization strategies. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1346237
|
| 538 |
Kexin Zheng, Xiaozhong Guo, Ji Feng, Zhaohui Bai, Xiaodong Shao, Fangfang Yi, Yongguo Zhang, Rui Zhang, Han Liu, Fernando Gomes Romeiro, Xingshun Qi. Gastrointestinal Bleeding due to Pancreatic Disease-Related Portal Hypertension. Gastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/3825186
|
| 539 |
Mikolaj Kowal, Andrew Smith, Sanjay Pandanaboyana, Samir Pathak. Editorial: Technological innovations and pancreatic cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1497367
|
| 540 |
Siqi Zhou, Qiyuan Guo, Aotian Chen, Xihan Li, Xiaoping Zou. Integrated bioinformatics analysis identifies PCSK9 as a prognosticator correlated with lipid metabolism in pancreatic adenocarcinoma. World Journal of Surgical Oncology 2024; 22(1) doi: 10.1186/s12957-024-03532-0
|
| 541 |
Ashutosh Gupta, Atanas G. Atanasov, Yutong Li, Neeraj Kumar, Anupam Bishayee. Chlorogenic acid for cancer prevention and therapy: Current status on efficacy and mechanisms of action. Pharmacological Research 2022; 186: 106505 doi: 10.1016/j.phrs.2022.106505
|
| 542 |
Daniel Cui Zhou, Reyka G. Jayasinghe, Siqi Chen, John M. Herndon, Michael D. Iglesia, Pooja Navale, Michael C. Wendl, Wagma Caravan, Kazuhito Sato, Erik Storrs, Chia-Kuei Mo, Jingxian Liu, Austin N. Southard-Smith, Yige Wu, Nataly Naser Al Deen, John M. Baer, Robert S. Fulton, Matthew A. Wyczalkowski, Ruiyang Liu, Catrina C. Fronick, Lucinda A. Fulton, Andrew Shinkle, Lisa Thammavong, Houxiang Zhu, Hua Sun, Liang-Bo Wang, Yize Li, Chong Zuo, Joshua F. McMichael, Sherri R. Davies, Elizabeth L. Appelbaum, Keenan J. Robbins, Sara E. Chasnoff, Xiaolu Yang, Ashley N. Reeb, Clara Oh, Mamatha Serasanambati, Preet Lal, Rajees Varghese, Jay R. Mashl, Jennifer Ponce, Nadezhda V. Terekhanova, Lijun Yao, Fang Wang, Lijun Chen, Michael Schnaubelt, Rita Jui-Hsien Lu, Julie K. Schwarz, Sidharth V. Puram, Albert H. Kim, Sheng-Kwei Song, Kooresh I. Shoghi, Ken S. Lau, Tao Ju, Ken Chen, Deyali Chatterjee, William G. Hawkins, Hui Zhang, Samuel Achilefu, Milan G. Chheda, Stephen T. Oh, William E. Gillanders, Feng Chen, David G. DeNardo, Ryan C. Fields, Li Ding. Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer. Nature Genetics 2022; 54(9): 1390 doi: 10.1038/s41588-022-01157-1
|
| 543 |
Xi Yang, Leiming Wang, Fei Zhou, Song Ye, Qianghu Sun. Yin Yang 1-induced activation of LINC01133 facilitates the progression of pancreatic cancer by sponging miR-199b-5p to upregulate myelin regulatory factor expression. Bioengineered 2022; 13(5): 13352 doi: 10.1080/21655979.2022.2038900
|
| 544 |
Fangfang Zhuo, Shuang Luo, Wei He, Zhanhui Feng, Ya’nan Hu, Jingxia Xu, Zejun Wang, Jianwei Xu. The Role of Signaling Pathways in Pancreatic Cancer Targeted Therapy. American Journal of Clinical Oncology 2023; 46(3): 121 doi: 10.1097/COC.0000000000000979
|
| 545 |
Viviana Vitolo, Lorenzo Cobianchi, Silvia Brugnatelli, Amelia Barcellini, Andrea Peloso, Angelica Facoetti, Alessandro Vanoli, Sara Delfanti, Lorenzo Preda, Silvia Molinelli, Catherine Klersy, Piero Fossati, Roberto Orecchia, Francesca Valvo. Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6108-0
|
| 546 |
Yimei Lu, Tingting Zhang, Shuyan Yang, Baofeng Yang, Jinning Li, Huanhuan Liu, Defan Yao, Gang Ren, Dengbin Wang. Dynamic Contrast-Enhanced MRI Assessing Antifibrotic Therapeutic Effects of Pancreatic Fibrosis with Curcumin – An Experimental Study at 11.7 T. Academic Radiology 2023; 30: S230 doi: 10.1016/j.acra.2023.05.028
|
| 547 |
Megan D. Hopkins, Ian J. Costello, Zachary C. Brandeburg, Emily L. Slay, Levi A. Zanders, Caroline E. Dunn, Carina A. Derewonko, Colin L. Davitt, Madison A. Reeder, Kate Prichard, Beatrice Chiew, Adam McCluskey, Robert J. Sheaff, Angus A. Lamar. Expansion of a Synthesized Library of N‐Benzyl Sulfonamides Derived from an Indole Core to Target Pancreatic Cancer. ChemMedChem 2023; 18(19) doi: 10.1002/cmdc.202300265
|
| 548 |
Mohd Farhan, Asim Rizvi, Mohammad Aatif, Aamir Ahmad. Current Understanding of Flavonoids in Cancer Therapy and Prevention. Metabolites 2023; 13(4): 481 doi: 10.3390/metabo13040481
|
| 549 |
Yu Kang, Xiao Wang, Xingchuan Wei, Dongli Li, Lishe Gan, Jingwei Jin, Rihui Wu, Panpan Wu, Zhaojun Sheng, Kun Zhang, Susan Goodin, Xuetao Xu, Xi Zheng. Synergistic inhibitory effect of α-humulene and sclareol on human pancreatic cancer cells. Journal of Functional Foods 2022; 89: 104958 doi: 10.1016/j.jff.2022.104958
|
| 550 |
Esther Frimpong, Raviteja Bulusu, Joy Okoro, Andriana Inkoom, Nkafu Ndemazie, Sherise Rogers, Xue Zhu, Bo Han, Edward Agyare. Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic cancer. European Journal of Pharmaceutical Sciences 2024; 196: 106754 doi: 10.1016/j.ejps.2024.106754
|
| 551 |
I Gede Putu Supadmanaba, Annalisa Comandatore, Luca Morelli, Elisa Giovannetti, Tonny Lagerweij. Organotypic-liver slide culture systems to explore the role of extracellular vesicles in pancreatic cancer metastatic behavior and guide new therapeutic approaches. Expert Opinion on Drug Metabolism & Toxicology 2021; 17(8): 937 doi: 10.1080/17425255.2021.1925646
|
| 552 |
Yang Li, Lujuan Pan, Joseph Mugaanyi, Hua Li, Gehui Li, Jing Huang, Lei Dai. Pathomic and bioinformatics analysis of clinical-pathological and genomic factors for pancreatic cancer prognosis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-79619-1
|
| 553 |
Lina Cadili, Elizaveta Vasilyeva, Jennifer Li, Peter Kim, Stephen Chung, Maja Segedi. Pancreas tail adenocarcinoma tumor size is highly predictive of positive margins after a nonradical resection. The American Journal of Surgery 2022; 224(2): 728 doi: 10.1016/j.amjsurg.2022.05.021
|
| 554 |
Chi Zhang, Andrea Zironda, Robert A. Vierkant, Patrick Starlinger, Susanne Warner, Rory Smoot, Michael Kendrick, Sean Cleary, Mark Truty, Cornelius Thiels. Quality of Life and Gastrointestinal Symptoms in Long-term Survivors of Pancreatic Cancer Following Pancreatoduodenectomy. Annals of Surgery 2023; doi: 10.1097/SLA.0000000000006053
|
| 555 |
BM Idowu, SO Onigbinde, BI Afolabi, VO Oyedepo, OI Ajayi, OD Ogholoh, NN Nwafor, TA Okedere, OO. Fanimi. Aetiological Spectrum of Pancreaticobiliary Diseases in Adult Nigerians on Magnetic Resonance Cholangiopancreatography. Nigerian Journal of Clinical Practice 2024; 27(5): 592 doi: 10.4103/njcp.njcp_619_23
|
| 556 |
Osama M. Mosalem, Ahmed Abdelhakeem, Nayef H. Abdel-Razeq, Hani Babiker. Pancreatic ductal adenocarcinoma (PDAC): clinical progress in the last five years. Expert Opinion on Investigational Drugs 2025; 34(3): 149 doi: 10.1080/13543784.2025.2473698
|
| 557 |
Lenka N.C. Boyd, Mahsoem Ali, Mariska M.G. Leeflang, Giorgio Treglia, Ralph de Vries, Tessa Y.S. Le Large, Marc G. Besselink, Elisa Giovannetti, Hanneke W.M. van Laarhoven, Geert Kazemier. Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: a meta-analysis of aggregate and individual participant data. eClinicalMedicine 2023; 55: 101747 doi: 10.1016/j.eclinm.2022.101747
|
| 558 |
Yiqiao Bao, Evan McNeil, William F. Hickey, Chun-Chieh Lin, George Zanazzi. Pineal gland invasion and leptomeningeal dissemination of pancreatic mucinous adenocarcinoma. Human Pathology Reports 2025; 39: 300771 doi: 10.1016/j.hpr.2025.300771
|
| 559 |
Ryota Kawamura, Yasutaka Ishii, Masahiro Serikawa, Tomofumi Tsuboi, Ken Tsushima, Shinya Nakamura, Tetsuro Hirano, Juri Ikemoto, Yusuke Kiyoshita, Sho Saeki, Yosuke Tamura, Sayaka Miyamoto, Kazuki Nakamura, Masaru Furukawa, Katsunari Ishida, Koji Arihiro, Kenichiro Uemura, Hiroshi Aikata. Optimal indication of endoscopic retrograde pancreatography-based cytology in the preoperative pathological diagnosis of pancreatic ductal adenocarcinoma. Pancreatology 2022; 22(3): 414 doi: 10.1016/j.pan.2022.02.001
|
| 560 |
Esther N. Pijnappel, J. Annelie Suurmeijer, Bas Groot Koerkamp, Milan Kos, Jens T. Siveke, Roberto Salvia, Paula Ghaneh, Casper H. J. van Eijck, Faridi S. van Etten-Jamaludin, Ross Abrams, Birute Brasiūnienė, Markus W. Büchler, Riccardo Casadei, Jean-Luc van Laethem, Jordan Berlin, Narikazu Boku, Thierry Conroy, Henriette Golcher, Marianne Sinn, John P. Neoptolemos, Geertjan van Tienhoven, Marc G. Besselink, Johanna W. Wilmink, Hanneke W. M. van Laarhoven. Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB). JAMA Oncology 2022; 8(6): 929 doi: 10.1001/jamaoncol.2022.0168
|
| 561 |
Carlotta Cattolico, Peter Bailey, Simon T. Barry. Modulation of Type I Interferon Responses to Influence Tumor-Immune Cross Talk in PDAC. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.816517
|
| 562 |
Egarit Noulsri, Surada Lerdwana. Attenuation of tryptophan metabolism by Fe chelators: A hypothesis regarding inhibiting tumor suppressive microenvironments in pancreatic ductal adenocarcinoma. Medical Hypotheses 2022; 165: 110907 doi: 10.1016/j.mehy.2022.110907
|
| 563 |
Peter L. Qiao, Mahdusudhana Gargesha, Yiqiao Liu, Victoria E.A. Laney, Ryan C. Hall, Amita M. Vaidya, Hannah Gilmore, Kara Gawelek, Bryan B. Scott, Debashish Roy, David L. Wilson, Zheng-Rong Lu. Magnetic resonance molecular imaging of extradomain B fibronectin enables detection of pancreatic ductal adenocarcinoma metastasis. Magnetic Resonance Imaging 2022; 86: 37 doi: 10.1016/j.mri.2021.11.008
|
| 564 |
Minjie Guo, Wanying Sheng, Xiao Yuan, Xu Wang. Neutrophils as promising therapeutic targets in pancreatic cancer liver metastasis. International Immunopharmacology 2024; 140: 112888 doi: 10.1016/j.intimp.2024.112888
|
| 565 |
Fatemeh Abbaszadeh, Sajad Fakhri, Sana Piri, Haroon Khan. Phytonutrients in the Treatment of Gastrointestinal Cancer. 2023; : 1 doi: 10.2174/9789815049633123010004
|
| 566 |
Laura Guarga, Noelia Paco, Paula Manchon-Walsh, Emili Vela, Joaquim Delgadillo, Caridad Pontes, Josep Maria Borràs. Management, Survival, and Costs of Pancreatic Cancer: Population-Based Observational Study in Catalonia. International Journal of Environmental Research and Public Health 2023; 20(9): 5673 doi: 10.3390/ijerph20095673
|
| 567 |
Antony Hsieh, Jason R. Pitarresi, Jonathan Lerner, Greg Donahue, David Hsiehchen, Anil K. Rustgi, Kenneth Zaret.
Growth of pancreatic cancers with hemizygous chromosomal 17p loss of
MYBBP1A
can be preferentially targeted by PARP inhibitors
. Science Advances 2020; 6(49) doi: 10.1126/sciadv.abc4517
|
| 568 |
Roberta Angelico, Leandro Siragusa, Cristine Brooke Pathirannehalage Don, Bruno Sensi, Federica Billeci, Leonardo Vattermoli, Belen Padial, Giampiero Palmieri, Alessandro Anselmo, Alessandro Coppola, Giuseppe Tisone, Tommaso Maria Manzia. Pancreatic Adeno-MiNEN, a Rare Newly Defined Entity with Challenging Diagnosis and Treatment: A Case Report with Systematic Literature Review and Pooled Analysis. Journal of Clinical Medicine 2022; 11(17): 5021 doi: 10.3390/jcm11175021
|
| 569 |
Qingya Hao, Lihua Gao, Wenyang Niu, Liang Chen, Peng Zhang, Zhong Chen. POTEE stimulates the proliferation of pancreatic cancer by activating the PI3K/Akt/GSK‐3β/β‐catenin signaling. BioFactors 2020; 46(4): 685 doi: 10.1002/biof.1640
|
| 570 |
Dário Ligeiro, Martin Rao, Andreia Maia, Mireia Castillo, Antonio Beltran, Markus Maeurer. Tumor Microenvironment. Advances in Experimental Medicine and Biology 2020; 1273: 175 doi: 10.1007/978-3-030-49270-0_10
|
| 571 |
Yihao Liu, Wenxin Qi, Jingxin Yin, Xirui He, Songqi Duan, Haili Bao, Chen Li, Minmin Shi, Jiao Wang, Shaohua Song. High CTCF expression mediated by FGD5-AS1/miR-19a-3p axis is associated with immunosuppression and pancreatic cancer progression. Heliyon 2023; 9(12): e22584 doi: 10.1016/j.heliyon.2023.e22584
|
| 572 |
Gustav Andersson, Sebastian Lundgren, Margareta Heby, Björn Nodin, Jacob Elebro, Karin Jirström. Clinical significance of stromal ER and PR expression in periampullary adenocarcinoma. Biomarker Research 2019; 7(1) doi: 10.1186/s40364-019-0176-9
|
| 573 |
Lu Liu, Tian-Xiang Liu, Wan-Xia Huang, Zhong Yang, Shang Wang, Ming-Xu Da, Yang Dong. Distal pancreatectomy with En bloc celiac axis resection for locally advanced pancreatic body/tail cancer: A systematic review and meta-analysis. Asian Journal of Surgery 2022; 45(1): 51 doi: 10.1016/j.asjsur.2021.06.002
|
| 574 |
Qiang Qing, Xiang Deng, Xin Deng, Tong Mou, Bin Li, Ye Tan, Qiao Wu. A single-center study examining the safety and effectiveness of ERCP with pancreatoscopy and endoluminal radiofrequency ablation for main-duct IPMN treatment. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-89889-y
|
| 575 |
Sofia Laila Wik, Wenxin Tian, Claire Chenwen Zhong, Apurva Sawhney, Mingjun Gao, Qinyao Yu, Fanyu Xue, Sze Chai Chan, Shui Hang Chow, Yusuff Adebayo Adebisi, Jinqiu Yuan, Don Eliseo Lucero‐Prisno, Martin C. S. Wong, Junjie Huang. Distribution, Risk Factors and Epidemiological Trends of Pancreatic Cancer Across Countries’ Income Levels: A Comprehensive Analysis. Cancer Reports 2025; 8(2) doi: 10.1002/cnr2.70154
|
| 576 |
Xin Wei, Chunlei Mei, Xixi Li, Yingjun Xie. The Unique Microbiome and Immunity in Pancreatic Cancer. Pancreas 2021; 50(2): 119 doi: 10.1097/MPA.0000000000001744
|
| 577 |
Weizhong Yang, Lu Xu, Xiaohong Qin. Application of MicroRNA-124-Loaded Liposome Nanoparticles for Suppressing Pancreatic Cancer Cell Progression and Restraining Autophagy Through Targeting BECN1. Journal of Biomedical Nanotechnology 2024; 20(6): 954 doi: 10.1166/jbn.2024.3856
|
| 578 |
Ruiying Luo, Shuang Li, Chi Yang, Baoyuan Tang, Long Li, Changjiang Luo. Curcumin Inhibits the Development of Pancreatic Cancer by Targeting the circ_0079440/miR-522-3p/EIF4A1 Pathway. Cell Biochemistry and Biophysics 2024; 83(1): 377 doi: 10.1007/s12013-024-01466-8
|
| 579 |
Peng Chen, Zhirui Zeng, Jie Wang, Wenpeng Cao, Chunzhuo Song, Shan Lei, Yichuan Li, Zhangxia Ren. Long noncoding RNA LINC00857 promotes pancreatic cancer proliferation and metastasis by regulating the miR-130b/RHOA axis. Cell Death Discovery 2022; 8(1) doi: 10.1038/s41420-022-01008-2
|
| 580 |
Kuan-Yin Lin, Po See Chen, Cheng-Feng Lin. Physical function as a predictor of chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03227-6
|
| 581 |
Xianzheng Qin, Taojing Ran, Yifei Chen, Yao Zhang, Dong Wang, Chunhua Zhou, Duowu Zou. Artificial Intelligence in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration/Biopsy (EUS-FNA/B) for Solid Pancreatic Lesions: Opportunities and Challenges. Diagnostics 2023; 13(19): 3054 doi: 10.3390/diagnostics13193054
|
| 582 |
Enrique Gili Ortiz. Factors influencing mortality trends of pancreatic cancer in Spain, 1955-2020. Revista Española de Enfermedades Digestivas 2022; doi: 10.17235/reed.2022.8559/2021
|
| 583 |
Ryota Chijimatsu, Shogo Kobayashi, Yu Takeda, Masatoshi Kitakaze, Shotaro Tatekawa, Yasuko Arao, Mika Nakayama, Naohiro Tachibana, Taku Saito, Daisuke Ennishi, Shuta Tomida, Kazuki Sasaki, Daisaku Yamada, Yoshito Tomimaru, Hidenori Takahashi, Daisuke Okuzaki, Daisuke Motooka, Takahito Ohshiro, Masateru Taniguchi, Yutaka Suzuki, Kazuhiko Ogawa, Masaki Mori, Yuichiro Doki, Hidetoshi Eguchi, Hideshi Ishii. Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma. iScience 2022; 25(8): 104659 doi: 10.1016/j.isci.2022.104659
|
| 584 |
Muhammad Nurmahir Mohamad Sehmi, Mohammad Faizal Ahmad Fauzi, Wan Siti Halimatul Munirah Wan Ahmad, Elaine Wan Ling Chan. PancreaSys: An Automated Cloud-Based Pancreatic Cancer Grading System. Frontiers in Signal Processing 2022; 2 doi: 10.3389/frsip.2022.833640
|
| 585 |
Guochen Shang, Qi He, Chaoqun Han, Xianwen Guo, Weigang Chen, Zhen Ding, Rong Lin. Impact of biliary-pancreatic double stents on EUS-guided tissue acquisition among patients with solid pancreatic lesions: A multicenter study. Endoscopic Ultrasound 2024; 13(5): 287 doi: 10.1097/eus.0000000000000082
|
| 586 |
Weiyu Ge, Jingyu Ma, Tiebo Mao, Haiyan Xu, Xiaofei Zhang, Shumin Li, Yongchao Wang, Jiayu Yao, Ming Yue, Feng Jiao, Yu Wang, Meng Zhuo, Ting Han, Jiong Hu, Xiao Zhang, Jiujie Cui, Liwei Wang. Distinguishable Prognostic Signatures and Tumor Immunogenicity Between Pancreatic Head Cancer and Pancreatic Body/Tail Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.890715
|
| 587 |
Laura del Puerto-Nevado, María J. Fernández-Aceñero, Arancha Cebrián, Yuliia Fatych, Luis I. Díez-Valladares, Elia Pérez-Aguirre, Sofía de la Serna, Alejandra García-Botella, Javier Martínez-Useros, Jesús García-Foncillas, Pedro A. Mateos-Gómez. POLQ immunostaining behaves as a prognostic factor for pancreatic carcinoma. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1433179
|
| 588 |
Lin Chen, Jingtong Tang, Weiwei Sheng, Jian Sun, Yuteng Ma, Ming Dong. ATP11A promotes EMT by regulating Numb PRRL in pancreatic cancer cells. PeerJ 2022; 10: e13172 doi: 10.7717/peerj.13172
|
| 589 |
Kari G. Rabe, Maria A. Stevens, Amanda Toledo Hernández, Shruti Chandra, Joleen M. Hubbard, Jennifer L. Kemppainen, Shounak Majumder, Gloria M. Petersen. Pancreatic cancer risk to siblings of probands in bilineal cancer settings. Genetics in Medicine 2022; 24(5): 1008 doi: 10.1016/j.gim.2022.01.016
|
| 590 |
L. I. Moskvicheva, L. V. Bolotina. Possibilities of palliative chemotherapy in patients with locally advanced and metastatic pancreatic cancer. Research and Practical Medicine Journal 2020; 7(4): 118 doi: 10.17709/2409-2231-2020-7-4-10
|
| 591 |
Peng Xia, Pan Liu, Qiang Fu, Chuanjiang Liu, Qiankun Luo, Xu Zhang, Liyou Cheng, Tao Qin, Hongwei Zhang. Long noncoding RNA EPIC1 interacts with YAP1 to regulate the cell cycle and promote the growth of pancreatic cancer cells. Biochemical and Biophysical Research Communications 2020; 522(4): 978 doi: 10.1016/j.bbrc.2019.11.167
|
| 592 |
Jelena Djokic Kovac, Aleksandra Djikic-Rom, Aleksandar Bogdanovic, Aleksandra Jankovic, Nikica Grubor, Goran Djuricic, Vladimir Dugalic. The Role of MRI in the Diagnosis of Solid Pseudopapillary Neoplasm of the Pancreas and Its Mimickers: A Case-Based Review with Emphasis on Differential Diagnosis. Diagnostics 2023; 13(6): 1074 doi: 10.3390/diagnostics13061074
|
| 593 |
Liping Zhuang, Changjing Huang, Zhouyu Ning, Lina Yang, Wenbin Zou, Peng Wang, Chien‐Shan Cheng, Zhiqiang Meng. Circulating tumor‐associated autoantibodies as novel diagnostic biomarkers in pancreatic adenocarcinoma. International Journal of Cancer 2023; 152(5): 1013 doi: 10.1002/ijc.34334
|
| 594 |
Kathryn E. Cole, Quan P. Ly, Michael A. Hollingsworth, Jesse L. Cox, Kurt W. Fisher, James C. Padussis, Jason M. Foster, Luciano M. Vargas, James E. Talmadge. Splenic and PB immune recovery in neoadjuvant treated gastrointestinal cancer patients. International Immunopharmacology 2022; 106: 108628 doi: 10.1016/j.intimp.2022.108628
|
| 595 |
Igor E. Khatkov, Dmitry S. Bordin, Konstantin A. Lesko, Elena A. Dubtsova, Nikolay S. Karnaukhov, Maria A. Kiriukova, Nadezhda V. Makarenko, Alexey S. Dorofeev, Irina V. Savina, Diana A. Salimgereeva, Elena I. Shurygina, Ludmila V. Vinokurova. Contrast-Enhanced Computed Tomography and Laboratory Parameters as Non-Invasive Diagnostic Markers of Pancreatic Fibrosis. Diagnostics 2023; 13(14): 2435 doi: 10.3390/diagnostics13142435
|
| 596 |
Diogo Oliveira Chaves, Aline Cândida Bastos, Alessandra Maciel Almeida, Maximiliano Ribeiro Guerra, Maria Teresa Bustamante Teixeira, Ana Paula Souto Melo, Valéria Maria de Azeredo Passos. The increasing burden of pancreatic cancer in Brazil from 2000 to 2019: estimates from the Global Burden of Disease Study 2019.. Revista da Sociedade Brasileira de Medicina Tropical 2022; 55( suppl 1) doi: 10.1590/0037-8682-0271-2021
|
| 597 |
Žan Čebron, Mihajlo Djokić, Miha Petrič, Maja Čemažar, Maša Bošnjak, Gregor Serša, Blaž Trotovšek. Intraoperative electrochemotherapy of the posterior resection surface after pancreaticoduodenectomy: Preliminary results of a hybrid approach treatment of pancreatic cancer. Bioelectrochemistry 2024; 155: 108576 doi: 10.1016/j.bioelechem.2023.108576
|
| 598 |
Babu P. Mohan, Antonio Facciorusso, Shahab R. Khan, Deepak Madhu, Lena L. Kassab, Suresh Ponnada, Saurabh Chandan, Stefano F. Crino, Gursimran S. Kochhar, Douglas G. Adler, Michael B. Wallace. Pooled diagnostic parameters of artificial intelligence in EUS image analysis of the pancreas. Endoscopic Ultrasound 2022; 11(3): 156 doi: 10.4103/EUS-D-21-00063
|
| 599 |
Harshavardhan Rao B, Judy A Trieu, Priya Nair, Gilad Gressel, Mukund Venu, Rama P Venu. Artificial intelligence in endoscopy: More than what meets the eye in screening colonoscopy and endosonographic evaluation of pancreatic lesions. Artificial Intelligence in Gastrointestinal Endoscopy 2022; 3(3): 16-30 doi: 10.37126/aige.v3.i3.16
|
| 600 |
Yuanwei Xu, Yuefan Wang, Naseruddin Höti, David J. Clark, Shao‐Yung Chen, Hui Zhang. The next “sweet” spot for pancreatic ductal adenocarcinoma: Glycoprotein for early detection. Mass Spectrometry Reviews 2023; 42(2): 822 doi: 10.1002/mas.21748
|
| 601 |
Ville Teränen, Samuli Nissinen, Antti Roine, Anne Antila, Antti Siiki, Yrjö Vaalavuo, Pekka Kumpulainen, Niku Oksala, Johanna Laukkarinen. Bile-volatile organic compounds in the diagnostics of pancreatic cancer and biliary obstruction: A prospective proof-of-concept study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.918539
|
| 602 |
Michael Muggilli, Donna Russell, Zhongren Zhou. Comparison of programmed death ligand 1 immunostaining for pancreatic ductal adenocarcinoma between paired cytological and surgical samples. Cytojournal 2021; 18: 28 doi: 10.25259/Cytojournal_78_2020
|
| 603 |
Xun Liu, Bobo Chen, Jiahui Chen, Shaolong Sun. A novel tp53-associated nomogram to predict the overall survival in patients with pancreatic cancer. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08066-2
|
| 604 |
Hao Fu, Weiming Mi, Boju Pan, Yucheng Guo, Junjie Li, Rongyan Xu, Jie Zheng, Chunli Zou, Tao Zhang, Zhiyong Liang, Junzhong Zou, Hao Zou. Automatic Pancreatic Ductal Adenocarcinoma Detection in Whole Slide Images Using Deep Convolutional Neural Networks. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.665929
|
| 605 |
Melina Pelling, Subashini Chandrapalan, Emily West, Ramesh P. Arasaradnam. A Systematic Review and Meta-Analysis: Volatile Organic Compound Analysis in the Detection of Hepatobiliary and Pancreatic Cancers. Cancers 2023; 15(8): 2308 doi: 10.3390/cancers15082308
|
| 606 |
Alpha Raj Mekapogu, Zhihong Xu, Srinivasa Pothula, Chamini Perera, Tony Pang, S.M. Zahid Hosen, Vishnu Damalanka, James Janetka, David Goldstein, Romano Pirola, Jeremy Wilson, Minoti Apte. HGF/c-Met pathway inhibition combined with chemotherapy increases cytotoxic T-cell infiltration and inhibits pancreatic tumour growth and metastasis. Cancer Letters 2023; 568: 216286 doi: 10.1016/j.canlet.2023.216286
|
| 607 |
Yu Takeda, Shogo Kobayashi, Masatoshi Kitakaze, Daisaku Yamada, Hirofumi Akita, Ayumu Asai, Masamitsu Konno, Takahiro Arai, Toru Kitagawa, Ken Ofusa, Masami Yabumoto, Takaaki Hirotsu, Andrea Vecchione, Masateru Taniguchi, Yuichiro Doki, Hidetoshi Eguchi, Hideshi Ishii. Immuno-Surgical Management of Pancreatic Cancer with Analysis of Cancer Exosomes. Cells 2020; 9(7): 1645 doi: 10.3390/cells9071645
|
| 608 |
Yue Jiang, Yingquan Ye, Yi Huang, Yue Wu, Gaoxiang Wang, Zhongxuan Gui, Mengmeng Zhang, Mei Zhang. Identification and validation of a novel anoikis-related long non-coding RNA signature for pancreatic adenocarcinoma to predict the prognosis and immune response. Journal of Cancer Research and Clinical Oncology 2023; 149(16): 15069 doi: 10.1007/s00432-023-05285-x
|
| 609 |
Chao Dai, Jonathan P. Rennhack, Taylor E. Arnoff, Maneesha Thaker, Scott T. Younger, John G. Doench, August Yue Huang, Annan Yang, Andrew J. Aguirre, Belinda Wang, Evan Mun, Joyce T. O’Connell, Ying Huang, Katherine Labella, Jessica A. Talamas, Ji Li, Nina Ilic, Justin Hwang, Andrew L. Hong, Andrew O. Giacomelli, Ole Gjoerup, David E. Root, William C. Hahn. SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization. Cell Reports 2021; 36(4): 109443 doi: 10.1016/j.celrep.2021.109443
|
| 610 |
Qingbo Li, Patrick Kwabena Oduro, Rui Guo, Ruiqiao Li, Ling Leng, Xianbin Kong, Qilong Wang, Long Yang. Oncolytic Viruses: Immunotherapy Drugs for Gastrointestinal Malignant Tumors. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.921534
|
| 611 |
Michal Zuzčák, Jan Trnka. Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review). International Journal of Oncology 2022; 61(2) doi: 10.3892/ijo.2022.5383
|
| 612 |
Daisy Evans, Nader Ghassemi, Shahab Hajibandeh, Shahin Hajibandeh, Saleh Romman, Richard W. Laing, Damien Durkin, Tejinderjit S. Athwal. Meta-analysis of adjuvant chemotherapy versus no adjuvant chemotherapy for resected stage I pancreatic cancer. Surgery 2024; 175(6): 1470 doi: 10.1016/j.surg.2023.11.027
|
| 613 |
Giulia Mantini, Laura L. Meijer, Ilias Glogovitis, Sjors G. J. G. In ‘t Veld, Rosita Paleckyte, Mjriam Capula, Tessa Y. S. Le Large, Luca Morelli, Thang V. Pham, Sander R. Piersma, Adam E. Frampton, Connie R. Jimenez, Geert Kazemier, Danijela Koppers-Lalic, Thomas Wurdinger, Elisa Giovannetti. Omics Analysis of Educated Platelets in Cancer and Benign Disease of the Pancreas. Cancers 2020; 13(1): 66 doi: 10.3390/cancers13010066
|
| 614 |
Ruihua Zhao, Zhuo Han, Haiting Zhou, Yaru Xue, Xiaobing Chen, Xinguang Cao. Diagnostic and prognostic role of circRNAs in pancreatic cancer: a meta-analysis. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1174577
|
| 615 |
Zhen Yang, Guangjun Shi, Ping Zhang. Development and Validation of Nomograms to Predict Overall Survival and Cancer-Specific Survival in Patients With Pancreatic Adenosquamous Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.831649
|
| 616 |
Yan Chen, Fa-Hong Wu, Peng-Qiang Wu, Hong-Yun Xing, Tao Ma. The Role of The Tumor Microbiome in Tumor Development and Its Treatment. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.935846
|
| 617 |
Arezoo Farhadi, Arash Poursheikhani, Mohammad Foad Heidari, Mohsen Rajaeinejad, Reza Mosaed, Ali Faridfar, Mohaddeseh Aminzadeh Khosroshahi, Peyman Aslani, Shiva Khalil-Moghaddam, Javad Behroozi. Effects of miR-330 restoration on pancreatic cancer cells oncogenesis. Pathology - Research and Practice 2024; 258: 155337 doi: 10.1016/j.prp.2024.155337
|
| 618 |
Yu-Qi Shi, Xiao-Chong Zhou, Peng Du, Min-Yue Yin, Lan Xu, Wen-Jie Chen, Chun-Fang Xu. Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes. Medicine 2020; 99(37): e21687 doi: 10.1097/MD.0000000000021687
|
| 619 |
Sizhen Wang, Xiaohui Zhang, Xuemei Zou, Maorong Wen, Chi Gan, Xiaochun Jiang, Min Li, Rongxi Shen, Daojun Zhu, Anlong Yao, Yu Fang, Bernard A. Fox, Hong-Ming Hu, Guangjie Yu, Xinbo Wang. Expansion of KRAS hotspot mutations reactive T cells from human pancreatic tumors using autologous T cells as the antigen-presenting cells. Cancer Immunology, Immunotherapy 2023; 72(5): 1301 doi: 10.1007/s00262-022-03335-w
|
| 620 |
Fuqiang Zu, Peng Liu, Huaitao Wang, Ting Zhu, Jian Sun, Weiwei Sheng, Xiaodong Tan. Integrated analysis identifies a pathway-related competing endogenous RNA network in the progression of pancreatic cancer. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07470-4
|
| 621 |
Khashayar Danandeh, Maryam Balibegloo, Nima Rezaei. Gastrointestinal Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 4: 1 doi: 10.1007/16833_2022_12
|
| 622 |
Marcin Cholewa, Julia Wójcik, Maciej Kuca, Karolina Jaglarz, Maksymilian Janeczek, Karolina Kinga Kantor, Julia Plewniok, Wiktoria Maria Szymańska, Kacper Wojciech Pamuła, Maria Partyka. Pancreatic cancer – challenge for modern medicine. Polish Journal of Public Health 2024; 134: 89 doi: 10.12923/2083-4829/2024-0019
|
| 623 |
Hsiu-An Lee, Kuan-Wen Chen, Chien-Yeh Hsu. Prediction Model for Pancreatic Cancer—A Population-Based Study from NHIRD. Cancers 2022; 14(4): 882 doi: 10.3390/cancers14040882
|
| 624 |
Soon Lee, Eunmi Hong, Eunbi Jo, Z-Hun Kim, Kyung June Yim, Sung Hwan Woo, Yong-Soo Choi, Hyun-Jin Jang. Gossypol Induces Apoptosis of Human Pancreatic Cancer Cells via CHOP/Endoplasmic Reticulum Stress Signaling Pathway. Journal of Microbiology and Biotechnology 2022; 32(5): 645 doi: 10.4014/jmb.2110.10019
|
| 625 |
Lingming Kong, Peng Liu, Mingjun Zheng, Busheng Xue, Keke Liang, Xiaodong Tan. Multi-Omics Analysis Based on Integrated Genomics, Epigenomics and Transcriptomics in Pancreatic Cancer. Epigenomics 2020; 12(6): 507 doi: 10.2217/epi-2019-0374
|
| 626 |
Nayeralsadat Fatemi, Mina Karimpour, Hoda Bahrami, Mohammad Reza Zali, Vahid Chaleshi, Andrea Riccio, Ehsan Nazemalhosseini-Mojarad, Mehdi Totonchi. Current trends and future prospects of drug repositioning in gastrointestinal oncology. Frontiers in Pharmacology 2024; 14 doi: 10.3389/fphar.2023.1329244
|
| 627 |
Letian Pan, Nuoming Yin, Mingyu Duan, Qixiang Mei, Yue Zeng, Guan-Hong Wang. The role of gut microbiome and its metabolites in pancreatitis. mSystems 2024; 9(10) doi: 10.1128/msystems.00665-24
|
| 628 |
Ahmad Hamad, Jennifer Underhill, Aliya Ansari, Varna Thayaparan, Jordan M. Cloyd, Yaming Li, Timothy M. Pawlik, Allan Tsung, Laith Abushahin, Aslam Ejaz. Surgical treatment of hepatic oligometastatic pancreatic ductal adenocarcinoma: An analysis of the National Cancer Database. Surgery 2022; 171(6): 1464 doi: 10.1016/j.surg.2021.12.029
|
| 629 |
Te-Min Ke, Artitaya Lophatananon, Kenneth R. Muir. Strengthening the Evidence for a Causal Link between Type 2 Diabetes Mellitus and Pancreatic Cancer: Insights from Two-Sample and Multivariable Mendelian Randomization. International Journal of Molecular Sciences 2024; 25(9): 4615 doi: 10.3390/ijms25094615
|
| 630 |
Daryl Ramai, Jonathan K. Lai, Emmanuel Ofori, Sandar Linn, Madhavi Reddy. Evaluation and Management of Premalignant Conditions of the Esophagus. Journal of Clinical Gastroenterology 2019; 53(9): 627 doi: 10.1097/MCG.0000000000001247
|
| 631 |
Muhammed Talha Zavalsiz, Sleiman Alhajj, Kashfia Sailunaz, Tansel Ozyer, Reda Alhajj. Pancreatic Tumor Detection by Convolutional Neural Networks. 2022 International Arab Conference on Information Technology (ACIT) 2022; : 1 doi: 10.1109/ACIT57182.2022.9994181
|
| 632 |
Roisin McMorrow, Giorgia Zambito, Alex Nigg, Karishma Lila, Thierry P. P. van den Bosch, Clemens W. G. M. Lowik, Laura Mezzanotte. Whole-body bioluminescence imaging of T-cell response in PDAC models. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1207533
|
| 633 |
Khalid Rashid, Christian Röder, Freya Goumas, Jan-Hendrik Egberts, Holger Kalthoff. CD95L Inhibition Impacts Gemcitabine-Mediated Effects and Non-Apoptotic Signaling of TNF-α and TRAIL in Pancreatic Tumor Cells. Cancers 2021; 13(21): 5458 doi: 10.3390/cancers13215458
|
| 634 |
Roseane Guimarães Ferreira, Luis Eduardo Mosquera Narvaez, Kaio Murilo Monteiro Espíndola, Amanda Caroline R. S. Rosario, Wenddy Graziela N. Lima, Marta Chagas Monteiro. Can Nimesulide Nanoparticles Be a Therapeutic Strategy for the Inhibition of the KRAS/PTEN Signaling Pathway in Pancreatic Cancer?. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.594917
|
| 635 |
Özgen Ahmet YILDIRIM, Erkan ERDUR. Pancreatic cancer treatment after FOLFIRINOX: prognostic importance of chemotherapy dose intensity and albumin/globulin ratio in second line. Journal of Health Sciences and Medicine 2022; 5(1): 156 doi: 10.32322/jhsm.1011658
|
| 636 |
P. А. Ponomarev, V. E. Moiseenko, А. V. Pavlovsky, G. R. Avanesyan, A. G. Manikhas, D. А. Granov. Analysis of association between new-onset type 2 diabetes mellitus and pancreatic cancer: retrospective research. Perm Medical Journal 2024; 40(6): 5 doi: 10.17816/pmj4065-15
|
| 637 |
V. Chuabio, J. Bandoy, A. Ong, M. Te, R. Maralit. Pancreatic Masses Clinically Diagnosed as Tuberculosis: A Case Series. ESGE Days 2024 2024; 56 doi: 10.1055/s-0044-1783318
|
| 638 |
. 2021; doi: 10.54718/DBSP3936
|
| 639 |
Jason Chekmarev, Mahan Gholam Azad, Des R. Richardson. The Oncogenic Signaling Disruptor, NDRG1: Molecular and Cellular Mechanisms of Activity. Cells 2021; 10(9): 2382 doi: 10.3390/cells10092382
|
| 640 |
Lulu Tan, Zhihua Chen, Alamgeer Yuchi. miR-193a-5p Enhances the Radioresistance of Pancreatic Cancer Cells by Targeting ZFP57 and Activating the Wnt Pathway. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/8071343
|
| 641 |
Fu Xiang, Chenhui Yao, Guoxin Guan, Fuwen Luo. Application of 3D Printing to Design and Manufacture Pancreatic Duct Stent and Animal Experiments. Bioengineering 2024; 11(10): 1004 doi: 10.3390/bioengineering11101004
|
| 642 |
Hongkai Zhuang, Zixuan Zhou, Zedan Zhang, Xinming Chen, Zuyi Ma, Shanzhou Huang, Yuanfeng Gong, Chuanzhao Zhang, Baohua Hou. B3GNT3 overexpression promotes tumor progression and inhibits infiltration of CD8+ T cells in pancreatic cancer. Aging 2021; 13(2): 2310 doi: 10.18632/aging.202255
|
| 643 |
Wangli Huang, Lingbo Kong, Yang Cao, Liang Yan. Identification and Quantification, Metabolism and Pharmacokinetics, Pharmacological Activities, and Botanical Preparations of Protopine: A Review. Molecules 2021; 27(1): 215 doi: 10.3390/molecules27010215
|
| 644 |
Jiuyi Zheng, Bangjie He, Liming Deng, Xuewen Zhu, Rizhao Li, Kaiyu Chen, Chongming Zheng, Daojie Wang, Yi Wang, Chang Yu, Gang Chen. Prognostic value of diffuse reduction of spleen density on postoperative survival of pancreatic ductal adenocarcinoma: A retrospective study. Asia-Pacific Journal of Clinical Oncology 2024; 20(2): 275 doi: 10.1111/ajco.13936
|
| 645 |
Yang Yang, Tao Cheng, Peng Xie, Lishan Wang, Hong Chen, Zhangjun Cheng, Jiahua Zhou. PMEPA1 interference activates PTEN/PI3K/AKT, thereby inhibiting the proliferation, invasion and migration of pancreatic cancer cells and enhancing the sensitivity to gemcitabine and cisplatin. Drug Development Research 2022; 83(1): 64 doi: 10.1002/ddr.21844
|
| 646 |
Sini Vehviläinen, Antti Kuuliala, Marianne Udd, Anna Nurmi, Katriina Peltola, Caj Haglund, Leena Kylänpää, Hanna Seppänen. Cholangitis and Interruptions of Neoadjuvant Chemotherapy Associate with Reduced Overall and Progression-Free Survival in Pancreatic Cancer. Annals of Surgical Oncology 2024; 31(4): 2621 doi: 10.1245/s10434-023-14793-6
|
| 647 |
Abdullah Bin Zubair, Ismail Abdur Rahman Khan Sherwani, Muhammad Ahmad, Mohammed Ahmad Tahir, Muhammad Ibrahim Khalil, Mohammad Mudassar Bukhari, Muzammil Sabir, Assadullah A Bhatti, Nitasha Afzal, Mehwish Kaneez. The Spectrum of Postoperative Complications and Outcomes After Pancreaticoduodenectomy: A Retrospective Outlook From a Developing Country. Cureus 2022; doi: 10.7759/cureus.22218
|
| 648 |
Akram Pourshams, Sadaf G Sepanlou, Kevin S Ikuta, Catherine Bisignano, Saeid Safiri, Gholamreza Roshandel, Mehdi Sharif, Morteza Khatibian, Christina Fitzmaurice, Molly R Nixon, Nooshin Abbasi, Mohsen Afarideh, Elham Ahmadian, Tomi Akinyemiju, Fares Alahdab, Tahiya Alam, Vahid Alipour, Christine A Allen, Nahla Hamed Anber, Alireza Ansari-Moghaddam, Jalal Arabloo, Alaa Badawi, Mojtaba Bagherzadeh, Yaschilal Muche Belayneh, Belete Biadgo, Ali Bijani, Antonio Biondi, Tone Bjørge, Antonio M Borzì, Cristina Bosetti, Andrey Nikolaevich Briko, Nikolay Ivanovich Briko, Giulia Carreras, Félix Carvalho, Jee-Young J Choi, Dinh-Toi Chu, Anh Kim Dang, Ahmad Daryani, Dragos Virgil Davitoiu, Gebre Teklemariam Demoz, Rupak Desai, Subhojit Dey, Hoa Thi Do, Huyen Phuc Do, Aziz Eftekhari, Alireza Esteghamati, Farshad Farzadfar, Eduarda Fernandes, Irina Filip, Florian Fischer, Masoud Foroutan, Mohamed M Gad, Silvano Gallus, Birhanu Geta, Giuseppe Gorini, Nima Hafezi-Nejad, James D Harvey, Milad Hasankhani, Amir Hasanzadeh, Soheil Hassanipour, Simon I Hay, Hagos D Hidru, Chi Linh Hoang, Sorin Hostiuc, Mowafa Househ, Olayinka Stephen Ilesanmi, Milena D Ilic, Seyed Sina Naghibi Irvani, Nader Jafari Balalami, Spencer L James, Farahnaz Joukar, Amir Kasaeian, Tesfaye Dessale Kassa, Andre Pascal Kengne, Rovshan Khalilov, Ejaz Ahmad Khan, Amir Khater, Fatemeh Khosravi Shadmani, Jonathan M Kocarnik, Hamidreza Komaki, Ai Koyanagi, Vivek Kumar, Carlo La Vecchia, Platon D Lopukhov, Farzad Manafi, Navid Manafi, Ana-Laura Manda, Fariborz Mansour-Ghanaei, Dhruv Mehta, Varshil Mehta, Toni Meier, Hagazi Gebre Meles, Getnet Mengistu, Tomasz Miazgowski, Mehdi Mohamadnejad, Abdollah Mohammadian-Hafshejani, Milad Mohammadoo-Khorasani, Shafiu Mohammed, Farnam Mohebi, Ali H Mokdad, Lorenzo Monasta, Maryam Moossavi, Rahmatollah Moradzadeh, Gurudatta Naik, Ionut Negoi, Cuong Tat Nguyen, Long Hoang Nguyen, Trang Huyen Nguyen, Andrew T Olagunju, Tinuke O Olagunju, Alyssa Pennini, Mohammad Rabiee, Navid Rabiee, Amir Radfar, Mahdi Rahimi, Goura Kishor Rath, David Laith Rawaf, Salman Rawaf, Robert C Reiner, Nima Rezaei, Aziz Rezapour, Anas M Saad, Seyedmohammad Saadatagah, Amirhossein Sahebkar, Hamideh Salimzadeh, Abdallah M Samy, Juan Sanabria, Arash Sarveazad, Monika Sawhney, Mario Sekerija, Pavel Shabalkin, Masood Ali Shaikh, Rajesh Sharma, Sara Sheikhbahaei, Reza Shirkoohi, Sudeep K Siddappa Malleshappa, Mekonnen Sisay, Kjetil Soreide, Sergey Soshnikov, Rasoul Sotoudehmanesh, Vladimir I Starodubov, Michelle L Subart, Rafael Tabarés-Seisdedos, Degena Bahray Bahrey Tadesse, Eugenio Traini, Bach Xuan Tran, Khanh Bao Tran, Irfan Ullah, Marco Vacante, Amir Vahedian-Azimi, Elena Varavikova, Ronny Westerman, Dawit Dawit Zewdu Wondafrash, Rixing Xu, Naohiro Yonemoto, Vesna Zadnik, Zhi-Jiang Zhang, Reza Malekzadeh, Mohsen Naghavi. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology 2019; 4(12): 934 doi: 10.1016/S2468-1253(19)30347-4
|
| 649 |
Barbara Salas-Salas, Laura Ferrera-Alayon, Alberto Espinosa-Lopez, Maria Luisa Perez-Rodriguez, Antonio Alayón Afonso, Andres Vera-Rosas, Gabriel Garcia-Plaza, Rodolfo Chicas-Sett, Maria Soledad Martinez-Martin, Elisa Salcedo, Andrea Kannemann, Marta Lloret-Saez-Bravo, Pedro C. Lara. Dose-Escalated SBRT for Borderline and Locally Advanced Pancreatic Cancer: Resectability Rate and Pathological Results of a Multicenter Prospective Study. Cancers 2025; 17(2): 191 doi: 10.3390/cancers17020191
|
| 650 |
Nagabhishek Sirpu Natesh, Brianna M. White, Maia M. C. Bennett, Metin Uz, Rakhee Rathnam Kalari Kandy, Surinder K. Batra, Surya K. Mallapragada, Satyanarayana Rachagani. Emerging Role of miR-345 and Its Effective Delivery as a Potential Therapeutic Candidate in Pancreatic Cancer and Other Cancers. Pharmaceutics 2021; 13(12): 1987 doi: 10.3390/pharmaceutics13121987
|
| 651 |
George Manias, Harm Op Den Akker, Ainhoa Azqueta, Diego Burgos, Nikola Dino Capocchiano, Borja Llobell Crespo, Athanasios Dalianis, Andrea Damiani, Krasimir Filipov, Giorgos Giotis, Maritini Kalogerini, Rostislav Kostadinov, Pavlos Kranas, Dimosthenis Kyriazis, Artitaya Lophatananon, Shwetambara Malwade, George Marinos, Fabio Melillo, Vicent Moncho Mas, Kenneth Muir, Marzena Nieroda, Antonio De Nigro, Claudia Pandolfo, Marta Patino-Martinez, Florin Picioroaga, Aristodemos Pnevmatikakis, Shabbir Syed-Abdul, Tanja Tomson, Dilyana Vicheva, Usman Wajid. iHELP: Personalised Health Monitoring and Decision Support Based on Artificial Intelligence and Holistic Health Records. 2021 IEEE Symposium on Computers and Communications (ISCC) 2021; : 1 doi: 10.1109/ISCC53001.2021.9631475
|
| 652 |
Muhammad Nurmahir Mohamad Sehmi, Mohammad Faizal Ahmad Fauzi, Wan Siti Halimatul Munirah Wan Ahmad, Elaine Wan Ling Chan. Pancreatic cancer grading in pathological images using deep learning convolutional neural networks. F1000Research 2021; 10: 1057 doi: 10.12688/f1000research.73161.1
|
| 653 |
Vinit Sharma, Anjali Aggarwal, Justin Jacob, Daisy Sahni. Myeloid‐derived suppressor cells: Bridging the gap between inflammation and pancreatic adenocarcinoma. Scandinavian Journal of Immunology 2021; 93(5) doi: 10.1111/sji.13021
|
| 654 |
Erica Pizzocaro, Roberta Vella, Isabella Frigerio, Alessandro Giardino, Paolo Regi, Filippo Scopelliti, Elisa Bannone, Roberto Girelli, Laura Bignotto, Francesca Dal Mas, Lorenzo Cobianchi, Laura Di Renzo, Giovanni Butturini. Personalized nutrition after discharge for pancreatic surgery: A study protocol. Nutrition and Health 2024; doi: 10.1177/02601060241290281
|
| 655 |
Lei Zhang, Xuefei Zhang, Bolin Wu, Xue Han, Cunli Guo, Bo Li, Hui Jing, Wen Cheng. Prognostic value of albumin-bilirubin score in pancreatic cancer patients after pancreatoduodenectomy with liver metastasis following radiofrequency ablation. Pathology and Oncology Research 2023; 29 doi: 10.3389/pore.2023.1611175
|
| 656 |
Humaid O. Al-Shamsi, Faryal Iqbal, Neil A. Nijhawan, Hampig R. Kourie, Nadia Abdelwahed, Ibrahim H. Abu-Gheida, Basil Ammori. Cancer Care in the United Arab Emirates. 2024; : 473 doi: 10.1007/978-981-99-6794-0_29
|
| 657 |
Miguel S. Gonzalez‐Mancera, Saman S. Ahmadian, Carmen Gomez‐Fernandez, Jaylou Velez‐Torres, Merce Jorda, Monica T. García‐Buitrago. Risk of malignancy associated with the diagnostic categories proposed by the Papanicolaou Society of Cytopathology for pancreaticobiliary specimens: An institutional experience. Diagnostic Cytopathology 2022; 50(2): 49 doi: 10.1002/dc.24910
|
| 658 |
Jun Yao, Ruoyu Gao, Minghan Luo, Defeng Li, Liliangzi Guo, Zichao Yu, Feng Xiong, Cheng Wei, Benhua Wu, Zhenglei Xu, Dingguo Zhang, Jianyao Wang, Lisheng Wang. Exosomal LINC00460/miR-503-5p/ANLN positive feedback loop aggravates pancreatic cancer progression through regulating T cell–mediated cytotoxicity and PD-1 checkpoint. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02741-5
|
| 659 |
Nicolas A. Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, Odile Gayet, Julie Roques, Emmanuel Telle, Patricia Santofimia-Castaño, María Teresa Borrello, Eduardo Chuluyan, Nelson Dusetti, Juan Iovanna. Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib. Clinical Cancer Research 2020; 26(20): 5506 doi: 10.1158/1078-0432.CCR-20-1232
|
| 660 |
Hai-di Chen, Zeng Ye, Hai-feng Hu, Gui-xiong Fan, Yu-heng Hu, Zheng Li, Bo-rui Li, Shun-rong Ji, Chen-jie Zhou, Xiao-wu Xu, Xian-jun Yu, Yi Qin. SMAD4 endows TGF-β1-induced highly invasive tumor cells with ferroptosis vulnerability in pancreatic cancer. Acta Pharmacologica Sinica 2024; 45(4): 844 doi: 10.1038/s41401-023-01199-z
|
| 661 |
Kuan-Yu Tseng, Chiann-Yi Hsu, Yu-Hsuan Shih, Hsin-Chen Lin, You-Cheng Li, Chieh-Lin Jerry Teng, Cheng-Wei Chou. The concomitant use of the renin–angiotensin system inhibitors and survival outcomes of patients with pancreatic adenocarcinoma: an analysis from a tertiary center. Therapeutic Advances in Medical Oncology 2024; 16 doi: 10.1177/17588359241247019
|
| 662 |
Damiano Caputo, Giulio Caracciolo. Nanoparticle-enabled blood tests for early detection of pancreatic ductal adenocarcinoma. Cancer Letters 2020; 470: 191 doi: 10.1016/j.canlet.2019.11.030
|
| 663 |
Wenyue Li, Peisen Zhang, Chuang Liu, Yuping Xu, Zhihua Gan, Lei Kang, Yi Hou. Oncogene-targeting nanoprobes for early imaging detection of tumor. Journal of Nanobiotechnology 2023; 21(1) doi: 10.1186/s12951-023-01943-x
|
| 664 |
Shih‐Min Chen, Phan Thanh Phuc, Phung‐Anh Nguyen, Whitney Burton, Shwu‐Jiuan Lin, Weei‐Chin Lin, Christine Y. Lu, Min‐Huei Hsu, Chi‐Tsun Cheng, Jason C. Hsu. A novel prediction model of the risk of pancreatic cancer among diabetes patients using multiple clinical data and machine learning. Cancer Medicine 2023; 12(19): 19987 doi: 10.1002/cam4.6547
|
| 665 |
Patrick Ristau, Claudia Oetting-Roß, Andreas Büscher. Coping in patients with pancreatic cancer: a scoping review and narrative synthesis. BMJ Supportive & Palliative Care 2023; 13(e3): e695 doi: 10.1136/bmjspcare-2021-003266
|
| 666 |
Hye Yeon Yang, Min Yu Kang, Chang Moo Kang, Woo Jung Lee, Ho Kyoung Hwang. Correlation between Angiotensin Inhibitor Administration and Longer Survival in Patients Who Underwent Curative Resection for Pancreatic Cancer. Yonsei Medical Journal 2024; 65(6): 324 doi: 10.3349/ymj.2023.0399
|
| 667 |
Siyabonga Matchaba, Rafik Fellague-Chebra, Purushottam Purushottam, Adam Johns. Early Diagnosis of Pancreatic Cancer via Machine Learning Analysis of a National Electronic Medical Record Database. JCO Clinical Cancer Informatics 2023; (7) doi: 10.1200/CCI.23.00076
|
| 668 |
Mohit J. Mehta, Dongjun Shin, Hyun Sung Park, Jun Su An, Seong Il Lim, Hyun Jin Kim, Seungpyo Hong, Jiyoon Bu. Exosome‐Based Theranostic for Gastrointestinal Cancer: Advances in Biomarker Discovery and Therapeutic Engineering. Small Methods 2025; doi: 10.1002/smtd.202402058
|
| 669 |
Ana S. Leal, Karen T. Liby. The BRD4 Inhibitor I-BET-762 Reduces HO-1 Expression in Macrophages and the Pancreas of Mice. International Journal of Molecular Sciences 2024; 25(18): 9985 doi: 10.3390/ijms25189985
|
| 670 |
Satvik Tripathi, Azadeh Tabari, Arian Mansur, Harika Dabbara, Christopher P. Bridge, Dania Daye. From Machine Learning to Patient Outcomes: A Comprehensive Review of AI in Pancreatic Cancer. Diagnostics 2024; 14(2): 174 doi: 10.3390/diagnostics14020174
|
| 671 |
Lubomir Vecera, Petr Prasil, Josef Srovnal, Emil Berta, Monika Vidlarova, Tomas Gabrhelik, Pavla Kourilova, Martin Lovecek, Pavel Skalicky, Jozef Skarda, Zdenek Kala, Pavel Michalek, Marian Hajduch. Morphine Analgesia, Cannabinoid Receptor 2, and Opioid Growth Factor Receptor Cancer Tissue Expression Improve Survival after Pancreatic Cancer Surgery. Cancers 2023; 15(16): 4038 doi: 10.3390/cancers15164038
|
| 672 |
Rachel Newsome, Christian Jobin. Finding clues in unexpected places: detection of pancreatic cancer through the faecal microbiome. Gut 2022; 71(7): 1247 doi: 10.1136/gutjnl-2021-326710
|
| 673 |
Antonella Argentiero, Angela Calabrese, Angela Monica Sciacovelli, Sabina Delcuratolo, Antonio Giovanni Solimando, Oronzo Brunetti. Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma, When Surgery Could Represent a Therapeutic Option. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/8679751
|
| 674 |
Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Tomas Koltai, Khalid O. Alfarouk, Stephan J. Reshkin, Rosa A. Cardone. Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches. Cancers 2021; 13(23): 6135 doi: 10.3390/cancers13236135
|
| 675 |
Qurat ul Ain Riaz Sipra, Mahnoor Islam, Irbaz Bin Riaz, Jin Zhaohui, Hani M. Babiker, Tanios S. Bekaii-Saab, Mohamad Bassam Sonbol. Contemporary Management of Pancreatic Cancer from an Internist Perspective. The American Journal of Medicine 2021; 134(5): 576 doi: 10.1016/j.amjmed.2020.11.009
|
| 676 |
Xihao Yao, Yingqing Mao, Di Wu, Yi Zhu, Jingjing Lu, Yan Huang, Yibing Guo, Zhiwei Wang, Shajun Zhu, Xiaohong Li, Yuhua Lu. Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion, migration, proliferation and stemness of pancreatic cancer cells by sponging miR-338-5p and targeting the Wif1/Wnt8/β-catenin axis. Cancer Letters 2021; 512: 38 doi: 10.1016/j.canlet.2021.04.030
|
| 677 |
Emily Jiggens, Maria Mortoglou, Guy H. Grant, Pinar Uysal-Onganer. The Role of CDK4 in the Pathogenesis of Pancreatic Cancer. Healthcare 2021; 9(11): 1478 doi: 10.3390/healthcare9111478
|
| 678 |
Tiancong Du, Ke Zhang, Zhongbo Zhang, Aijia Guo, Guilin Yu, Yuanhong Xu. ITGBL1 transcriptionally inhibited by JDP2 promotes the development of pancreatic cancer through the TGF-beta/Smad pathway. Brazilian Journal of Medical and Biological Research 2022; 55 doi: 10.1590/1414-431x2022e11989
|
| 679 |
Rezvan Yazdian-Robati, Atena Mansouri, Peyman Asadi, Mehdi Mogharabi-Manzari, Mohsen Chamanara. Recent Advances in Nanocarriers for Pancreatic Cancer Therapy. 2024; : 401 doi: 10.1016/B978-0-443-19142-8.00003-6
|
| 680 |
José Gabriel Rodríguez TARAZONA, Emne Ali ABDALLAH, Bianca de Cássia Troncarelli FLORES, Alexcia Camila BRAUN, Cláudia Malheiros Coutinho CAMILLO, Fabio Albuquerque MARCHI, Anna Paula Carreta RUANO, Ludmilla Thome Domingos CHINEN. PROTEÍNAS MIR-203A-3P E MMP-2 SÃO ALTAMENTE EXPRESSAS EM CÉLULAS TUMORAIS CIRCULANTES DE PACIENTES COM CARCINOMA PANCREÁTICO. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2021; 34(4) doi: 10.1590/0102-672020210002e1628
|
| 681 |
Hessamaddin Sohrabi, Roghayeh Mahmoudi-Maleki, Mir Reza Majidi, Fatemeh Oroojalian, Amir Ali Mokhtarzadeh, Miguel de la Guardia. Recent advances in nanostructure-enhanced optical assays focused on luminescence-based biosensors for detection of cancer biomarkers. TrAC Trends in Analytical Chemistry 2024; 176: 117753 doi: 10.1016/j.trac.2024.117753
|
| 682 |
Jillian G Baker, Erica K Sloan, Kevin D G Pfleger, Peter J McCormick, Cristina Salmerón, Paul A Insel. Pancreatic Ductal Adenocarcinoma, β-blockers, and Antihistamines: A Clinical Trial Is Needed. Function 2025; 6(1) doi: 10.1093/function/zqae050
|
| 683 |
Kilian Dossow, Sara Acciuffi, Christine March, Dörthe Jechorek, Roland S. Croner, Frank Meyer, Sara Al-Madhi. Tumorläsion des Pankreas mit unklarer Dignität. Die Chirurgie 2024; 95(10): 841 doi: 10.1007/s00104-024-02132-8
|
| 684 |
Luis Alberto Bravo-Vázquez, Natalia Frías-Reid, Ana Gabriela Ramos-Delgado, Sofía Madeline Osorio-Pérez, Hania Ruth Zlotnik-Chávez, Surajit Pathak, Antara Banerjee, Anindya Bandyopadhyay, Asim K. Duttaroy, Sujay Paul. MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications. Translational Oncology 2023; 27: 101579 doi: 10.1016/j.tranon.2022.101579
|
| 685 |
Yuan Wei, Ping Zhu. Long non-coding RNA TINCR suppresses growth and epithelial-mesenchymal transition by inhibiting Wnt/β-catenin signaling pathway in human pancreatic cancer PANC-1 cells: Insights from in vitro and in vivo studies. Acta Pharmaceutica 2024; 74(1): 131 doi: 10.2478/acph-2024-0009
|
| 686 |
Thomas J. George, Azka Ali, Yu Wang, Ji-Hyun Lee, Alison M. Ivey, David DeRemer, Karen C. Daily, Carmen J. Allegra, Steven J. Hughes, Z. Hugh Fan, Miles E. Cameron, Andrew R. Judge, Jose G. Trevino. Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic Adenocarcinoma. The Oncologist 2021; 26(10): 825 doi: 10.1002/onco.13853
|
| 687 |
Wungki Park, Catherine A. O'Connor, Chaitanya Bandlamudi, Daniella Forman, Joanne F. Chou, Shigeaki Umeda, Marsha Reyngold, Anna M. Varghese, Fergus Keane, Fiyinfolu Balogun, Kenneth H. Yu, David P. Kelsen, Christopher Crane, Marinela Capanu, Christine Iacobuzio-Donahue, Eileen M. O'Reilly. Clinico-genomic Characterization ofATMand HRD in Pancreas Cancer: Application for Practice. Clinical Cancer Research 2022; 28(21): 4782 doi: 10.1158/1078-0432.CCR-22-1483
|
| 688 |
Jonathan Dao, Patrick J. Conway, Baskaran Subramani, Devi Meyyappan, Sammy Russell, Daruka Mahadevan. Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation. International Journal of Molecular Sciences 2023; 24(17): 13219 doi: 10.3390/ijms241713219
|
| 689 |
Yamirka Sánchez, Martha L. Concepción, Yohan Amador, Angel Piriz, René Rabassa, Ariel Leyva, Odalys Arguelles, Lisett Leblanch, Sheyla Moret, Gilberto Rivero, Ana L. Vasallo, Beatriz Martorell, Pedro P. Guerra, Ana R. Valls, Lisset Sánchez, Yaimarelis Saumell, Hu Wang. Nimotuzumab Concurrent with Gemcitabine as First‐Line Treatment of Locally Advanced or Metastatic Pancreatic Adenocarcinoma. BioMed Research International 2023; 2023(1) doi: 10.1155/2023/1496072
|
| 690 |
Łukasz Nawacki, Iwona Gorczyca-Głowacka, Paweł Zieliński, Przemysław Znamirowski, Monika Kozłowska-Geller, Agnieszka Ciba-Stemplewska, Magdalena Kołomańska. A 22-G or a 25-G Needle: Which One to Use in the Diagnostics of Solid Pancreatic Lesions? A Systematic Review and Meta-Analysis. Cancers 2024; 16(12): 2266 doi: 10.3390/cancers16122266
|
| 691 |
Min-Yue Yin, Li-Ting Xi, Lu Liu, Jin-Zhou Zhu, Li-Juan Qian, Chun-Fang Xu. Pancreatic cancer incidence and mortality patterns in 2006-2015 and prediction of the epidemiological trend to 2025 in China. World Journal of Clinical Cases 2022; 10(14): 4404-4413 doi: 10.12998/wjcc.v10.i14.4404
|
| 692 |
Huakai Wang, Shiyong Yu, Huan Peng, Yijun Shu, Wenjie Zhang, Qi Zhu, Yingxia Wu, Yijun Xu, Jiqi Yan, Honggang Xiang. Long noncoding RNA Linc00337 functions as an E2F1 co-activator and promotes cell proliferation in pancreatic ductal adenocarcinoma. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01725-5
|
| 693 |
Fariba Dehghanian, Zahra Azhir, Sheyda Khalilian, Björn Grüning. Non‐coding RNAs underlying the pathophysiological links between type 2 diabetes and pancreatic cancer: A systematic review. Journal of Diabetes Investigation 2022; 13(3): 405 doi: 10.1111/jdi.13727
|
| 694 |
Min Kyu Sung, Yejong Park, Bong Jun Kwak, Eunsung Jun, Woohyung Lee, Ki Byung Song, Jae Hoon Lee, Dae Wook Hwang, Song Cheol Kim. Comparison of Characteristics and Survival Rates of Resectable Pancreatic Ductal Adenocarcinoma according to Tumor Location. Biomedicines 2021; 9(11): 1706 doi: 10.3390/biomedicines9111706
|
| 695 |
Eunji Hong, Wojciech Barczak, Sujin Park, Jin Sun Heo, Akira Ooshima, Shonagh Munro, Chang Pyo Hong, Jinah Park, Haein An, Joon Oh Park, Seok Hee Park, Nick B. La Thangue, Seong-Jin Kim. Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors. Cell Death & Disease 2023; 14(2) doi: 10.1038/s41419-023-05630-5
|
| 696 |
Yukako Ito, Shinji Kobuchi, Amiri Kawakita, Kazuki Tosaka, Yume Matsunaga, Shoma Yoshioka, Shizuka Jonan, Kikuko Amagase, Katsunori Hashimoto, Mitsuro Kanda, Takuya Saito, Hayao Nakanishi. Mobilization of Circulating Tumor Cells after Short- and Long-Term FOLFIRINOX and GEM/nab-PTX Chemotherapy in Xenograft Mouse Models of Human Pancreatic Cancer. Cancers 2023; 15(22): 5482 doi: 10.3390/cancers15225482
|
| 697 |
Wei-Peng Li, Chia-Jui Yen, Bo-Sheng Wu, Tak-Wah Wong. Recent Advances in Photodynamic Therapy for Deep-Seated Tumors with the Aid of Nanomedicine. Biomedicines 2021; 9(1): 69 doi: 10.3390/biomedicines9010069
|
| 698 |
Rumiana Tenchov, Aparna K. Sapra, Janet Sasso, Krittika Ralhan, Anusha Tummala, Norman Azoulay, Qiongqiong Angela Zhou. Biomarkers for Early Cancer Detection: A Landscape View of Recent Advancements, Spotlighting Pancreatic and Liver Cancers. ACS Pharmacology & Translational Science 2024; 7(3): 586 doi: 10.1021/acsptsci.3c00346
|
| 699 |
Etienne Buscail, Catherine Alix-Panabières, Pascaline Quincy, Thomas Cauvin, Alexandre Chauvet, Olivier Degrandi, Charline Caumont, Séverine Verdon, Isabelle Lamrissi, Isabelle Moranvillier, Camille Buscail, Marion Marty, Christophe Laurent, Véronique Vendrely, François Moreau-Gaudry, Aurélie Bedel, Sandrine Dabernat, Laurence Chiche. High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery. Cancers 2019; 11(11): 1656 doi: 10.3390/cancers11111656
|
| 700 |
Chiharu Tanaka, Kaoru Furihata, Seiji Naganuma, Mitsunari Ogasawara, Reiko Yoshioka, Hideki Taniguchi, Mutsuo Furihata, Keisuke Taniuchi. Establishment of a mouse model of pancreatic cancer using human pancreatic cancer cell line S2-013-derived organoid. Human Cell 2022; 35(2): 735 doi: 10.1007/s13577-022-00684-7
|
| 701 |
Jiarong Li, Linglong Liu, Mingxia Chen, Wang Su, Tianying Yao, Xiaoxuan Li. Effect of intimacy and dyadic coping on psychological distress in pancreatic cancer patients and spousal caregivers. Frontiers in Psychology 2023; 14 doi: 10.3389/fpsyg.2023.1040460
|
| 702 |
Yu Lu, Xin-Yuan Zhou, Cheng-Liang Zhou, Jie Liu, Tao Yong, Yong Fan, Chen Wang. Insulin receptor tyrosine kinase substrate (IRTKS) promotes the tumorigenesis of pancreatic cancer via PI3K/AKT signaling. Human Cell 2022; 35(6): 1885 doi: 10.1007/s13577-022-00770-w
|
| 703 |
Xidong Chen, Haichao Zhao, Changzhou Chen, Jian Li, Jiefeng He, Xifeng Fu, Haoliang Zhao. The HPA/SDC1 axis promotes invasion and metastasis of pancreatic cancer cells by activating EMT via FGF2 upregulation. Oncology Letters 2019; doi: 10.3892/ol.2019.11121
|
| 704 |
Abraham Fourie Bezuidenhout, Kristy Lee, Masoud Nakhaei, Khoschy Schawkat, Jesse Wei, Karen Lee, Koenraad Mortele. Management of Patients With Common Bile Duct Dilatation Without a Sonographic Evident Cause: Evaluating the Yield of Subsequent Magnetic Resonance Imaging and Findings Correlated With Causative Pancreaticobiliary Pathology. Journal of Computer Assisted Tomography 2022; 46(2): 163 doi: 10.1097/RCT.0000000000001277
|
| 705 |
Shailendra K. Gautam, Parvez Khan, Gopalakrishnan Natarajan, Pranita Atri, Abhijit Aithal, Apar K. Ganti, Surinder K. Batra, Mohd W. Nasser, Maneesh Jain. Mucins as Potential Biomarkers for Early Detection of Cancer. Cancers 2023; 15(6): 1640 doi: 10.3390/cancers15061640
|
| 706 |
Lin Lin, Liang Xiao, Chang'e Jin, Ying Qin, Haoyuan Deng, Meixiang Li, Huan Lin, Xuehao Gong. Circ_0058058 Drives the Malignant Phenotypes and Immune Evasion of Pancreatic Cancer by the MicroRNA-557–Dependent Regulation of PDL1. Pancreas 2022; 51(10): 1444 doi: 10.1097/MPA.0000000000002205
|
| 707 |
Mitra Darbandi, Zahra Khorrami, Ali Karamoozian, Omid Aboubakri, Mahsa Miryan, Leila Rezakhani, Fatemeh Khosravi Shadmani, Bibi Razieh Hosseini Farash. A comparison of the burden of cancers between 1990 and 2019 in Iran: A national and subnational study. PLOS ONE 2025; 20(2): e0309699 doi: 10.1371/journal.pone.0309699
|
| 708 |
Chris Anama-Green, Megan Quinn. Survival Analysis of Demographic Factors Associated With 5+ Year Survival of Pancreatic Carcinoma. Cureus 2021; doi: 10.7759/cureus.13032
|
| 709 |
Lingyu Hu, Haokai Xu, Xiaoguang Wang, Bin Wu, Fei Chen, Wei Chen, Yong Gao, Zhengxiang Zhong. The expression and clinical prognostic value of protein phosphatase 1 catalytic subunit beta in pancreatic cancer. Bioengineered 2021; 12(1): 2763 doi: 10.1080/21655979.2021.1934243
|
| 710 |
Yalan Deng, Xianghou Xia, Yang Zhao, Zilong Zhao, Consuelo Martinez, Wenjuan Yin, Jun Yao, Qinglei Hang, Weiche Wu, Jie Zhang, Yang Yu, Weiya Xia, Fan Yao, Di Zhao, Yutong Sun, Haoqiang Ying, Mien-Chie Hung, Li Ma. Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-27349-7
|
| 711 |
Carlo De Matteis, Lucilla Crudele, Raffaella Maria Gadaleta, Ersilia Di Buduo, Fabio Novielli, Stefano Petruzzelli, Marica Cariello, Antonio Moschetta. Low Adherence to Mediterranean Diet Characterizes Metabolic Patients with Gastrointestinal Cancer. Nutrients 2024; 16(5): 630 doi: 10.3390/nu16050630
|
| 712 |
Raquel Herranz Pérez, Felipe de la Morena López, Pedro L Majano Rodríguez, Francisca Molina Jiménez, Lorena Vega Piris, Cecilio Santander Vaquero. Molecular analysis of pancreatic cystic neoplasm in routine clinical practice. World Journal of Gastrointestinal Endoscopy 2021; 13(2): 56-71 doi: 10.4253/wjge.v13.i2.56
|
| 713 |
Theodoros Sidiropoulos, Nikolas Dovrolis, Hector Katifelis, Nikolaos V. Michalopoulos, Panagiotis Kokoropoulos, Nikolaos Arkadopoulos, Maria Gazouli. Dysbiosis Signature of Fecal Microbiota in Patients with Pancreatic Adenocarcinoma and Pancreatic Intraductal Papillary Mucinous Neoplasms. Biomedicines 2024; 12(5): 1040 doi: 10.3390/biomedicines12051040
|
| 714 |
P. Santosh Reddy, M. Chandra Sekhar. Sentiment Analysis and Deep Learning. Advances in Intelligent Systems and Computing 2023; 1432: 629 doi: 10.1007/978-981-19-5443-6_48
|
| 715 |
Kanan Panchal, Rakesh Kumar Sahoo, Umesh Gupta, Akash Chaurasiya. Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview. International Immunopharmacology 2021; 95: 107508 doi: 10.1016/j.intimp.2021.107508
|
| 716 |
Mahdi Sheikh, Sahar Masoudi, Razieh Bakhshandeh, Alireza Moayyedkazemi, Farhad Zamani, Sepideh Nikfam, Masoumeh Mansouri, Neda Ghamarzad Shishavan, Saman Nikeghbalian, Paul Brennan, Reza Malekzadeh, Akram Pourshams, Ulrich Wellner. Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study. PLOS ONE 2020; 15(12): e0243511 doi: 10.1371/journal.pone.0243511
|
| 717 |
Masato Ono, Yusuke Ono, Toru Nakamura, Takahiro Tsuchikawa, Tomotaka Kuraya, Shota Kuwabara, Yoshitsugu Nakanishi, Toshimichi Asano, Aya Matsui, Kimitaka Tanaka, Yuma Ebihara, Yo Kurashima, Takehiro Noji, Soichi Murakami, Toshiaki Shichinohe, Tomoko Mitsuhashi, Yuko Omori, Toru Furukawa, Kenzui Taniue, Mayumi Suzuki, Ayumu Sugitani, Hidenori Karasaki, Yusuke Mizukami, Satoshi Hirano. Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scoring in Combination with CA19-9. Annals of Surgical Oncology 2022; 29(8): 5007 doi: 10.1245/s10434-022-11630-0
|
| 718 |
Cielo García-Montero, Oscar Fraile-Martinez, David Cobo-Prieto, Diego De Leon-Oliva, Diego Liviu Boaru, Patricia De Castro-Martinez, Leonel Pekarek, Raquel Gragera, Mauricio Hernández-Fernández, Luis G. Guijarro, María Del Val Toledo-Lobo, Laura López-González, Raul Díaz-Pedrero, Jorge Monserrat, Melchor Álvarez-Mon, Miguel A. Saez, Miguel A. Ortega. Abnormal Histopathological Expression of Klotho, Ferroptosis, and Circadian Clock Regulators in Pancreatic Ductal Adenocarcinoma: Prognostic Implications and Correlation Analyses. Biomolecules 2024; 14(8): 947 doi: 10.3390/biom14080947
|
| 719 |
Haoran Fei, Xiao Shi, Dan Sun, Haishen Yang, Dali Wang, Kai Li, Xinxin Si, Wei Hu. Integrated analysis identified the role of three family members of ARHGAP in pancreatic adenocarcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-62577-z
|
| 720 |
Jia Huang, Xiaofei Fan, Wentian Liu. Applications and Prospects of Artificial Intelligence-Assisted Endoscopic Ultrasound in Digestive System Diseases. Diagnostics 2023; 13(17): 2815 doi: 10.3390/diagnostics13172815
|
| 721 |
Guizhen Zhang, Liwen Liu, Jianhao Li, Yu Chen, Yun Wang, Yize Zhang, Zihui Dong, Wenhua Xue, Ranran Sun, Guangying Cui. NSUN2 stimulates tumor progression via enhancing TIAM2 mRNA stability in pancreatic cancer. Cell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01521-y
|
| 722 |
Jin Wang, Ru Si, Qingqing Zhang, Wen Lu, Jie Zhang. Discovery of Imaging and Therapeutic Integration Bifunctional Molecules Based on Bio-Orthogonal Reaction and Releasable Disulfide Bond. Bioconjugate Chemistry 2022; 33(5): 918 doi: 10.1021/acs.bioconjchem.2c00133
|
| 723 |
Peng Hong, Mengshuo Wu, Xingchuan Wei, Xuetao Xu, Panpan Wu, Lishe Gan, Rihui Wu, Jingwei Jin, Kun Zhang, Dongli Li, Min Chen, Wingleung Wong, Wenfeng Liu, Xi Zheng. Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells. Bioorganic Chemistry 2024; 142: 106937 doi: 10.1016/j.bioorg.2023.106937
|
| 724 |
Ömer Faruk AKMEŞE. Data privacy-aware machine learning approach in pancreatic cancer diagnosis. BMC Medical Informatics and Decision Making 2024; 24(1) doi: 10.1186/s12911-024-02657-2
|
| 725 |
Urushi Rehman, Mohammed A.S. Abourehab, Amit Alexander, Prashant Kesharwani. Polymeric micelles assisted combinatorial therapy: Is it new hope for pancreatic cancer?. European Polymer Journal 2023; 184: 111784 doi: 10.1016/j.eurpolymj.2022.111784
|
| 726 |
J. Anakha, Yenisetti Rajendra Prasad, Nisha Sharma, Abhay H. Pande. Human arginase I: a potential broad-spectrum anti-cancer agent. 3 Biotech 2023; 13(5) doi: 10.1007/s13205-023-03590-3
|
| 727 |
Amit Gupta, Deepak Rajput, Shyam Karuppusamy Krishnasamy, Oshin Sharma, Rahul Mishra, Amoli Tandon, Sweety Gupta. Clinical presentation and outcomes of pancreatic cancer at a tertiary care hospital in the sub-Himalayan region: A retrospective observational study. Cancer Research, Statistics, and Treatment 2023; 6(1): 44 doi: 10.4103/crst.crst_201_22
|
| 728 |
Arza Izzadeen, Lewis Dymock, Clare Hoskins. Small-Scale Particles Showing Large-Scale Impact in Pancreatic Cancer. Nanomedicine 2023; 18(25): 1795 doi: 10.2217/nnm-2023-0283
|
| 729 |
Daniel H. Ahn, Tanios Bekaii-Saab. The Continued Struggle for Defining a Role for Radiotherapy in Pancreas Cancer. JAMA Oncology 2022; 8(9): 1257 doi: 10.1001/jamaoncol.2022.2309
|
| 730 |
Ko Tomishima, Toshio Fujisawa, Yuki Fukumura, Mako Ushio, Taito Fukuma, Sho Takahashi, Yusuke Takasaki, Akinori Suzuki, Koichi Ito, Shigeto Ishii, Takashi Yao, Akihito Nagahara, Hiroyuki Isayama. Pancreatic Adenocarcinoma With Strong Expression of Interleukin-13 Receptor α2 Shows a Poor Response to Gemcitabine-Based Chemotherapy. Pancreas 2022; 51(9): 1133 doi: 10.1097/MPA.0000000000002151
|
| 731 |
Cosmas Rinaldi Adithya Lesmana. Impact of endoscopic ultrasound-guided radiofrequency ablation in managing pancreatic malignancy. World Journal of Gastrointestinal Surgery 2023; 15(2): 163-168 doi: 10.4240/wjgs.v15.i2.163
|
| 732 |
Paula A. Lopes, Elisabete Fonseca, Inês V. da Silva, Emanuel Vigia, Jorge Paulino, Graça Soveral. Aquaporins Transcripts with Potential Prognostic Value in Pancreatic Cancer. Genes 2023; 14(9): 1694 doi: 10.3390/genes14091694
|
| 733 |
Karolina Buchholz, Justyna Durślewicz, Anna Klimaszewska-Wiśniewska, Magdalena Wiśniewska, Maciej Słupski, Dariusz Grzanka. SKA3 Expression as a Prognostic Factor for Patients with Pancreatic Adenocarcinoma. International Journal of Molecular Sciences 2024; 25(10): 5134 doi: 10.3390/ijms25105134
|
| 734 |
Tiequan Zhang, Mi Li, Haofeng Lu, Tao Peng. Up-Regulation of circEIF6 Contributes to Pancreatic Cancer Development Through Targeting miR-557/SLC7A11/PI3K/AKT Signaling. Cancer Management and Research 2021; : 247 doi: 10.2147/CMAR.S280307
|
| 735 |
Yubin Lei, Zhen Tan, He Xu, Jin Xu, Chen Liang, Qingcai Meng, Jie Hua, Jiang Liu, Heng Zhu, Wei Wang, Xianjun Yu, Si Shi. Collapsin Response Mediator Protein 1 Acts as a Tumor Suppressor in Pancreatic Cancer Mediated by AXIN1/ β-Catenin Signaling Axis. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3989797
|
| 736 |
Elisabeth Maurer, Detlef K. Bartsch. Surgical aspects related to hereditary pancreatic cancer. Familial Cancer 2024; 23(3): 341 doi: 10.1007/s10689-024-00384-1
|
| 737 |
Hiroaki Yaku, Ken Takahashi, Hirokazu Okada, Kouji Kobiyama, Masahiro Shiokawa, Norimitsu Uza, Yuzo Kodama, Ken J. Ishii, Hiroshi Seno. Near-infrared photoimmunotherapy as a complementary modality to in situ vaccine in a preclinical pancreatic cancer model. Biochemical and Biophysical Research Communications 2024; 737: 150534 doi: 10.1016/j.bbrc.2024.150534
|
| 738 |
A-min Wang, Ru Qiu, Duo Zhang, Xiao-yan Zhao. Therapeutic effects of an innovative BS-HH-002 drug on pancreatic cancer cells via induction of complete MCL-1 degradation. Translational Oncology 2022; 15(1): 101288 doi: 10.1016/j.tranon.2021.101288
|
| 739 |
Francisco Quiñonero, Cristina Mesas, Jose A. Muñoz-Gámez, Cristina Jiménez-Luna, Gloria Perazzoli, Jose Prados, Consolación Melguizo, Raul Ortiz. PARP1 inhibition by Olaparib reduces the lethality of pancreatic cancer cells and increases their sensitivity to Gemcitabine. Biomedicine & Pharmacotherapy 2022; 155: 113669 doi: 10.1016/j.biopha.2022.113669
|
| 740 |
I Gede Putu Supadmanaba, Giulia Mantini, Ornella Randazzo, Mjriam Capula, Ittai B. Muller, Stella Cascioferro, Patrizia Diana, Godefridus J. Peters, Elisa Giovannetti. Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma. Epigenetics 2022; 17(4): 381 doi: 10.1080/15592294.2021.1916697
|
| 741 |
Ming Tan, Klaus Brusgaard, Anne-Marie Gerdes, Michael Bau Mortensen, Sönke Detlefsen, Ove B. Schaffalitzky de Muckadell, Maiken Thyregod Joergensen. Cohort profile and heritability assessment of familial pancreatic cancer: a nation-wide study. Scandinavian Journal of Gastroenterology 2021; 56(8): 965 doi: 10.1080/00365521.2021.1937697
|
| 742 |
Ozden Oz, Asuman Argon, TuluAyata Kebat, Ozlem Ozdemir, Savas Yakan. Prognostic significance of ımmunhistochemical axl expression in pancreas ductal adenocarcinomas. Indian Journal of Pathology and Microbiology 2023; 66(3): 533 doi: 10.4103/ijpm.ijpm_1002_21
|
| 743 |
Youfu Zhang, Jinran Yang, Xuyang Wang, Xinchang Li. GNG7 and ADCY1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma through bioinformatic-based analyses. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-99544-x
|
| 744 |
Marie Buchholz, Britta Majchrzak-Stiller, Ilka Peters, Stephan Hahn, Lea Skrzypczyk, Lena Beule, Waldemar Uhl, Chris Braumann, Johanna Strotmann, Philipp Höhn. Maintenance Therapy for Pancreatic Cancer, a New Approach Based on the Synergy between the Novel Agent GP-2250 (Misetionamide) and Gemcitabine. Cancers 2024; 16(14): 2612 doi: 10.3390/cancers16142612
|
| 745 |
Scott D. Haller, Karim Essani. Oncolytic Tanapoxvirus Variants Expressing mIL-2 and mCCL-2 Regress Human Pancreatic Cancer Xenografts in Nude Mice. Biomedicines 2024; 12(8): 1834 doi: 10.3390/biomedicines12081834
|
| 746 |
Mirjami Kaasinen, Jaana Hagström, Harri Mustonen, Timo Sorsa, Malin Sund, Caj Haglund, Hanna Seppänen. Matrix Metalloproteinase 8 Expression in a Tumour Predicts a Favourable Prognosis in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2022; 23(6): 3314 doi: 10.3390/ijms23063314
|
| 747 |
Neha Parveen, Afsana Sheikh, Mohammed A.S. Abourehab, Ritu Karwasra, Surender Singh, Prashant Kesharwani. Self-nanoemulsifying drug delivery system for pancreatic cancer. European Polymer Journal 2023; 190: 111993 doi: 10.1016/j.eurpolymj.2023.111993
|
| 748 |
A S M Mahadiuzzaman, F.A. Dain Md Opo, Saleh Alkarim. Stem cell-based targeted therapy in pancreatic cancer: Current approaches and future prospects. Tissue and Cell 2024; 89: 102449 doi: 10.1016/j.tice.2024.102449
|
| 749 |
Lei Jin, Daohai Qian, Xiaolei Tang, Yong Huang, Junwei Zou, Zhaoying Wu. SMYD2 Imparts Gemcitabine Resistance to Pancreatic Adenocarcinoma Cells by Upregulating EVI2A. Molecular Biotechnology 2024; 66(10): 2920 doi: 10.1007/s12033-023-00908-7
|
| 750 |
Shuwei Chen, Yanfei Hao, Shaoyang Huang, Dong Leng, Yuxiang Ma. Resection of rectal metastasis after previous radical surgery for pancreatic cancer: Case report and literature review. Medicine 2023; 102(49): e36365 doi: 10.1097/MD.0000000000036365
|
| 751 |
Alessio Biagioni, Shima Tavakol, Nooshin Ahmadirad, Masoumeh Zahmatkeshan, Lucia Magnelli, Ali Mandegary, Hojjat Samareh Fekri, Malek Hossein Asadi, Reza Mohammadinejad, Kwang Seok Ahn. Small nucleolar RNA host genes promoting epithelial–mesenchymal transition lead cancer progression and metastasis. IUBMB Life 2021; 73(6): 825 doi: 10.1002/iub.2501
|
| 752 |
Marek Olakowski, Łukasz Bułdak. Modifiable and Non-Modifiable Risk Factors for the Development of Non-Hereditary Pancreatic Cancer. Medicina 2022; 58(8): 978 doi: 10.3390/medicina58080978
|
| 753 |
Hu Ren, Chao-Rui Wu, Guo-Tong Qiu, Li-Peng Zhang, Saderbieke Aimaiti, Cheng-Feng Wang. Equipping the American Joint Committee on Cancer Staging for Resectable Pancreatic Ductal Adenocarcinoma with Tumor Grade: A Novel Staging System. Journal of Oncology 2020; 2020: 1 doi: 10.1155/2020/9093729
|
| 754 |
Xiaoting Sun, Xingkang He, Yin Zhang, Kayoko Hosaka, Patrik Andersson, Jing Wu, Jieyu Wu, Xu Jing, Qiqiao Du, Xiaoli Hui, Bo Ding, Ziheng Guo, An Hong, Xuan Liu, Yan Wang, Qing Ji, Rudi Beyaert, Yunlong Yang, Qi Li, Yihai Cao. Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism. Gut 2022; 71(1): 129 doi: 10.1136/gutjnl-2020-322744
|
| 755 |
M. V. Naboka, A. V. Otmakhova, P. V. Bogdanchikova, D. M. Viushkov. Epidemiology of pancreatic cancer. Experimental and Clinical Gastroenterology 2023; (3): 17 doi: 10.31146/1682-8658-ecg-211-3-17-21
|
| 756 |
Concetta Panebianco, Valerio Pazienza. Body site-dependent variations of microbiota in pancreatic cancer pathophysiology. Critical Reviews in Clinical Laboratory Sciences 2019; 56(4): 260 doi: 10.1080/10408363.2019.1615407
|
| 757 |
Leonel Pekarek, Oscar Fraile‑Μartinez, Cielo Garcia‑Montero, Miguel Alvarez‑Mon, Julio Acero, Lidia Ruiz‑Llorente, Natalio García‑Honduvilla, Agustin Albillos, Julia Buján, Melchor Alvarez‑Mon, Luis Guijarro, Miguel Ortega. Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives (Review). Oncology Letters 2021; 22(5) doi: 10.3892/ol.2021.13070
|
| 758 |
Ming Tan, Klaus Brusgaard, Anne‐Marie Gerdes, Martin Jakob Larsen, Michael Bau Mortensen, Sönke Detlefsen, Ove B. Schaffalitzky de Muckadell, Maiken Thyregod Joergensen. Whole genome sequencing identifies rare genetic variants in familial pancreatic cancer patients. Annals of Human Genetics 2022; 86(4): 195 doi: 10.1111/ahg.12464
|
| 759 |
Unai Illarregi, Angela Gutierrez-Camino, Idoia Martin-Guerrero, Elixabet Lopez-Lopez. MicroRNA. 2022; : 503 doi: 10.1016/B978-0-323-89774-7.00018-2
|
| 760 |
Hong Dai, Xingxuan Chen, Jiawen Yang, Rodrigo Azevedo Loiola, Aiping Lu, Kenneth C. P. Cheung. Insights and therapeutic advances in pancreatic cancer: the role of electron microscopy in decoding the tumor microenvironment. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1460544
|
| 761 |
Yuda Zhang, Fanxu Zeng, Shixuan Peng, Yangqian Chen, Wenjuan Jiang, Zhan Wang, Li Deng, Zhe Huang, Haoyue Qin, Huan Yan, Xing Zhang, Lin Zhang, Nong Yang, Qian Gong, Liang Zeng, Yongchang Zhang. Stratification of patients with KRAS-mutated advanced non-small cell lung cancer: improving prognostics. Expert Review of Respiratory Medicine 2023; 17(9): 743 doi: 10.1080/17476348.2023.2265810
|
| 762 |
Audrius Dulskas, Ausvydas Patasius, Donata Linkeviciute-Ulinskiene, Lina Zabuliene, Giedre Smailyte. Cohort Study of Antihyperglycemic Medication and Pancreatic Cancer Patients Survival. International Journal of Environmental Research and Public Health 2020; 17(17): 6016 doi: 10.3390/ijerph17176016
|
| 763 |
Jonathan M. Wyse, Anand V. Sahai. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy. 2021; : 1 doi: 10.1007/978-3-030-29964-4_109-1
|
| 764 |
L. Gutierrez-Sainz, D. Viñal, J. Villamayor, D. Martinez-Perez, J. A. Garcia-Cuesta, I. Ghanem, A. Custodio, J. Feliu. Prognostic factors in advanced pancreatic ductal adenocarcinoma patients-receiving second-line treatment: a single institution experience. Clinical and Translational Oncology 2021; 23(9): 1838 doi: 10.1007/s12094-021-02589-7
|
| 765 |
Dorothy Priyanka Dorairaj, Jebiti Haribabu, Yu-Lun Chang, Sodio C. N. Hsu, Cesar Echeverria, Javier Echeverria, Ramasamy Karvembu. Effect of new Pd(II)-aroylthiourea complex on pancreatic cancer cells. Inorganic Chemistry Communications 2021; 134: 109018 doi: 10.1016/j.inoche.2021.109018
|
| 766 |
Craig Grobbelaar, Mpho Kgomo, Peace Mabeta. Angiogenesis and Pancreatic Cancer: Novel Approaches to Overcome
Treatment Resistance. Current Cancer Drug Targets 2024; 24(11): 1116 doi: 10.2174/0115680096284588240105051402
|
| 767 |
Chao Dang, Min Wang, Tingting Qin, Renyi Qin. Clinical importance of preoperative red-cell volume distribution width as a prognostic marker in patients undergoing radical surgery for pancreatic cancer. Surgery Today 2022; 52(3): 465 doi: 10.1007/s00595-021-02374-7
|
| 768 |
Subhrasima Nayak, Arka Karmakar, Lalit Kumar. Advanced Targeting of the Lymphatic System. 2024; : 337 doi: 10.1007/978-3-031-64828-1_17
|
| 769 |
Junji Furuse, Fumihiko Osugi, Koji Machii, Koji Niibe, Toshimitsu Endo. Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan. International Journal of Clinical Oncology 2024; 29(4): 456 doi: 10.1007/s10147-024-02467-6
|
| 770 |
Zhao Liu, Hiromitsu Hayashi, Kazuki Matsumura, Norio Uemura, Yuta Shiraishi, Hiroki Sato, Hideo Baba. Biological and Clinical Impacts of Glucose Metabolism in Pancreatic Ductal Adenocarcinoma. Cancers 2023; 15(2): 498 doi: 10.3390/cancers15020498
|
| 771 |
George Kim, Paul Cockrum, Andy Surinach, Shu Wang, Zev Wainberg. Real-world safety and supportive care use of second-line 5-fluorouracil-based regimens among patients with metastatic pancreatic ductal adenocarcinoma. Current Medical Research and Opinion 2022; 38(8): 1295 doi: 10.1080/03007995.2022.2059976
|
| 772 |
Reem A. Al Alawi, Jörg D. Hoheisel, Mohamed Saiel Saeed Alhamdani, Younis Baqi. Phoenix dactylifera L. (date palm) fruit extracts and fractions exhibit anti-proliferative activity against human pancreatic cancer cell lines. Heliyon 2025; 11(3): e42274 doi: 10.1016/j.heliyon.2025.e42274
|
| 773 |
Jinhai Chang, Xuguang Hu, Jinniang Nan, Xianghua Zhang, Xintian Jin. HOXD9‑induced SCNN1A upregulation promotes pancreatic cancer cell proliferation, migration and predicts prognosis by regulating epithelial‑mesenchymal transformation. Molecular Medicine Reports 2021; 24(5) doi: 10.3892/mmr.2021.12459
|
| 774 |
Mahdieh Farhoudi Sefidan Jadid, Behrouz Shademan, Reza Chavoshi, Nasrin Seyyedsani, Elnaz Aghaei, Elham Taheri, Pouya Goleij, Saba Hajazimian, Vahidreza Karamad, Javad Behroozi, Mehrdad Nasrollahzadeh Sabet, Alireza Isazadeh, Behzad Baradaran. Enhanced anticancer potency of hydroxytyrosol and curcumin by PLGA‐PAA nano‐encapsulation on PANC‐1 pancreatic cancer cell line. Environmental Toxicology 2021; 36(6): 1043 doi: 10.1002/tox.23103
|
| 775 |
Khoschy Schawkat, Maria A. Manning, Jonathan N. Glickman, Koenraad J. Mortele. Pancreatic Ductal Adenocarcinoma and Its Variants: Pearls and Perils. RadioGraphics 2020; 40(5): 1219 doi: 10.1148/rg.2020190184
|
| 776 |
Danling Guo, Chao Chen, Sangying Lv, Guanzuan Wu, Wei Shi, Huaifeng Li, Hongjie Hu. Management of Primary Squamous Cell Carcinoma of the Pancreas: A Case Report. Frontiers in Surgery 2021; 8 doi: 10.3389/fsurg.2021.700229
|
| 777 |
Silvia Batista, Ana C. Gregório, Andreia Hanada Otake, Nuno Couto, Bruno Costa-Silva. The Gastrointestinal Tumor Microenvironment: An Updated Biological and Clinical Perspective. Journal of Oncology 2019; 2019: 1 doi: 10.1155/2019/6240505
|
| 778 |
Heleen Driessens, Laura van Wijk, Carlijn I. Buis, Joost M. Klaase. Low health literacy is associated with worse postoperative outcomes following hepato-pancreato-biliary cancer surgery. HPB 2022; 24(11): 1869 doi: 10.1016/j.hpb.2022.07.006
|
| 779 |
Ghena Lababidi, Noura Wahoud, Lina Ghandour, Nour Moukalled, Rami Mahfouz. The molecular evidence behind the adjunct use of anticoagulants and chemotherapy in pancreatic cancer treatment: A new role for anticoagulants?. Human Gene 2024; 41: 201307 doi: 10.1016/j.humgen.2024.201307
|
| 780 |
Zeen Zhu, Xueni Wang, Wunai Zhang, Mengyuan Gong, Simei Zhang, Bao Yang, Bolun Qu, Zheng Wu, Qingyong Ma, Zheng Wang, Weikun Qian. Huaier suppresses pancreatic cancer progression via activating cell autophagy induced ferroptosis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.960858
|
| 781 |
Cade Bennett, Mike Suguitan, John Abad, Akhil Chawla. Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines. Pancreatology 2022; 22(6): 719 doi: 10.1016/j.pan.2022.05.005
|
| 782 |
Robert G. Pergolizzi, Steven T. Brower. Molecular Targets for the Diagnosis and Treatment of Pancreatic Cancer. International Journal of Molecular Sciences 2024; 25(19): 10843 doi: 10.3390/ijms251910843
|
| 783 |
Pengfei Zhang, Weiwei Tao, Cai Lu, Lu Fan, Qihang Jiang, Chengbin Yang, Erxin Shang, Haibo Cheng, Chuntao Che, Jinao Duan, Ming Zhao. Bruceine A induces cell growth inhibition and apoptosis through PFKFB4/GSK3β signaling in pancreatic cancer. Pharmacological Research 2021; 169: 105658 doi: 10.1016/j.phrs.2021.105658
|
| 784 |
V. E. Moiseenko, A. V. Pavlovsky, D. A. Granov, I. G. Kardanova, L. V. Kochorova, I. V. Dodonova. Incidence of pancreatic malignancies in the Russian Federation: a retrospective cohort trial. Kuban Scientific Medical Bulletin 2021; 28(3): 97 doi: 10.25207/1608-6228-2021-28-3-97-111
|
| 785 |
Xingcheng Xiong, Jiarui Feng, Xiao Yang, Hanjun Li, Qiao Shi, Jing Tao, Jian Chang. Circular RNA CDR1as promotes tumor progression by regulating miR-432-5p/E2F3 axis in pancreatic cancer. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01812-3
|
| 786 |
Irem Guvendir, Itir Ebru Zemheri, Kamil Ozdil. Impact of rapid on-site evaluation on diagnostic accuracy of EUS-guided fine-needle aspiration of solid pancreatic lesions: experience from a single center. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02330-w
|
| 787 |
Nemanja Djokovic, Ana Djuric, Dusan Ruzic, Tatjana Srdic-Rajic, Katarina Nikolic. Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma. Pharmaceuticals 2023; 16(2): 294 doi: 10.3390/ph16020294
|
| 788 |
Irene Deftereos, Nicole Kiss, Elizabeth Isenring, Vanessa M. Carter, Justin MC. Yeung. A systematic review of the effect of preoperative nutrition support on nutritional status and treatment outcomes in upper gastrointestinal cancer resection. European Journal of Surgical Oncology 2020; 46(8): 1423 doi: 10.1016/j.ejso.2020.04.008
|
| 789 |
Xiaoxia Hu, Xiaoyu Peng, Yue Zhang, Shuangqin Fan, Xing Liu, Yuxuan Song, Shuang Ren, Lin Chen, Yi Chen, Rong Wang, Jianqing Peng, Xiangchun Shen, Yan Chen. Shikonin reverses cancer-associated fibroblast-induced gemcitabine resistance in pancreatic cancer cells by suppressing monocarboxylate transporter 4-mediated reverse Warburg effect. Phytomedicine 2024; 123: 155214 doi: 10.1016/j.phymed.2023.155214
|
| 790 |
Xiuxue Feng, Qiang Liu, Huikai Li, Jing Yang, Enqiang Linghu. Identification of PSMD2 as a promising biomarker for pancreatic cancer patients based on comprehensive bioinformatics and in vitro studies. Heliyon 2024; 10(22): e40117 doi: 10.1016/j.heliyon.2024.e40117
|
| 791 |
Muhammad Sardar, Alejandro Recio-Boiles, Kabir Mody, Christian Karime, Sreenivasa R Chandana, Daruka Mahadevan, Jason Starr, Jeremy Jones, Mitesh Borad, Hani Babiker. Pharmacotherapeutic options for pancreatic ductal adenocarcinoma. Expert Opinion on Pharmacotherapy 2022; 23(18): 2079 doi: 10.1080/14656566.2022.2149322
|
| 792 |
Elie M. Ghabi, Sami Shoucair, Ding Ding, Ammar A. Javed, Elizabeth D. Thompson, Lei Zheng, John L. Cameron, Christopher L. Wolfgang, Christopher R. Shubert, Kelly J. Lafaro, Richard A. Burkhart, William R. Burns, Jin He. Tailoring Adjuvant Chemotherapy to Biologic Response Following Neoadjuvant Chemotherapy Impacts Overall Survival in Pancreatic Cancer. Journal of Gastrointestinal Surgery 2023; 27(4): 691 doi: 10.1007/s11605-022-05476-w
|
| 793 |
Yu. Yu. Rakina, N. V. Krakhmal, D. S. Pismenny, A. V. Zavyalov, S. V. Vtorushin, S. G. Afanasyev, M. V. Zavyalova. Expression levels of β1, β3 integrins and MMP2 and features of morphological heterogeneity of pancreatic ductal adenocarcinoma associated with distant metastasis. Siberian journal of oncology 2023; 22(2): 93 doi: 10.21294/1814-4861-2023-22-2-93-102
|
| 794 |
Miguel A. Ortega, Oscar Fraile-Martinez, Leonel Pekarek, Cielo García-Montero, Miguel Angel Alvarez-Mon, Alejandro J. Castellanos, Natalio García-Honduvilla, Julia Buján, Melchor Alvarez-Mon, Miguel A. Sáez, Luis G. Guijarro, Angel Asúnsolo. Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer. Antioxidants 2022; 11(4): 759 doi: 10.3390/antiox11040759
|
| 795 |
Rafique Umer Harvitkar, Harish Peri, Sri Nikhil Zallipalli, Suneet John Joseph, Giri Babu Gattupalli, Khursheed Ansari. Non-Cancer Causes of Death in Patients With Pancreatic Adenocarcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Based Study. Cureus 2021; doi: 10.7759/cureus.20289
|
| 796 |
Lingfeng Li, Xu Zhang, Nian Liu, Xiang Chen, Cong Peng. LINC00473: A novel oncogenic long noncoding RNA in human cancers. Journal of Cellular Physiology 2021; 236(6): 4174 doi: 10.1002/jcp.30176
|
| 797 |
Zhenlu Li, Xing Huang, Weiming Hu, Huimin Lu. Down-regulation of USP22 reduces cell stemness and enhances the sensitivity of pancreatic cancer cells to cisplatin by inactivating the Wnt/β-catenin pathway. Tissue and Cell 2022; 77: 101787 doi: 10.1016/j.tice.2022.101787
|
| 798 |
Yexin Tong, Mingjun Sun, Lingli Chen, Yunzhi Wang, Yan Li, Lingling Li, Xuan Zhang, Yumeng Cai, Jingbo Qie, Yanrui Pang, Ziyan Xu, Jiangyan Zhao, Xiaolei Zhang, Yang Liu, Sha Tian, Zhaoyu Qin, Jinwen Feng, Fan Zhang, Jiajun Zhu, Yifan Xu, Wenhui Lou, Yuan Ji, Jianyuan Zhao, Fuchu He, Yingyong Hou, Chen Ding. Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma. Journal of Hematology & Oncology 2022; 15(1) doi: 10.1186/s13045-022-01384-3
|
| 799 |
Hongtao Duan, Rui Zhang, Lu Yuan, Yiyuan Liu, Aiminuer Asikaer, Yang Liu, Yan Shen. Exploring the therapeutic mechanisms of Gleditsiae Spina acting on pancreatic cancervianetwork pharmacology, molecular docking and molecular dynamics simulation. RSC Advances 2023; 13(20): 13971 doi: 10.1039/D3RA01761C
|
| 800 |
Jing Chen, Cui-Cui Zhao, Fei-Ran Chen, Guo-Wei Feng, Fei Luo, Tao Jiang, Sakthivel Muniyan. KIF20B Promotes Cell Proliferation and May Be a Potential Therapeutic Target in Pancreatic Cancer. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/5572402
|
| 801 |
Takuro Kobori, Chihiro Tanaka, Yoko Urashima, Nobumasa Takagaki, Tokio Obata. IFN-γ and IL-12 from Concentrated Ascites in Patients with Pancreatic Cancer Exerts Growth Inhibitory Effects against Pancreatic Cancer Cells. YAKUGAKU ZASSHI 2022; 142(12): 1409 doi: 10.1248/yakushi.22-00150
|
| 802 |
Domenica Lucia D’Antonio, Simona Marchetti, Pamela Pignatelli, Samia Umme, Domenico De Bellis, Paola Lanuti, Adriano Piattelli, Maria Cristina Curia. Effect of 5-Aminolevulinic Acid (5-ALA) in “ALADENT” Gel Formulation and Photodynamic Therapy (PDT) against Human Oral and Pancreatic Cancers. Biomedicines 2024; 12(6): 1316 doi: 10.3390/biomedicines12061316
|
| 803 |
Stella Ploukou, Εleni Papakosta-Gaki, Efharis Panagopoulou, Alexios Benos, Emmanoui Smyrnakis. Unmet Needs in the Process of Chemotherapy Provision in Pancreatic Cancer Patients from the Healthcare Provider Perspective: A Phenomenological Study in Greece. Slovenian Journal of Public Health 2024; 63(2): 73 doi: 10.2478/sjph-2024-0011
|
| 804 |
Jesús M. Urman, José M. Herranz, Iker Uriarte, María Rullán, Daniel Oyón, Belén González, Ignacio Fernandez-Urién, Juan Carrascosa, Federico Bolado, Lucía Zabalza, María Arechederra, Gloria Alvarez-Sola, Leticia Colyn, María U. Latasa, Leonor Puchades-Carrasco, Antonio Pineda-Lucena, María J. Iraburu, Marta Iruarrizaga-Lejarreta, Cristina Alonso, Bruno Sangro, Ana Purroy, Isabel Gil, Lorena Carmona, Francisco Javier Cubero, María L. Martínez-Chantar, Jesús M. Banales, Marta R. Romero, Rocio I.R. Macias, Maria J. Monte, Jose J. G. Marín, Juan J. Vila, Fernando J. Corrales, Carmen Berasain, Maite G. Fernández-Barrena, Matías A. Avila. Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning Approach. Cancers 2020; 12(6): 1644 doi: 10.3390/cancers12061644
|
| 805 |
Nayla Mroueh, Jinjin Cao, Avinash Kambadakone. Dual-Energy CT in the Pancreas. Journal of Gastrointestinal and Abdominal Radiology 2022; 5(02): 114 doi: 10.1055/s-0042-1744494
|
| 806 |
Pınar KOÇATAKAN, Aziz KÜÇÜK, Zeki KADI, Hilmi ATASEVEN. Whipple Operasyonlarında Endoskopik Ultrasonagrafinin Önemi ve Fayda-Maliyet Analizi. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 2021; 8(4): 657 doi: 10.34087/cbusbed.907903
|
| 807 |
Anant Ramaswamy, Darshit Shah, Prabhat Bhargava, Sujay Srinivas, Sadhana Kannan, Minit Shah, Mannavi Suman, Shasanka Das, Mehak Trikha, Vikas Ostwal. Modified FOLFIRINOX compared to Gemcitabine & nab-Paclitaxel in advanced pancreatic ductal adenocarcinoma - results of a match-pair analysis. Indian Journal of Medical Research 2023; 157(1): 57 doi: 10.4103/ijmr.ijmr_980_21
|
| 808 |
Sheng Li, Dongping Jiang, Linling Jiang, Shumei Yan, Lizhi Liu, Guangying Ruan, Xuhui Zhou, Shuiqing Zhuo. Dual-energy computed tomography in a multiparametric regression model for diagnosing lymph node metastases in pancreatic ductal adenocarcinoma. Cancer Imaging 2024; 24(1) doi: 10.1186/s40644-024-00687-7
|
| 809 |
Lili Su, Guang Liu, Ying Guo, Xuanping Zhang, Xiaoyan Zhu, Jiayin Wang. Integration of Protein-Protein Interaction Networks and Gene Expression Profiles Helps Detect Pancreatic Adenocarcinoma Candidate Genes. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.854661
|
| 810 |
Xiaoting Ma, Xiu Liu, Kai Ou, Manman Zhang, Lizhen Gao, Lin Yang. Advanced pancreatic cancer with KRAS wild-type and EGFR-sensitive mutation respond favorably to furmonertinib: A case report. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1151178
|
| 811 |
So Heun Lee, Dae Wook Hwang, Changhoon Yoo, Kyu-pyo Kim, Sora Kang, Jae Ho Jeong, Dongwook Oh, Tae Jun Song, Sang Soo Lee, Do Hyun Park, Dong Wan Seo, Jin-hong Park, Ki Byung Song, Jae Hoon Lee, Woohyung Lee, Yejong Park, Bong Jun Kwak, Heung-Moon Chang, Baek-Yeol Ryoo, Song Cheol Kim. Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX. Cancer Research and Treatment 2023; 55(3): 956 doi: 10.4143/crt.2022.409
|
| 812 |
Jonathan M. Wyse, Anand V. Sahai. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy. 2022; : 1895 doi: 10.1007/978-3-030-56993-8_109
|
| 813 |
Yuli Zhang, Haohong Zhang, Bingqiang Liu, Kang Ning. Highly accurate diagnosis of pancreatic cancer by integrative modeling using gut microbiome and exposome data. iScience 2024; 27(3): 109294 doi: 10.1016/j.isci.2024.109294
|
| 814 |
Chao Ma, Panpan Yang, Jing Li, Yun Bian, Li Wang, Jianping Lu. Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imaging, and pathologic specimens. Abdominal Radiology 2020; 45(3): 782 doi: 10.1007/s00261-019-02125-w
|
| 815 |
Yu Shi, Yan Wang, Jing Qian, Xiaodi Yan, Yong Han, Ninghua Yao, Jianbo Ma. MGMT expression affects the gemcitabine resistance of pancreatic cancer cells. Life Sciences 2020; 259: 118148 doi: 10.1016/j.lfs.2020.118148
|
| 816 |
Mohini Singh, Paulami Pal, Rajat Subhra Dutta, Daphisha Marbaniang, Subhabrata Ray, Bhaskar Mazumder. Nanodiamond Mediated Molecular Targeting in Pancreatic Ductal Adenocarcinoma:
Disrupting the Tumor-stromal Cross-talk, Next Hope on the
Horizon?. Current Cancer Drug Targets 2023; 23(8): 620 doi: 10.2174/1568009623666230227120837
|
| 817 |
Yang Wu, Chun Zhang, Kuirong Jiang, Jens Werner, Alexandr V. Bazhin, Jan G. D’Haese. The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.621937
|
| 818 |
Irene Deftereos, Justin M. C. Yeung, Janan Arslan, Vanessa M. Carter, Elizabeth Isenring, Nicole Kiss. Assessment of Nutritional Status and Nutrition Impact Symptoms in Patients Undergoing Resection for Upper Gastrointestinal Cancer: Results from the Multi-Centre NOURISH Point Prevalence Study. Nutrients 2021; 13(10): 3349 doi: 10.3390/nu13103349
|
| 819 |
George Younan. Pancreas Solid Tumors. Surgical Clinics of North America 2020; 100(3): 565 doi: 10.1016/j.suc.2020.02.008
|
| 820 |
António M. Palma, Vignesh Vudatha, Maria Leonor Peixoto, Esha Madan. Pancreatic Cancer: Basic Mechanisms and Therapies. Advances in Cancer Research 2023; 159: 203 doi: 10.1016/bs.acr.2023.02.005
|
| 821 |
Mona Mohmed Eddfair, Othman Abdulrahman, Omar Alqawi, Mourad Assidi, Abdelbaset Buhmeida, Abdulfattah Elturki, Abdalla Jebriel, Mohamed Elfagieh, Eramah Ermiah. Correlations of demographical and clinicopathological features with patient outcome of pancreatic ductal adenocarcinoma: A retrospective study (2010-2018) from a Libyan Cohort. Journal of Cancer Research and Therapeutics 2023; 19(3): 745 doi: 10.4103/jcrt.jcrt_1778_21
|
| 822 |
Maria Cristina Conti Bellocchi, Micol Bernuzzi, Alessandro Brillo, Laura Bernardoni, Antonio Amodio, Nicolò De Pretis, Luca Frulloni, Armando Gabbrielli, Stefano Francesco Crinò. EUS-FNA versus EUS-FNB in Pancreatic Solid Lesions ≤ 15 mm. Diagnostics 2024; 14(4): 427 doi: 10.3390/diagnostics14040427
|
| 823 |
Usama A. Fahmy, Shaimaa M. Badr-Eldin, Hibah M. Aldawsari, Nabil A. Alhakamy, Osama A. A. Ahmed, Mohamed F. Radwan, Basma G. Eid, Shaban R. M. Sayed, Gamal A. El Sherbiny, Walaa Abualsunun. Potentiality of raloxifene loaded melittin functionalized lipidic nanovesicles against pancreatic cancer cells. Drug Delivery 2022; 29(1): 1863 doi: 10.1080/10717544.2022.2072544
|
| 824 |
Yong Zhu, Hailin Jin, Yingfan Mao, Jun Chen, Yudong Qiu, Zhongqiu Wang, Jian He. Unexplained Distal Obstructive Biliary Dilatation. Journal of Clinical Gastroenterology 2022; 56(8): 724 doi: 10.1097/MCG.0000000000001614
|
| 825 |
İlknur Çınar Ayan, Ebru Güçlü, Hasibe Vural, Hatice Gül Dursun. Piceatannol induces apoptotic cell death through activation of caspase-dependent pathway and upregulation of ROS-mediated mitochondrial dysfunction in pancreatic cancer cells. Molecular Biology Reports 2022; 49(12): 11947 doi: 10.1007/s11033-022-08006-8
|
| 826 |
Rita Balsano, Valentina Zanuso, Angelo Pirozzi, Lorenza Rimassa, Silvia Bozzarelli. Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights. Current Oncology 2023; 30(4): 3871 doi: 10.3390/curroncol30040293
|
| 827 |
Xinlong Wang, Huahui Zeng, Xin Zhu, Duanjie Xu, Qikang Tian, Can Wang, Lingzhou Zhao, Junwei Zhao, Mingsan Miao, Xiangxiang Wu. TP-CSO: A Triptolide Prodrug for Pancreatic Cancer Treatment. Molecules 2022; 27(12): 3686 doi: 10.3390/molecules27123686
|
| 828 |
Hong Dai, Razack Abdullah, Xiaoqiu Wu, Fangfei Li, Yuan Ma, Aiping Lu, Ge Zhang. Pancreatic Cancer: Nucleic Acid Drug Discovery and Targeted Therapy. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.855474
|
| 829 |
Isabelle Kuchenreuther, Finn-Niklas Clausen, Johanne Mazurie, Sushmita Paul, Franziska Czubayko, Anke Mittelstädt, Ann-Kathrin Koch, Alara Karabiber, Frederik J. Hansen, Lisa-Sophie Arnold, Nadine Weisel, Susanne Merkel, Maximilian Brunner, Christian Krautz, Julio Vera, Robert Grützmann, Georg F. Weber, Paul David. Increased Herpesvirus Entry Mediator Expression on Circulating Monocytes and Subsets Predicts Poor Outcomes in Pancreatic Ductal Adenocarcinoma Patients. International Journal of Molecular Sciences 2025; 26(7): 2875 doi: 10.3390/ijms26072875
|
| 830 |
Bilal Rah, Manzoor Ahmad Banday, Gh Rasool Bhat, Omar J Shah, Humira Jeelani, Fizalah Kawoosa, Tahira Yousuf, Dil Afroze. Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer. World Journal of Gastroenterology 2021; 27(36): 6093-6109 doi: 10.3748/wjg.v27.i36.6093
|
| 831 |
Jiali Du, Jichun Gu, Junyuan Deng, Lei Kong, Yujie Guo, Chen Jin, Yun Bao, Deliang Fu, Ji Li. The Expression and Survival Significance of Glucose Transporter-1 in Pancreatic Cancer: Meta-Analysis, Bioinformatics Analysis and Retrospective Study. Cancer Investigation 2021; 39(9): 741 doi: 10.1080/07357907.2021.1950755
|
| 832 |
Venkatesh Panthangi, Adrienne R Cyril Kurupp, Anjumol Raju, Gaurav Luthra, Mahrukh Shahbaz, Halah Almatooq, Paul Foucambert, Faith D Esbrand, Sana Zafar, Safeera Khan. Association Between Helicobacter pylori Infection and the Risk of Pancreatic Cancer: A Systematic Review Based on Observational Studies. Cureus 2022; doi: 10.7759/cureus.28543
|
| 833 |
Jiadeng Chao, Lei Jin, Xudong Zhang, Dong Ding, Siyuan Wu, Le Ma, Bei Zhu, Shiting Shan, Xiao Yun, Peng Gao, Jun Li, Chunfu Zhu, Xihu Qin. Insight into the effects of microRNA‑23a‑3p on pancreatic cancer and its underlying molecular mechanism. Oncology Letters 2019; doi: 10.3892/ol.2019.11117
|
| 834 |
Mareike Waldenmaier, Tanja Seibold, Thomas Seufferlein, Tim Eiseler. Pancreatic Cancer Small Extracellular Vesicles (Exosomes): A Tale of Short- and Long-Distance Communication. Cancers 2021; 13(19): 4844 doi: 10.3390/cancers13194844
|
| 835 |
Christian Chapa-González, Karina López, Kimberly Michelle Lomelí, Jorge Alberto Roacho-Pérez, Jazmín Cristina Stevens. A Review on the Efficacy and Safety of Nab-Paclitaxel with Gemcitabine in Combination with Other Therapeutic Agents as New Treatment Strategies in Pancreatic Cancer. Life 2022; 12(3): 327 doi: 10.3390/life12030327
|
| 836 |
Zachary C. Brandeburg, Sakariyau A. Waheed, Carina A. Derewonko, Caroline E. Dunn, Ethan C. Pfeiffer, Ann Marie E. Flusche, Robert J. Sheaff, Angus A. Lamar. Synthesis and Biological Evaluation of N‐(1H‐Indol‐6‐ylmethyl)benzenesulfonamide Analogs as Metabolic Inhibitors of Mitochondrial ATP Production in Pancreatic Cancer Cells. ChemMedChem 2025; 20(1) doi: 10.1002/cmdc.202400536
|
| 837 |
Benoît Cruciani, Chloé Touzet, Elisabeth Robin, Camille Bismuth. Left pancreaticoduodenostomy after removal of the right lobe and the head of the pancreas in a cat. Veterinary Surgery 2022; 51(8): 1304 doi: 10.1111/vsu.13887
|
| 838 |
Taija Korpela, Marianne Udd, Harri Mustonen, Ari Ristimäki, Caj Haglund, Hanna Seppänen, Leena Kylänpää. Association between chronic pancreatitis and pancreatic cancer: A 10‐year retrospective study of endoscopically treated and surgical patients. International Journal of Cancer 2020; 147(5): 1450 doi: 10.1002/ijc.32971
|
| 839 |
Ahmed Arafa, Ehab Salah Eshak, Jia-Yi Dong, Kokoro Shirai, Isao Muraki, Hiroyasu Iso, Akiko Tamakoshi. Dairy intake and the risk of pancreatic cancer: the Japan Collaborative Cohort Study (JACC Study) and meta-analysis of prospective cohort studies. British Journal of Nutrition 2022; 128(6): 1147 doi: 10.1017/S0007114521004232
|
| 840 |
Ida Micaily, Edik M. Blais, Randi Carhart, Sophia Lam, Steven J. Cohen, Shawna J. Cannaday, David Halverson, Lynn M. Matrisian, Patricia DeArbeloa, Dzung Thach, Emanuel Petricoin, Michael J. Pishvaian, Harish Lavu, Charles J. Yeo, Atrayee Basu Mallick. Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy. JCO Precision Oncology 2023; (7) doi: 10.1200/PO.22.00648
|
| 841 |
Salih Hattapoglu, Elif Hattapoglu. The Radiology of Cancer. 2024; : 185 doi: 10.69860/nobel.9786053359364.15
|
| 842 |
Daniel Closa. Pancreatic cancer, stroma, and exosomes. Journal of Physiology and Biochemistry 2023; 79(1): 205 doi: 10.1007/s13105-022-00898-1
|
| 843 |
Citadel J. Cabasag, Melina Arnold, Mark Rutherford, Aude Bardot, Jacques Ferlay, Eileen Morgan, Alana Little, Prithwish De, Elijah Dixon, Ryan R. Woods, Nathalie Saint-Jacques, Sue Evans, Gerda Engholm, Mark Elwood, Neil Merrett, David Ransom, Dianne L. O’Connell, Freddie Bray, Isabelle Soerjomataram. Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study. British Journal of Cancer 2022; 126(12): 1774 doi: 10.1038/s41416-022-01752-3
|
| 844 |
Songlin Fang, Lezeng Wang, Chunmei Luo, Hang Yi, Xiangrui Wang, Bo Ning. Curcumol inhibits the growth of xenograft-tumors in mice and the biological activities of pancreatic cancer cells by regulating the miR-21-5p/SMAD7 axis. Cell Cycle 2022; 21(12): 1249 doi: 10.1080/15384101.2022.2046983
|
| 845 |
E. Yu. Antonova, I. S. Bazin, A. M. Garin, I. A. Pokataev, I. B. Sagaidak, A. N. Polyakov, Y. E. Chihareva, A. Yu. Volkov, I. V. Bazina. A PARADIGM SHIFT IN THE TREATMENT OF PATIENTS WITH RESECTABLE PANCREATIC CANCER. Siberian journal of oncology 2020; 19(3): 156 doi: 10.21294/1814-4861-2020-19-3-156-163
|
| 846 |
Keinosuke Ishido, Norihisa Kimura, Taiichi Wakiya, Hayato Nagase, Yutaro Hara, Taishu Kanda, Hiroaki Fujita, Kenichi Hakamada. Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma. Annals of Surgical Oncology 2022; 29(2): 1281 doi: 10.1245/s10434-021-10866-6
|
| 847 |
Yangdong Wu, Jianrui Zhou, Qingyan Kou, Lin Sun, Yuan Ma, Tingting Yang, Xiao Hu. Establishment of a Prognostic Model for Pancreatic Cancer Based on Hypoxia-Related Genes. Technology in Cancer Research & Treatment 2024; 23 doi: 10.1177/15330338241288687
|
| 848 |
Beate Haugk, Shreya Raman, Yvonne Bury. Pancreatic pathology: where are we in 2019?. Surgery (Oxford) 2019; 37(6): 310 doi: 10.1016/j.mpsur.2019.03.003
|
| 849 |
Wei Wang, Chun-Fan Jiang, Hai-Sen Yin, Shan Gao, Bao-Ping Yu. Targeting mitochondrial transcription factor A sensitizes pancreatic cancer cell to gemcitabine. Hepatobiliary & Pancreatic Diseases International 2023; 22(5): 519 doi: 10.1016/j.hbpd.2023.03.006
|
| 850 |
FERRAN CORDÓN GRANADOS, MERITXELL SAURA PARRAMON. Cáncer de páncreas. Actualización en Medicina de Familia 2024; : 206 doi: 10.55783/AMF.200404
|
| 851 |
Luoluo Wang, Xiang Wu, Yi Ruan, Xueming Zhang, Xinhua Zhou. Exosome-transmitted hsa_circ_0012634 suppresses pancreatic ductal adenocarcinoma progression through regulating miR-147b/HIPK2 axis. Cancer Biology & Therapy 2023; 24(1) doi: 10.1080/15384047.2023.2218514
|
| 852 |
Yoshitaka Matsumoto, Nobuyoshi Fukumitsu, Hitoshi Ishikawa, Kei Nakai, Hideyuki Sakurai. A Critical Review of Radiation Therapy: From Particle Beam Therapy (Proton, Carbon, and BNCT) to Beyond. Journal of Personalized Medicine 2021; 11(8): 825 doi: 10.3390/jpm11080825
|
| 853 |
Siyuan Tang, Ekta Kapoor, Ling Ding, Ao Yu, Weimin Tang, Yu Hang, Lynette M. Smith, Diptesh Sil, David Oupický. Effect of tocopherol conjugation on polycation-mediated siRNA delivery to orthotopic pancreatic tumors. Biomaterials Advances 2023; 145: 213236 doi: 10.1016/j.bioadv.2022.213236
|
| 854 |
Petro Muraviov, Boris Zaporozhchenko, Igor Borodaev, V.v. Kolodiy, Anatoliy Gorbunov, E.p. Kirpichnikova, Nicolae Bacalbasa, Irina Balescu, Makrem Harhouri. Diagnostic approach and treatment specificity in patients with focal lesions of the biliopancreatic area complicated by mechanical jaundice. Experimental and Therapeutic Medicine 2021; 23(2) doi: 10.3892/etm.2021.11082
|
| 855 |
Kazuki Takakura, Atsushi Kawamura, Yuichi Torisu, Shigeo Koido, Naohisa Yahagi, Masayuki Saruta. The Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer. International Journal of Molecular Sciences 2019; 20(13): 3331 doi: 10.3390/ijms20133331
|
| 856 |
Ye Lu, Min He, Liyou Lian, Huijun Lei, Yongran Cheng, Liangyou Wang, Tianhui Chen, Jinfei Chen. Use of period analysis to provide a timely assessment of 5-year relative survival for pancreatic cancer patients from Taizhou, eastern China. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11119-3
|
| 857 |
Timothy Samuel, Sara Rapic, Cristiana O’Brien, Michael Edson, Yuan Zhong, Ralph S. DaCosta. Quantitative intravital imaging for real-time monitoring of pancreatic tumor cell hypoxia and stroma in an orthotopic mouse model. Science Advances 2023; 9(23) doi: 10.1126/sciadv.ade8672
|
| 858 |
Yi Jin, Eric S. Christenson, Lei Zheng, Keyu Li. Neutrophils in pancreatic ductal adenocarcinoma: bridging preclinical insights to clinical prospects for improved therapeutic strategies. Expert Review of Clinical Immunology 2024; 20(8): 945 doi: 10.1080/1744666X.2024.2348605
|
| 859 |
Daniele Nucci, Omar Enzo Santangelo, Sandro Provenzano, Cristina Fatigoni, Mariateresa Nardi, Pietro Ferrara, Vincenza Gianfredi. Dietary Fiber Intake and Risk of Pancreatic Cancer: Systematic Review and Meta-Analysis of Observational Studies. International Journal of Environmental Research and Public Health 2021; 18(21): 11556 doi: 10.3390/ijerph182111556
|
| 860 |
Iman Abdelhady Elshnoudy, Abdallah M. Elkhouly, Mira Masoud, Hanin A. Rabea, Fotouh R. Mansour. Medicinal plants cultivated in Egypt with anticancer potential; a systematic review. Phytochemistry Reviews 2025; 24(1): 527 doi: 10.1007/s11101-024-09957-5
|
| 861 |
Sophia Tsokkou, Ioannis Konstantinidis, Maria-Nefeli Georgaki, Dimitrios Kavvadas, Kyriaki Papadopoulou, Antonios Keramas, Antonia Sioga, Theodora Papamitsou, Sofia Karachrysafi. Gestational Diabetes Mellitus and Its Correlation in the Development of Pancreatic Cancer: A 10-Year Systematic Review. Cancers 2024; 16(10): 1840 doi: 10.3390/cancers16101840
|
| 862 |
Jinghao Lei, Qiang Wang, Tengfei Qu, Lichao Cha, Hanxiang Zhan, Jianwei Xu, Shanglong Liu, Lantian Tian, Chuandong Sun, Jingyu Cao, Fabo Qiu, Weidong Guo, Bin Zhou. KCNH2 regulates the growth and metastasis of pancreatic cancer. Journal of Pancreatology 2023; 6(3): 101 doi: 10.1097/JP9.0000000000000123
|
| 863 |
Jing Zhou, Shuyan Qie, Hongjuan Fang, Jianing Xi. MiR-487a-3p suppresses the malignant development of pancreatic cancer by targeting SMAD7. Experimental and Molecular Pathology 2020; 116: 104489 doi: 10.1016/j.yexmp.2020.104489
|
| 864 |
Reef Einoch Amor, Assaf Zinger, Yoav Y. Broza, Avi Schroeder, Hossam Haick. Artificially Intelligent Nanoarray Detects Various Cancers by Liquid Biopsy of Volatile Markers. Advanced Healthcare Materials 2022; 11(17) doi: 10.1002/adhm.202200356
|
| 865 |
Albert J. Farias, Samantha A. Streicher, Daniel O. Stram, Songren Wang, Stephen J. Pandol, Loïic Le Marchand, Veronica W. Setiawan. Racial/ethnic disparities in weight or BMI change in adulthood and pancreatic cancer incidence: The multiethnic cohort. Cancer Medicine 2021; 10(12): 4097 doi: 10.1002/cam4.3958
|
| 866 |
Laura Zeppa, Cristina Aguzzi, Giorgia Versari, Margherita Luongo, Maria Beatrice Morelli, Federica Maggi, Consuelo Amantini, Giorgio Santoni, Oliviero Marinelli, Massimo Nabissi. Evening Primrose Oil Improves Chemotherapeutic Effects in Human Pancreatic Ductal Adenocarcinoma Cell Lines—A Preclinical Study. Pharmaceuticals 2022; 15(4): 466 doi: 10.3390/ph15040466
|
| 867 |
Emin Gayibov, Tomáš Sychra, Alžběta Spálenková, Pavel Souček, Martin Oliverius. The use of patient-derived xenografts and patient-derived organoids in the search for new therapeutic regimens for pancreatic carcinoma. A review. Biomedicine & Pharmacotherapy 2025; 182: 117750 doi: 10.1016/j.biopha.2024.117750
|
| 868 |
Qiqian Liu, Hui Liu, Audrey Griveau, Xiaowu Li, Joel Eyer, Celia Arib, Jolanda Spadavecchia. NFL-TBS.40-63 Peptide Gold Complex Nanovector: A Novel Therapeutic Approach to Increase Anticancer Activity by Breakdown of Microtubules in Pancreatic Adenocarcinoma (PDAC). ACS Pharmacology & Translational Science 2022; 5(12): 1267 doi: 10.1021/acsptsci.2c00159
|
| 869 |
Yufei Chen, Chao Ma, Panpan Yang, Kuanzheng Mao, Yisha Gao, Luguang Chen, Zhen Wang, Yun Bian, Chengwei Shao, Jianping Lu. Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12934-y
|
| 870 |
Nannan Yang, Lin Liu, Xiaoyu Liu, Yingjie Chen, Jian Lu, Zhongmin Wang, Wen Shi. hnRNPC Promotes Malignancy in Pancreatic Cancer through Stabilization of IQGAP3. BioMed Research International 2022; 2022(1) doi: 10.1155/2022/6319685
|
| 871 |
Geir Hetland, Jon-Magnus Tangen, Faiza Mahmood, Mohammad Reza Mirlashari, Lise Sofie Haug Nissen-Meyer, Ivo Nentwich, Stig Palm Therkelsen, Geir Erland Tjønnfjord, Egil Johnson. Antitumor, Anti-inflammatory and Antiallergic Effects of Agaricus blazei Mushroom Extract and the Related Medicinal Basidiomycetes Mushrooms, Hericium erinaceus and Grifola frondosa: A Review of Preclinical and Clinical Studies. Nutrients 2020; 12(5): 1339 doi: 10.3390/nu12051339
|
| 872 |
Jia Chen, Dongting Yao, Weiqin Chen, Zhen Li, Yuanyuan Guo, Fan Zhu, Xiaobo Hu. Serum exosomal miR-451a acts as a candidate marker for pancreatic cancer. The International Journal of Biological Markers 2022; 37(1): 74 doi: 10.1177/17246008211070018
|
| 873 |
Arezou Sayad, Sajad Najafi, Bashdar Mahmud Hussen, Elena Jamali, Mohammad Taheri, Soudeh Ghafouri-Fard. The role of circular RNAs in pancreatic cancer: new players in tumorigenesis and potential biomarkers. Pathology - Research and Practice 2022; 232: 153833 doi: 10.1016/j.prp.2022.153833
|
| 874 |
Michael T. Zimmermann, Angela J. Mathison, Tim Stodola, Douglas B. Evans, Jenica L. Abrudan, Wendy Demos, Michael Tschannen, Mohammed Aldakkak, Jennifer Geurts, Gwen Lomberk, Susan Tsai, Raul Urrutia. Interpreting Sequence Variation in PDAC-Predisposing Genes Using a Multi-Tier Annotation Approach Performed at the Gene, Patient, and Cohort Level. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.606820
|
| 875 |
Tommaso Schepis, Sara Sofia De Lucia, Antonio Pellegrino, Angelo del Gaudio, Rossella Maresca, Gaetano Coppola, Michele Francesco Chiappetta, Antonio Gasbarrini, Francesco Franceschi, Marcello Candelli, Enrico Celestino Nista. State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine. Cancers 2023; 15(13): 3423 doi: 10.3390/cancers15133423
|
| 876 |
Ruchi Singhal, Sherise C Rogers, Ji-Hyun Lee, Brian Ramnaraign, Ilyas Sahin, Jesus C Fabregas, Ryan M. Thomas, Steven J Hughes, Ibrahim Nassour, Kathryn Hitchcock, Karen Russell, Omar Kayaleh, Anita Turk, Robert Zlotecki, David L DeRemer, Thomas J George. A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma. Future Oncology 2023; 19(27): 1843 doi: 10.2217/fon-2023-0256
|
| 877 |
Akihiro Tamaki, Takuya Kato, Yasutaka Sakurai, Keita Sato, Kai Adachi, Masayoshi Tadehara, Taro Kogami, Masahiro Matsushita, Akiyoshi Hoshino, Itaru Sanoyama, Yoshiko Numata, Atsuko Umezawa, Masaaki Ichinoe, Masatoshi Ichihara, Chika Kusano, Yoshiki Murakumo. REV7 is involved in outcomes of platinum‐based chemotherapy in pancreatic cancer by controlling the DNA damage response. Cancer Science 2024; 115(2): 660 doi: 10.1111/cas.16044
|
| 878 |
Yoshiko Tsuji, Tomoaki Hara, Sikun Meng, Hiromichi Sato, Yasuko Arao, Ken Ofusa, Hideshi Ishii. Role of RNA methylation in the regulation of pancreatic cancer stem cells (Review). Oncology Letters 2023; 26(2) doi: 10.3892/ol.2023.13922
|
| 879 |
Vahideh Hamidi-Sofiani, Reza Rakhshi, Niloufar Moradi, Parisa Zeynali, Mohsen Nakhaie, Emad Behboudi. Oncolytic viruses and pancreatic cancer. Cancer Treatment and Research Communications 2022; 31: 100563 doi: 10.1016/j.ctarc.2022.100563
|
| 880 |
Wenjie Shi, Chen Li, Thomas Wartmann, Christoph Kahlert, Renfei Du, Aristotelis Perrakis, Thomas Brunner, Roland S. Croner, Ulf D. Kahlert. Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents. Journal of Personalized Medicine 2022; 12(3): 478 doi: 10.3390/jpm12030478
|
| 881 |
Faez Falah Alshehri. Integrative bioinformatics analysis to decipher common pathogenic processes in type 2 diabetes mellitus and pancreatic cancer. Journal of Taibah University for Science 2024; 18(1) doi: 10.1080/16583655.2024.2420468
|
| 882 |
Huahui Zeng, Xin Zhu, Qikang Tian, Yinyin Yan, Lan Zhang, Min Yan, Ruiqin Li, Xiaofang Li, Guoqiang Wang, Jinlian Ma, Yufang Su, Xiangbo Zhang, Linyu Ma, Zhenqiang Zhang, Xiangxiang Wu.
In vivo
antitumor effects of carboxymethyl chitosan-conjugated triptolide after oral administration
. Drug Delivery 2020; 27(1): 848 doi: 10.1080/10717544.2020.1770370
|
| 883 |
Ling-Fang Hsu, Yun-Hsiang Lee, Hui-Ying Yang, Yun-Jen Chou, Yu-Wen Tien, Chieh-Yu Liu, Shiow-Ching Shun. Changes in nutritional status and fatigue and their associations with quality of life in patients with pancreatic cancer after surgery: A 12-month longitudinal study. Applied Nursing Research 2024; 80: 151858 doi: 10.1016/j.apnr.2024.151858
|
| 884 |
Flavien Bessaguet, Alexis Desmoulière. Le pancréas. Actualités Pharmaceutiques 2021; 60(607): 55 doi: 10.1016/j.actpha.2021.03.037
|
| 885 |
Shao-Cheng Lyu, Han-Xuan Wang, Ze-Ping Liu, Jing Wang, Jin-Can Huang, Qiang He, Ren Lang. Clinical value of extended lymphadenectomy in radical surgery for pancreatic head carcinoma at different T stages. World Journal of Gastrointestinal Surgery 2022; 14(11): 1204-1218 doi: 10.4240/wjgs.v14.i11.1204
|
| 886 |
Yoghalakshmi Nagarajan, Natarajan Chandrasekaran, Venkatachalam Deepa Parvathi. Functionalized Nanomaterials In Pancreatic Cancer Theranostics And Molecular Imaging. ChemistryOpen 2025; 14(1) doi: 10.1002/open.202400232
|
| 887 |
Sílvia M. Torres, Francisca P. Carmo, Luís C. Monteiro, Cláudia Silva, Nelson Andrade, Fátima Martel. Gallic acid markedly stimulates GLUT1-mediated glucose uptake by the AsPC-1 pancreatic cancer cell line. Canadian Journal of Physiology and Pharmacology 2023; 101(2): 90 doi: 10.1139/cjpp-2022-0260
|
| 888 |
Dhruv Sanjay Gupta, Daksh Sanjay Gupta, Saritha R. Shetty. Biosimilars for Cancer Treatment. 2024; : 157 doi: 10.1007/978-981-97-3001-8_9
|
| 889 |
Anthony D. Nehlsen, Karyn A. Goodman. Controversies in radiotherapy for pancreas cancer. Journal of Surgical Oncology 2021; 123(6): 1460 doi: 10.1002/jso.26313
|
| 890 |
Ziyan Cui, Zegao Zhou, Ziyan Sun, Jiayue Duan, Runtian Liu, Cheng Qi, Changqing Yan. Melittin and phospholipase A2: Promising anti-cancer candidates from bee venom. Biomedicine & Pharmacotherapy 2024; 179: 117385 doi: 10.1016/j.biopha.2024.117385
|
| 891 |
Hoang Quan Nguyen, Ngoc Trinh Thi Pham, Van Trung Hoang, Hoang Anh Thi Van, Chinh Huynh, Duc Thanh Hoang, Mauro Cives. Diffuse Pancreatic Carcinoma with Hepatic Metastases. Case Reports in Oncological Medicine 2020; 2020: 1 doi: 10.1155/2020/8815745
|
| 892 |
Defeng Sun, Tu dai, Yuan Ji, Weibo Shen, Wuyang Bian. COL11A1‐driven positive feedback loop modulates fibroblast transformation and activates pancreatic cancer progression. Cell Biology International 2023; 47(6): 1081 doi: 10.1002/cbin.12009
|
| 893 |
Konstantin Schlick, Dominik Kiem, Florian Huemer, Daniel Neureiter, Lukas Weiss, Richard Greil. Non-pegylated Liposomal Doxorubicin as Palliative Chemotherapy in pre-Treated Advanced Pancreatic Cancer: A Retrospective Analysis of Twenty-Eight Patients. Technology in Cancer Research & Treatment 2021; 20 doi: 10.1177/15330338211042139
|
| 894 |
Abakundana Nsenga Ariston Gabriel, Qinlian Jiao, Umwali Yvette, Xuemei Yang, Samed A. Al-Ameri, Lutao Du, Yun-shan Wang, Chuanxin Wang. Differences between KC and KPC pancreatic ductal adenocarcinoma mice models, in terms of their modeling biology and their clinical relevance. Pancreatology 2020; 20(1): 79 doi: 10.1016/j.pan.2019.11.006
|
| 895 |
Yuting Zhang, Huan He, Lanying He, Bing Shi. IL-6 Accelerates the Proliferation and Metastasis of Pancreatic Cancer Cells via the miR-455-5p/IGF-1R Axis. Cancer Biotherapy and Radiopharmaceuticals 2024; 39(4): 255 doi: 10.1089/cbr.2022.0045
|
| 896 |
Tiffany R. Sanchez, Yaa Asantewaa Kafui Klu, Jeanine M. Genkinger, James V. Lacey, Nadia T. Chung, Ana Navas-Acien. Association between rice consumption and risk of cancer incidence in the California Teachers Study. Cancer Causes & Control 2020; 31(12): 1129 doi: 10.1007/s10552-020-01350-9
|
| 897 |
Deepak Rohila, In Hwan Park, Timothy V. Pham, Jonathan Weitz, Tatiana Hurtado de Mendoza, Suresh Madheswaran, Mehreen Ishfaq, Cooper Beaman, Elisabette Tapia, Siming Sun, Jay Patel, Pablo Tamayo, Andrew M. Lowy, Shweta Joshi. Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma. Cancer Research 2023; 83(16): 2675 doi: 10.1158/0008-5472.CAN-22-3645
|
| 898 |
Aleš Dvořák, Miroslav Souček. New onset of diabetes mellitus and weight loss as a manifestation of pancreatic cancer. Vnitřní lékařství 2022; 68(6): E23 doi: 10.36290/vnl.2022.087
|
| 899 |
Kento Kuzuu, Noboru Misawa, Keiichi Ashikari, Shigeki Tamura, Shingo Kato, Kunihiro Hosono, Masato Yoneda, Takashi Nonaka, Shozo Matsushima, Tatsuji Komatsu, Atsushi Nakajima, Takuma Higurashi. Changes in the Number of Gastrointestinal Cancers and Stage at Diagnosis with COVID-19 Pandemic in Japan: A Multicenter Cohort Study. Cancers 2023; 15(17): 4410 doi: 10.3390/cancers15174410
|
| 900 |
Chengyan Wei, Chunwei Zhang, Yuanzhi Zhou, Jingjing Wang, Yong Jin. Progress of Exosomal LncRNAs in Pancreatic Cancer. International Journal of Molecular Sciences 2024; 25(16): 8665 doi: 10.3390/ijms25168665
|
| 901 |
Naga Sai Rasagna Mareddy, Mohana Chakkera. Immune Therapy for Pancreatic and Colon Cancers. 2025; : 23 doi: 10.1016/B978-0-443-24742-2.00016-2
|
| 902 |
Jiahong Jiang, Yaping Xu, Lianpeng Chang, Guoqing Ru, Xuefeng Xia, Ling Yang, Xin Yi, Zheling Chen, Dong-Sheng Huang, Liu Yang. Genomic Landscape in Neoplasm-Like Stroma Reveals Distinct Prognostic Subtypes of Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.771247
|
| 903 |
Jaroslav Tumas, Birute Tumiene, Jolita Jurkeviciene, Eugenijus Jasiunas, Audrius Sileikis. Nutritional and immune impairments and their effects on outcomes in early pancreatic cancer patients undergoing pancreatoduodenectomy. Clinical Nutrition 2020; 39(11): 3385 doi: 10.1016/j.clnu.2020.02.029
|
| 904 |
Hengqing Zhu, Qing Li, Yulan Zhao, Hong Peng, Liangyun Guo, Jing Zhu, Zi Jiang, Zhaoxia Zeng, Bin Xu, Sisi Chen. Vaccinia-related kinase 2 drives pancreatic cancer progression by protecting Plk1 from Chfr-mediated degradation. Oncogene 2021; 40(28): 4663 doi: 10.1038/s41388-021-01893-4
|
| 905 |
Shahin Ahmadi, Shahram Lotfi, Ali Azimi, Parvin Kumar. Multicellular target QSAR models for predicting of novel inhibitors against pancreatic cancer by Monte Carlo approach. Results in Chemistry 2024; 10: 101734 doi: 10.1016/j.rechem.2024.101734
|
| 906 |
Erbo Liang, Yishi Lu, Yanqiang Shi, Qian Zhou, Fachao Zhi. MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity. Oncogene 2020; 39(41): 6437 doi: 10.1038/s41388-020-01443-4
|
| 907 |
Mengjiao Fan, Yue Ma, Guochao Deng, Haiyan Si, Ru Jia, Zhikuan Wang, Guanghai Dai. A real-world analysis of second-line treatment option, gemcitabine plus anlotinib and anti-PD1, in advanced pancreatic cancer. Pancreatology 2024; 24(4): 579 doi: 10.1016/j.pan.2024.03.017
|
| 908 |
James R. Bundred, Sivesh K. Kamarajah, John S. Hammond, Colin H. Wilson, James Prentis, Sanjay Pandanaboyana. Prehabilitation prior to surgery for pancreatic cancer: A systematic review. Pancreatology 2020; 20(6): 1243 doi: 10.1016/j.pan.2020.07.411
|
| 909 |
Magdalena Boćkowska, Przemysław Kostro, Zbigniew Kamocki. Phase Angle and Postoperative Complications in a Model of Immunonutrition in Patients with Pancreatic Cancer. Nutrients 2023; 15(20): 4328 doi: 10.3390/nu15204328
|
| 910 |
Giorgia Arcovito, Iosè Di Stefano, Laura Boldrini, Francesca Manassero, Jacopo Durante, Alessio Tognarelli, Pinuccia Faviana. Unusual Case of Pancreatic Adenocarcinoma with Bladder Metastasis. Medicina 2020; 56(12): 708 doi: 10.3390/medicina56120708
|
| 911 |
Vimal Arora, Dinesh Kumar Chellappan, Krishnan Anand, Harish Dureja. Advanced Drug Delivery Systems in the Management of Cancer. 2021; : 243 doi: 10.1016/B978-0-323-85503-7.00030-4
|
| 912 |
Florentine E. F. Timmer, Bart Geboers, Sanne Nieuwenhuizen, Evelien A. C. Schouten, Madelon Dijkstra, Jan J. J. de Vries, M. Petrousjka van den Tol, Martijn R. Meijerink, Hester J. Scheffer. Locoregional Treatment of Metastatic Pancreatic Cancer Utilizing Resection, Ablation and Embolization: A Systematic Review. Cancers 2021; 13(7): 1608 doi: 10.3390/cancers13071608
|
| 913 |
Dong Han, Fei Gao, Jin Long Liu, Hao Wang, Qi Fu, Guo Wang Yang. Analysis of radiotherapy impact on survival in resected stage I/II pancreatic cancer patients: a population-based study. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08288-4
|
| 914 |
Mukesh Jogi, Hitakshi Asnani, Sohini Singh, Pramod Kumar. Nimbolide: A Potential Phytochemical Agent in Multimodal Pancreatic Cancer Therapies. Mini-Reviews in Medicinal Chemistry 2025; 25(1): 27 doi: 10.2174/0113895575293138240527061556
|
| 915 |
Mundla Srilatha, Ramarao Malla, Megha Priya Adem, Jeremy B. Foote, Ganji Purnachandra Nagaraju. Obesity associated pancreatic ductal adenocarcinoma: Therapeutic challenges. Seminars in Cancer Biology 2023; 97: 12 doi: 10.1016/j.semcancer.2023.11.002
|
| 916 |
Siyuan Tan, Haodong Tang, Zheng Zhang, Yang Wang, Haifeng Li, Wenyuan Shi, Hao Ye, Peng Xie, Jiahua Zhou. Identification of Transcriptomic Signatures of Pancreatic Ductal Adenocarcinoma–Derived Exosomes That Promote Macrophage M2 Polarization and Predict Prognosis: S100A9 Reveals Tumor Progression. Clinical Medicine Insights: Oncology 2024; 18 doi: 10.1177/11795549241239042
|
| 917 |
Fumika Horinuki, Yumiko Saito, Chikako Yamaki, Yasushi Toh, Tomoko Takayama. Healthcare professionals roles in pancreatic cancer care: patient and family views and preferences. BMJ Supportive & Palliative Care 2024; 14(e3): e2922 doi: 10.1136/spcare-2024-004921
|
| 918 |
Tomás P. Griffin, Aonghus O'Loughlin, Sean F. Dinneen. Clinical Dilemmas in Diabetes. 2021; : 45 doi: 10.1002/9781119603207.ch4
|
| 919 |
Rasoul Rahimi, Seyed Mahmood Reza Hashemi Rafsanjani, Saeid Heidari-Soureshjani, Catherine Mary Turner Sherwin, Karamali Kasiri. The Association between use of Renin-Angiotensin-Aldosterone System Inhibitors and the Risk and Mortality of Pancreatic Cancer: A Systematic Review and Meta-Analysis. Current Reviews in Clinical and Experimental Pharmacology 2025; 20(1): 60 doi: 10.2174/0127724328291047240409062436
|
| 920 |
John Silke, Lorraine Ann O’Reilly. NF-κB and Pancreatic Cancer; Chapter and Verse. Cancers 2021; 13(18): 4510 doi: 10.3390/cancers13184510
|
| 921 |
Christopher C. Attaway, Zhaohai Yang, Roseann I. Wu. Diversity and pitfalls of pancreatic neuroendocrine tumors: A case series of cytologic-histologic correlation. Human Pathology Reports 2022; 28: 300630 doi: 10.1016/j.hpr.2022.300630
|
| 922 |
Young Hoon Choi, Tae Ho Hong, Seung Bae Yoon, In Seok Lee, Myung Ah Lee, Ho Joong Choi, Moon Hyung Choi, Eun Sun Jung. Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer. Biomedicines 2022; 10(6): 1289 doi: 10.3390/biomedicines10061289
|
| 923 |
ZhiYu Zhao, Wei Liu. Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033820962117
|
| 924 |
Ylenia Nodari, Manuel Gentiluomo, Beatrice Mohelnikova-Duchonova, Edita Kreivenaite, Anna Caterina Milanetto, Jurgita Skieceviciene, Stefano Landi, Rita T Lawlor, Maria Chiara Petrone, Paolo Giorgio Arcidiacono, Martin Lovecek, Maria Gazouli, Maarten F. Bijlsma, Luca Morelli, Vytautas Kiudelis, Matteo Tacelli, Dalila Lucíola Zanette, Pavel Soucek, Faik Uzunoglu, Rudolf Kaaks, Jakob Izbicki, Ugo Boggi, Raffaele Pezzilli, Andrea Mambrini, Claudio Pasquali, Hanneke W. van Laarhoven, Verena Katzke, Giulia Martina Cavestro, Cosimo Sperti, Martin Loos, Anna Latiano, Bálint Erőss, Martin Oliverius, Theron Johnson, Daniela Basso, John P. Neoptolemos, Mateus Nóbrega Aoki, William Greenhalf, Pavel Vodicka, Livia Archibugi, Giuseppe Vanella, Maurizio Lucchesi, Renata Talar-Wojnarowska, Krzysztof Jamroziak, Mohammed Al Saeedi, Casper H.J. van Eijck, Juozas Kupcinskas, Tamás Hussein, Marta Puzzono, Stefania Bunduc, Mara Götz, Silvia Carrara, Andrea Szentesi, Francesca Tavano, Stefania Moz, Péter Hegyi, Claudio Luchini, Gabriele Capurso, Francesco Perri, Stefano Ermini, George Theodoropoulos, Giovanni Capretti, Orazio Palmieri, Laura Ginocchi, Niccolò Furbetta, Federico Canzian, Daniele Campa. Genetic and non-genetic risk factors for early-onset pancreatic cancer. Digestive and Liver Disease 2023; 55(10): 1417 doi: 10.1016/j.dld.2023.02.023
|
| 925 |
Marika Franczak, Barbara Kutryb-Zajac, Btissame El Hassouni, Elisa Giovannetti, Carlotta Granchi, Filippo Minutolo, Ryszard T. Smolenski, Godefridus J. Peters. The effect of lactate dehydrogenase-A inhibition on intracellular nucleotides and mitochondrial respiration in pancreatic cancer cells. Nucleosides, Nucleotides & Nucleic Acids 2022; 41(12): 1375 doi: 10.1080/15257770.2022.2031215
|
| 926 |
Yuting Guo, She Tian, Haiyang Li, Shi Zuo, Chao Yu, Chengyi Sun. Transcription factor KLF9 inhibits the proliferation, invasion, and migration of pancreatic cancer cells by repressing KIAA1522. Asia-Pacific Journal of Clinical Oncology 2024; 20(3): 423 doi: 10.1111/ajco.14048
|
| 927 |
Jindan Li, Chaojiang Fu, Sheng Zhao, Yongzhu Pu, Fake Yang, Shuguang Zeng, Conghui Yang, Hongqiang Gao, Long Chen. The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.920896
|
| 928 |
Alexander S. Rosemurgy, Sharona Ross, Kenneth Luberice, Harrison Browning, Iswanto Sucandy. Robotic Pancreatic Surgery for Solid, Cystic, and Mixed Lesions. Surgical Clinics of North America 2020; 100(2): 303 doi: 10.1016/j.suc.2019.12.006
|
| 929 |
X. Fernandes Miguel, M. Padrón José. Inhibition of Glutamine Metabolism as a Therapeutic Approach Against Pancreatic Ductal Adenocarcinoma. Journal of Molecular and Clinical Medicine 2019; 2(4) doi: 10.31083/j.jmcm.2019.04.5121
|
| 930 |
Fortunato Cassalia, Anna Bolzon, Monica Ponzano, Laura Ventura, Andrea Danese, Paolo Del Fiore, Anna Belloni Fortina, Elio Jovine, Giampaolo Perri, Umberto Cillo, Giovanni Marchegiani. The Importance of Reading the Skin: Cutaneous Metastases of Pancreatic Cancer, a Systematic Review. Journal of Clinical Medicine 2023; 13(1): 104 doi: 10.3390/jcm13010104
|
| 931 |
Xin Luo, Bo Yu, Nan Jiang, Qiong Du, Xuan Ye, Huan Li, Wen-Quan Wang, Qing Zhai. Chemotherapy-Induced Reduction of Neutrophil-to-Lymphocyte Ratio Is Associated With Better Survival in Pancreatic Adenocarcinoma: A Meta-Analysis. Cancer Control 2020; 27(1) doi: 10.1177/1073274820977135
|
| 932 |
Kunpeng Wang, Xiongying Miao, Fanhua Kong, Siqi Huang, Jinggang Mo, Chong Jin, Yanwen Zheng. Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pancreatic Cancer Treatment. Drug Design, Development and Therapy 2021; : 3749 doi: 10.2147/DDDT.S323360
|
| 933 |
Chun‐Lin Yang, Yi‐Wen Wu, Huang‐Ju Tu, Yun‐Hsuan Yeh, Tony Eight Lin, Tzu‐Ying Sung, Mu‐Chun Li, Shih‐Chung Yen, Jui‐Hua Hsieh, Ming‐Chin Yu, Sen‐Yung Hsieh, Hsing‐Pang Hsieh, Shiow‐Lin Pan, Kai‐Cheng Hsu. Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer Using Structure‐Based Virtual Screening. Advanced Science 2025; doi: 10.1002/advs.202416323
|
| 934 |
Alexandru Constantinescu, Oana‐Mihaela Plotogea, Mădălina Stan‐Ilie, Tudorel Ciurea, Dan Ionut Gheonea, Bogdan Silviu Ungureanu, Gheorghe Bălan, Ecaterina Rinja, Nikola Panic, Vasile Şandru, Gabriel Constantinescu. Impact of biliary stenting in endoscopic ultrasound‐guided tissue acquisition among patients with pancreatic cancer. Journal of Clinical Ultrasound 2022; 50(6): 844 doi: 10.1002/jcu.23186
|
| 935 |
Nurbanu Demirtürk, Erem Bilensoy. Nanocarriers targeting the diseases of the pancreas. European Journal of Pharmaceutics and Biopharmaceutics 2022; 170: 10 doi: 10.1016/j.ejpb.2021.11.006
|
| 936 |
Jiaqi Chen, Hui Chen, Tongchao Zhang, Xiaolin Yin, Jinyu Man, Xiaorong Yang, Ming Lu. Burden of pancreatic cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030. Pancreatology 2022; 22(5): 608 doi: 10.1016/j.pan.2022.04.011
|
| 937 |
Md. Hafiz Uddin, Md. Najeeb Al-Hallak, Philip A. Philip, Herbert Chen, Bassel El-Rayes, Asfar S. Azmi. Aberrant transcription factors in the cancers of the pancreas. Seminars in Cancer Biology 2022; 86: 28 doi: 10.1016/j.semcancer.2022.08.011
|
| 938 |
Gloria Perazzoli, Olga M. García-Valdeavero, Mercedes Peña, Jose Prados, Consolación Melguizo, Cristina Jiménez-Luna. Evaluating Metabolite-Based Biomarkers for Early Diagnosis of Pancreatic Cancer: A Systematic Review. Metabolites 2023; 13(7): 872 doi: 10.3390/metabo13070872
|
| 939 |
Beata Jabłońska, Robert Król, Sławomir Mrowiec. Vascular Resection in Pancreatectomy—Is It Safe and Useful for Patients with Advanced Pancreatic Cancer?. Cancers 2022; 14(5): 1193 doi: 10.3390/cancers14051193
|
| 940 |
Borna A Assarian, Christopher D Byrne, Declan McDonnell, Zaed Hamady. Physical Activity and Incident Pancreatic Cancer: Results From the UK Biobank Prospective Cohort. Cureus 2025; doi: 10.7759/cureus.78040
|
| 941 |
Alberto Meyer, Bárbara J Carvalho, Kayo AA Medeiros, Leonardo Z Pipek, Fernanda S Nascimento, Milena O Suzuki, João VT Munhoz, Leandro R Iuamoto, Luiz A Carneiro-D'Alburquerque, Wellington Andraus. Change in neoadjuvant chemotherapy could alter the prognosis of patients with pancreatic adenocarcinoma: A case report. World Journal of Clinical Cases 2021; 9(14): 3418-3423 doi: 10.12998/wjcc.v9.i14.3418
|
| 942 |
Soraya Hernández-Hatibi, Pedro Enrique Guerrero, José Manuel García-Aznar, Elena García-Gareta. Polydopamine Interfacial Coating for Stable Tumor-on-a-Chip Models: Application for Pancreatic Ductal Adenocarcinoma. Biomacromolecules 2024; 25(8): 5169 doi: 10.1021/acs.biomac.4c00551
|
| 943 |
Marco Spadaccini, Glenn Koleth, James Emmanuel, Kareem Khalaf, Antonio Facciorusso, Fabio Grizzi, Cesare Hassan, Matteo Colombo, Benedetto Mangiavillano, Alessandro Fugazza, Andrea Anderloni, Silvia Carrara, Alessandro Repici. Enhanced endoscopic ultrasound imaging for pancreatic lesions: The road to artificial intelligence. World Journal of Gastroenterology 2022; 28(29): 3814-3824 doi: 10.3748/wjg.v28.i29.3814
|
| 944 |
Yusheng Chen, Xuan Lin, Xuan Zou, Yunzhen Qian, Yu Liu, Ruijie Wang, Xu Wang, Xianjun Yu, Chen Liu, He Cheng. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02748-w
|
| 945 |
Smriti Kochhar, Allison Zuckerberg, Mariusz Kocur, Veera Jayasree Latha Bommu, Ifeanyi Ikwuanusi, Thomas Lake, Harrison Cotler, Pramil Cheriyath. A Unique Case of Exploratory Laparotomy in the Setting of Large Bowel Obstruction Led to the Detection of Pancreatic Carcinoma. Cureus 2022; doi: 10.7759/cureus.21565
|
| 946 |
Chen Luo, Yi Yu, Jinfeng Zhu, Leifeng Chen, Dan Li, Xingyu Peng, Zitao Liu, Qing Li, Qing Cao, Kai Huang, Rongfa Yuan. Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 degradation. Cell & Bioscience 2024; 14(1) doi: 10.1186/s13578-024-01213-9
|
| 947 |
Bowen Liu, Chengbin Dong, Quan Chen, Zhenhua Fan, Yu Zhang, Yifan Wu, Ting Cui, Fuquan Liu. Circ_0007534 as new emerging target in cancer: Biological functions and molecular interactions. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1031802
|
| 948 |
Qisthina Syifa Setiawan, Zuherman Rustam, Sri Hartini, Velery Virgina Putri Wibowo, Jane Eva Aurelia. Comparing Decision Tree and Logistic Regression for Pancreatic Cancer Classification. 2020 International Conference on Decision Aid Sciences and Application (DASA) 2020; : 623 doi: 10.1109/DASA51403.2020.9317036
|
| 949 |
Sridevi Mardham, Soumya Dakshinamurthy. Immune Therapy for Pancreatic and Colon Cancers. 2025; : 325 doi: 10.1016/B978-0-443-24742-2.00001-0
|
| 950 |
Min Young Park, Woohyung Lee, Jaewoo Kwon, Ki Byung Song, Dae Wook Hwang, Jae Hoon Lee, Song Cheol Kim. Comparison of perioperative outcomes in pancreatic head cancer patients following either a laparoscopic or open pancreaticoduodenectomy with a superior mesenteric artery first approach. Annals of Hepato-Biliary-Pancreatic Surgery 2021; 25(3): 358 doi: 10.14701/ahbps.2021.25.3.358
|
| 951 |
Xiaohu Zeng, Xin Zhu, Qikang Tian, Xiaoke Tan, Ning Sun, Min Yan, Junwei Zhao, Xiangxiang Wu, Ruiqin Li, Zhenqiang Zhang, Huahui Zeng. Celastrol-conjugated chitosan oligosaccharide for the treatment of pancreatic cancer. Drug Delivery 2022; 29(1): 89 doi: 10.1080/10717544.2021.2018521
|
| 952 |
Rodrigo Villaseñor-Echavarri, Javier Melchor-Ruan, Mercedes Aranda-Audelo, Gabriela Arredondo-Saldaña, Patricia Volkow-Fernandez, Maria del Carmen Manzano-Robleda, Alejandro E Padilla-Rosciano, Diana Vilar-Compte. Surgical site infection following pancreaticoduodenectomy in a referral cancer center in Mexico. Hepatobiliary & Pancreatic Diseases International 2024; 23(5): 502 doi: 10.1016/j.hbpd.2023.04.004
|
| 953 |
Selvaraj Jayaraman, Bhuvaneswari Ponnusamy, Ponnulakshmi Rajagopal, S. Gowtham Kumar, Kirubhanand Chandrasekar. Handbook of Animal Models and its Uses in Cancer Research. 2023; : 777 doi: 10.1007/978-981-19-3824-5_39
|
| 954 |
Kei Yamane, Takayuki Anazawa, Kazuyuki Nagai, Yosuke Kasai, Toshihiko Masui, Aya Izuwa, Koki Kurahashi, Satoshi Ishida, Satoshi Ogiso, Michio Yoshimura, Takahiro Iwai, Junichi Matsubara, Akihisa Fukuda, Hiroyoshi Isoda, Yu Hidaka, Yumiko Ibi, Etsuro Hatano. Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery for Resectable Pancreatic Cancer: A Retrospective Cohort Study. Annals of Surgical Oncology 2025; doi: 10.1245/s10434-025-16956-z
|
| 955 |
Daniela Paasch, Nico Lachmann. CAR macrophages tuning the immune symphony of anti-cancer therapies. Cell Stem Cell 2024; 31(6): 791 doi: 10.1016/j.stem.2024.05.006
|
| 956 |
Cheng‐Bin Yang, Si‐Nan Lu, Cai Lu, Ming‐Ming Xu, Jin‐Ao Duan, Chun‐Tao Che, Junfei Zhou, Ming Zhao. A New C22‐Quassinoid with Anti‐Pancreatic Adenocarcinoma Activity from Seeds of Brucea javanica. Chemistry & Biodiversity 2022; 19(6) doi: 10.1002/cbdv.202101004
|
| 957 |
Julie Bulsei, Andrea Chierici, Marco Alifano, Antonio Castaldi, Céline Drai, Serena De Fatico, Edoardo Rosso, Eric Fontas, Antonio Iannelli. Bariatric surgery reduces the risk of pancreatic cancer in individuals with obesity before the age of 50 years: A nationwide administrative data study in France. European Journal of Surgical Oncology 2023; 49(4): 788 doi: 10.1016/j.ejso.2022.11.013
|
| 958 |
Yu-Meng Qin, Jie Sha. Progress in understanding of relationship between intestinal microecology and pancreatic cancer. World Chinese Journal of Digestology 2023; 31(24): 1001 doi: 10.11569/wcjd.v31.i24.1001
|
| 959 |
Miltiadis Tsesmelis, Kanishka Tiwary, Katja Steiger, Nadine Sperb, Melanie Gerstenlauer, Uta Manfras, Harald Maier, Patrick Hermann, Lap Chan, Thomas Wirth. Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice. Cancers 2021; 13(18): 4541 doi: 10.3390/cancers13184541
|
| 960 |
Peng Dong, Yu Yan, Yujun Fan, Hui Wang, Danzhu Wu, Liyuan Yang, Junpeng Zhang, Xiaoyang Yin, Yajuan Lv, Jiandong Zhang, Yuzhu Hou, Fengjun Liu, Xinshuang Yu. The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer. Technology in Cancer Research & Treatment 2022; 21 doi: 10.1177/15330338221142472
|
| 961 |
Olga Partyka, Monika Pajewska, Daria Kwaśniewska, Aleksandra Czerw, Andrzej Deptała, Michał Budzik, Elżbieta Cipora, Izabela Gąska, Lucyna Gazdowicz, Aneta Mielnik, Katarzyna Sygit, Marian Sygit, Edyta Krzych-Fałta, Daria Schneider-Matyka, Szymon Grochans, Anna M. Cybulska, Jarosław Drobnik, Ewa Bandurska, Weronika Ciećko, Piotr Ratajczak, Karolina Kamecka, Michał Marczak, Remigiusz Kozłowski. Overview of Pancreatic Cancer Epidemiology in Europe and Recommendations for Screening in High-Risk Populations. Cancers 2023; 15(14): 3634 doi: 10.3390/cancers15143634
|
| 962 |
Rita Peila, Mace Coday, Tracy E. Crane, Nazmus Saquib, Aladdin H. Shadyab, Fred K. Tabung, Xiaochen Zhang, Jean Wactawski-Wende, Thomas E. Rohan. Healthy lifestyle index and risk of pancreatic cancer in the Women’s Health Initiative. Cancer Causes & Control 2022; 33(5): 737 doi: 10.1007/s10552-022-01558-x
|
| 963 |
Ariadna Martín-Blázquez, Cristina Jiménez-Luna, Caridad Díaz, Joaquina Martínez-Galán, Jose Prados, Francisca Vicente, Consolación Melguizo, Olga Genilloud, José Pérez del Palacio, Octavio Caba. Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics. Cancers 2020; 12(4): 1002 doi: 10.3390/cancers12041002
|
| 964 |
Matias Estaras, Antonio Gonzalez. Modulation of cell physiology under hypoxia in pancreatic cancer. World Journal of Gastroenterology 2021; 27(28): 4582-4602 doi: 10.3748/wjg.v27.i28.4582
|
| 965 |
Cinzia Forni, Massimiliano Rossi, Ilaria Borromeo, Giordana Feriotto, Giovambattista Platamone, Claudio Tabolacci, Carlo Mischiati, Simone Beninati. Flavonoids: A Myth or a Reality for Cancer Therapy?. Molecules 2021; 26(12): 3583 doi: 10.3390/molecules26123583
|
| 966 |
Heng‐Chung Kung, Jun Yu. Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study. MedComm 2023; 4(2) doi: 10.1002/mco2.216
|
| 967 |
R. Swaathi, Madhu Narayan, Rajkumar Krishnan. Salivary biomarkers in cancer - A narrative review. Oral Oncology Reports 2024; 10: 100503 doi: 10.1016/j.oor.2024.100503
|
| 968 |
Hanshen Yang, Xiaozhen Zhang, Mengyi Lao, Kang Sun, Lihong He, Jian Xu, Yi Duan, Yan Chen, Honggang Ying, Muchun Li, Chengxiang Guo, Qingsong Lu, Sicheng Wang, Wei Su, Tingbo Liang, Xueli Bai. Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer. Cell Death & Differentiation 2023; 30(2): 560 doi: 10.1038/s41418-022-01102-z
|
| 969 |
Qiang Ren, Jian Wang, Chao Liu, Ling-xin Meng, Rui-kun Qian, Hui-jie Gao, Wei Qin, Cai-ju Zhou, Sen Qiao, Hui-yun Wang, Li-tao Zhang, Yun-tao Zhang. Exploring the sulfate patterns of chondroitin sulfate/dermatan sulfate and keratan sulfate in human pancreatic cancer. Journal of Pharmaceutical and Biomedical Analysis 2021; 205: 114339 doi: 10.1016/j.jpba.2021.114339
|
| 970 |
Alexandra M. Roch, Rachel C. Kim, Trang K. Nguyen, Michael G. House, Nicholas J. Zyromski, Attila Nakeeb, C. Max Schmidt, Eugene P. Ceppa. Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening?. Journal of Surgical Oncology 2023; 128(2): 289 doi: 10.1002/jso.27289
|
| 971 |
Abdel Hadi Hajjar, Roland Eid, Fady Gh Haddad, Hampig Raphael Kourie. FOLFIRINOX: A New Standard of Care In The Adjuvant Setting of Resectable Pancreatic Adenocarcinomas. Future Oncology 2019; 15(17): 1947 doi: 10.2217/fon-2019-0136
|
| 972 |
Ayoub Madani, Anass Derkaoui, Tarik Deflaoui, Hanane El Aggari, Nadir Miry, Benani Amal, Rachid Jabi, Mohamed Bouziane. Rhabdoid carcinoma of the pancreas: A rare cause of unidentified carcinomas of the pancreas. Surgery Open Digestive Advance 2023; 9: 100076 doi: 10.1016/j.soda.2022.100076
|
| 973 |
Li‐Hong He, Yong‐Lin He, Wen‐Hang Zuo, Yue Kang, Huan Xue, Ling‐Yun Wang, Yun‐Liang Zhang, Yong Meng. Neuropilin1 silencing impairs the proliferation and migration of cells in pancreatic cancer. Journal of Clinical Laboratory Analysis 2020; 34(9) doi: 10.1002/jcla.23394
|
| 974 |
Navin Viswakarma, Gautam Sondarva, Daniel R. Principe, Rakesh Sathish Nair, Sandeep Kumar, Sunil Kumar Singh, Subhasis Das, Subhash C. Sinha, Paul J. Grippo, Sam Grimaldo, Pier Cristoforo Giulianotti, Basabi Rana, Ajay Rana. Mixed Lineage Kinase 3 phosphorylates prolyl-isomerase PIN1 and potentiates GLI1 signaling in pancreatic cancer development. Cancer Letters 2021; 515: 1 doi: 10.1016/j.canlet.2021.04.015
|
| 975 |
Davide Placido, Bo Yuan, Jessica X. Hjaltelin, Chunlei Zheng, Amalie D. Haue, Piotr J. Chmura, Chen Yuan, Jihye Kim, Renato Umeton, Gregory Antell, Alexander Chowdhury, Alexandra Franz, Lauren Brais, Elizabeth Andrews, Debora S. Marks, Aviv Regev, Siamack Ayandeh, Mary T. Brophy, Nhan V. Do, Peter Kraft, Brian M. Wolpin, Michael H. Rosenthal, Nathanael R. Fillmore, Søren Brunak, Chris Sander. A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories. Nature Medicine 2023; 29(5): 1113 doi: 10.1038/s41591-023-02332-5
|
| 976 |
Revathi Myneni, Priya Pathak, Amy Hacker-Prietz, Jin He, Rachit Kumar, Amol K. Narang. Effect of travel distance on utilization of ancillary services among patients with pancreatic ductal adenocarcinoma: A single institution study. Supportive Care in Cancer 2025; 33(4) doi: 10.1007/s00520-025-09339-3
|
| 977 |
Tianli Zhang, Mengmeng Liu, Qing Liu, Gary Guishan Xiao. Wogonin increases gemcitabine sensitivity in pancreatic cancer by inhibiting Akt pathway. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1068855
|
| 978 |
Steven Forsythe, Tracey Pu, Aleksander Skardal. Using organoid models to predict chemotherapy efficacy: the future of precision oncology?. Expert Review of Precision Medicine and Drug Development 2019; 4(6): 317 doi: 10.1080/23808993.2019.1685868
|
| 979 |
Ling Li, Tao Deng, Qiuying Zhang, Yanlong Yang, Yang Liu, Leyong Yuan, Mingshui Xie. AK4P1 is a cancer‑promoting pseudogene in pancreatic adenocarcinoma cells whose transcripts can be transmitted by exosomes. Oncology Letters 2022; 23(5) doi: 10.3892/ol.2022.13283
|
| 980 |
Pedram Paragomi, Renwei Wang, Joyce Y. Huang, Øivind Midttun, Arve Ulvik, Per M. Ueland, Woon-Puay Koh, Jian-Min Yuan, Hung N. Luu. The Association Between Serum Riboflavin and Flavin Mononucleotide With Pancreatic Cancer. Pancreas 2023; 52(2): e127 doi: 10.1097/MPA.0000000000002220
|
| 981 |
Jiang Deng, Qian Zhang, Liping Lv, Ping Ma, Yangyang Zhang, Ning Zhao, Yanyu Zhang. Identification of an autophagy-related gene signature for predicting prognosis and immune activity in pancreatic adenocarcinoma. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-11050-w
|
| 982 |
Alaina C. Larson, Shelby M. Knoche, Gabrielle L. Brumfield, Kenadie R. Doty, Benjamin D. Gephart, Promise R. Moore-Saufley, Joyce C. Solheim. Gemcitabine Modulates HLA-I Regulation to Improve Tumor Antigen Presentation by Pancreatic Cancer Cells. International Journal of Molecular Sciences 2024; 25(6): 3211 doi: 10.3390/ijms25063211
|
| 983 |
Konstantin Schlick, Dominik Kiem, Richard Greil. Recent Advances in Pancreatic Cancer: Novel Prognostic Biomarkers and Targeted Therapy—A Review of the Literature. Biomolecules 2021; 11(10): 1469 doi: 10.3390/biom11101469
|
| 984 |
Dushyant Singh Dahiya, Sumant Inamdar, Abhilash Perisetti, Asim Kichloo, Amandeep Singh, Shantanu Solanki, Dhanshree Solanki, Mohammad Al-Haddad. Decreasing length of stay and inpatient mortality associated with pancreatic cancer hospitalizations: A United States national survey from 2008 to 2017. Pancreatology 2022; 22(5): 590 doi: 10.1016/j.pan.2022.04.008
|
| 985 |
Beatriz Gros, Alberto Gómez Pérez, María Pleguezuelo, Francisco Javier Serrano Ruiz, Manuel de la Mata, Manuel Rodríguez-Perálvarez. Helicobacter Species and Hepato-Biliary Tract Malignancies: A Systematic Review and Meta-Analysis. Cancers 2023; 15(3): 595 doi: 10.3390/cancers15030595
|
| 986 |
Peng-Wei Cao, Lei Liu, Zi-Han Li, Feng Cao, Fu-Bao Liu. Prognostic Value of Drug Targets Predicted Using Deep Bioinformatic Analysis of m6A-Associated lncRNA-Based Pancreatic Cancer Model Characteristics and Its Tumour Microenvironment. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.853471
|
| 987 |
Pierpaolo Vendittelli, John-Melle Bokhorst, Esther M. M. Smeets, Valentyna Kryklyva, Lodewijk A. A. Brosens, Caroline Verbeke, Geert Litjens, Shuai Ren. Automatic quantification of tumor-stroma ratio as a prognostic marker for pancreatic cancer. PLOS ONE 2024; 19(5): e0301969 doi: 10.1371/journal.pone.0301969
|
| 988 |
Naru Kim, Danbee Kang, Sang Hyun Shin, Jin Seok Heo, Sungkeun Shim, Jihyun Lim, Juhee Cho, In Woong Han. Effects of cancer stigma on quality of life of patients with hepatobiliary and pancreatic cancer. Annals of Hepato-Biliary-Pancreatic Surgery 2023; 27(2): 172 doi: 10.14701/ahbps.22-084
|
| 989 |
Wei Yao, Yihui Wang, Xin Zhang, Yuhe Lin. B3GNT5 is a novel marker correlated with malignant phenotype and poor outcome in pancreatic cancer. iScience 2024; 27(10): 110889 doi: 10.1016/j.isci.2024.110889
|
| 990 |
晶 王. Prognostic Value of NLR in Patients with Advanced Pancreatic Cancer. Advances in Clinical Medicine 2022; 12(11): 10579 doi: 10.12677/ACM.2022.12111523
|
| 991 |
Maira du Plessis, Marios Loukas. A comprehensive study of the abdominal ganglia part 1: Celiac, phrenic and superior mesenteric ganglia. Clinical Anatomy 2022; 35(7): 998 doi: 10.1002/ca.23894
|
| 992 |
Allison Solanki, Diana King, Guillaume Thibault, Lei Wang, Summer L. Gibbs, Irina V. Lebedeva. Quantification of fluorophore distribution and therapeutic response in matched in vivo and ex vivo pancreatic cancer model systems. PLOS ONE 2020; 15(2): e0229407 doi: 10.1371/journal.pone.0229407
|
| 993 |
Mario Terlizzi, Etienne Buscail, Olayidé Boussari, Sarah Adgié, Nicolas Leduc, Eric Terrebonne, Denis Smith, Jean-Frédéric Blanc, Bruno Lapuyade, Christophe Laurent, Laurence Chiche, Geneviève Belleannée, Karine Le Malicot, Renaud Trouette, Claudia Pouypoudat, Véronique Vendrely. Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to upfront surgery. Acta Oncologica 2021; 60(9): 1114 doi: 10.1080/0284186X.2021.1944662
|
| 994 |
Linhui Wu, Ke Yu, Kai Chen, Xuelian Zhu, Zheng Yang, Qi Wang, Junjie Gao, Yingying Wang, Tong Cao, Hui Xu, Xueshan Pan, Lixia Wang, Jun Xia, Yuyun Li, Zhiwei Peter Wang, Jia Ma. Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation. Cell Death & Disease 2022; 13(3) doi: 10.1038/s41419-022-04675-2
|
| 995 |
Hongchen Ji, Qiong Zhang, Xiang-Xu Wang, Junjie Li, Xiaowen Wang, Wei Pan, Zhuochao Zhang, Ben Ma, Hong-Mei Zhang. Identification of stromal microenvironment characteristics and key molecular mining in pancreatic cancer. Discover Oncology 2022; 13(1) doi: 10.1007/s12672-022-00532-y
|
| 996 |
Ankit Kumar, Awanish Mishra. Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy. 2024; : 233 doi: 10.1016/B978-0-323-95303-0.00004-6
|
| 997 |
Wenxin Da, Ziyu Song, Xiaodong Liu, Yahui Wang, Shengjun Wang, Jie Ma. The role of TET2 in solid tumors and its therapeutic potential: a comprehensive review. Clinical and Translational Oncology 2024; 26(9): 2156 doi: 10.1007/s12094-024-03478-5
|
| 998 |
Seiji Nakahara, Shunsuke Doi, Satoshi Nishiwada, Satoshi Yasuda, Minako Nagai, Kota Nakamura, Yasuko Matsuo, Taichi Terai, Yuichiro Kohara, Takeshi Sakata, Yuji Nitta, Kohei Morita, Masayuki Sho. Pancreatic ductal adenocarcinoma arising from the pancreatic parenchyma compressed by a huge pancreatic lipoma: a case report. Surgical Case Reports 2023; 9(1) doi: 10.1186/s40792-023-01720-w
|
| 999 |
Xueyuan Huang, Hao Chi, Siqi Gou, Xiyuan Guo, Lin Li, Gaoge Peng, Jinhao Zhang, Jiayu Xu, Siji Nian, Qing Yuan. An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma. Genes 2023; 14(1): 124 doi: 10.3390/genes14010124
|
| 1000 |
Anita Thyagarajan, Mamdouh Salman A. Alshehri, Kelly L.R. Miller, Catherine M. Sherwin, Jeffrey B. Travers, Ravi P. Sahu. Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches. Cancers 2019; 11(11): 1627 doi: 10.3390/cancers11111627
|
| 1001 |
Sowmya Narayanan, Samer AlMasri, Mazen Zenati, Ibrahim Nassour, Asmita Chopra, Caroline Rieser, Katelyn Smith, Vivianne Oyefusi, Tracy Daum, Nathan Bahary, David Bartlett, Kenneth Lee, Amer Zureikat, Alessandro Paniccia. Predictors of early recurrence following neoadjuvant chemotherapy and surgical resection for localized pancreatic adenocarcinoma. Journal of Surgical Oncology 2021; 124(3): 308 doi: 10.1002/jso.26510
|
| 1002 |
Iris Beirith, Bernhard W. Renz, Shristee Mudusetti, Natalja Sergejewna Ring, Julian Kolorz, Dominik Koch, Alexandr V. Bazhin, Michael Berger, Jing Wang, Martin K. Angele, Jan G. D’Haese, Markus O. Guba, Hanno Niess, Joachim Andrassy, Jens Werner, Matthias Ilmer. Identification of the Neurokinin-1 Receptor as Targetable Stratification Factor for Drug Repurposing in Pancreatic Cancer. Cancers 2021; 13(11): 2703 doi: 10.3390/cancers13112703
|
| 1003 |
Akira Kurita, Yoshiharu Mori, Yuko Someya, Shigeto Kubo, Shunjiro Azuma, Kosuke Iwano, Satoshi Ikeda, Ryosuke Okumura, Shujiro Yazumi. High signal intensity on diffusion-weighted magnetic resonance images is a useful finding for detecting early-stage pancreatic cancer. Abdominal Radiology 2021; 46(10): 4817 doi: 10.1007/s00261-021-03199-1
|
| 1004 |
Somayeh Jafari, Milad Ravan, Iman Karimi-Sani, Hamid Aria, Amin Moradi Hasan-Abad, Bahar Banasaz, Amir Atapour, Gholamreza Anani Sarab. Screening and identification of potential biomarkers for pancreatic cancer: An integrated bioinformatics analysis. Pathology - Research and Practice 2023; 249: 154726 doi: 10.1016/j.prp.2023.154726
|
| 1005 |
Yingqing Mao, Xian Su, Qingsong Guo, Xihao Yao, Qun Zhao, Yibing Guo, Yao Wang, Xiaohong Li, Yuhua Lu. Long non-coding RNA LINC00930 targeting miR-6792-3p/ZBTB16 regulates the proliferation and EMT of pancreatic cancer. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12365-9
|
| 1006 |
Caitlin E Harmon, Sanjay P Lamsal, Taylor S Harmon, Khaled Mohamed, Travis E Meyer. The Path of Most Resistance: A Rare Instance of Metastatic Pancreatic Adenocarcinoma Identified Within Skeletal Muscle. Cureus 2021; doi: 10.7759/cureus.13947
|
| 1007 |
Wenxin Qi, Qian Liu, Wenjun Fu, Jiaming Shi, Minmin Shi, Songqi Duan, Zhe Li, Shaohua Song, Jiao Wang, Yihao Liu. BHLHE40, a potential immune therapy target, regulated by FGD5-AS1/miR-15a-5p in pancreatic cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-43577-x
|
| 1008 |
Dina Mikdadi, Kyle A. O’Connell, Philip J. Meacham, Madeleine A. Dugan, Michael O. Ojiere, Thaddeus B. Carlson, Juergen A. Klenk, Karin D. Rodland. Applications of artificial intelligence (AI) in ovarian cancer, pancreatic cancer, and image biomarker discovery. Cancer Biomarkers 2022; 33(2): 173 doi: 10.3233/CBM-210301
|
| 1009 |
Kai-lian Zheng, Xiao-yi Yin, Hao-yu Gu, Chang-jin Li, Chen-ming Ni, Guo-xiao Zhang, Huan Wang, Zhen Wang, Gang Jin. Impact of previous upper/lower abdominal surgery on pancreatic surgical outcomes and complications: a propensity score matching study. Langenbeck's Archives of Surgery 2022; 407(4): 1517 doi: 10.1007/s00423-022-02494-9
|
| 1010 |
Chao Song, Ganggang Wang, Mengmeng Liu, Zijin Xu, Xin Liang, Kai Ding, Yu Chen, Wenquan Wang, Wenhui Lou, Liang Liu. Identification of methylation driver genes for predicting the prognosis of pancreatic cancer patients based on whole-genome DNA methylation sequencing technology. Heliyon 2024; 10(9): e29914 doi: 10.1016/j.heliyon.2024.e29914
|
| 1011 |
Mireille Simon, Aurore Meurat, Sophie Stanislas, Hervé Dréau, Geneviève Belleannée, Christophe Laurent, Jean-Frédéric Blanc, Sandra Mounicou. Metallic trace elements in pancreatic tissue are associated with higher risk of pancreatic adenocarcinoma - METAPANDA study.. Pancreatology 2025; doi: 10.1016/j.pan.2025.03.006
|
| 1012 |
Debora Basile, Carla Corvaja, Riccardo Caccialanza, Giuseppe Aprile. Sarcopenia: looking to muscle mass to better manage pancreatic cancer patients. Current Opinion in Supportive & Palliative Care 2019; 13(4): 279 doi: 10.1097/SPC.0000000000000455
|
| 1013 |
Mingming Zhang, Xiaoru Hu, Ye Kang, Wanfeng Xu, Xianghong Yang. Association between fasting blood glucose levels at admission and overall survival of patients with pancreatic cancer. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-07859-9
|
| 1014 |
Martin Roessler, Jochen Schmitt, Christoph Bobeth, Michael Gerken, Kees Kleihues-van Tol, Christoph Reissfelder, Bettina M. Rau, Marius Distler, Pompiliu Piso, Christian Günster, Monika Klinkhammer-Schalke, Olaf Schoffer, Veronika Bierbaum. Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09731-w
|
| 1015 |
Noor Oudah Mohammed Albuthyab, Hossein Hosseini, Masoud Homayouni Tabrizi, Matin Kharaghani, Seyedeh Samira Saghravanian. The urolithin B nanomicellar delivery system as an efficient selective anticancer compound. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-023-09112-x
|
| 1016 |
Sujitha Jayaprakash, Mangala Hegde, Bandari BharathwajChetty, Sosmitha Girisa, Mohammed S. Alqahtani, Mohamed Abbas, Gautam Sethi, Ajaikumar B. Kunnumakkara. Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer. International Journal of Molecular Sciences 2022; 23(20): 12380 doi: 10.3390/ijms232012380
|
| 1017 |
川雄 魏. Research Progress of circRNA in Pancreatic Cancer. Advances in Clinical Medicine 2023; 13(07): 11295 doi: 10.12677/ACM.2023.1371578
|
| 1018 |
Hanna Santos Marques, Breno Bittencourt de Brito, Filipe Antônio França da Silva, Maria Luísa Cordeiro Santos, Júlio César Braga de Souza, Thiago Macêdo Lopes Correia, Luana Weber Lopes, Nayara Silva de Macêdo Neres, Rafael Santos Dantas Miranda Dórea, Anna Carolina Saúde Dantas, Lorena Lôbo Brito Morbeck, Iasmin Souza Lima, Amanda Alves de Almeida, Maiara Raulina de Jesus Dias, Fabrício Freire de Melo. Relationship between Th17 immune response and cancer. World Journal of Clinical Oncology 2021; 12(10): 845-867 doi: 10.5306/wjco.v12.i10.845
|
| 1019 |
Fengjuan Lin, Huiyu Luo, Jiexian Wang, Qing Li, Longying Zha. Macrophage-derived extracellular vesicles as new players in chronic non-communicable diseases. Frontiers in Immunology 2025; 15 doi: 10.3389/fimmu.2024.1479330
|
| 1020 |
Dimitrios Moris, Ioannis Liapis, Piyush Gupta, Ioannis A. Ziogas, Georgia-Sofia Karachaliou, Nikolaos Dimitrokallis, Brian Nguyen, Pejman Radkani. An Overview for Clinicians on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas. Cancers 2024; 16(22): 3825 doi: 10.3390/cancers16223825
|
| 1021 |
Xiaoke Tan, Xin Zhu, Duanjie Xu, Yanmei Shi, Zhenzhen Wang, Mingzhuo Cao, Kai Hu, Lingzhou Zhao, Junwei Zhao, Mingsan Miao, Huahui Zeng, Xiangxiang Wu. A mitochondria-targeted nano-platform for pancreatic cancer therapy. Frontiers in Chemistry 2022; 10 doi: 10.3389/fchem.2022.951434
|
| 1022 |
Vernon Chuabio, Johanna Bandoy, Aaron Ong, Mateo Te, Ruter Maralit. Pancreatic masses clinically diagnosed as tuberculosis: Case reports. SAGE Open Medical Case Reports 2024; 12 doi: 10.1177/2050313X241262192
|
| 1023 |
Zhe Liu, Neha Parveen, Urushi Rehman, Aisha Aziz, Afsana Sheikh, Mohammed A. S. Abourehab, Wei Guo, Junhao Huang, Zhenning Wang, Prashant Kesharwani. Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer. Molecular Cancer 2023; 22(1) doi: 10.1186/s12943-022-01696-5
|
| 1024 |
Jonas Dinter, Ralf P. Friedrich, Hai Yang, Christian Pilarsky, Harald Mangge, Marina Pöttler, Christina Janko, Christoph Alexiou, Stefan Lyer. Mitoxantrone and Mitoxantrone-Loaded Iron Oxide Nanoparticles Induce Cell Death in Human Pancreatic Ductal Adenocarcinoma Cell Spheroids. Materials 2023; 16(7): 2906 doi: 10.3390/ma16072906
|
| 1025 |
Edson J. Comparetti, Paula M. P. Lins, João V. B. Quitiba, Valtencir Zucolotto. Cancer cell membrane-derived nanoparticles improve the activity of gemcitabine and paclitaxel on pancreatic cancer cells and coordinate immunoregulatory properties on professional antigen-presenting cells. Materials Advances 2020; 1(6): 1775 doi: 10.1039/D0MA00367K
|
| 1026 |
Paulina F Toledo, Zoltan Berger, Laura Carreño, Gonzalo Cardenas, Jaime Castillo, Omar Orellana. Sarcomatoid carcinoma of the pancreas — a rare tumor with an uncommon presentation and course: A case report and review of literature. World Journal of Clinical Cases 2021; 9(15): 3716-3725 doi: 10.12998/wjcc.v9.i15.3716
|
| 1027 |
Akpunonu Chinaemelum, Muhammad Musaab Munir, Lovette Azap, Selamawit Woldesenbet, Mary Dillhoff, Jordan Cloyd, Aslam Ejaz, Timothy M. Pawlik. Impact of Food Insecurity on Outcomes Following Resection of Hepatopancreaticobiliary Cancer. Annals of Surgical Oncology 2023; 30(9): 5365 doi: 10.1245/s10434-023-13723-w
|
| 1028 |
Gengjia Chen, Yujun Cai, Bo Li, Minzhao Lin, Xiaobin Wang, Zhiyong Wang, Xintao Shuai. Theranostic nanosystem mediating cascade catalytic reactions for effective immunotherapy of highly immunosuppressive and poorly penetrable pancreatic tumor. Science China Chemistry 2022; 65(7): 1383 doi: 10.1007/s11426-022-1262-x
|
| 1029 |
Hung-Jun Lin, Tien-Li Liang, Yao-Yuan Chang, Der-Zen Liu, Jia-Yu Fan, Steve R. Roffler, Shyr-Yi Lin. Development of Irinotecan Liposome Armed with Dual-Target Anti-Epidermal Growth Factor Receptor and Anti-Fibroblast Activation Protein-Specific Antibody for Pancreatic Cancer Treatment. Pharmaceutics 2022; 14(6): 1202 doi: 10.3390/pharmaceutics14061202
|
| 1030 |
Tesfaye Aga Dinagde, Zeki Abubeker. Surgical management of pancreatic cancer in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a 5 years retrospective descriptive study. BMC Surgery 2024; 24(1) doi: 10.1186/s12893-024-02503-2
|
| 1031 |
Raoof Nopour. Prediction of 12-month recurrence of pancreatic cancer using machine learning and prognostic factors. BMC Medical Informatics and Decision Making 2024; 24(1) doi: 10.1186/s12911-024-02766-y
|
| 1032 |
Maria Chiara Mentella, Franco Scaldaferri, Caterina Ricci, Antonio Gasbarrini, Giacinto Abele Donato Miggiano. Cancer and Mediterranean Diet: A Review. Nutrients 2019; 11(9): 2059 doi: 10.3390/nu11092059
|
| 1033 |
Chengxia Kan, Na Liu, Kexin Zhang, Di Wu, Yunzi Liang, Weiqin Cai, Qi Jing, Fang Han, Shunjie Xing, Xiaodong Sun. Global, Regional, and National Burden of Pancreatic Cancer, 1990–2019: Results from the Global Burden of Disease Study 2019. Annals of Global Health 2023; 89(1): 33 doi: 10.5334/aogh.4019
|
| 1034 |
Peng An, Yong Lin, Junyan Zhang, Yan Hu, Ping Qin, Yingjian Ye, Xiumei Li, Guoyan Feng, Jinsong Wang. Prognostic Predicting Model of Pancreatic Body Tail Carcinoma Using Clinical and CT Radiomic Data. Technology in Cancer Research & Treatment 2023; 22 doi: 10.1177/15330338231186739
|
| 1035 |
Neel Ingemann Nissen, Stephanie Kehlet, Astrid Z. Johansen, Inna M. Chen, Morten Karsdal, Julia S. Johansen, Hadi M. H. Diab, Lars N. Jørgensen, Shu Sun, Tina Manon‐Jensen, Yi He, Lasse Langholm, Nicholas Willumsen. Noninvasive prognostic biomarker potential of quantifying the propeptides of Type XI collagen alpha‐1 chain (PRO‐C11) in patients with pancreatic ductal adenocarcinoma. International Journal of Cancer 2021; 149(1): 228 doi: 10.1002/ijc.33551
|
| 1036 |
Jie Yang, Rui Li. Single-Cell Sequencing Data Analysis Unveiled HDAC1 as the Therapeutic Target for Chronic Pancreatitis. Molecular Biotechnology 2024; 66(1): 68 doi: 10.1007/s12033-023-00718-x
|
| 1037 |
Mickensone Andre, Allen Caobi, Jana S. Miles, Arti Vashist, Marco A. Ruiz, Andrea D. Raymond. Diagnostic potential of exosomal extracellular vesicles in oncology. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-11819-4
|
| 1038 |
Mengxin Li, Xuanzhong Wang, Xuyang Chen, Jinghui Hong, Ye Du, Dong Song. GK921, a transglutaminase inhibitor, strengthens the antitumor effect of cisplatin on pancreatic cancer cells by inhibiting epithelial-to-mesenchymal transition. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(2): 166925 doi: 10.1016/j.bbadis.2023.166925
|
| 1039 |
Yuyao Song, Shan Gao, Jingwei Jiang, Yuebin Zhang, Jingyu Zhang, Xiaona Wang, Li Lv, Zunchun Zhou, Jihong Wang. Inhibition Effects and Mechanism Study of rAj-HRP30, a Recombinant Histidine-Rich Peptide from Apostichopus japonicus, on the Viability of Pancreatic Ductal Adenocarcinoma Cells Panc01 and Panc02. International Journal of Molecular Sciences 2025; 26(4): 1485 doi: 10.3390/ijms26041485
|
| 1040 |
Ling Wang, Siying Chong, Shuangyan Wu, Yaguang Sun, Ying Zhang, Chiyu Sun, Mingchang Zhu. Construction of Zn (II)/Mn (II) complexes based carboxylic acid ligands and their drug delivery, antiproliferation and DNA interaction. Journal of Molecular Liquids 2025; 425: 127187 doi: 10.1016/j.molliq.2025.127187
|
| 1041 |
Shira Orr, Ling Huang, James Moser, Dina Stroopinsky, Omar Gandarilla, Cori DeCicco, Jessica Liegel, Cansu Tacettin, Adam Ephraim, Giulia Cheloni, Daniela Torres, Donald Kufe, Jacalyn Rosenblatt, Manuel Hidalgo, Senthil K. Muthuswamy, David Avigan. Personalized tumor vaccine for pancreatic cancer. Cancer Immunology, Immunotherapy 2023; 72(2): 301 doi: 10.1007/s00262-022-03237-x
|
| 1042 |
Weiyi Wu, Xiaoying Liu, Robert B. Hamilton, Arief A. Suriawinata, Saeed Hassanpour. Graph Convolutional Neural Networks for Histologic Classification of Pancreatic Cancer. Archives of Pathology & Laboratory Medicine 2023; 147(11): 1251 doi: 10.5858/arpa.2022-0035-OA
|
| 1043 |
Qiang Ma, Huanwen Wu, Ying Xiao, Zhiyong Liang, Tonghua Liu. Upregulation of exosomal microRNA‑21 in pancreatic stellate cells promotes pancreatic cancer cell migration and enhances Ras/ERK pathway activity. International Journal of Oncology 2020; doi: 10.3892/ijo.2020.4986
|
| 1044 |
Pascaline Nanga Fru, Ekene Emmanuel Nweke, Nompumelelo Mthimkhulu, Sindisiwe Mvango, Marietha Nel, Lynne Alison Pilcher, Mohammed Balogun. Anti-Cancer and Immunomodulatory Activity of a Polyethylene Glycol-Betulinic Acid Conjugate on Pancreatic Cancer Cells. Life 2021; 11(6): 462 doi: 10.3390/life11060462
|
| 1045 |
Macarena Teja, María I Garrido, Abrahams Ocanto, Felipe Couñago. Prognostic impact of inflammatory and nutritional biomarkers in pancreatic cancer. World Journal of Clinical Oncology 2025; 16(1): 101191 doi: 10.5306/wjco.v16.i1.101191
|
| 1046 |
Yung‐Ling Tseng, Yun‐Ching Lin, Wan‐Ju Hsu, Ya‐Chun Kang, Hsin‐Yin Su, Shao‐Yi Cheng, Jaw‐Shiun Tsai, Tai‐Yuan Chiu, Hsien‐Liang Huang. Shared decision making with Oncologists and Palliative care specialists (SOP) model help advanced pancreatic cancer patients reaching goal concordant care: A prospective cohort study. Cancer Medicine 2023; 12(19): 20119 doi: 10.1002/cam4.6590
|
| 1047 |
Guoliang Qiao, Crisanta H. Ilagan, Carlos Fernandez-del Castillo, Cristina R. Ferrone, Quisette P. Janseen, Vinod P. Balachandran, Naomi M. Sell, Jeffrey A. Drebin, Thomas Hank, T. Peter Kingham, Michael I. D’Angelica, William R. Jarnagin, Keith D. Lillemoe, Alice C. Wei, Motaz Qadan. Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy. Surgery 2022; 172(4): 1228 doi: 10.1016/j.surg.2022.05.024
|
| 1048 |
Huaibin Mabel Ko, Runjan Chetty. Pancreatic pathology for the surgeon. Surgery (Oxford) 2022; 40(4): 227 doi: 10.1016/j.mpsur.2022.01.003
|
| 1049 |
Naomi Sanjana Sharath, Ranjita Misra, Jyotirmoy Ghosh. Recent Advances in Nanocarriers for Pancreatic Cancer Therapy. 2024; : 73 doi: 10.1016/B978-0-443-19142-8.00011-5
|
| 1050 |
Hung N. Luu, Pedram Paragomi, Renwei Wang, Joyce Y. Huang, Jennifer Adams-Haduch, Øivind Midttun, Arve Ulvik, Tin C. Nguyen, Randall E. Brand, Yutang Gao, Per Magne Ueland, Jian-Min Yuan. The Association between Serum Serine and Glycine and Related-Metabolites with Pancreatic Cancer in a Prospective Cohort Study. Cancers 2022; 14(9): 2199 doi: 10.3390/cancers14092199
|
| 1051 |
A. S. Kudashkina, I. G. Kamyshanskaya, V. M. Cheremisin, K. V. Pavelets, D. S. Rusanov, S. A. Kalyuzhnyy. The role of 3D modeling in pancreas surgery: a review. Diagnostic radiology and radiotherapy 2023; 14(3): 18 doi: 10.22328/2079-5343-2023-14-3-18-26
|
| 1052 |
Alberto Servetto, Antonio Santaniello, Fabiana Napolitano, Francesca Foschini, Roberta Marciano, Priscilla Cascetta, Anna Rita Amato, Maria Rosaria Augurio, Lucia Maresca, Pietro De Placido, Sabino De Placido, Luigi Formisano, Roberto Bianco. FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Adenocarcinoma: An Observational Study. Future Oncology 2022; 18(21): 2643 doi: 10.2217/fon-2021-1142
|
| 1053 |
Roya Ramezankhani, Afshin Abdi Ghavidel, Saadyeh Rashidi, Mahbubeh Rojhannezhad, Hamid Reza Abolkheir, Malihe Mirhosseini, Sara Taleahmad, Massoud Vosough. Gender-related differentially expressed genes in pancreatic cancer: possible culprits or accomplices?. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.966941
|
| 1054 |
Kun Huang, Xinzhu Yuan, Pingwu Zhao, Yunshen He, Filomena de Nigris. Effect of chemotherapy on prognosis in patients with primary pancreatic signet ring cell carcinoma: A large real-world study based on machine learning. PLOS ONE 2024; 19(5): e0302685 doi: 10.1371/journal.pone.0302685
|
| 1055 |
Juan Manuel Castillo Tuñón, María Elisa Valle Rodas, Francisco Botello Martínez, Adela Rojas Holguín, Diego López Guerra, Jesús Santos Naharro, Isabel Jaén Torrejímeno, Gerardo Blanco Fernández. Implementation of a regional reference center in pancreatic surgery. Experience after 631 procedures. Cirugía Española (English Edition) 2021; 99(10): 745 doi: 10.1016/j.cireng.2021.11.001
|
| 1056 |
Przemysław Dyrla, Arkadiusz Lubas, Jerzy Gil, Marek Saracyn, Maciej Gonciarz. Dynamic Doppler Ultrasound Assessment of Tissue Perfusion Is a Better Tool than a Single Vessel Doppler Examination in Differentiating Malignant and Inflammatory Pancreatic Lesions. Diagnostics 2021; 11(12): 2289 doi: 10.3390/diagnostics11122289
|
| 1057 |
Selvaraj Jayaraman, Bhuvaneswari Ponnusamy, Ponnulakshmi Rajagopal, S. Gowtham Kumar, Kirubhanand Chandrasekar. Handbook of Animal Models and its Uses in Cancer Research. 2022; : 1 doi: 10.1007/978-981-19-1282-5_39-1
|
| 1058 |
Fereshteh Asgharzadeh, Kiarash Roustai Geraylow, Majid Khazaei, Mohammadreza Nassiri, Seyed Mahdi Hassanian, Gordon A Ferns, Amir Avan. Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor
Blockers as Potential Therapeutic Options for Pancreatic Cancer. Current Cancer Drug Targets 2022; 22(10): 785 doi: 10.2174/1568009622666220517104411
|
| 1059 |
Angel Nogales Muñoz, Inmaculada Sanchez-Matamoros Martin, Juan Manuel Castillo Tuñon, Juan Bellido-Luque. Recent Innovations in Surgical Procedures of Pancreatic Neoplasms. 2023; : 55 doi: 10.1007/978-3-031-21351-9_5
|
| 1060 |
Beste Turanli, Esra Yildirim, Gizem Gulfidan, Kazim Yalcin Arga, Raghu Sinha. Current State of “Omics” Biomarkers in Pancreatic Cancer. Journal of Personalized Medicine 2021; 11(2): 127 doi: 10.3390/jpm11020127
|
| 1061 |
Kartik S. Jhaveri, Ali Babaei Jandaghi, Seng Thipphavong, Osvaldo Espin-Garcia, Anna Dodd, Shawn Hutchinson, Trevor W. Reichman, Carol-Anne Moulton, Ian D. McGilvary, Steven Gallinger. Can preoperative liver MRI with gadoxetic acid help reduce open-close laparotomies for curative intent pancreatic cancer surgery?. Cancer Imaging 2021; 21(1) doi: 10.1186/s40644-021-00416-4
|
| 1062 |
Simone Frassini, Francesca Calabretto, Stefano Granieri, Paola Fugazzola, Jacopo Viganò, Nicola Fazzini, Luca Ansaloni, Lorenzo Cobianchi. Intraperitoneal chemotherapy in the management of pancreatic adenocarcinoma: A systematic review and meta-analysis. European Journal of Surgical Oncology 2022; 48(9): 1911 doi: 10.1016/j.ejso.2022.05.030
|
| 1063 |
Mahrou Vahabi, Annalisa Comandatore, Chiara Centra, Giovanni Blandino, Luca Morelli, Elisa Giovannetti. Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancer. Seminars in Cancer Biology 2023; 97: 50 doi: 10.1016/j.semcancer.2023.11.003
|
| 1064 |
Hsuan‐Chia Yang, Wen‐Chi Chou, Phung‐Anh Nguyen, Nhi Thi Hong Nguyen, Nguyen Thi Phuong, Ching‐Huan Wang, Jason C. Hsu, Ming‐Chin Lin, Chih‐Wei Huang. The protective role of anti‐parkinsonian drugs in pancreatic cancer risk: A comprehensive case–control study in Taiwan. Cancer Science 2025; 116(3): 783 doi: 10.1111/cas.16422
|
| 1065 |
Zhen Yang, Guangjun Shi. Comparison of clinicopathologic characteristics and survival outcomes between invasive IPMN and invasive MCN: A population-based analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.899761
|
| 1066 |
Jiahui Tian, Chunyan Fu, Xuan Zeng, Xiaoxiao Fan, Yi Wu, Muhammad Babar Khawar. An Independent Prognostic Model Based on Ten Autophagy-Related Long Noncoding RNAs in Pancreatic Cancer Patients. Genetics Research 2022; 2022: 1 doi: 10.1155/2022/3895396
|
| 1067 |
Elisabeth Maurer, Bettina Lehman, Elvira Matthäi, Ulrike Denzer, Jens Figiel, Moritz Jesinghaus, Emily P. Slater, Ulrich Stefenelli, Thomas M. Gress, Detlef K. Bartsch. Pancreatic cancer screening is effective in individuals at risk with predisposing germline gene variants, but not in gene variant‐negative familial pancreatic cancer families. United European Gastroenterology Journal 2024; 12(9): 1211 doi: 10.1002/ueg2.12631
|
| 1068 |
Evelyn Waugh, Juan Glinka, Daniel Breadner, Rachel Liu, Ephraim Tang, Laura Allen, Stephen Welch, Ken Leslie, Anton Skaro. Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer. Annals of Hepato-Biliary-Pancreatic Surgery 2024; 28(2): 229 doi: 10.14701/ahbps.23-107
|
| 1069 |
Michail Galanopoulos, Aris Doukatas, Filippos Gkeros, Nikos Viazis, Christos Liatsos. Room for improvement in the treatment of pancreatic cancer: Novel opportunities from gene targeted therapy. World Journal of Gastroenterology 2021; 27(24): 3568-3580 doi: 10.3748/wjg.v27.i24.3568
|
| 1070 |
Mark Stasiewicz, Marek Kwaśniewski, Tomasz M. Karpiński. Microbial Associations with Pancreatic Cancer: A New Frontier in Biomarkers. Cancers 2021; 13(15): 3784 doi: 10.3390/cancers13153784
|
| 1071 |
Neda Kabiri, Rahim Khodayari‐zarnaq, Manouchehr Khoshbaten, Ali Janati. Policy Analysis of Gastrointestinal Cancer Prevention in Iran: A Framework Based on a Qualitative Study. World Medical & Health Policy 2021; 13(3): 548 doi: 10.1002/wmh3.389
|
| 1072 |
Prashant Dogra, Javier R. Ramírez, María J. Peláez, Zhihui Wang, Vittorio Cristini, Gulshan Parasher, Manmeet Rawat. Mathematical Modeling to Address Challenges in Pancreatic Cancer. Current Topics in Medicinal Chemistry 2020; 20(5): 367 doi: 10.2174/1568026620666200101095641
|
| 1073 |
Ryosuke Iwama, Hitoshi Miyashita, Atsumu Koketsu, Kiyoshi Kume, Fumiyoshi Fujishima, Atsushi Masamune, Tetsu Takahashi. A case of synchronous double cancers consisting of maxillary gingival carcinoma and intraductal papillary mucinous carcinoma, invasive: case report. BMC Oral Health 2023; 23(1) doi: 10.1186/s12903-023-03253-y
|
| 1074 |
Xiaole Zhu, Rong Yu, Yunpeng Peng, Yi Miao, Kuirong Jiang, Qiang Li. Identification of genomic instability related lncRNA signature with prognostic value and its role in cancer immunotherapy in pancreatic cancer. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.990661
|
| 1075 |
Joaquina Martínez-Galán, Cristina Jiménez-Luna, Isabel Rodriguez, Elisabeth Maza, Carlos García-Collado, Antonio Rodríguez-Fernández, Javier Luis López-Hidalgo, Octavio Caba. Metastatic pancreatic and lung cancer patient in complete remission following immunotherapy: A case report and review of literature. World Journal of Gastrointestinal Oncology 2024; 16(5): 2233-2240 doi: 10.4251/wjgo.v16.i5.2233
|
| 1076 |
Ali Dinari, Hafiz Ashfaq Ahmad, Minh Phú Bùi, Seungjun Oh, Yun-Hee Kim, Dae-Hong Kim, Jungwon Yoon. Targeted Cellular Tracking of Pancreatic Cancer Cells via Magnetic Particle Spectroscopy (MPS). Bio-Algorithms and Med-Systems 2024; 20(Special Issue): 63 doi: 10.5604/01.3001.0054.9363
|
| 1077 |
Kyuseok Im, Niharika Kareddy, Vikas Satyananda, Victoria V. O’Connor. Is pancreatic adenosquamous carcinoma (PASC) a surgical disease? A large healthcare system review. Surgical Oncology Insight 2024; 1(4): 100102 doi: 10.1016/j.soi.2024.100102
|
| 1078 |
Chun‐Hao Pan, Yuka Otsuka, BanuPriya Sridharan, Melissa Woo, Cindy V. Leiton, Sruthi Babu, Mariana Torrente Gonçalves, Ryan R. Kawalerski, Ji Dong K. Bai, David K. Chang, Andrew V. Biankin, Louis Scampavia, Timothy Spicer, Luisa F. Escobar‐Hoyos, Kenneth R. Shroyer. An unbiased high‐throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer. Molecular Oncology 2020; 14(8): 1800 doi: 10.1002/1878-0261.12743
|
| 1079 |
Qinmeng Zhang, Jin He, Danji Zhu, Yunxuan Chen, Mengdie Fu, Shifan Lu, Yuesheng Qiu, Guodong Zhou, Guoli Yang, Zhiwei Jiang. Genetically modified organoids for tissue engineering and regenerative medicine. Advances in Colloid and Interface Science 2025; 335: 103337 doi: 10.1016/j.cis.2024.103337
|
| 1080 |
Hong Xiang, Fangyue Guo, Qi Zhou, Xufeng Tao, Deshi Dong. Activated Pancreatic Stellate Cells Promote Acinar Duct Metaplasia by
Disrupting Mitochondrial Respiration and Releasing Reactive Oxygen
Species. Current Chinese Science 2022; 2(1): 76 doi: 10.2174/2210298101666210928122952
|
| 1081 |
Ke Zhang, Yu-Jie Li, Lin-Jia Peng, Hui-Feng Gao, Lu-Ming Liu, Hao Chen. M2 macrophage-derived exosomal miR-193b-3p promotes progression and glutamine uptake of pancreatic cancer by targeting TRIM62. Biology Direct 2023; 18(1) doi: 10.1186/s13062-023-00356-y
|
| 1082 |
Nedal Bukhari, Khalda Abdalla, Fahad Ibnshamsa, Waleed Alselwi, Shakir Al-Shakir, Mohammed Alqahtani. Exceptional Response to Second-Line Gemcitabine/Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Adenocarcinoma. Cureus 2021; doi: 10.7759/cureus.18756
|
| 1083 |
Tomoki Sugimoto, Yoshifumi Iwagami, Shogo Kobayashi, Chihiro Yamanaka, Kazuki Sasaki, Daisaku Yamada, Yoshito Tomimaru, Tadafumi Asaoka, Takehiro Noda, Hidenori Takahashi, Junzo Shimizu, Yuichiro Doki, Hidetoshi Eguchi. Skeletal Muscle-Derived Irisin Enhances Gemcitabine Sensitivity and Suppresses Migration Ability in Pancreatic Ductal Adenocarcinoma. Annals of Surgical Oncology 2024; 31(6): 3718 doi: 10.1245/s10434-024-15118-x
|
| 1084 |
Virneliz Fernandez-Vega, Shurong Hou, Dennis Plenker, Hervé Tiriac, Pierre Baillargeon, Justin Shumate, Louis Scampavia, Jan Seldin, Glauco R. Souza, David A. Tuveson, Timothy P. Spicer. Lead identification using 3D models of pancreatic cancer. SLAS Discovery 2022; 27(3): 159 doi: 10.1016/j.slasd.2022.03.002
|
| 1085 |
Ahmad Ali, Ugo Chianese, Chiara Papulino, Antonella Toraldo, Mawada Elmagboul Abdalla Abakar, Eugenia Passaro, Rosario Cennamo, Nunzio Del Gaudio, Lucia Altucci, Rosaria Benedetti. Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma. Cancers 2022; 14(15): 3799 doi: 10.3390/cancers14153799
|
| 1086 |
Joanna Jiang, Wei-Lun Chao, Stacey Culp, Somashekar G. Krishna. Artificial Intelligence in the Diagnosis and Treatment of Pancreatic Cystic Lesions and Adenocarcinoma. Cancers 2023; 15(9): 2410 doi: 10.3390/cancers15092410
|
| 1087 |
Shuxin Sun, Yang Liu, Chaobin He, Wanming Hu, Wenfeng Liu, Xin Huang, Jiali Wu, Fengxiao Xie, Chen Chen, Jun Wang, Yuan Lin, Wenbo Zhu, Guangmei Yan, Jing Cai, Shengping Li. Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer. Cancer Letters 2021; 502: 9 doi: 10.1016/j.canlet.2020.12.018
|
| 1088 |
Fumihiro Kikuyama, Sayo Suzuki, Aya Jibiki, Yuta Yokoyama, Hitoshi Kawazoe, Susumu Kitanaka, Tomonori Nakamura. Ingenol mebutate inhibits the growth of pancreatic cancer cells in vitro via STING with an efficacy comparable to that of clinically used anticancer agents. Journal of Natural Medicines 2023; 77(2): 343 doi: 10.1007/s11418-023-01682-1
|
| 1089 |
Samuel J. S. Rubin, Raoul S. Sojwal, John Gubatan, Stephan Rogalla. The Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Neither Hot nor Cold. Cancers 2022; 14(17): 4236 doi: 10.3390/cancers14174236
|
| 1090 |
Dong-Qin Xia, Yong Zhou, Shuang Yang, Fang-Fei Li, Li-Ya Tian, Yan-Hua Li, Hai-Yan Xu, Cai-Zhi Xiao, Wei Wang. Combining prognostic value of serum carbohydrate antigen 19-9 and tumor size reduction ratio in pancreatic ductal adenocarcinoma. World Journal of Gastrointestinal Oncology 2024; 16(3): 798-809 doi: 10.4251/wjgo.v16.i3.798
Abstract(388) |
Core Tip(403) |
Full Article(HTML)(1428)
|
Full Article with Cover (PDF)-2130K(65)
|
Full Article (Word)-886K(8)
|
Audio-236K(0)
|
Peer-Review Report-261K(47)
|
Answering Reviewers-163K(62)
|
Full Article (PDF)-1863K(121)
|
Full Article (XML)-126K(56)
|
Times Cited (1)
|
Total Visits (4563)
|
Open
|
| 1091 |
Gengjia Chen, Bo Li, Tan Li, Minzhao Lin, Huihai Zhong, Xiaoxue Xie, Qiaoyun Zhang, Qi Chen, Xiaochun Meng, Zecong Xiao, Xintao Shuai. Core–Satellite Nanoassembly Overcomes Spatial Heterogeneity of Dendric Cell Distribution in Pancreatic Tumors for Effective Chemoimmunotherapy. ACS Nano 2025; 19(4): 4739 doi: 10.1021/acsnano.4c15444
|
| 1092 |
Cong Bi, Gang Wang. LINC00472 suppressed by ZEB1 regulates the miR‐23a‐3p/FOXO3/BID axis to inhibit the progression of pancreatic cancer. Journal of Cellular and Molecular Medicine 2021; 25(17): 8312 doi: 10.1111/jcmm.16784
|
| 1093 |
Hanieh Azari, Pegah Mousavi, Elham Karimi, Fatemeh Sadri, Mahboobeh Zarei, Milad Rafat, Mohammad Shekari. The expanding role of CDR1‐AS in the regulation and development of cancer and human diseases. Journal of Cellular Physiology 2021; 236(2): 771 doi: 10.1002/jcp.29950
|
| 1094 |
Alvaro Gregorio Morales Taboada, Pablo Lozano Lominchar, María Fernández Martínez, Pilar García-Alfonso, Andrés Muñoz Martin, Jose Manuel Asencio. Neoadjuvant therapy impact in early pancreatic cancer: “bioborderline” vs. “non-bioborderline”. Annals of Hepato-Biliary-Pancreatic Surgery 2022; 26(4): 363 doi: 10.14701/ahbps.22-023
|
| 1095 |
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1427802
|
| 1096 |
Apostolis Papaefthymiou, Aris Doukatas, Michail Galanopoulos. Pancreatic cancer and oligonucleotide therapy: Exploring novel therapeutic options and targeting chemoresistance. Clinics and Research in Hepatology and Gastroenterology 2022; 46(5): 101911 doi: 10.1016/j.clinre.2022.101911
|
| 1097 |
Na Su, Rui Tang, Yice Zhang, Jiaqi Ni, Yimei Huang, Chunqi Liu, Yuzhou Xiao, Baoting Zhu, Yinglan Zhao. Using machine learning to identify risk factors for pancreatic cancer: a retrospective cohort study of real-world data. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1510220
|
| 1098 |
Fotini Poyia, Christiana M. Neophytou, Maria-Ioanna Christodoulou, Panagiotis Papageorgis. The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives. International Journal of Molecular Sciences 2024; 25(17): 9555 doi: 10.3390/ijms25179555
|
| 1099 |
Lei Liu, Xinyu Wang, Dekai Guo, Ruirui Ma, Haibing Gong, Congjun Wang. Hormone replacement therapy and risk of pancreatic cancer in postmenopausal women: Evidence from the US National Inpatient Sample 2008–2018. Heliyon 2024; 10(18): e37588 doi: 10.1016/j.heliyon.2024.e37588
|
| 1100 |
Manar A. Abdel-Rahman, Hany O. Habashy, Eman O. Arram, Mohammad K. El Badrway. Protein expression study of IMP3 in pancreatic and lung cancers. Egyptian Journal of Pathology 2021; 41(2): 165 doi: 10.4103/egjp.egjp_50_21
|
| 1101 |
Abhay Dev Tripathi, Yamini Labh, Soumya Katiyar, Anurag Kumar Singh, Vivek K. Chaturvedi, Abha Mishra. Folate-Mediated Targeting and Controlled Release: PLGA-Encapsulated Mesoporous Silica Nanoparticles Delivering Capecitabine to Pancreatic Tumor. ACS Applied Bio Materials 2024; 7(12): 7838 doi: 10.1021/acsabm.4c00019
|
| 1102 |
André Cristovão, Nelson Andrade, Fátima Martel, Cláudia Silva. Effect of Sodium-Glucose Co-Transporter 2 Inhibitors Combined with Metformin on Pancreatic Cancer Cell Lines. International Journal of Molecular Sciences 2024; 25(18): 9932 doi: 10.3390/ijms25189932
|
| 1103 |
Pratibha Prabhakaran, Chella Perumal Palanisamy, Abirami Shanmugam, Prabhu Damodharan, Harshini Swaminathan, Dhivya Devaraj, Rathi Muthaiyan Ahalliya, Gopalakrishnan Velliyur Kanniappan. Isolation, structural characterization, and molecular docking studies on the bioactive compound from n-Hexane extract of Emilia sonchifolia (L.) DC against the pancreatic cancer target Aurora 2 Kinase. Journal of Complementary and Integrative Medicine 2025; 22(1): 165 doi: 10.1515/jcim-2024-0290
|
| 1104 |
Chung-Tsui Huang, Cheng-Kuan Lin, Tzong-Hsi Lee, Yao-Jen Liang. Pancreatic Fibrosis and Chronic Pancreatitis: Mini-Review of Non-Histologic Diagnosis for Clinical Applications. Diagnostics 2020; 10(2): 87 doi: 10.3390/diagnostics10020087
|
| 1105 |
Rafael Álvarez-Gallego, Roberto Pazo-Cid, Borja López de San Vicente, Teresa Macarulla, Eva Martinez, Fernando Garicano, Irene Hernández, Monica Granja, Ismael Ghanem, Joaquina Martinez, Paula Ribera, Roberto Diaz, Jose Ignacio Martin Valadés, Maria Cristina Angeles, Antonio Cubillo. Real-world effectiveness and safety of second- or third-line pegylated liposomal irinotecan plus 5-fluorouracil and folinic acid in pancreatic ductal adenocarcinoma in Spain. Therapeutic Advances in Medical Oncology 2025; 17 doi: 10.1177/17588359241309828
|
| 1106 |
Fan Xu, Min Huang, Yun Bai, Xueshi Yin, Jingzhe Yan, Fangfang Liu, Jie Chen, Xiechuan Weng. Landmarks in pancreatic cancer studies. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02803-8
|
| 1107 |
Si-qi Yang, Rui-qi Zou, Yu-shi Dai, Fu-yu Li, Hai-jie Hu. Comparison of the upfront surgery and neoadjuvant therapy in resectable and borderline resectable pancreatic cancer: an updated systematic review and meta-analysis. Updates in Surgery 2024; 76(1): 1 doi: 10.1007/s13304-023-01626-0
|
| 1108 |
Feilong Meng, Shuai Hua, Xuedong Chen, Nanfeng Meng, Ting Lan. Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer. BMC Medical Genomics 2023; 16(1) doi: 10.1186/s12920-023-01696-4
|
| 1109 |
Rongchen Dai, Mengfan Liu, Xincheng Xiang, Yang Li, Zhichao Xi, Hongxi Xu. OMICS Applications for Medicinal Plants in Gastrointestinal Cancers: Current Advancements and Future Perspectives. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.842203
|
| 1110 |
Scott Widmann, Shivangi Srivastava, Chin-Yo Lin. A Novel Liver X Receptor Inverse Agonist Impairs Cholesterol and Phospholipid Metabolism and Induces Apoptosis and Necroptosis in Pancreatic Ductal Adenocarcinoma Cells. Receptors 2023; 2(1): 34 doi: 10.3390/receptors2010003
|
| 1111 |
George Bagias, Prodromos Kanavidis, Michail Vailas, Markos Despotidis, Maria Sotiropoulou, Ioannis Katsaros, Ioannis Maroulis, Dimitrios Filippou, Dimitrios Schizas. Surgical management of familial pancreatic cancer: a systematic review of the literature. ANZ Journal of Surgery 2022; 92(11): 2816 doi: 10.1111/ans.17834
|
| 1112 |
Haiyang Hu, Huangqin Song, Bin Han, Haoliang Zhao, Jiefeng He. Tumor-Educated Platelet RNA and Circulating Free RNA: Emerging Liquid Biopsy Markers for Different Tumor Types. Frontiers in Bioscience-Landmark 2024; 29(2) doi: 10.31083/j.fbl2902080
|
| 1113 |
Kanae Inoue, Koh Fukushi, Shota Yamaguchi, Tomonao Taira, Taro Shibuki, Tomoyuki Satake, Kazuo Watanabe, Mitsuhito Sasaki, Hiroshi Imaoka, Shuichi Mitsunaga, Masafumi Ikeda. Treatment outcomes of gemcitabine plus nab-paclitaxel in pancreatic cancer patients with malignant ascites. Pancreatology 2024; 24(4): 616 doi: 10.1016/j.pan.2024.03.015
|
| 1114 |
Bharti Sharma, Kate Twelker, Cecilia Nguyen, Scott Ellis, Navin D. Bhatia, Zachary Kuschner, Andrew Agriantonis, George Agriantonis, Monique Arnold, Jasmine Dave, Juan Mestre, Zahra Shafaee, Shalini Arora, Hima Ghanta, Jennifer Whittington. Bile Acids in Pancreatic Carcinogenesis. Metabolites 2024; 14(7): 348 doi: 10.3390/metabo14070348
|
| 1115 |
Etienne Buscail, Alexandre Chauvet, Pascaline Quincy, Olivier Degrandi, Camille Buscail, Isabelle Lamrissi, Isabelle Moranvillier, Charline Caumont, Severine Verdon, Alain Brisson, Marion Marty, Laurence Chiche, Christophe Laurent, Veronique Vendrely, François Moreau-Gaudry, Aurelie Bedel, Sandrine Dabernat. CD63-GPC1-Positive Exosomes Coupled with CA19-9 Offer Good Diagnostic Potential for Resectable Pancreatic Ductal Adenocarcinoma. Translational Oncology 2019; 12(11): 1395 doi: 10.1016/j.tranon.2019.07.009
|
| 1116 |
Mohammad-Jalil Zare-Mehrjardi, Mahtab Hatami-Araghi, Majid Jafari-Khorchani, Zahra Oushyani Roudsari, Mortaza Taheri-Anganeh, Mona Abdolrahmat, Hassan Ghasemi, Saleh Aiiashi. RNA biosensors for detection of pancreatic cancer. Clinica Chimica Acta 2025; 571: 120237 doi: 10.1016/j.cca.2025.120237
|
| 1117 |
Wei Huang, Hao Hua, Guoliang Xiao, Xianjin Yang, Qin Yang, Lu Jin. ZC3HAV1 promotes the proliferation and metastasis via regulating KRAS in pancreatic cancer. Aging 2021; 13(14): 18482 doi: 10.18632/aging.203296
|
| 1118 |
Binhan Wang, Manni Wang, Danyi Ao, Xiawei Wei. CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(5): 188799 doi: 10.1016/j.bbcan.2022.188799
|
| 1119 |
Signe E. J. Hansen, Anne Langsted, Anette Varbo, Christian M. Madsen, Anne Tybjærg-Hansen, Børge G. Nordestgaard. Low and high pancreatic amylase is associated with pancreatic cancer and chronic pancreatitis. European Journal of Epidemiology 2021; 36(9): 975 doi: 10.1007/s10654-021-00801-0
|
| 1120 |
Maria Moccia, Veronica Caratelli, Stefano Cinti, Biagio Pede, Concetta Avitabile, Michele Saviano, Anna Lisa Imbriani, Danila Moscone, Fabiana Arduini. Paper-based electrochemical peptide nucleic acid (PNA) biosensor for detection of miRNA-492: a pancreatic ductal adenocarcinoma biomarker. Biosensors and Bioelectronics 2020; 165: 112371 doi: 10.1016/j.bios.2020.112371
|
| 1121 |
Zhang Jie, Zhang Jinna, Zhang Jingjun, Li Pengcheng, Yang Fang, Chen Qinyang, Chen Taiyu, Jiang Hequn, Ren Tao, Enas Abdulhay. Antitumor Effects of 10058-F4 and Curcumin in Combination Therapy for Pancreatic Cancer In Vitro and In Vivo. Journal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/1620802
|
| 1122 |
Ahmed Abdullah Ahmed, Chiara Marchetti, Stephan A. Ohnmacht, Stephen Neidle. A G-quadruplex-binding compound shows potent activity in human gemcitabine-resistant pancreatic cancer cells. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-68944-w
|
| 1123 |
Javeria Muhammadzai, Kamal Haider, Michael Moser, Haji Chalchal, John Shaw, Donald Gardiner, Dorie-Anna Dueck, Osama Ahmed, Bryan Brunet, Mussawar Iqbal, Yigang Luo, Gavin Beck, Adnan Zaidi, Shahid Ahmed, Jason Chia-Hsun Hsieh. Early discontinuation of adjuvant chemotherapy in patients with early-stage pancreatic cancer correlates with inferior survival: A multicenter population-based cohort study. PLOS ONE 2022; 17(2): e0263250 doi: 10.1371/journal.pone.0263250
|
| 1124 |
Sherille D. Bradley, Amjad H. Talukder, Ivy Lai, Rebecca Davis, Hector Alvarez, Herve Tiriac, Minying Zhang, Yulun Chiu, Brenda Melendez, Kyle R. Jackson, Arjun Katailiha, Heather M. Sonnemann, Fenge Li, Yaan Kang, Na Qiao, Bih-Fang Pan, Philip L. Lorenzi, Mark Hurd, Elizabeth A. Mittendorf, Christine B. Peterson, Milind Javle, Christopher Bristow, Michael Kim, David A. Tuveson, David Hawke, Scott Kopetz, Robert A. Wolff, Patrick Hwu, Anirban Maitra, Jason Roszik, Cassian Yee, Gregory Lizée. Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers. Nature Communications 2020; 11(1) doi: 10.1038/s41467-020-19141-w
|
| 1125 |
Yuntao Ding, Huizhi Wang, Wenyu Cao, Tianyu Cao, Han Jiang, Zhengyue Yu, Yujing Zhou, Min Xu. TTC22 as a potential prognostic marker and therapeutic target in pancreatic cancer: Insights into immune infiltration and epithelial‑mesenchymal transition. Oncology Letters 2023; 27(1) doi: 10.3892/ol.2023.14143
|
| 1126 |
Ziyu Jiang, Jing Ni, Songyang Zhou, Liu Yang, Xing Huang, Jun Bao, Jingbing Liu. NiWo4- RGO composite exerts cytotoxic effects on pancreatic carcinoma cells via a cross-talk between reactive oxygen species-independent canonical autophagy of the mitochondria and epithelial-mesenchymal transition. Journal of Drug Delivery Science and Technology 2024; 95: 105584 doi: 10.1016/j.jddst.2024.105584
|
| 1127 |
Lu Yao, Hoda Amar, Somaiah Aroori. Incidental double duct sign: Should we be worried? Results from a long-term follow-up study. Annals of Hepato-Biliary-Pancreatic Surgery 2024; 28(1): 53 doi: 10.14701/ahbps.23-063
|
| 1128 |
Yue Gao, Shiyu Chen, Jiayi Sun, Siyu Su, Dong Yang, Li Xiang, Xianli Meng. Traditional Chinese medicine may be further explored as candidate drugs for pancreatic cancer: A review. Phytotherapy Research 2021; 35(2): 603 doi: 10.1002/ptr.6847
|
| 1129 |
Takayuki Oguma, Takanori Kanazawa, Yukiko K. Kaneko, Ren Sato, Miku Serizawa, Akira Ooka, Momoka Yamaguchi, Tomohisa Ishikawa, Hiromu Kondo. Effects of phospholipid type and particle size on lipid nanoparticle distribution in vivo and in pancreatic islets. Journal of Controlled Release 2024; 373: 917 doi: 10.1016/j.jconrel.2024.07.059
|
| 1130 |
Sarah Powell-Brett, Rupaly Pande, Keith J. Roberts. Achieving ‘Marginal Gains’ to Optimise Outcomes in Resectable Pancreatic Cancer. Cancers 2021; 13(7): 1669 doi: 10.3390/cancers13071669
|
| 1131 |
Xiaobo Guo, Di Liu, Siyuan Dong, Yuyang Wang, Meng Li. Self-assembled peptide nanoparticles for photodynamic therapy: morphological and mechanical effects on hepatocellular carcinoma cells. Biomedical Materials 2023; 18(4): 045026 doi: 10.1088/1748-605X/acddc2
|
| 1132 |
Giulia A. Zamboni, Marco Chincarini, Matilde Bariani, Giancarlo Mansueto. Multimodality Imaging and Intervention in Oncology. 2023; : 201 doi: 10.1007/978-3-031-28524-0_10
|
| 1133 |
Eric J. O’Neill, Danja J. Den Hartogh, Karim Azizi, Evangelia Tsiani. Anticancer Properties of Carnosol: A Summary of In Vitro and In Vivo Evidence. Antioxidants 2020; 9(10): 961 doi: 10.3390/antiox9100961
|
| 1134 |
Anna Testa, Emilio Venturelli, Maria Felice Brizzi. Extracellular Vesicles as a Novel Liquid Biopsy-Based Diagnosis for the Central Nervous System, Head and Neck, Lung, and Gastrointestinal Cancers: Current and Future Perspectives. Cancers 2021; 13(11): 2792 doi: 10.3390/cancers13112792
|
| 1135 |
Ryuhei Aoyama, Tomohide Hori, Hidekazu Yamamoto, Hideki Harada, Michihiro Yamamoto, Masahiro Yamada, Takefumi Yazawa, Ben Sasaki, Masaki Tani, Asahi Sato, Hikotaro Katsura, Yasuyuki Kamada, Ryotaro Tani, Yudai Sasaki, Masazumi Zaima, Claudio Feo. A Thought-Provoking Case of Successfully Treated Carcinoma of the Head of the Pancreas with Metachronous Lung Metastasis: Impact of Distal Spleno-Renal Shunt for Regional Invasion on Long-Term Period after Pancreaticoduodenectomy. Case Reports in Surgery 2021; 2021: 1 doi: 10.1155/2021/6689419
|
| 1136 |
Lizhou Lin, Yichao Du, Jialing Hao, Rong Wu, Lianfang Du. UTMD inhibits pancreatic cancer growth and metastasis by inducing macrophage polarization and vessel normalization. Biomedicine & Pharmacotherapy 2023; 160: 114322 doi: 10.1016/j.biopha.2023.114322
|
| 1137 |
Senju Hashimoto, Takumi Tochio, Kohei Funasaka, Kazuki Funahashi, Tenagy Hartanto, Yuka Togashi, Misa Saito, Yuichiro Nishimoto, Mizuguchi Yoshinori, Kazunori Nakaoka, Ayako Watanabe, Mitsuo Nagasaka, Yoshihito Nakagawa, Ryoji Miyahara, Tomoyuki Shibata, Yoshiki Hirooka. Changes in intestinal bacteria and imbalances of metabolites induced in the intestines of pancreatic ductal adenocarcinoma patients in a Japanese population: a preliminary result. Scandinavian Journal of Gastroenterology 2023; 58(2): 193 doi: 10.1080/00365521.2022.2114812
|
| 1138 |
Xiao Wang, Wenbin Kuang, Jiayu Ding, Jiaxing Li, Minghui Ji, Weijiao Chen, Hao Shen, Zhongrui Shi, Dawei Wang, Liping Wang, Peng Yang. Systematic Identification of the RNA-Binding Protein STAU2 as a Key Regulator of Pancreatic Adenocarcinoma. Cancers 2022; 14(15): 3629 doi: 10.3390/cancers14153629
|
| 1139 |
Mansunderbir Singh, Priyanka Anvekar, Bhavana Baraskar, Namratha Pallipamu, Srikanth Gadam, Akhila Sai Sree Cherukuri, Devanshi N. Damani, Kanchan Kulkarni, Shivaram P. Arunachalam. Prospective of Pancreatic Cancer Diagnosis Using Cardiac Sensing. Journal of Imaging 2023; 9(8): 149 doi: 10.3390/jimaging9080149
|
| 1140 |
Lily M. Channon, Victoria M. Tyma, Zhihong Xu, David W. Greening, Jeremy S. Wilson, Chamini J. Perera, Minoti V. Apte. Small extracellular vesicles (exosomes) and their cargo in pancreatic cancer: Key roles in the hallmarks of cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(3): 188728 doi: 10.1016/j.bbcan.2022.188728
|
| 1141 |
Thomas J. Vogl, Charlotte Lilienthal, Tatjana Gruber-Rouh, Zahra Afraz, Hamzah Adwan. Degradable Starch Microspheres Transarterial Chemoembolization with or without Lipiodol for Liver Metastases from Pancreatic Cancer: A Prospective Randomized Trial. Cancers 2023; 15(21): 5239 doi: 10.3390/cancers15215239
|
| 1142 |
Eduardo Mere Del Aguila, Xiao-Han Tang, Lorraine J. Gudas. Pancreatic Ductal Adenocarcinoma: New Insights into the Actions of Vitamin A. Oncology Research and Treatment 2022; 45(5): 291 doi: 10.1159/000522425
|
| 1143 |
Can Huang, Juan Iovanna, Patricia Santofimia-Castaño. Targeting Fibrosis: The Bridge That Connects Pancreatitis and Pancreatic Cancer. International Journal of Molecular Sciences 2021; 22(9): 4970 doi: 10.3390/ijms22094970
|
| 1144 |
Zhenglei Xu, Zeming Chen, Minsi Peng, Zhuliang Zhang, Weixiang Luo, Ruiyue Shi, Lisheng Wang, Yingcai Hong. MicroRNA MiR-490-5p suppresses pancreatic cancer through regulating epithelial-mesenchymal transition via targeting MAGI2 antisense RNA 3. Bioengineered 2022; 13(2): 2673 doi: 10.1080/21655979.2021.2024653
|
| 1145 |
Gemma van Duijneveldt, Michael D.W. Griffin, Tracy L. Putoczki. Emerging roles for the IL-6 family of cytokines in pancreatic cancer. Clinical Science 2020; 134(16): 2091 doi: 10.1042/CS20191211
|
| 1146 |
Shotaro Tatekawa, Keisuke Tamari, Ryota Chijimatsu, Masamitsu Konno, Daisuke Motooka, Suguru Mitsufuji, Hirofumi Akita, Shogo Kobayashi, Yoshiki Murakumo, Yuichiro Doki, Hidetoshi Eguchi, Hideshi Ishii, Kazuhiko Ogawa. N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-15196-5
|
| 1147 |
Vinay Kumar Kohli, Chitra Kohli, Akanksha Singh. Comprehensive Multiple-Choice Questions in Pathology. 2022; : 105 doi: 10.1007/978-3-031-08767-7_13
|
| 1148 |
Barbara A. Centeno, Mauro Saieg, Momin T. Siddiqui, Miguel Perez‐Machado, Lester J. Layfield, Birgit Weynand, Michelle D. Reid, Edward B. Stelow, Maria D. Lozano, Noriyoshi Fukushima, Ian A. Cree, Ravi Mehrotra, Fernando C. Schmitt, Andrew S. Field, Martha B. Pitman. The World Health Organization Reporting System for Pancreaticobiliary Cytopathology: Overview and Summary. Cancer Cytopathology 2024; 132(7): 396 doi: 10.1002/cncy.22806
|
| 1149 |
Nikhil Gupta, Jung Eun Park, Wilford Tse, Jee Keem Low, Oi Lian Kon, Neil McCarthy, Siu Kwan Sze. ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer. Oncotarget 2019; 10(57): 5970 doi: 10.18632/oncotarget.27235
|
| 1150 |
Hye In Lee, Hyun-Cheol Kang, Eui Kyu Chie. Consolidatory ablative stereotactic body radiation therapy after induction chemotherapy for unresectable pancreatic cancer: A single center experience. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.974454
|
| 1151 |
Dandan Zheng, Paul M. Grandgenett, Qi Zhang, Michael Baine, Yu Shi, Qian Du, Xiaoying Liang, Jeffrey Wong, Subhan Iqbal, Kiersten Preuss, Ahsan Kamal, Hongfeng Yu, Huijing Du, Michael A. Hollingsworth, Chi Zhang. radioGWAS links radiome to genome to discover driver genes with somatic mutations for heterogeneous tumor image phenotype in pancreatic cancer. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-62741-5
|
| 1152 |
Cristina P.R. Xavier, Inês Castro, Hugo R. Caires, Dylan Ferreira, Bruno Cavadas, Luisa Pereira, Lúcio L. Santos, Maria J. Oliveira, M. Helena Vasconcelos. Chitinase 3-like-1 and fibronectin in the cargo of extracellular vesicles shed by human macrophages influence pancreatic cancer cellular response to gemcitabine. Cancer Letters 2021; 501: 210 doi: 10.1016/j.canlet.2020.11.013
|
| 1153 |
Heidelinde Sammallahti, Virinder Kaur Sarhadi, Arto Kokkola, Reza Ghanbari, Sama Rezasoltani, Hamid Asadzadeh Aghdaei, Pauli Puolakkainen, Sakari Knuutila. Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool. Biomolecules 2022; 12(5): 652 doi: 10.3390/biom12050652
|
| 1154 |
Songyuan Zheng, Dongyan Liu, Feifei Wang, Youyan Jin, Siqiao Zhao, Siyu Sun, Sheng Wang. ABCA12 Promotes Proliferation and Migration and Inhibits Apoptosis of Pancreatic Cancer Cells Through the AKT Signaling Pathway. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.906326
|
| 1155 |
Liu Liu, Hongjie Xiong, Wenyu Sun, Tingya Wang, Yihan Wang, Jing Wang, Xuemei Wang, Hui Jiang. Chymotrypsin etched ultrasmall gold nanoclusters for dual response diagnosis and deeply penetrated chemodynamic therapy of pancreatic cancer. Sensors and Actuators B: Chemical 2024; 413: 135880 doi: 10.1016/j.snb.2024.135880
|
| 1156 |
Jun He, Yu Wang, Xiangmei Chen, Wenxiang Chen, Jianyin Zhou. Value of thyroid cancer history in the prognosis of pancreatic cancer: a SEER population-based study. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32635-z
|
| 1157 |
Shu Dong, Xian Miao, Ke Zhang, Xiaoyan Zhu, Yi Gao, Hao Chen. Elastic modulus-reflected liver lesion stiffness relates to worse prognosis in pancreatic cancer patients with liver metastasis. World Journal of Surgical Oncology 2023; 21(1) doi: 10.1186/s12957-023-03140-4
|
| 1158 |
Mari Rivelsrud, Ingvild Paur, Kari Sygnestveit, Roy M. Nilsen, Randi J. Tangvik. Nutritional treatment is associated with longer survival in patients with pancreatic disease and concomitant risk of malnutrition. Clinical Nutrition 2021; 40(4): 2128 doi: 10.1016/j.clnu.2020.09.037
|
| 1159 |
Pan Xi, Xiaojuan Ma, Fuquan Hu, Liang Li, Huijuan Liu, Jing Zhou, Wenan Wu. ROS‐Sp1 axis is involved in thermochemotherapy‐enhanced sensitivity of pancreatic cancer cells to gemcitabine. Cell Biology International 2023; 47(11): 1825 doi: 10.1002/cbin.12073
|
| 1160 |
Alban Piotrowsky, Markus Burkard, Hendrik Schmieder, Sascha Venturelli, Olga Renner, Luigi Marongiu. The therapeutic potential of vitamins A, C, and D in pancreatic cancer. Heliyon 2025; 11(1): e41598 doi: 10.1016/j.heliyon.2024.e41598
|
| 1161 |
Chih-Wei Lin, Yu-Jen Wang, Ting-Yen Lai, Tsui-Ling Hsu, Shin-Ying Han, Han-Chung Wu, Chia-Ning Shen, Van Dang, Ming-Wei Chen, Lan-Bo Chen, Chi-Huey Wong. Homogeneous antibody and CAR-T cells with improved effector functions targeting SSEA-4 glycan on pancreatic cancer. Proceedings of the National Academy of Sciences 2021; 118(50) doi: 10.1073/pnas.2114774118
|
| 1162 |
Jonathan Fergus, Daniel W. Nelson, Michael Sung, David Lee, Simon Lavotshkin, Louis A. Difronzo, Victoria V. O'Connor. Pancreatectomy in Stage I pancreas cancer: national underutilization of surgery persists. HPB 2020; 22(12): 1703 doi: 10.1016/j.hpb.2020.03.017
|
| 1163 |
Lu-Lu Sun, Ming Cheng, Xiao-Dong Xu. MicroRNA-30c inhibits pancreatic cancer cell proliferation by targeting twinfilin 1 and indicates a poor prognosis. World Journal of Gastroenterology 2019; 25(42): 6311-6321 doi: 10.3748/wjg.v25.i42.6311
|
| 1164 |
Xinlei Zou, Canghai Guan, Jianjun Gao, Wujiang Shi, Yunfu Cui, Xiangyu Zhong. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1222719
|
| 1165 |
Natalia Khalaf, Ann Xu, Theresa Nguyen Wenker, Jennifer R. Kramer, Yan Liu, Hardeep Singh, Hashem B. El-Serag, Fasiha Kanwal. The Impact of Race on Pancreatic Cancer Treatment and Survival in the Nationwide Veterans Affairs Healthcare System. Pancreas 2024; 53(1): e27 doi: 10.1097/MPA.0000000000002272
|
| 1166 |
Leifeng Chen, Zheng Xu, Qing Li, Qian Feng, Cihua Zheng, Yunyan Du, Rongfa Yuan, Xiaogang Peng. USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1. Cell Death & Disease 2021; 12(10) doi: 10.1038/s41419-021-04163-z
|
| 1167 |
Karolina Skubisz, Krzysztof Dąbkowski, Emilia Samborowska, Teresa Starzyńska, Anna Deskur, Filip Ambrozkiewicz, Jakub Karczmarski, Mariusz Radkiewicz, Katarzyna Kusnierz, Beata Kos-Kudła, Tadeusz Sulikowski, Patrycja Cybula, Agnieszka Paziewska. Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study. Cancers 2023; 15(12): 3242 doi: 10.3390/cancers15123242
|
| 1168 |
Consuelo Gajate, Odile Gayet, Nicolas A. Fraunhoffer, Juan Iovanna, Nelson Dusetti, Faustino Mollinedo. Induction of Apoptosis in Human Pancreatic Cancer Stem Cells by the Endoplasmic Reticulum-Targeted Alkylphospholipid Analog Edelfosine and Potentiation by Autophagy Inhibition. Cancers 2021; 13(23): 6124 doi: 10.3390/cancers13236124
|
| 1169 |
|
| 1170 |
Navni Sharma, Ritika Puri, Vimal Arora. Biocompatible nanosponges for drug targeting in pancreatic cancer. Materials Today: Proceedings 2022; 68: 867 doi: 10.1016/j.matpr.2022.06.353
|
| 1171 |
D. Schlanger, F. Graur, C. Popa, E. Moiș, N. Al Hajjar. The role of artificial intelligence in pancreatic surgery: a systematic review. Updates in Surgery 2022; 74(2): 417 doi: 10.1007/s13304-022-01255-z
|
| 1172 |
Sooin Byeon, Taymin du Toit‐Thompson, Josef Gillson, Anthony J. Gill, Jaswinder S. Samra, Anubhav Mittal, Sumit Sahni. Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis. Cancer Medicine 2023; 12(17): 18020 doi: 10.1002/cam4.6407
|
| 1173 |
İlhan Yıldırım, Tezcan Kaya, Kubilay İşsever, Ahmed Cihad Genç, Alper Karacan, Attila Önmez, İlhan Hacıbekiroğlu. Psoas muscle mass, nutritional status, inflammation, and their relationship with prognosis in patients with pancreatic adenocarcinoma. Nutrición Hospitalaria 2021; doi: 10.20960/nh.03573
|
| 1174 |
Candace Miyaki, Launa M Lynch. An Update on Common Pharmaceuticals in the Prevention of Pancreatic Cancer. Cureus 2022; doi: 10.7759/cureus.25496
|
| 1175 |
Jakob Kirkegård, Anders Bo Bojesen, Mette Fugleberg Nielsen, Frank Viborg Mortensen. Trends in pancreatic cancer incidence, characteristics, and outcomes in Denmark 1980–2019: A nationwide cohort study. Cancer Epidemiology 2022; 80: 102230 doi: 10.1016/j.canep.2022.102230
|
| 1176 |
Ryosuke Tonozuka, Shuntaro Mukai, Takao Itoi. The Role of Artificial Intelligence in Endoscopic Ultrasound for Pancreatic Disorders. Diagnostics 2020; 11(1): 18 doi: 10.3390/diagnostics11010018
|
| 1177 |
Shurong Hou, Zhenzhen Li, Xiaoling Chen, Wenxin Wang, Ting Duan, Louis Scampavia, Yaxia Yuan, Timothy P. Spicer, Xiabin Chen, Tian Xie. Elemene sensitizes pancreatic cancer cells to bortezomib by enhancing proteasome inhibition via molecular patch mechanism. Signal Transduction and Targeted Therapy 2023; 8(1) doi: 10.1038/s41392-023-01373-z
|
| 1178 |
Davide Busato, Monica Mossenta, Michele Dal Bo, Paolo Macor, Giuseppe Toffoli. The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2022; 23(18): 10279 doi: 10.3390/ijms231810279
|
| 1179 |
Kristine Elberg Dengsø, Anne Berg, Carsten Palnæs Hansen, Stefan K. Burgdorf, Paul S. Krohn, Martin Sillesen, Nina Spiegelhauer, Mette Tholstrup Bach, Marianne Melton, Betina Nielsen, Bo Marcel Christensen, Jeanette Finderup, Jens Hillingsø. Have a vital end-user been overlooked? Developing a shared decision intervention for patients with potential pancreatic cancer regarding the choice of surgery. PEC Innovation 2024; 4: 100269 doi: 10.1016/j.pecinn.2024.100269
|
| 1180 |
Valerie Jentzsch, James Davis, Mustafa Djamgoz. Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management. Cancers 2020; 12(11): 3096 doi: 10.3390/cancers12113096
|
| 1181 |
Seval Ay, Muhammed Mustafa Atcı, Rukiye Arıkan, Özgecan Dülgar, Deniz Tataroğlu Özyükseler, Nail Paksoy, İzzet Doğan, Buğra Öztosun, Didem Taştekin, Başak Bala Öven, Mahmut Gümüş. FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer. Journal of Chemotherapy 2022; 34(7): 465 doi: 10.1080/1120009X.2022.2026125
|
| 1182 |
Dudu Erkoç Kaya, Fatma Göktürk, Fatma Batırbek, Hilal Arıkoğlu. Investigation of the Effects of Juglone-Selenium Treatments on Epithelial-Mesenchimal Transition and Migration in BxPC-3 and PANC-1 Human Pancreatic Cancer Cells. Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy 2023; 19(3): 248 doi: 10.4274/BMJ.galenos.2023.2023.3-9
|
| 1183 |
Qin Yu, Christian Jobin, Ryan M. Thomas. Implications of the microbiome in the development and treatment of pancreatic cancer: Thinking outside of the box by looking inside the gut. Neoplasia 2021; 23(2): 246 doi: 10.1016/j.neo.2020.12.008
|
| 1184 |
Victor R. Lincha, Jun Zhao, Xiaoxia Wen, Chiyi Xiong, Diana S-L Chow, Chun Li. A polymeric micellar drug delivery system developed through a design of Experiment approach improves pancreatic tumor accumulation of calcipotriol and paclitaxel. International Journal of Pharmaceutics 2021; 601: 120523 doi: 10.1016/j.ijpharm.2021.120523
|
| 1185 |
N Bharanidharan, Pratham Aggarwal, Aryan Batra, Deep Shah, Sannasi Chakravarthy S R, Harikumar Rajaguru. Pancreatic Cancer Diagnosis using Swarm Optimization Combined with Machine Learning Techniques. 2023 Third International Conference on Smart Technologies, Communication and Robotics (STCR) 2023; : 1 doi: 10.1109/STCR59085.2023.10397020
|
| 1186 |
Maxim S Petrov. Post-pancreatitis diabetes mellitus and excess intra-pancreatic fat deposition as harbingers of pancreatic cancer. World Journal of Gastroenterology 2021; 27(17): 1936-1942 doi: 10.3748/wjg.v27.i17.1936
|
| 1187 |
Yufu Zhou, Yulin Tang, Feizhou Huang, Zhichao Wang, Zhengbin Wen, Qi Fang, Changfa Wang. The miR-1305/KLF5 negative regulatory loop affects pancreatic cancer cell proliferation and apoptosis. Human Cell 2025; 38(2) doi: 10.1007/s13577-025-01173-3
|
| 1188 |
Liudmila G. Zhukova, Dmitry S. Bordin, Elena A. Dubtsova, Matvey A. Ilin, Mariia A. Kiriukova, Polina S. Feoktistova, Vyacheslav I. Egorov. How a significant increase in survival in pancreatic cancer is achieved. The role of nutritional status and supportive care: A review. Journal of Modern Oncology 2024; 25(4) doi: 10.26442/18151434.2023.4.202541
|
| 1189 |
Shintaro Ichikawa, Marie-Luise Kromrey, Utaroh Motosugi, Hiroshi Onishi. Optimal target b-value on computed diffusion-weighted magnetic resonance imaging for visualization of pancreatic ductal adenocarcinoma and focal autoimmune pancreatitis. Abdominal Radiology 2021; 46(2): 636 doi: 10.1007/s00261-020-02695-0
|
| 1190 |
Matic Broz, Anja Kolarič, Marko Jukič, Urban Bren. Neuropilin (NRPs) Related Pathological Conditions and Their Modulators. International Journal of Molecular Sciences 2022; 23(15): 8402 doi: 10.3390/ijms23158402
|
| 1191 |
Naureen Ali, Nimisha Srivastava. Recent Advancements for the Management of Pancreatic Cancer: Current Insights. Current Cancer Therapy Reviews 2021; 17(4): 267 doi: 10.2174/1573394717666210625153256
|
| 1192 |
Guo Chen, Haiyang Song, Zelong Yang, Tianshu Du, Yu Zheng, Zifan Lu, Kunpeng Zhang, Di Wei. AQP5 Is a Novel Prognostic Biomarker in Pancreatic Adenocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.890193
|
| 1193 |
Zidong Zhang, Kaushik Gokul, Leslie J. Hinyard, Divya S. Subramaniam. The Paradox of Palliative Care at the End of Life: Higher Rates of Aggressive Interventions in Patients with Pancreatic Cancer. Journal of Clinical Medicine 2024; 13(17): 5286 doi: 10.3390/jcm13175286
|
| 1194 |
Damiano Caputo. Hot topics in pancreatic cancer management. World Journal of Gastrointestinal Surgery 2023; 15(2): 121-126 doi: 10.4240/wjgs.v15.i2.121
|
| 1195 |
Jufeng Sun, Joey I. Ambrus, Jennifer R. Baker, Cecilia C. Russell, Peter J. Cossar, Jennette A. Sakoff, Christopher J. Scarlett, Adam McCluskey. 3,5-Bis(trifluoromethyl)phenylsulfonamides, a novel pancreatic cancer active lead. Investigation of the terminal aromatic moiety. Bioorganic & Medicinal Chemistry Letters 2022; 61: 128591 doi: 10.1016/j.bmcl.2022.128591
|
| 1196 |
Marco Cintoni, Futura Grassi, Marta Palombaro, Emanuele Rinninella, Gabriele Pulcini, Agnese Di Donato, Lisa Salvatore, Giuseppe Quero, Giampaolo Tortora, Sergio Alfieri, Antonio Gasbarrini, Maria Cristina Mele. Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies. Nutrients 2023; 15(3): 727 doi: 10.3390/nu15030727
|
| 1197 |
Ramez Kouzy, Joseph Abi Jaoude, Bruce D Minsky, Prajnan Das, Albert C Koong, Ishwaria M Subbiah, Ethan B Ludmir, Cullen M Taniguchi. Gastrointestinal malignancies and supportive care trials: a snapshot of the last two decades. BMJ Supportive & Palliative Care 2022; 12(1): 42 doi: 10.1136/bmjspcare-2020-002538
|
| 1198 |
Puneeth Guruprasad, Yong Gu Lee, Ki Hyun Kim, Marco Ruella. The current landscape of single-cell transcriptomics for cancer immunotherapy. Journal of Experimental Medicine 2021; 218(1) doi: 10.1084/jem.20201574
|
| 1199 |
Zhiping Fu, Xing Liang, Ligang Shi, Liang Tang, Danlei Chen, Anan Liu, Chenghao Shao. SYT8 promotes pancreatic cancer progression via the TNNI2/ERRα/SIRT1 signaling pathway. Cell Death Discovery 2021; 7(1) doi: 10.1038/s41420-021-00779-4
|
| 1200 |
David O. Nauheim, Hannah Hackbart, Emily Papai, David Moskal, Charles J. Yeo, Harish Lavu, Avinoam Nevler. Preoperative sarcopenia is a negative predictor for enhanced postoperative recovery after pancreaticoduodenectomy. Langenbeck's Archives of Surgery 2022; 407(6): 2355 doi: 10.1007/s00423-022-02558-w
|
| 1201 |
Wenjing Song, Zhicheng Liu, Kunlei Wang, Kai Tan, Anbang Zhao, Xinyin Li, Yufeng Yuan, Zhiyong Yang. Pyroptosis-related genes regulate proliferation and invasion of pancreatic cancer and serve as the prognostic signature for modeling patient survival. Discover Oncology 2022; 13(1) doi: 10.1007/s12672-022-00495-0
|
| 1202 |
Rui Chen, Zhengli Zhou, Qihua Dang, Changjing Zuo, Tao Wang. High expression of Testin predicted worse prognosis in pancreatic adenocarcinoma associated with immune infiltration. Molecular & Cellular Toxicology 2024; doi: 10.1007/s13273-024-00448-4
|
| 1203 |
Bo Zhu, Xiaomei Wu, Tianyu Guo, Ning Guan, Yefu Liu. Epidemiological Characteristics of Pancreatic Cancer in China From 1990 to 2019. Cancer Control 2021; 28 doi: 10.1177/10732748211051536
|
| 1204 |
S. Lu, J. Liang, S. Liao, D. Wu, F. Wu, H. Li. Use of MRI signal intensity ratio to differentiate between autoimmune pancreatitis and pancreatic ductal adenocarcinoma. Clinical Radiology 2022; 77(1): e84 doi: 10.1016/j.crad.2021.10.003
|
| 1205 |
Jing Li, Yunmei Li, Chong Chen, Jiayu Guo, Mengmeng Qiao, Jun Lyu. Recent estimates and predictions of 5-year survival rate in patients with pancreatic cancer: A model-based period analysis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.1049136
|
| 1206 |
Juan Tan, Shan Liao, Bowen Yuan, Xinrong Liu, Wentao Yu, Han Zhan, Yan Jiang, Yang Liu. Targeting SMYD2 promotes ferroptosis and impacts the progression of pancreatic cancer through the c-Myc/NCOA4 axis-mediated ferritinophagy. Biochimica et Biophysica Acta (BBA) - General Subjects 2024; 1868(10): 130683 doi: 10.1016/j.bbagen.2024.130683
|
| 1207 |
Zhu Zhang, Ken Kin-Lam Yung, Joshua Ka-Shun Ko. Therapeutic Intervention in Cancer by Isoliquiritigenin from Licorice: A Natural Antioxidant and Redox Regulator. Antioxidants 2022; 11(7): 1349 doi: 10.3390/antiox11071349
|
| 1208 |
Tianyu Lin, Xiaofan Pu, Senhao Zhou, Zhengze Huang, Qi Chen, Yiyin Zhang, Qijiang Mao, Yuelong Liang, Guoping Ding. Identification of exosomal miR-484 role in reprogramming mitochondrial metabolism in pancreatic cancer through Wnt/MAPK axis control. Pharmacological Research 2023; 197: 106980 doi: 10.1016/j.phrs.2023.106980
|
| 1209 |
Chang Liu, Henan Qin, Huiying Liu, Tianfu Wei, Zeming Wu, Mengxue Shang, Haihua Liu, Aman Wang, Jiwei Liu, Dong Shang, Peiyuan Yin. Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.991051
|
| 1210 |
Alexander R. Loftis, Michael S. Santos, Nicholas L. Truex, Marco Biancucci, Karla J. F. Satchell, Bradley L. Pentelute. Anthrax Protective Antigen Retargeted with Single‐Chain Variable Fragments Delivers Enzymes to Pancreatic Cancer Cells. ChemBioChem 2020; 21(19): 2772 doi: 10.1002/cbic.202000201
|
| 1211 |
Faith Moraa, Amsalu Degu. Survival Outcomes Among Pancreatic Cancer Patients at Kenyatta National Hospital. Journal of Gastrointestinal Cancer 2022; 53(4): 958 doi: 10.1007/s12029-021-00723-w
|
| 1212 |
Yan Chen, Xiaozhen Zhang, Hanshen Yang, Tingbo Liang, Xueli Bai. The “Self-eating” of cancer-associated fibroblast: A potential target for cancer. Biomedicine & Pharmacotherapy 2023; 163: 114762 doi: 10.1016/j.biopha.2023.114762
|
| 1213 |
Stanley Borowicz, Daniel R. Principe, Matthew J. Dorman, Austin J. McHenry, Gautam Sondarva, Sandeep Kumar, Vijayalakshmi Ananthanarayanan, Patricia E. Simms, Ashley Hess, Ajay Rana, Rajeev Samant. HAI-1 is an independent predictor of lung cancer mortality and is required for M1 macrophage polarization. PLOS ONE 2021; 16(6): e0252197 doi: 10.1371/journal.pone.0252197
|
| 1214 |
Jonathan M. Wyse, Anand V. Sahai. EUS-guided celiac plexus neurolysis for pancreas cancer – Finally established or still under review?. Best Practice & Research Clinical Gastroenterology 2022; : 101809 doi: 10.1016/j.bpg.2022.101809
|
| 1215 |
Bowen Xu, Wenchao Dan, Xiaoxiao Zhang, Heping Wang, Luchang Cao, Shixin Li, Jie Li, Yue Gu. [Retracted] Gene Differential Expression and Interaction Networks Illustrate the Biomarkers and Molecular Biological Mechanisms of Unsaponifiable Matter in Kanglaite Injection for Pancreatic Ductal Adenocarcinoma. BioMed Research International 2022; 2022(1) doi: 10.1155/2022/6229462
|
| 1216 |
Ling Zhang, Ya-Nan Li, Yue-Fen Shu, Fan Zhang, He Cheng, Wen-Jie Tang. Influence of continuing nursing care team mode on the rehabilitation of patients with pancreatic cancer after postoperative daily chemotherapy. Supportive Care in Cancer 2022; 30(11): 9003 doi: 10.1007/s00520-022-07308-8
|
| 1217 |
Jorge Yassen Díaz-Blancas, Ismael Dominguez-Rosado, Carlos Chan-Nuñez, Jorge Melendez-Zajgla, Vilma Maldonado. Pancreatic Cancer Cells Induce MicroRNA Deregulation in Platelets. International Journal of Molecular Sciences 2022; 23(19): 11438 doi: 10.3390/ijms231911438
|
| 1218 |
Sabrina Di Masi, Marco Costa, Francesco Canfarotta, Antonio Guerreiro, Alicia Hartley, Sergey A. Piletsky, Cosimino Malitesta. An impedimetric sensor based on molecularly imprinted nanoparticles for the determination of trypsin in artificial matrices – towards point-of-care diagnostics. Analytical Methods 2024; 16(5): 742 doi: 10.1039/D3AY01762A
|
| 1219 |
Morgan Connaughton, Mahsa Dabagh. Modeling Physical Forces Experienced by Cancer and Stromal Cells Within Different Organ-Specific Tumor Tissue. IEEE Journal of Translational Engineering in Health and Medicine 2024; 12: 413 doi: 10.1109/JTEHM.2024.3388561
|
| 1220 |
Li-Juan Gao, Jia-Lei Li, Rui-Rui Yang, Zhong-Mei He, Min Yan, Xia Cao, Ji-Min Cao. Biological Characterization and Clinical Value of OAS Gene Family in Pancreatic Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.884334
|
| 1221 |
Nikhil Gupta, Raghav Yelamanchi. Pancreatic adenocarcinoma: A review of recent paradigms and advances in epidemiology, clinical diagnosis and management. World Journal of Gastroenterology 2021; 27(23): 3158-3181 doi: 10.3748/wjg.v27.i23.3158
|
| 1222 |
Jennifer L. McGarry, Ben Creavin, Michael E. Kelly, Tom K. Gallagher. Risk of pancreatic ductal adenocarcinoma associated with carriage of BRCA1 and/or BRCA2 mutation: A systematic review and meta‐analysis. Journal of Surgical Oncology 2022; 126(6): 1028 doi: 10.1002/jso.26994
|
| 1223 |
Tomas Sychra, Alzbeta Spalenkova, Stepan Balatka, Radka Vaclavikova, Karolina Seborova, Marie Ehrlichova, Jaroslav Truksa, Cristian Sandoval-Acuña, Vlasta Nemcova, Arpad Szabo, Kamila Koci, Tereza Tesarova, Lei Chen, Iwao Ojima, Martin Oliverius, Pavel Soucek. Third-generation taxanes SB-T-121605 and SB-T-121606 are effective in pancreatic ductal adenocarcinoma. iScience 2024; 27(2): 109044 doi: 10.1016/j.isci.2024.109044
|
| 1224 |
Alexander Chowdhury, Hasan Kassem, Nicolas Padoy, Renato Umeton, Alexandros Karargyris. Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries. Lecture Notes in Computer Science 2022; 12962: 3 doi: 10.1007/978-3-031-08999-2_1
|
| 1225 |
Claudio Cabral-Romero, Rene Hernández-Delgadillo, Sergio Eduardo Nakagoshi-Cepeda, Rosa Isela Sánchez-Najéra, Erandi Escamilla-García, Juan Manuel Solís-Soto, Claudia María García-Cuellar, Yesennia Sánchez-Pérez, Samantha Maribel Flores-Treviño, Nayely Pineda-Aguilar, Juan Valerio Cauich-Rodríguez, Irene Meester, Shankararaman Chellam. Antimicrobial and antitumor activities of an alginate-based membrane loaded with bismuth nanoparticles and cetylpyridinium chloride. Journal of Applied Biomaterials & Functional Materials 2024; 22 doi: 10.1177/22808000241236590
|
| 1226 |
Yuechuan Liu, Mingwei Gao, Yilin Song, Liming Wang. Establishment of a nomogram model for predicting distant metastasis in pancreatic ductal adenocarcinoma: a comparative analysis of different lymph node staging systems based on the SEER database. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-69126-8
|
| 1227 |
Zi Wayne Sin, Vipul Bhardwaj, Amit Kumar Pandey, Manoj Garg. A brief overview of antitumoral actions of bruceine D. Exploration of Targeted Anti-tumor Therapy 2020; 1(4): 200 doi: 10.37349/etat.2020.00013
|
| 1228 |
Sandy Chan, Wahid Wassef. Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Diagnosis of Pancreatic Metastases Secondary to Ovarian Carcinoma. ACG Case Reports Journal 2021; 8(2): e00544 doi: 10.14309/crj.0000000000000544
|
| 1229 |
V. S. Tikhonova, G. G. Karmazanovsky, E. V. Kondratyev, I. S. Gruzdev, A. V. Glotov. Influence of the low-dose CE-MDCT scanning protocol parameters on the results of pancreatic ductal adenocarcinoma radiomic analysis. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2021; 26(1): 25 doi: 10.16931/1995-5464.2021125-33
|
| 1230 |
Gustavo A. Arias-Pinilla, Angus G. Dalgleish, Satvinder Mudan, Izhar Bagwan, Anthony J. Walker, Helmout Modjtahedi. Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-019-57287-w
|
| 1231 |
Asha Kandathil, Rathan M. Subramaniam. Imaging Diagnostics in Pancreatic Cancer. Clinical Gastroenterology 2021; : 89 doi: 10.1007/978-3-030-69940-6_5
|
| 1232 |
Suresh Kumar, Navin Noushad, M. P. Viswanathan, Arvind Raj. Surgical Outcomes and Survival in Pancreatic and Periampullary Cancers: A Single Centre Experience. Indian Journal of Surgical Oncology 2024; doi: 10.1007/s13193-024-02116-4
|
| 1233 |
Jakub Wnuk, Joanna Katarzyna Strzelczyk, Iwona Gisterek. Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma–A Review of the Literature. International Journal of Molecular Sciences 2023; 24(6): 5113 doi: 10.3390/ijms24065113
|
| 1234 |
Guojun Yan, Kai Zhang, Lijun Yan, Yanbin Zhang. Efficacy and safety of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pancreatic cancer peritoneal metastasis. World Journal of Surgical Oncology 2024; 22(1) doi: 10.1186/s12957-024-03464-9
|
| 1235 |
Doaa Bugazia, Ebtesam Al-Najjar, Abdullah Esmail, Saifudeen Abdelrahim, Karen Abboud, Adham Abdelrahim, Godsfavour Umoru, Hashem A. Rayyan, Ala Abudayyeh, Ala-Eddin Al Moustafa, Maen Abdelrahim. Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1386699
|
| 1236 |
Ricardo V. Lloyd. Pathology: Historical and Contemporary Aspects. 2023; : 85 doi: 10.1007/978-3-031-39554-3_10
|
| 1237 |
Shan Lei, Zhirui Zeng, Zhiwei He, Wenpeng Cao. miRNA‑7515 suppresses pancreatic cancer cell proliferation, migration and invasion via downregulating IGF‑1 expression. Oncology Reports 2021; 46(3) doi: 10.3892/or.2021.8151
|
| 1238 |
Shijia Wu, Yong Ai, Huimin Huang, Guangyu Wu, Shipeng Zhou, Weilong Hong, Percy David Papa Akuetteh, Guihua Jin, Xingling Zhao, Yihua Zhang, Xiaolong Zhang, Linhua Lan. A synthesized olean-28,13β-lactam targets YTHDF1-GLS1 axis to induce ROS-dependent metabolic crisis and cell death in pancreatic adenocarcinoma. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02562-6
|
| 1239 |
Pravinkumar Kanaram Gehlot, Kayomarz Sohrab Sethna. Solid pseudopapillary epithelial neoplasm of the pancreas with liver metastasis. BMJ Case Reports 2025; 18(1): e261955 doi: 10.1136/bcr-2024-261955
|
| 1240 |
Samer S. AlMasri, Mazen S. Zenati, Annissa Desilva, Ibrahim Nassour, Brian A. Boone, Aatur D. Singhi, David L. Bartlett, Lance A. Liotta, Virginia Espina, Patricia Loughran, Michael T. Lotze, Alessandro Paniccia, Herbert J. Zeh, Amer H. Zureikat, Nathan Bahary. Encouraging long‐term survival following autophagy inhibition using neoadjuvant hydroxychloroquine and gemcitabine for high‐risk patients with resectable pancreatic carcinoma. Cancer Medicine 2021; 10(20): 7233 doi: 10.1002/cam4.4211
|
| 1241 |
Hiroshi Nobuhara, Yasuhiro Matsugu, Junko Tanaka, Tomoyuki Akita, Keiko Ito. The preventive effects of perioperative oral care on surgical site infections after pancreatic cancer surgery: a retrospective study. Supportive Care in Cancer 2022; 30(4): 3337 doi: 10.1007/s00520-021-06791-9
|
| 1242 |
Abdul Qahar Khan Yasinzai, Bisma Tareen, Katharine Tracy, Nimra Jamil, Marjan Khan, Hafeez Ullah, Muhammad Raza, Amin Ullah Khan, Dauod Arif, Abdul Waheed, Feroze Sidhwa, Subhasis Misra, Nabin Raj Karki, Nagla Abdel Karim, Ludimila Cavalcante, Asad Ullah. Pancreatic ductal adenocarcinoma: exploring clinicopathological trends and racial disparities in a comprehensive U.S. population-based study. Clinical and Translational Oncology 2024; 26(10): 2618 doi: 10.1007/s12094-024-03484-7
|
| 1243 |
Jie Zhang, Zhang Zhang. Mechanisms of circular RNA circ_0066147 on pancreatic cancer progression. Open Life Sciences 2021; 16(1): 495 doi: 10.1515/biol-2021-0047
|
| 1244 |
Raja Kalayarasan, Sankar Narayanan, Jayaprakash Sahoo, Pazhanivel Mohan. Impact of surgery for chronic pancreatitis on the risk of pancreatic cancer: Untying the Gordian knot. World Journal of Gastroenterology 2021; 27(27): 4371-4382 doi: 10.3748/wjg.v27.i27.4371
|
| 1245 |
Neel I. Nissen, Astrid Z. Johansen, Inna M. Chen, Christina Jensen, Emilie A. Madsen, Carsten P. Hansen, Jeppe Thorlacius-Ussing, Morten Karsdal, Julia S. Johansen, Hadi M. H. Diab, Lars N. Jørgensen, Nicholas Willumsen. High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients with pancreatic ductal adenocarcinoma. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1158058
|
| 1246 |
Hao Liu, Jianhua Zhang, Chaoguang Wei, Zhao Liu, Wei Zhou, Pan Yang, Yifu Gong, Yuxiang Zhao. Prognostic signature construction of energy metabolism-related genes in pancreatic cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.917897
|
| 1247 |
Tomonari Shimagaki, Keishi Sugimachi, Yohei Mano, Takahiro Tomino, Emi Onishi, Yuichiro Nakashima, Masahiko Sugiyama, Manabu Yamamoto, Masaru Morita, Mototsugu Shimokawa, Tomoharu Yoshizumi, Yasushi Toh, Robert Jeenchen Chen. A new scoring system with simple preoperative parameters as predictors of early recurrence of pancreatic ductal adenocarcinoma. PLOS ONE 2023; 18(7): e0288033 doi: 10.1371/journal.pone.0288033
|
| 1248 |
Lidong Cao, Jiacheng Wu, Xianzhi Qu, Jiyao Sheng, Mengying Cui, Shui Liu, Xu Huang, Yien Xiang, Bingjin Li, Xuewen Zhang, Ranji Cui. Glycometabolic rearrangements--aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01765-x
|
| 1249 |
Meiqi Liu, Moran Wang, Sheng Li. Prognostic Factors of Survival in Pancreatic Cancer Metastasis to Liver at Different Ages of Diagnosis: A SEER Population-Based Cohort Study. Frontiers in Big Data 2021; 4 doi: 10.3389/fdata.2021.654972
|
| 1250 |
Petr Vanek, Michal Eid, Robert Psar, Vincent Zoundjiekpon, Ondrej Urban, Lumir Kunovsky. Current trends in the diagnosis of pancreatic cancer. Vnitřní lékařství 2022; 68(6): 363 doi: 10.36290/vnl.2022.076
|
| 1251 |
Defeng Lei, Yicui Piao, Tongning Zhong, Citing Zhang, Weipeng Ai, Yixing Kang, Haijun Ye, Biao Zheng, Jianhua Qu, Zilong Yan, Zhengquan Lai, Jikui Liu, Miranda Li Xu. Quercetin Attenuates Cancer‐Associated Fibroblast Activation via Tumor‐Stromal Interactions and Demonstrates Its Clinical Value in Pancreatic Cancer. Journal of Food Biochemistry 2024; 2024(1) doi: 10.1155/2024/2177516
|
| 1252 |
Nabeel Merali, Tarak Chouari, Julien Terroire, Maria-Danae Jessel, Daniel S. K. Liu, James-Halle Smith, Tyler Wooldridge, Tony Dhillon, José I. Jiménez, Jonathan Krell, Keith J. Roberts, Timothy A. Rockall, Eirini Velliou, Shivan Sivakumar, Elisa Giovannetti, Ayse Demirkan, Nicola E. Annels, Adam E. Frampton. Bile Microbiome Signatures Associated with Pancreatic Ductal Adenocarcinoma Compared to Benign Disease: A UK Pilot Study. International Journal of Molecular Sciences 2023; 24(23): 16888 doi: 10.3390/ijms242316888
|
| 1253 |
Wen-liang Huang, Shu-fen Wu, Xiao Huang, Shan Zhou, Luca Falzone. Integrated Analysis of ECT2 and COL17A1 as Potential Biomarkers for Pancreatic Cancer. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/9453549
|
| 1254 |
Parisa Naeli, Mohammad Hossein Pourhanifeh, Mohammad Reza Karimzadeh, Zahra Shabaninejad, Ahmad Movahedpour, Hossein Tarrahimofrad, Hamid Reza Mirzaei, Hassan Hassani Bafrani, Amir Savardashtaki, Hamed Mirzaei, Michael R. Hamblin. Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role. Critical Reviews in Oncology/Hematology 2020; 145: 102854 doi: 10.1016/j.critrevonc.2019.102854
|
| 1255 |
Olga Michel, Wojciech Szlasa, Dagmara Baczyńska, Jolanta Saczko, Mounir Tarek, Julita Kulbacka. The role of catechin in electroporation of pancreatic cancer cells – Effects on pore formation and multidrug resistance proteins. Bioelectrochemistry 2022; 147: 108199 doi: 10.1016/j.bioelechem.2022.108199
|
| 1256 |
Yiting Wu, Pinqi Fang, Xiangning Wang, Jie Shen. Predicting pancreatic diseases from fundus images using deep learning. The Visual Computer 2025; 41(5): 3553 doi: 10.1007/s00371-024-03619-5
|
| 1257 |
Yasuko Murakawa, Kazunori Ootsuka, Makoto Abue. The Appropriate First-Line Chemotherapy Regimen for Incurable Pancreatic Cancer in Clinical Practice: A Consideration of Patients' Overall Survival and Quality of Life. Journal of Pancreatic Cancer 2021; 7(1): 48 doi: 10.1089/pancan.2021.0005
|
| 1258 |
Macarena Teja, Abrahams Ocanto, Felipe Couñago. Circulating tumor cells in pancreatic cancer: The prognostic impact in surgical patients. World Journal of Clinical Oncology 2024; 15(8): 987-991 doi: 10.5306/wjco.v15.i8.987
|
| 1259 |
Jaime Feliu, Mónica Jorge Fernández, Teresa Macarulla, Bartomeu Massuti, Ana Albero, José Federico González González, Guillermo Quintero-Aldana, Juan Ignacio Delgado-Mingorance, Ana Fernández Montes, Carmen García Piernavieja, Manuel Valladares-Ayerbes, Ana María López Muñoz, Rebeca Mondéjar Solís, Pilar Vicente, Esther Casado Gonzalez, Irene González Cebrián, Guillermo López-Vivanco. Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study. Cancer Chemotherapy and Pharmacology 2021; 87(4): 543 doi: 10.1007/s00280-020-04214-w
|
| 1260 |
Hao Xie, Qiang Xu, Bin Zhao, Wenming Wu. Drug-associated pancreatic cancer: insights from real-world pharmacovigilance and network pharmacology. Expert Opinion on Drug Safety 2025; : 1 doi: 10.1080/14740338.2025.2469273
|
| 1261 |
Yan Luo, Jisheng Hu, Yong Liu, Le Li, Yilong Li, Bei Sun, Rui Kong. Invadopodia: A potential target for pancreatic cancer therapy. Critical Reviews in Oncology/Hematology 2021; 159: 103236 doi: 10.1016/j.critrevonc.2021.103236
|
| 1262 |
Jialin Guo, Mingrui Gu, Yahui Chen, Tao Xiong, Yiyang Zhang, Simin Chen, Mingle Li, Xiaoqiang Chen, Xiaojun Peng. Nucleic acid delivery by lipid nanoparticles for organ targeting. Chinese Chemical Letters 2025; : 110849 doi: 10.1016/j.cclet.2025.110849
|
| 1263 |
Sumeet Sharma, Prerna Sharma, Nidhi Rani. Beyond Insulin: A Deeper Dive into Pancreatic Disease. Current Nutrition & Food Science 2025; 21(3): 265 doi: 10.2174/0115734013307659240820060042
|
| 1264 |
Ugo Marchese, Vanessa Pauly, Anna Pellat, Yasmina Richa, Guillaume Fond, Stylianos Tzedakis, Martin Gaillard, Basile Fuchs, Veronica Orleans, David Fuks, Mehdi El Amrani, Laurent Boyer. End-of-life care for patients with pancreatic cancer in France: a nationwide population-based cohort study. Therapeutic Advances in Medical Oncology 2025; 17 doi: 10.1177/17588359251320731
|
| 1265 |
Srujan Rajesh, Michael J Cox, Franscois Runau. Molecular advances in pancreatic cancer: A genomic, proteomic and metabolomic approach . World Journal of Gastroenterology 2021; 27(31): 5171-5180 doi: 10.3748/wjg.v27.i31.5171
|
| 1266 |
Jérémy Pecourneau, Raúl Losantos, Axel Gansmuller, Stéphane Parant, Yann Bernhard, Maxime Mourer, Antonio Monari, Andreea Pasc. Tuning the competition between photoisomerization and photothermy in biomimetic cyclocurcumin analogues. Journal of Photochemistry and Photobiology A: Chemistry 2023; 439: 114583 doi: 10.1016/j.jphotochem.2023.114583
|
| 1267 |
Douglas Dias e Silva, Vincent Chung. Neoadjuvant treatment for pancreatic cancer: Controversies and advances. Cancer Treatment and Research Communications 2024; 39: 100804 doi: 10.1016/j.ctarc.2024.100804
|
| 1268 |
Laura E. Kane, Gregory S. Mellotte, Kevin C. Conlon, Barbara M. Ryan, Stephen G. Maher. Multi-Omic Biomarkers as Potential Tools for the Characterisation of Pancreatic Cystic Lesions and Cancer: Innovative Patient Data Integration. Cancers 2021; 13(4): 769 doi: 10.3390/cancers13040769
|